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Summary 
 
Tetrazoles are a class of heterocycles with a wide range of applications in medicinal 
chemistry and in material sciences 
1
.
 
However a versatile method to synthesize tetrazoles 
through safe protocols is still highly desirable. Indeed each of the general known 
procedures uses either toxic metals, expensive reagents, harsh reaction conditions and 
may lead to the formation of dangerous hydrazoic acid or explosive sublimates. We 
report herein the discovery and development of a novel efficient process for transforming 
a wide variety of nitriles into the corresponding tetrazoles in high yield, using a simple 
and safe protocol. It has been found that the organoaluminum azides are effective 
reagents for the direct conversion of nitriles to tetrazoles (Scheme 1) 
141,142
.
 
 
R2AlCl     +    NaN3 R2AlN3  +   NaCl
Toluene
0°C to r.t.
   4-6h
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Scheme 1. Novel synthesis of tetrazole rings 
 
The organic soluble dialkylaluminum azides are prepared in a short time (4-6 
h, r.t.) from the corresponding cheap dialkylaluminum chlorides. The 
cycloaddition occurs under mild conditions, and it is possible to synthesize a 
broad range of tetrazole derivatives with a high selectivity. This methodology 
can be applied to the synthesis of the pyrrolidine tetrazole, a versatile 
alternative of proline in organocatalysis. A variety of new catalysts based on 
pyrrolidine tetrazole skeleton are therefore efficiently  prepared and tested 
142
.  
 
 
 Resumé 
 
Les besoins récents en chimie organique de synthèse appliquée focalisent les 
efforts des chercheurs au développement de nouvelles voies efficaces et versatiles pour la 
préparation de molécules bioactives, en prenant en comptes en particulier les critères 
économiques et environnementaux. Nous avons développé une méthode novatrice et 
écologique pour la préparation de tetrazoles 
141,142
. Ce groupe fonctionnel trouve des 
applications dans des domaines variés allant des matériaux aux explosifs, et est d’un 
intérêt tout particulier en chimie médicinale
 1
.  
Cette importance a conduit au développement de diverses méthodes de préparation des 
tétrazoles, toutes présentant cependant des désavantages majeurs comme l’utilisation de 
réactifs toxiques ou explosifs, entre autres. La méthode alternative que nous avons 
développée permet la formation de tétrazoles à partir de nitriles en utilisant des azides de 
dialkylaluminium, qui  possèdent l’avantage d’être des réactifs bon marché et non 
toxiques et permettent la préparation d’une large variété de tétrazoles de façon très 
efficace, adaptable à l’échelle industrielle (Scheme 1).  
 
R2AlCl   +   NaN3 R2AlN3  +   NaCl
Toluene
0°C à 25°C
    4-6h
R' C N
  Toluene
-40 à 120°C
R2AlN3 NHN
N N
R'
 
Scheme 1. Nouvelle méthodologie de formation de tétrazole 
 
Nous avons ensuite appliqué cette méthodologie à l’organocatalyse
 142
, c'est-à-dire à la 
préparation et l’étude de molécules organiques ayant la faculté de catalyser des 
transformations chimiques très sélectives, procédé particulièrement attractif d’un point de 
vu environnemental et économique en constant développement. 
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Chapter 1. 
The 5-Substituted Tetrazoles 
  
  
  
Tetrazoles are a class of heterocycles with a wide range of applications which are 
currently receiving considerable attention1, therefore the literature on tetrazole is 
expanding rapidly. This functional group has a role in coordination chemistry as a 
ligand,2,3,4 as well as in various materials sciences applications including photography 
and specialty explosives 5. Extensive work has also been carried out in the field of 
medicinal chemistry, where tetrazoles are frequently used as metabolically stable 
surrogates for carboxylic acids 6,7,8. 
 
 Less appreciated, but of enormous potential, are the many useful transformations that 
make tetrazoles versatile intermediates en route to substituted tetrazoles and especially to 
other 5-ring heterocycles via Huisgen rearrangement 9,10. The prime reason for the 
scarcity of practical applications for these sophisticated tetrazole-based reactions is the 
lack of appealing synthetic routes to the key intermediates 5-substituted tetrazoles. 
Tetrazoles readily tolerate a wide range of chemical environments 1 and new uses for this 
unique family of heterocycles continue to emerge in both materials science, and 
pharmaceutical applications.  
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1.1. The 5-Substituted Tetrazole 
 
 
 
5-Substituted tetrazoles that contain a free N-H bond are frequently referred to as 
tetrazolic acids and exist in two tautomeric forms (Figure 1) 1, 11,12.   
 
R
O
OH
R
N
H
N
NN
R
N NH
NN
 
                                 1H                               2H  
Figure 1. Tetrazolic acids are bioisosteres of carboxylic acids 
 
The tautomerism is a rapid process in solution and individual tautomers can not be 
detected even at low temperature. The corresponding dipole moments are 5.63 D for the 
1H-tautomer and 2.19 D for the 2H-form 1. In the gas phase, the 2H-tautomer tends to be 
the dominant form, while in solution the 1H-tautomer is favored because of solvation 
effects.  
Tetrazoles can be regarded as nitrogen analogues of carboxylic acids. The free N-H bond 
of tetrazoles makes them acidic molecules and both the aliphatic and aromatic 
heterocycles have pKa values similar to the corresponding carboxylic acids (4.5-4.9 vs 
4.2-4.4, respectively) due to the ability of the moiety to stabilize a negative charge by 
electron delocalization 1.  
Tetrazole nitrogens have a considerable amount of local electron density, which 
consequently leads to a wide range of stable metallic and molecular complexes 13. 
Furthermore, the tetrazole ring possesses a strong electron-withdrawing inductive effect 
(-I) which surpasses the weak mesomeric effect (+ M), therefore, the ring is a 
deactivating group 1. 
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1.1.1. Chemical & Physical Properties 
 
 
1.1.1.1. Aromaticity 
 
The tetrazole ring is a 6π-azapyrrole-type system 1,11. Reactivity of 5-substituted 
tetrazoles permits them to be classified as aromatic compounds 1,14. In tetrazoles, two of 
the six π-electrons required by the Hückel rule are provided by the lone pair of one 
nitrogen while the remaining four π-electrons are provided by the other four atoms of the 
ring.  
 
1.1.1.2. Tetrazolate anions: acidity  
 
5-Substituted tetrazoles display an acidity comparable with the corresponding 
carboxylic acids 1,15. One difference between the tetrazole ring and the carboxylic acid 
group is the annular tautomerism of the tetrazoles. Substituents at C-5 have effects 
similar to those for carboxylic acids, while in general, 5-aryltetrazoles are stronger acids. 
The increased acidity is ascribed to an enhanced resonance stabilization in the 5-
phenyltetrazole anion relative to benzoate 1b. The tetrazolate anions are easily generated 
with metal hydroxides and are stable in hot alcoholic and aqueous solutions (Figure 2) 16,1  
 
 
Cl
N N
NHN
Cl
N N
NNCsOH H2O
MeOH
r.t.
. Cs
 
                              1                                             2  
Figure 2. Example of a metal tetrazolate salt 
 
1.1.1.3. Solubility 
 
 5-Substituted tetrazoles are generally soluble in polar organic solvents such as ethyl 
acetate and DMSO, but under basic conditions they can be easily extracted into the water 
phase as a salt, like the carboxylic acid. Very polar tetrazole derivatives such as pyridine-
tetrazoles 103, 104 and 105 or pyrrolidine tetrazoles 113 are soluble in water therefore 
the extraction from water can be problematic. 
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1.1.2. Application of Tetrazole Derivatives 
 
 
Tetrazoles are an increasingly popular functionality with wide ranging application. 
They have found use in coordination chemistry 16,17  and in various materials sciences 
applications including photography 1,18, specialty explosives 5, information recording 
systems 19 and agricultural composition 20. In addition extensive work has been carried 
out in the field of medicinal chemistry 1,9.  
 
1.1.2.1. Application in medicinal chemistry 
 
1.1.2.1.1. cis-Amide bond mimic 
 
Marshall et al. 21 have proposed a new use for the tetrazole ring as a cis-amide bond 
mimic within a peptide chain and this structural motif can be used to pre-organise the 
amide bonds of peptides, enzyme substrates and inhibitors into a cis-conformation 21,22,23. 
Incorporation of tetrazole dipeptide analogues into biologically active peptides such as 
somatostatin and bradykinin has been demonstrated (Figure 3) 24. 
 
H
N
NH
O R' H
O
HN
O
R2
H
cis amide
H
N
N
O R' H
HN
O
R2
H
N
NN
tetrazole isostere
 
Figure 3. The tetrazole ring as a cis-amide bond mimic 
 
1.1.2.1.2. DNA, RNA synthesis 
 
5-Alkylthiotetrazoles, specifically 5-benzylthiotetrazole and 5-ethylthiotetrazole, 
are a powerful activators for DNA and RNA synthesis (Scheme 1) 25,26,27.  The presence 
of the thio group makes the tetrazole ring more acidic than the corresponding 5-
alkytetrazoles 28; this improves its ability to act as an activator. In addition, the solubility 
with biologically active compounds, where reactions are carried out in acetonitrile, is also 
enhanced. Comparison of 5-(benzylmercapto)-tetrazole to other activators revealed the 
following order in coupling yield of 2’-O-TBDMS phosphoramidites: 5-
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(benzylmercapto)-tetrazole > 5-(ethylmercapto)-tetrazole > 4,5-dicyanoimidazole > 1H-
tetrazole 25.  
 
H
N
N N
NS
O
OO
DMTrO R
Si
+
P
N
O
CN
O
OO
HO R
Si
O
OO
DMTrO R
SiPO
CN
O
O
OO
R
Si
CH3CN, 3 min, >99%
 
Scheme 1. RNA phosphoramidite coupling reaction with 5-(mercapto)-1H-tetrazole activation  
 
1.1.2.2. Pharmaceutical properties 
 
Tetrazole itself does not exhibit pharmacological activity ; however, many of its 
derivatives possess interesting biological activities and they are frequently used as 
metabolically stable surrogates for carboxylic acids, while tetrazoles generally offer a 
more favourable pharmacokinetic profile 1,29,30,31,32.  
Like their carboxylic acid analogues, tetrazoles exhibit a planar structure. However, 
Hansch has shown that anionic tetrazoles are almost 10 times more lipophilic than the 
corresponding carboxylate,33 which is an important factor in allowing the molecule to 
pass through cell membranes. Hydrogen bonding capability of tetrazolic anions with 
receptor recognition sites is a key interaction for enhanced binding affinity 34. In addition, 
in the design of drug molecules, one advantage of tetrazoles over carboxylic acids is that 
they are resistant to many biological metabolic degradation pathways 35. Tetrazole  
derivatives have been investigated in areas as diverse as anti-arrhythmic agents (3) 36, 
anti-diabetic agents 32f,37, anti-cholesterol agents 1b, antifungal agents 38, anti-allergic 
agents (5) 29,39,40, neurodegenerative diseases (6-9) 1,29,41 among others 8. Some examples 
are given in Figures 4-7. 
 
N N
NN
n
R2
R1
n= 0, 1, 2, 3, 4
R1= p-MeO-, p-Me-, p-F-
R2= p-Cl-, -O-Me-
 
                                                     3 
Figure 4. Anti-arrhythmic agents 36 
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Figure 5. Muscarinic agonist 42                            Figure 6. Anti-allergenics 
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Figure 7. Tetrazole derivatives with central nervous system activity 
 
 
1.1.2.2.1. Cardiovascular activity 
 
  The 5-(4’-methyl-1,1’-biphenyl-2-yl)-tetrazole subunit has been used as a 
carboxylic acid mimic in the class of so called sartan derivatives (Figure 8). Angiotensin 
II (AII) is the octapeptide responsible for the peripheral effects of the rennin-angiotensin 
system 43,44,45,46,47 which include the regulation of blood pressure and volume 
homeostasis. Lorsartan was the first nonpeptide angiotensin receptor antagonist to appear 
on the market 41,42,44,48 followed by Valsartan (Figure 8). The 5-(4’-methyl-1,1’-biphenyl-
2-yl)-1H-tetrazole subunit has become ubiquitous in the most potent and bioavailable 
antagonists disclosed to date 31.  
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N
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Valsartan
(Novartis)  
Figure 8. Sartans 
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1.1.3. Synthesis of Tetrazoles 
 
 
5-Substituted tetrazoles are usually obtained by the addition of azide ion to 
organic nitriles and many methods are reported in the literature 1,8,49,50,51. Unfortunately, 
each of those protocols suffers from some disadvantages: the use of both toxic metals and 
expensive reagents, drastic reaction conditions, water sensitivity and possible presence of 
dangerous hydrazoic acid or other explosive sublimates. 
 
The Huisgen 1,3-dipolar cycloaddition 
 
The Huisgen 1,3-dipolar cycloaddition is the reaction of alkynes to azides to form 
1,4-disubsituted-1,2,3-triazoles (Scheme 2)9. A notable variant of the Huisgen 
cycloaddition is the copper (I) catalyzed variant, in which organic azides and terminal 
alkynes are united to afford 1,4-regioisomers of 1,2,3-triazoles as sole products 52. 
Huisgen was the first to understand the scope of this organic reaction. This cycloaddition 
is considered the cream of the crop of “click chemistry”. The azide and alkyne functional 
groups are largely inert towards biological molecules and aqueous environments, which 
allows the use of the Huisgen 1,3-dipolar cycloaddition in target guided synthesis 53 and 
activity-based protein profiling 54. The resulting triazole has similarities to the ubiquitous 
amide moiety found in nature, but unlike amides, is not susceptible to cleavage.  
R N N
N
+ R'
Cu(I)
N
N
N
R'
R  
Scheme 2. Huisgen 1,3-dipolar cycloaddition of alkynes to azides 
 
1.1.3.1. Synthesis of tetrazoles from nitriles with azides 
 
Tetrazoles are generally prepared by the reaction of a hydrazoic acid source with a 
nitrile, in an inert solvent at high temperatures. They fall into three main categories: those 
that make use of tin or silicon azides, those that use strong Lewis acids 55,56 and those that 
are run in acidic media 57. The few methods that seek to avoid hydrazoic acid liberation 
during the reaction by avoiding acidic conditions, require a very large excess of sodium 
azide 58. In addition, all of the known methods use organic solvents, in particular, dipolar 
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aprotic solvents such as DMF. This is one of the solvent classes that process chemists 
would rather not use. 
The mechanism of the reaction of azide salts to nitriles is different for different azide 
species 59,60,61 and several possible reaction pathways can be envisioned 62,63,64. 
 
Neutral cycloaddition 
 
A [2+3] cycloaddition is the most likely pathway for the bimolecular addition of 
non-ionic azides to nitriles 61. In concerted cycloadditions, two different isomers of 
tetrazole, the 1,5- and the 2,5-disubstituted, can be  formed. Generally the TS1 is the 
preferred transition state using electron-withdrawing substituents R (Scheme 3). 
 
=
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N
N
N
N
R'
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N
N
N
N
R
R'
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N
N
N
R
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1,5-tetrazole
2,5-tetrazole
=
 
Scheme 3. Neutral cycloaddition 
 
Anionic mechanism 
 
In reactions where NaN3 is added to nitriles in aprotic organic solvents, such as 
dimethylformammide (DMF), it has been found that yields are generally lower and 
higher temperature are required 57,62. In theses cases, there are two possible 
mechanisms,61 either a direct [2+3] cycloaddition or a two step-mechanism sequence 
wherein the azide first nucleophilically attacks the nitrile, followed by ring closure. In 
this context, Sharpless et al. have calculated the barriers of cycloaddition of the azide 
anion to nitrile 61. As in the case of the neutral [2+3] cycloadditions, the barrier for 
anionic [2+3] cycloaddition decreases with increasing electron-withdrawing potential of 
the substituent on the nitrile. The geometry of the transition state of anionic reactions is 
more asymmetric than for neutral reactions. The Cnitrile-Nazide distance is significantly 
shorter than the Nnitrile-Nazide distance. The difference grows with the electron-
withdrawing potential of the substituent and for very strong electron-withdrawing groups 
like RSO2, an intermediate such as that shown in Figure 9 could be found. Despite the 
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existence of this intermediate for the strongly activated nitriles, the ∆G≠ of the transition 
state for the ring closing turns out to be identical to the ∆G≠  for concerted [2+3] 
transition state. The two pathways have therefore essentially the same rate 61.      
 
R N
N+
N-
N-
 
Figure 9. 
 
Proton involvement 
 
Koldobskii et al.65 showed that protic ammonium salts of azide are competent 
dipoles; tetrabutylammonium azide does not work. When a proton is available, the nitrile 
is activated and the reaction is supposed to proceed via an intermediate instead of a direct 
[2+3] dipolar cycloaddition (Scheme 4) 61.  
R N
N
N
N
N
R
N
N
N
H
+
R'2NH
Intermediate P
HN
N
N
N
R
H
 
Scheme 4. 
 
1.1.3.1.1. Hydrazoic acid 
 
The acid –catalysed cycloaddition between hydrazoic acid and nitriles has long 
been one of the main routes to 5-substituted tetrazoles 8,66. The first method to appear in 
the literature was the reaction of hydrazoic acid (HN3) with organic cyanides in 1932 67. 
This process is generally thought to occur by a concerted 1,3-dipolar cycloaddition 
mechanism, in which the nitrile acts as the dipolarophile toward the azide, which serves 
as the 1,3-dipolar species in the cycloaddition. Protonation of the tetrazolium anion upon 
workup provides the tetrazolic acid. In literature a two-step mechanism has also been 
reported 68. However this standard procedure needs the direct addition of a large excess 
of dangerous and harmful hydrazoic acid. Hydrazoic acid itself is poisonous, extremely 
explosive, and has a low boiling point (37 °C). Not many organic solvents are stable at 
the high temperatures that are necessary for this cycloaddition (sometimes as high as 130 
°C), and for this reason DMF is most commonly used for this purpose 1,29. 
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1.1.3.1.2.  Metal salt methods using sodium azide 
 
1.1.3.1.2.1. Ammonium and trialkyl ammonium azides 
 
The reaction of nitriles with the ammonium and trialkyl ammonium azides in 
organic solvents such as dimethylformamide, has been found fifteen years ago by 
Lofquist and Finnegan 62 to be a general method to give good yields of 5-substituted 
tetrazoles. The reactive azide species is prepared in situ by reaction of sodium azide and 
the appropriate ammonium or trialkyl ammonium chloride (Scheme 5). The proposed 
mechanism involves a nucleophilic attack of azide ion on the carbon of the nitrile group, 
followed by ring closure of the imino azide to form the tetrazole ring 62. Electronegative 
substitution on the nitrile enhances the rate of the reaction. The solubility of the azide salt 
also influences the rate of reaction. The ammonium azides are soluble in 
dimethylformamide.  
NH4N3
NN
HN
N
DMF
N
100-125°C, 7h
75 %  
                                                  10                                               11  
Scheme 5. Synthesis of 5-phenyltetrazole with ammonium azide 
 
This methodology is not appropriate for the preparation of 5-thiosubstituted tetrazoles 
because they easily undergo irreversible decomposition to hydrazoic acid and thiocyanate 
at or near their melting points, which are, in several cases, quite close to the reflux 
temperature of DMF 69; therefore using high temperature is not advisable in these cases. 
In addition this protocol for the synthesis of tetrazole rings is accompanied by the 
sublimation of explosive NH4N3 70. The sublimation of explosive NH4N3 also occurs 
when other aprotic solvents instead of the DMF are used for the reaction. 
Bernstein and Vacek showed that a combination of sodium azide and 
triethylammonium chloride is an useful alternative to synthesize tetrazoles when N-
methylpyrrolidinone is used as a solvent instead of the DMF (shorter reaction times) 
(Scheme 6) 71. DMF under heating and basic conditions partially decomposes and forms 
free nucleophilic amines which may react with starting nitriles which contain certain 
functional grups 71. An alternative to eliminate the amine sources was found to be the use 
of 1-methyl-2-pyrrolidinone as solvent.  
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R N + NaN3
N O
CH3
Et3N HCl / 150°C, 3-4h
46-76%
N
N
N
H
N
R
.
 
Scheme 6. Preparation of 5-substituted tetrazoles 
 
Koguro et al., reported a variant by using triethyl amine hydrochloride in toluene 72. 
In this procedure, the authors proposed that the intermediate complex [Et3N·HN3] is first 
ionized as Et3NH+ and N3-, then, each of these react with the triple bond of the nitrile 
group to produce 14 (Scheme 7). When an aromatic solvent such as toluene is used, both 
the cation and the anion are not solvated, and the reaction thus proceeds smoothly.  
R C N +  Et3NH 
   N3
N
N
H
N
N
R
RC NH
N3
NEt3
NEt3
HCl N
N
H
N
N
R
toluene
80-115°C
  1-30h  
          12                                            13                                      14                              15 
Scheme 7. Synthesis of tetrazoles with triethylammonium azide 
 
LeBlanc and Jursic recently reported a simple alternative for the method using 
sodium azide and ammonium chloride in DMF, by working under phase transfer 
conditions (PTC) (Scheme 8) 73. Hexadecyltrimethylammoniumbromide was found to be 
the most useful catalyst. The ratio of water and toluene as well as the reaction 
temperature are important factors to obtain satisfactory yields. This methodology can be a 
good alternative to the simple use of sodium azide and amonium chloride 69 for the 
preparation of 5-alkylthio and 5-arylthiotetrazoles, which are activators for RNA and 
DNA synthesis. However this procedure requires long reaction times, which makes an 
application in an industrial scale up improbable. 
 
S
N
S N
N
NHN
1.2 eq NaN3
1.2 eq NH4Cl
20 mol %PTC
Tol/Water 1:2
   65°C, 86h
       48 %  
                                    16                                                        17                                                           
Scheme 8. Synthesis of tetrazoles using PTC conditions 
 
1.1.3.1.2.2. NaN3 in the presence of Lewis acid 
 
Finnegan and Lofquist reported in 1958 the study of the tetrazole formation in the 
presence of Lewis acids 62. The proposed mechanism involves a nucleophilic attack of the 
Chapter 1 - Introduction 
 12 
azide ion on the carbon of nitrile group, followed by ring closure of the imino azide to 
form the tetrazole ring. Conditions which enhance or favour a δ+ charge on the nitrile 
carbon, such as the cordination of a Lewis acid, increase the rate of the reaction (Scheme 
9). 
R N +   BF3: R N:BF3
: N3 R
N N
N
H
N
 
             Scheme 9. Tetrazole formation in the presence of Lewis acid 
                             
Nearly four decades later Shechter et al. reported the preparation of a few simple 5-
(hydroxy-phenyl)tetrazoles by the addition of aryl nitriles with sodium azide in the 
presence of boron trifluoride (Scheme 10) 74.  
HO CN
NaN3, BF3
DMF, reflux
     88%
HO
N
H
N
NN
 
                                           18                                                 19 
Scheme 10. Preparation of tetrazoles with NaN3 in the presence of BF3 as Lewis acid 
 
Recently the use of aluminum chloride as a Lewis acid catalyst for the generation of 
aliphatic tetrazoles with a relatively low yield has been reported 75. The crude was 
protected as a resin-bound trityl derivatives, which was subjected to alkylation followed 
by cleavage from the solid support to generate the desired tetrazole derivatives (Scheme 
11).  
Cl CN NaN3, AlCl3
THF, 0°C
 33-71%
n Cl n
N
H
N
NN
Ph
Ph
Cl
Et3N, DMF, r.t.
Cl n
N
N
NN
1. ArOH, KI, 60°C
    K2CO3, NMP
2. TFA, CH2Cl2, r.t.
        24-99%
ArO n
N
NH
NN
Cl n
N
N
NN
 
 
Scheme 11. Tetrazole ring formation with NaN3 in the presence of AlCl3 as Lewis acid 
 
1.1.3.1.3. Sharpless methodology: The Click Chemistry approach  
 
The Click Chemistry 
 
The term “Click Chemistry“ was introduced by K. Barry Sharpless et al. in 2001 
76,77.  “Click chemistry” is a modular approach that uses only practical and reliable 
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reactions with readily available reagents. In several instances water is the ideal reaction 
solvent, providing the best yields and highest rates. Reaction work-up and purification 
uses benign solvents and avoids chromatography.  
One of the “click approaches” is the copper-(I)-catalyzed 1,2,3-triazole formation from 
azides and terminal acetylenes as a particularly powerful linking reaction, due to its high 
degree of reliability and complete specificity of the reactants.  
 
Synthesis of tetrazole rings 
 
 Sharpless et al. have reported a simple protocol for transforming a wide variety of 
nitriles into the corresponding 1H-tetrazoles, by using NaN3 in the presence of Zn(II) 
salts in aqueous conditions (Scheme 12) 61,63,78,79. This procedure shows a good level of 
generality, however, in the case of sterically hindered aromatic or alkyl inactivated 
nitriles, high temperatures (140 - 170 °C) are required. They have not been able to 
achieve significant conversions of aromatic nitriles bearing an sp3-hybridized substituent 
in the ortho position  63. 
When the reaction is run at a concentration of 1 M in sodium azide and 1 M of ZnBr2 a 
small amount of hydrazoic acid in the headspace above the reaction mixture is liberated 
78.  Even at 100 °C, release of hydrazoic acid is minimal. The exact role of zinc is not yet 
clear 78. The mechanism of the reaction has been controversial, with evidence supporting 
both a two-step mechanism and a concerted [2+3] cycloaddition 61. 
 
R CN N
N
NH
NR
i-PrOH/H2O
1.1 eq NaN3
  1 eq ZnBr2
reflux  
Scheme 12. Tetrazole ring formation with the Sharpless methodology 
 
The chief competing reaction is hydrolysis of the nitrile to primary amide; therefore with 
electron-poor nitriles, lowering the amount of zinc avoids significant formation of the 
amide byproduct. Other zinc salts such perchlorate and triflate also work; Zinc bromide is 
the best compromise between cost, selectivity and reactivity.  
 
1.1.3.1.4. Tin- and silicon-mediated methods 
 
Some of the newer methods for the preparation of 5-substituted tetrazoles involve 
the reaction of alkyl- or arylnitriles with safer organic soluble azides such as trialkyltin 
azide or trimethylsilylazide  29,1,80. 
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1.1.3.1.4.1. Trialkyltin azides 
 
Methods for the tetrazole formation from organic-soluble reagents 
trimethylstannyl81  or tri-n-butylstannyl azides 48,82 are more commonly utilized in larger 
scale than the sodium azide / ammonium salt protocols.  
Duncia and Carini,44 of DuPont, looking for a good alternative method to synthesize 
sartans (Section 1.1.2.2.1.)83 and using the biphenylnitrile 20 as a model system, 
discovered that both trimethyl- and n-butyltin azides react forming the trialkltin-tetrazole 
adducts. However, removal and disposal of stoichiometric (highly toxic) residual 
organotin at the end of the reaction is a major drawback of this methodology 48. 
Trialkyltin azide is typically prepared in situ from trialkyl chloride (volatile and toxic) 
and sodium azide, and has been shown to be effective in the synthesis of 5-substituted 
tetrazoles. Better yields are generally obtained compared to silicon-based azide reagents.  
The treatment of the starting nitrile 20 with trimethyl- or tri-n-butyltin azide 48 in toluene 
or xylene at refluxing gives the corresponding tetrazole. The insoluble tin-tetrazole 
adduct 21 precipitates and when the reaction is finished, the product is simply filtered and 
dried. Subsequent acid hydrolysis yields the desired tetrazole (Scheme 13). 
 
Me
N
Me3SnN3, Tol, 24h, ∆
85 %
Me N
NN
N Me N
NHN
N
SnMe3
H+
89 %
20                                                                    21                                                22  
Scheme 13. Synthesis of sartans precursor using trimethyltin azide 
 
Higher temperature and/or longer reaction time are required using tri-n-butyltin reagent 
because of the more bulky character. An alternative to remove the tributyltin moiety, is to 
substitute the tin group with a trityl protecting group.  
 
1.1.3.1.4.2.  Trimethylsilyl azide  
 
Trimethylsilyl azide has been reported to react with nitriles to give 5-substituted 
tetrazoles 84. It is an attractive azide source due to its stability and relatively high boiling 
point (105 °C). However, benzonitrile reacts with only very low conversion and ortho-
substituted benzontriles fail to undergo the reaction. 
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TMSN3 under solvent free conditions 
 
Pizzo et al. recently reported the use of TMSN3 in solvent free conditions 85. 
Catalytic amount of tetrabutylammonium fluoride (TBAF) is used for the anionic 
activation of the silicon-nitrogen bond 86. The use of TBAF has the advantage to activate 
the azide nucleophile and deprotects the N-silylated products. This catalytic system is 
relatively efficient and a wide range of tetrazoles are obtained in 1 to 48 hours at 85 to 
120 °C (Scheme 14). 
 
CN
1.5 eq TMSN3
0.5 eq TBAF 3H2O
120°C, 24h
N N
NH
N
 
                                    23                                                                24 
Scheme 14. Synthesis of tetrazoles with TMSN3 in the presence of TBAF 
 
TMSN3 in the presence of dibutyltin oxide as catalyst 
 
The use of trimethlsilyl azide in the presence of a catalytic amount of dibutyltin 
oxide to convert nitriles into tetrazoles has been developed (Scheme 15) 43,87 ,88.  
Br
NH
NN
N
Br
CN
TMSN3, (CH3)2SnO
PhCH3, 93°C
        80%  
                                                25                                                        26 
Scheme 15. Synthesis of tetrazoles with TMSN3 in the presence of dibutyltin oxide as catalyst 
 
In the general procedure the nitrile is treated in toluene at high temperature for 24 to 72 
hours, with  2 equivalents of trimethylsilyl azide  and 0.1 equivalent of dibutyltin oxide to 
provide the desired tetrazole. However in some cases,  full conversion is obtained using 
in total 1 equiv of tin reagent ad 5 equiv of (TMS)N3 at 100 °C (Scheme 15).  
The catalytic cycle involves the formation in situ of the dialkyl(O-trimethylsilyl)-
azidostannylhydrin 28 which reacts with the nitrile to give the N-(dialkyl-
(trimethylsloxy)stannyl)tetrazole 29 (Scheme 16). The intermediate N-(dialkyl 
(trimethylsoloxy)stanyl)tetrazole 29 breaks down into the N-(trimethylsilyl)tetrazole 30 
and the dialkyltin oxide 27 that carries on the catalytic cycle (Scheme 16) 43.  
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N
N N
NR'
R
Sn
R
O
Me3SiN3
Me3SiO
Sn
N3
R R
N
N N
NR'
Sn
O
SiMe3
R
R
R' CN
63 64
6562
SiMe3
 
Scheme 16. 
 
The trimethylsilyl  azide as the azide source greatly reduces the hazard posed by in 
situ generation of hydrazoic acid and eliminates the possibility of the exposure to the 
toxic trialkyltin chloride used for the preparation of trialkyltin azide. However, at least 
two equivalents of trimethylsilyl azide are required for the reaction to run to completion 
and it is still difficult to separate the desired product from the stannane compounds. In 
addition the stannane compounds used in these reactions are generally highly toxic and 
require additional treatment of the waste water.  
 
TMSN3 in the presence of trimethyl aluminium 
 
A method using trimethylsilyl azide was recently described by Lilly chemists Huff 
and Staszak,55 who showed that an equimolar mixture of trimethylaluminum and 
trimethylsilyl azide in hot toluene is an efficient combination to prepare 5-substituted 
tetrazoles (Scheme 17). However, highly hindered nitriles resulted in poor conversion 
and the results are similar to those obtained using nBu3SnN3.  
Roeder and Dehnicke 89 reported that trimethylaluminum when treated with trimethylsilyl 
azide forms a 1 to 1 complex at temperatures below 120 °C which reacts to give 
(Me2AlN3)3 only at higher temperature. Therefore, it is likely that trimethylaluminum 
simply acts as a Lewis acid under these reactions and does not form (Me2AlN3)2.   
N
CN
TMSN3, (CH3)3Al
Toluene, 80°C
        87%
N
N N
N
H
N
72 73               
Scheme 17. Synthesis of tetrazoles with TMSN3 in the presence of Me3Al 
 
27 
 28  29 
    30 
  31  32 
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TMSN3 in the presence of Pd(PPh3)4: Yamamoto methodology 
 
Yamamoto et al. reported the synthesis of 2-allyltetrazoles starting from cyano 
compounds via the palladium-catalyzed three-components coupling reaction 90. The N-
silyl tetrazole 34, derived from the cycloaddition reacts in situ with the π-allylpalladium 
species to provide the N-allylated product 34 (Scheme 18). 
 
NC CN
Ph
+ OAc
TMSN3, Pd(PPh3)4
THF, 60°C
     93%
NC
Ph
N
N
NN
Si(CH3)3
+
PdLn
NC
Ph
N
N
NN
74 75 76  
Scheme 18. Preparation of 2,5-disubstituted tetrazoles 
 
1.1.3.1.5. Aluminum azide  
 
Aluminum azides have already been reported by Wiberg and Michaud in a 1957 
German patent 91. The Al(N3)3 can be prepared by treatment of AlCl3 with 3 equivalents 
of NaN3 in THF at reflux 91,92. However, using aluminum azide for the preparation of 
tetrazoles, two moles of HN3 are formed for every mole of product during the acidic 
quench of the reaction. The mechanism proposed proceeds through intramolecular 
delivery of N3- from Al(N3)3 complexed with the nitrile (Scheme 19).  
 
R CN R
N N
N
H
NAl(N3)3
THF, 80°C
Al(N3)2
N
N
N
NR :
R
N
N
N
N
Al(N3)2
R
N N
NN
(N3)2Al
 
Scheme 19. Proposed mechanism fort the tetrazole formation with Al(N3)3 
 
1.1.3.1.6. Synthesis of 5-substituted tetrazoles using Zn/Al hydrotalcite catalyst 
  
Katam and et al. reported an alternative methods to prepare tetrazole rings using 
Zn/Al hydrotalcite as heterogeneous catalyst 93 (Scheme 20). The anionic [Zn-Al-Cl], 
with [Zn]/[Al] ratio of 3 to 1, is synthesized by co-precipitation at pH 9. This 
methodology requires relative high temperature and long reaction times in DMF, with the 
use of Zn which requires additional treatment of the waste water.  
   33 34 35 
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CN
N
H
N
NN
R R
Zn/Al hydrotalcite
         DMF 
120-130 °C, 12h
NaN3
69-91 %
 
Scheme 20. Zn/Al hydrotalcite catalyzed synthesis of 5-substituted-tetrazoles 
 
 
1.1.3.2. Synthesis of tetrazoles with other methods 
 
Several reports have appeared which make use of precursors other than nitriles to 
prepare 5-substituted-1H-tetrazoles. A short overview of these methods are given herein. 
 
1.1.3.2.1. From N-(cyanoethyl)amides  
 
N-(Cyanoethyl)amides 36 reacts with trimethylsilyl azide to provide 1N-protected 
tetrazole 38 (Scheme 21). Removal of the N-cyanoethyl moiety of 38 with aqueous 
sodium hydroxide, followed by acidification, led to the free tetrazole 39 in relative good 
overall yield (Scheme 21) 8 . 
TMSN3, DEAD
Ph3P, THF
Ph
H
N
BocHN
O
CN
Ph
H
N
BocHN
O
CNPh3P
Ph
BocHN
N N
N
N
CN
Ph
BocHN
N N
N
H
N1. NaOH (1N)
2. HCl (1N)
65% overall
N3
            36                                               37                                38                                        39  
Scheme 21. 
 
1.1.3.2.2. From oxime salts 
 
An useful process for the preparation of 5-substituted-tetrazoles is the reaction of 
oxime salt 41 with sodium azide developed by Antonowa and Hauptmann 94. In this 
procedure, benzaldehyde 40 may be directly transformed into the corresponding aryl 
tetrazole 42 (Scheme 22).  
 
CHO
1. NH2OH, Pyridine
2. TsOH
H
N
H OH
3. NaN3, DMF
130°C,4d
    35%
N
H
N
NN
40                                                               41                                                        42
TsO
 
Scheme 22. Synthesis of tetrazoles from oxime salts 
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1.1.3.2.3. From imidate salt and imidoyl chlorides 
 
Zard et al. proposed an alternative method to prepare 5-substituted tetrazoles from 
imidate salts which does not involve azides 95. The reaction of imidates 43  with N-formyl 
hydrazine is known to give 1,2,4-triazoles via the intermediate N-formyl amidrazones 44. 
However, by working at low temperature (0 °C) the triazole formation can be avoided 
and indeed, in the presence of sodium nitrite and diluted HCl, the desired tetrazole 47 can 
be isolated in good yields (Scheme 23). The triazole 46 can be isolated only upon heating 
in xylene. 
 
43                                                         44                                                              45
Ar NH2
OEt
X
H2N-NHCHO
Ar N
NH2
NH-CHO NaNO2/HCl
N
N
NN
Ar
CHO
Xylene/∆
(Ar=Ph)
N
N
H
N
Ar
N
N
NH
N
Ar
46                                                              47
                                                              Scheme 23. 
 
Few years later, Zard 96 proposed a method to prepare disubstituted tetrazoles. The 
reaction of imidoyl chloride 48 with sodium azide provides the 5-chloro methyl tetrazole 
49 which is then treated with potassium O-ethyl xanthate in acetone to give the 
corresponding tetrazole xanthates 50 (Scheme 24).  
R
N Cl
CH2Cl
 NaN3 N
N N
N R
Cl
EtOCSSK
Acetone
N
N N
N R
S
OEt
S
 
                  48                                        49                                             50 
Scheme 24. 
 
Koldobskii et al. proposed the synthesis of 1,5-disubstituted tetrazoles under phase-
transfer conditions from imidoyl chlorides by treatment with sodium azide (Scheme 
25)97.  
N R2
R1
Cl
       CH2Cl2/H2O/NaN3
tetrabutylammonium bromide
20°C, 1h, 36-95 %
N
N N
N
R1
R2
 
Scheme 25. Synthesis of tetrazoles from imidoyl chlorides 
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1.1.4. Reactivity of Tetrazoles 
 
 
Reactivity of 5-substituted tetrazoles permits to classify them as aromatic 
compounds. The ring undergoes electrophilic substitution, is stable toward oxidation and, 
in general, the tetrazole ring remains unchanged during reduction of susceptible 
substituents 1. 
 
1.1.4.1. Reaction with electrophiles 
 
Peculiarities of the π-electron system of the tetrazole ring is the availability of lone 
pairs of the nitrogens which allow these heteroatoms to be attacked by various 
electrophilic reagents 1,98. Aside from the variety of alkyl substituents, many other groups 
can be introduced including acyl, imidoyl, silyl, phosphoryl, sulfonyl, aryl, vinyl and 
amino functions 98. 
The most common nucleophile type reactions at the tetrazole nitrogens arise from the 
acidity of the ring N-H bond (Section 1.1.1.2.). The tetrazolic acids form stable anions 
when treated with bases and are more reactive than neutral tetrazoles towards 
electrophiles and alkylating agents (Scheme 26) 98. The product is a mixture of 1N- and 
2N-alkyl isomers, the relative proportions of which depend upon the conditions of the 
alkylation, the steric requirements of the alkylating agent and the influence of the 5-
substituent. In general, electron-donating substituents at C-5 tend to favor 2N-alkylation. 
A more exhaustive discussion of this topic is given in Chapter 2. 
N N
N
H
NR
N N
N
NR
N N
N
NR
N N
NH
NR OH-
N N
N
NR
R'
R'R'X +
N N
N
NR
N N
N
NR
R'
R'
R"
"R
 
Scheme 26. Reactions with electrophiles 
 
1.1.4.1.1.       Alkylation of tetrazolate anion salts 
 
Metal salts of 5-substituted tetrazoles undergo to alkylation on heating with alkyl 
halides in a wide range of solvents. The products are a mixture of 5-substituted 1N- and 
2N-alkyl tetrazoles (Scheme 27) 1. 
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N
N N
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N
N N
N
R
R'+R'X
 
Scheme 27. Alkylation to tetrazoles to form a mixture of 1,5- and 2,5-disubstitted tetrazoles 
 
1.1.4.1.2.       Acylation and alkylation of neutral tetrazoles 
 
There are a variety of electrophilic substitutions on 5-substituted tetrazoles with 
reagents such as hydrazonoyl halides, electron-deficient vinyl systems and acyl halides 49. 
These reactions are carried out in the presence of excess Et3N used to promote loss of 
halide or hydrogen halide (generating nitrilimines or nitrile oxides) and involve the 
tetrazolate anion as the reactive tetrazole species 1.  
 
Michael reaction 
The Michael reactions of 5-substituted tetrazoles with electron-deficient vinyl systems 
give the 2-alkylated products in yields of about 50-80 % 1 (Scheme 28). 
 
HN N
N
NR N
N N
N
R
+N N
N
NRZ
Z
Z
 
Scheme 28. Michael reactions of 5-substituted tetrazoles 
 
Acylation 
Electrophiles such as acyl halides and imidoyl halides attack the 5-substituted tetrazole 
ring at the N2-position which can give after thermal decomposition the Huisgen product 
(Scheme 29). 
RC N N
R'
X
N
N
N
H
N
R
R'CXCl
N
N
N
N
R
R'
X
-N2 RC N N
R'
X
NN
XR R'
X= O,S,N  
Scheme 29. Acylation of tetrazoles followed by thermal decomposition and Huisgen reaction
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1.1.5. The Chemistry of the Cyano Group 
 
 
1.1.5.1. Introduction 
 
Nitriles are very important intermediates in synthetic organic chemistry 99,100. They  
are also of considerable industrial importance as integral part of dyes, herbicides, natural 
products, agrochemicals and new biological active agents.  
 
1.1.5.1.1. History 
 
Hydrogen cyanide was discovered in 1782 by Carl Scheele, who was investigating 
the dye Prussian Blue or Berliner Blau, as it was known in the German-speaking world. 
Mixing the dye with an acid and heating gave him a flammable gas that dissolved well in 
water, producing an acidic solution. Logically enough, he called his discovery Berlin 
Blausäure (Prussic acid). Scheele's death in 1786 is sometimes attributed to accidental 
poisoning by hydrogen cyanide. J. L. Gay-Lussac was the first to prepare the pure acid in 
1811 and Friedrich Wöhler and Justus von Liebig were the first to prepare the first 
nitriles benzoyl cyanide and benzonitrile in 1832.  
   
1.1.5.2. Chemical & Physical properties 
 
The chemical and physical properties of nitriles are in this section briefly discussed. 
The cyanide ion CN- is isoelectronic with carbon monoxide and dinitrogen and, because 
of the highly electronegative nitrogen, the C≡N bond is highly polar, resulting in high 
molecular dipole moments 99. Nitriles, therefore, have strong permanent dipole-dipole 
attractions as well as van der Waals dispersion forces between the molecules. Hence, 
nitriles have higher boiling points than would otherwise be expected from their molecular 
weights. Alkane-nitriles with α-hydrogens typically have pKa ~ 25, but the acidity 
increases if more than one cyano group is present as seen in the case of the malononitrile 
(pKa 11.0). 
Nitriles are important laboratory and industrial solvents because of their 
characteristic physical properties. The common solvent acetonitrile can be taken as an 
example. It has a high boiling point for a two-carbon system (bp 81.6 °C/760 Torr), due 
to the above mentioned large dipole moment (3.9 D) leading to intermolecular 
association.  
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On account of their σ-donating, π-accepting and potential π-donating properties, 
nitriles act as ligands in coordination and organometallic compounds, besides the cyanide 
anion (Figure 10). 
LnM N R LnM
N
R
N
MLn
R
LnM
 
                                          σ-bonding                   π-bonding              σ-π-bonding 
Figure 10. Ligand binding models of nitriles 
The ability of the cyano group to act as a ligand has been exploited to form liquid –
crystalline metal complexes. These are found to have enhance electronic 
polarizabilities101 (Figure 11). 
N M N
Cl
Cl
 
Figure 11. Metal-complex liquid crystals with nitrile ligands 
 
 
1.1.5.3. Biological activity 
 
Although nitriles (organic cyanides) have sometimes been stigmatized as 
poisonous, compared to simple cyanide salts such as sodium and potassium cyanide, they 
are ordinarily much less toxic. The parent compound, hydrogen cyanide can cause rapid 
death in humans due to metabolic asphyxiation. Death can occur within seconds or 
minutes of the inhalation of high concentrations of hydrogen cyanide gas. A recent study 
reports an estimated LC(50) in humans of 270 ppm for a 6-8 minutes exposure 102.  
Organic compounds possessing a cyano group occur in nature, including compound 51, 
which has antibiotic activity and compound 52 which is an antiviral agent isolated from a 
Verongida sponge (Figure 12). 
HO
CN
O
O
OH
OH
H
H
NC
119                                   120  
Figure 12. Naturally occurring compounds containing a cyano group  
 51                                            52                                       
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Compounds containing a cyano group have applications in medicinal chemistry and some 
of them are also available on the market. A selection of drugs is given in Figure 13. 
 
N
N
N
CNNC
NC
N
N
N
CN
Me
MeO
MeO
OMe
OMe
N
H
O
N
OH
CN
                 Letrozole
            Femara (Novartis)
antineoplastic, aromatase inhibitor
       Verapamil
anti-arrhythmic and
vasodilatator agent
       Vildagliptin
 anti-diabetic agent
        (Novartis)
             Fadrozole
     Arensin (Ciba-Geigy)
antineoplastic, non-steroidal 
       aromatase inhibitor
121
122
123 124
 
 
Figure 13. Selected cyano-substituted pharmaceuticals 
 
 
1.1.5.4. Preparation of nitriles 
 
The development of new methods for the synthesis of nitriles is important in 
organic synthesis, since nitriles are useful as intermediates for the preparation of amines, 
tetrazoles and other functional groups. The synthetic methods for the preparation of 
nitriles can be related mainly to four reaction type: addition, substitution, elimination and 
conversion of other nitriles 103,104. 
 
1.1.5.4.1. Preparation of nitriles by addition of hydrogen cyanide 
 
Several methods for the preparation of nitriles by addition of hydrogen cyanide to 
unsaturated compounds have been developed 104a including  the addition of HCN in the 
presence of dicobalt octacarbonyl,105 nickel catalysts,106 and palladium catalysts 107.  
 
1.1.5.4.2. Preparation of alkyl nitriles by substitution 
 
One of the most general methods for the synthesis of nitriles is a direct nucleophilic 
substitution of alkyl halides with inorganic cyanides 104a (Scheme 30). The classical 
53                                  
       54 
  55   56 
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conditions involve heating a halide with a cyanide salt in aqueous alcohol solution or in 
aprotic polar solvents such as DMSO (Kolbe nitrile synthesis) (Scheme 31) 108. In 
analogy, the use of metal thiocyanates such as KSCN in a nucleophilic substitution with 
organic halides is a general procedure to introduce the thiocyanate group into a molecule 
109. 
N C
K
R X - KX R CN  
Scheme 30. Mechanism of the Kolbe nitrile synthesis 
Br +  NaCN
DMSO
90-160°C
   93 %
CN
 
Scheme 31. Synthesis of nitriles 
 
 
1.1.5.4.3. Preparation of aryl nitriles  
 
Aryl nitriles can be prepared by the cyanation of aryl halides with an excess of 
copper(I) cyanide in a polar high-boiling solvent such as DMF 110, nitrobenzene, or 
pyridine at reflux temperature (Rosenmund-von Braun Reaction) 111. The mechanism 
probably involves the formation of a Cu(III) species through oxidative addition of the 
aryl halide at the Cu(I). Subsequent reductive elimination then leads to the product 
(Scheme 32).  
Ar X +   CuCN
oxidative
addition
Ar
Cu
NC X
reductive elimination
- CuX
Ar CN
 
Br
CH3
CuCN CN
CH3
DMF
 
                                                    131                                 132 
Scheme 32. Synthesis of aryl nitriles catalyzed by copper salts 
 
Recently alternative procedures for the synthesis of aryl nitriles are reported, 
including the use of less toxic cyanide source such as K4[Fe(CN)6] 112, or palladium 
catalysis  (Scheme 33) 113.  
Cl CN
F3C F3C
+  KCN
Pd(OAc)2, dpppe
      TMEDA
   toluene
140 °C, 16h
133 134  
Scheme 33. Cyanation of aryl chlorides 
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1.1.5.4.3.1. Preparation of nitriles by dehydration  
 
In the last 40 years, a number of efficient methods have been developed for the 
dehydration of oximes and amides to nitriles and the search for better reagents is still on 
going 104,114,115. 
Numerous reagents such as Burgess reagent,116 PPh3 / CCl4,117 trifluoroacetic or 
acetic anhydride and anhydrous pyridine,118,119 alkyl cyanoformates,120 aluminum 
iodite,121 silica gel,122 tetrachloropyridine,123 phthalic anhydride,124 etc.125 have been 
developed. In addition Vilsmeier reagent, Propsal, cyanurchloride and N,N’-carbonyl-
diimidazole (DCI) are some examples which find an industrial application. 
The usefulness of this synthetic approach to nitriles, directly from aldehydes, is 
demonstrated in the one-pot synthesis of carbonitrile derivative 63 from 2-
hydroxyacetophenone 61. Compounds 61 are first subjected to the Vilsmeier-Haack 
reaction to form aldehyde 62 in situ. Treatment of this mixture with hydroxylamine 
hydrochloride provides the desired nitriles 63 (Scheme 34) 126. 
 
O
O
O
O
NOHR R
O
OH
R
O
O
R
1. DMF, POCl3, 0°C to r.t.
2. NH2OH  HCl, DMF, r.t., 3-4h
. CHO CN
 
         61                                                                   62                                                         63   
Scheme 34. One-pot synthesis of 4-oxo-4H-1-benzopyran-3-carbonitriles 
 
 
         A further method for the preparation of nitriles from primary amides utilizes the 
methyl (carboxysulfamoyl) triethylammonium hydroxide inner salt (Burgess reagent) 
127,128. The mechanism of the reaction involves formation of the sulfonate ester from the 
enolate form of the amide followed by syn elimination (Scheme 35). 
 
R NH2
O
R NH
OH O
N H
N
S CO2CH3
O O
R
CNR
 
Scheme 35. Conversion of primary amides into nitriles by using the Burgess reagent 
 
1.1.5.4.4. Preparation of nitriles from nitroalkanes  
 
Carreira et al. reported a convenient protocol for the synthesis of optically active 
aldoximes and nitriles starting from chiral nitroalkanes 129. The treatment of the starting 
nitro-compounds with benzyl bromide, KOH and nBu4NI followed by addition of SOCl2 
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leads directly to nitriles in relative good yields without loss of optical activity (Scheme 
36). 
1. BnBr, KOH, nBu4NI, THF
2. SOCl2, NEt3, THF
72-73 %
NO2 CN
141 142  
Scheme 36. Transformation of optically active nitroalkanes into nitriles in a one-pot procedure 
 
 
1.1.5.4.5. Preparation of nitriles from hydrazones 
 
Several procedure has been developed for the preparation of nitriles from 
hydrazones, including oxidative cleavage of dimethylhydrazone of aldehydes with 
magnesium monoperoxyphthalate hexahydrate (MMPP) 104b,130 and microwave-assisted 
solvent-free oxidative cleavage using oxone with wet alumina 131. 
A convenient procedure to form nitriles under mildly basic conditions is the  
treatment of dimethylhydrazones with excess of methyl iodide followed by reaction with 
DBU (Scheme 37)132. 
 
H
N
N
OMe
CN
1. MeI, THF, 6h
2. DBU, 0°C, 3h
143
144
 
Scheme 37.  Synthesis of nitriles from hydrazone of aldehydes 
 
 
1.1.5.5. Reactivity of nitriles 
 
The importance of nitriles as intermediates in organic synthesis is well established 
100,104a. However nitriles are relatively unreactive in comparison to other unsaturated 
organo-nitrogen compounds. A classic example is acetonitrile, commonly employed as a 
solvent in a variety of reactions. The low reactivity of nitriles is attributed to the low 
basicity of the sp-hybridised nitrogen atom.  
Nitriles typically undergo nucleophilic additions and the chemistry of the nitrile 
functional group, C≡N, is very similar to that of the carbonyl, C=O of aldehydes and 
ketones.  
 
64 
65 
66 
67 
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1.1.5.5.1. Hydration of nitriles to form primary amides 
 
Nitriles can be converted to the corresponding primary amides. Several methods has 
been developed including the application enzymatic reactions 133a, catalytic hydration 
with manganese dioxide on silica gel,133b alkaline solution of peroxide, microwave 
irradiation with sodium perborate tetrahydrate in a mixture of water/ethanol 134. 
Nitriles are activated by low-valent ruthenium complexes and undergo reactions 
with nucleophiles under neutral conditions (Scheme 38) 104a,135. 
 
RCN  + H2O
RuH2(PPh3)4  cat.
R NH2
O
 
Scheme 38.  Catalytic hydration of nitriles under neutral conditions 
 
1.1.5.5.2. Hydrolysis of nitriles to carboxylic acids 
 
Carboxylic acids can be prepared by hydrolysis of nitriles. The reaction requires 
strong acid (e.g. H2SO4) or strong base (e.g. NaOH)  and  heat.  
 
1.1.5.5.3. Reduction of nitriles to primary amines 
 
Nitriles can be converted to the corresponding primary amines by hydrogenation. 
Several catalysts can be used including Rh-AlO3 in ammonia ethanol 136, nickel catalysts 
such as Raney Nickel, Ni-Al-NaOH, palladium catalysts, BH3, NaBH4/AlCl3, LiAlH4 
among others (Scheme 39) 104a. 
RCH2NH2RCN
H2, Cat.
 
Scheme 39.  Reduction of nitriles to amines 
 
1.1.5.5.4. Pinner reaction 
 
The Pinner reaction is the partial solvolysis of a nitrile to yield an iminoether. 
Treatment of the nitrile with gaseous HCl in a mixture of anhydrous chloroform and an 
alcohol produces the imino ether hydrochloride. These salts are known as Pinner salts and 
may react further with various nucleophiles (Scheme 40) 137. 
 
R N HCl R N H Cl
R'OH
R
NH2
OR'
K2CO3
R
NH
OR'
Cl
 
Scheme 40.  Synthesis of imino ethers 
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1.1.5.5.5. Ritter reaction 
 
Nitriles are converted to the corrsponding N-alkyl amides via the Ritter reaction 
using various alkylating reagents, for example, strong acid and isobutylene 138 (Scheme 
41). Tertiary alcohols, such as tert-butyl acetate 139,140, react with nitriles in the presence 
of strong acids to form amides via a carbocation. 
R N
H2SO4
H2O
R N
H
O1.
2.  
Scheme 41. Ritter reaction  
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1.2.  Application of Click Chemistry for a new   
Synthesis of 5-Substituted Tetrazoles 
from Organoaluminum Azides and 
Nitriles.  
  Results and Discussion 
 
 
 
Recently tetrazole derivatives have attracted much attention for the use as starting 
materials in fine chemicals (Section 1.1). However, a versatile method for synthesizing 
tetrazoles through a safe and simple manipulation has not been developed. 
In the course of our investigation into an alternative synthesis of sartan derivatives 
(Figure 14), it became of interest to find an alternative safe process for the preparation of 
tetrazoles on an industrial scale.  
 
N
NHN
N
N
O OH
O
6  
Figure 14. Valsartan (Novartis) 
 
We report here the discovery and development of a novel process for the efficient 
transformation of a wide variety of nitriles into the corresponding tetrazoles using 
dialkylaluminum azide. We have found that organic aluminum compounds are effective 
azide sources for the direct conversion of nitriles to tetrazoles (Scheme 42) 141,142.   
R2AlCl     +    NaN3 R2AlN3  +   NaCl
Toluene
0°C to r.t.
   4-6h
R' C N
   Toluene
-40 to 120°C
R2AlN3 NHN
N N
R'
 
Scheme 42. [2+3] Cycloaddition route to tetrazoles 
Dialkylaluminum azides can be prepared rapidly (Scheme 42) by the addition of an 
equimolecular amount of dialkylaluminum chloride to sodium azide in an aprotic organic 
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solvent such as toluene, xylene or hexane 143,144. The alkyl residue (R) can be branched 
(isobutyl-) or linear (methyl- or ethyl-) 141,142. During the cycloaddition no by-products 
are formed and the desired tetrazole is produced in high yield. The product can easily be 
isolated in excellent purity with a simple work up proedure. Although the mechanism is 
not yet understood, we suggest that the aluminum  acts as a Lewis acid, activating the 
nitrile to azide addition (Scheme 43). 
 
AlR2
N
N
NR'
R'
N-AlR2
N
N
N
N
N
N
N
R'
R2Al
N  
 
Scheme 43. Proposed two-step mechanism for the formation of tetrazoles 
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1.2.1. Dialkylaluminum azides 
 
 
 1.2.1.1.   Introduction 
  
 1.2.1.1.1.  The dialkylaluminum azide 
 The structures of the diethylaluminum and dimethylaluminum azides in solution were 
already investigated in the 1960s and determined as a trimer (R2AlN3)3 which form a 
planar six-member ring with symmetry D3h (Figure 15) 145. 
 
N
Al
N
Al
N
Al N
N
N
N
N
N
R R
R
RR
R R = Me, Et
__
_
_ _
_
 
Figure 15. Trimeric form in solution of dialkylaluminum azide 
 
 1.2.1.1.2.   The reactions of the diethylaluminum azide 
  
Diethylaluminum azide is already known as an activated azide donor for the 
conversion of esters to acylazides 143, ring opening of epoxyalcohols 146 and triazole 
formation from α’-amino-α,β-unsaturated ketones 147, but has never been employed in the 
synthesis of tetrazoles. 
 
Conversion of esters to acylazides 
 
 Rawal and et al. reported a one-pot procedure for the conversion of esters to acyl 
azides using diethylaluminum azide which combine into one reagent the nucleophilic 
azide unit with a highly oxophilic species 143. The reaction is carried out at room 
temperature using two equivalents of diethylaluminum azide to form the desired 
acylazide with 60 - 77 % of yield (Scheme 44). 
 
R
O
OMe
Et2AlN3
Hexane
 r.t., 2d
R
O
N3
 
Scheme 44. One-pot procedure for the synthesis of acyl azides 
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Ring opening of epoxyalcohols 
 
Benedetti et al. reported the reaction of 2,3-epoxyalcohols with diethylaluminum 
azide to give 3-azido-1,2-diols under mild condition (Scheme 45) 146a. 
The reaction is highly selective, leading to the formation of the corresponding azido diols 
with inversion of configuration at C-3. 
 
Et2AlN3
BocHN
R
OH
O
R' BocHN
R'
R
OH
OH
N3
      Toluene
-78°C to r.t., 17h  
 
Scheme 45. Ring opening of 2,3-epoxyalcohols with Et2AlN3 
 
Triazole formation from α’-amino-α,β-unsaturated ketones 
  
 A few years later, Benedetti et al. reported the preparation of triazoles from α’-
amino-α,β-unsaturated ketones using diethylaluminum azide (Scheme 46) 147.  
Et2AlN3
      Toluene
     r.t., 1-48 h
Bn2N
R'
R
O
R
O
NH
NN
R'
10-41%
Bn2NAlEt2
 
Scheme 46. Triazole formation from α’-amino-α,β-unsaturated ketones with Et2AlN3 
 
1.2.1.2.    Diethylaluminum azide formation 
 
Dialkylaluminum azides can be prepared in a short time by addition of an 
equimolecular amount of dialkylaluminum chloride to sodium azide in an aprotic organic 
solvent such as toluene, xylene or hexane. According to literature procedures, 143 we have 
prepared a variety of dialkylaluminum azides where the alkyl residue is branched 
(isobutyl-) or linear (methyl- or ethyl-) (Scheme 47) 141,142.  
 
R2AlCl     +    NaN3 R2AlN3  +   NaCl
Toluene
0°C to r.t.
   4-6h  
Scheme 47. Preparation of dialkylaluminum azides 
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1.2.1.2.1.  FT-IR Study  
 
The formation of Et2AlN3 from diethylaluminum chloride and sodium azide was 
followed by FT-IR spectroscopy (Scheme 48, Figures 16-18). A clear solution of 
diethylaluminum chloride (3.7 ml, 2.7 M in xylene) was treated, at room temperature, 
with sodium azide (0.65 g) in one portion and the IR spectra measured every two minutes 
for a period of 24 hours. During the course of the reaction, the temperature was also 
monitored internally. 
 
Et2AlCl     +    NaN3 Et2AlN3  +   NaCl
Xylene
    r.t.  
Scheme 48. Formation of diethylaluminum azide 
 
The temperature increased during the first 15 minutes, from 25 to 34 °C and then 
decreased again to 25 °C. After the addition of sodium azide, the IR spectra showed 
immediately a strong signal at 2138 cm-1, typical of azides, νasim(N3), which increased 
during the time (Figure 17). The sodium azide is almost not soluble in a solvent such as 
xylene and is not detected by IR, that means that this band at 2138 cm-1 corresponds to 
the formation of diethylaluminum azide in solution. An other typical azide band appears 
at 1223 cm-1, but this signal decreased within 6-7 hours and a new signal at 1269 cm-1 
appeared, which corresponds to the symmetry valence νsim(N3) 145b. In conclusion, from 
the FT-IR pictures seams that the diethylaluminum azide is immediately formed, but the 
equilibrium in solution, may be between the monomeric and the trimeric forms, is 
stabilized within 6 – 7  hours (Figures 17, 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Proceeding of the reaction 
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Figure 17. Signal at 2138 cm-1 (3D picture) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Decrease of signal at 1223 cm-1, increase of signal at 1269 cm-1 (3D picture) 
 
 
 
1.2.1.2.2.     Differential scanning calorimetry (DSC) 
 
The thermal behaviors of diethylaluminum and tributyltin azides are indicated by 
the DSC thermographs shown in Figure 19 and 20 respectively. All calorimetric scans 
were performed with the Mettler Toledo 821 calorimeter.  
The diethylaluminum azide, warmed at 4 °C/min, starts an exothermic decomposition at 
220 °C, with the maximum peak at 278 °C, and an onset of the decomposition in the 
range of 230-260 °C (Figure 19). In the case of dibutyltin azide, under the same 
conditions (4 °C/min) the exothermic decomposition starts at 180 °C with the maximum 
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peak at 288 °C and an onset of the decomposition in the range of 230-280 °C (Figure 20). 
Of note, the DSC of diethylaluminm azide is better compared to that of tributyltin azide 
in terms of safety margins. The isothermal DSC was also measured at 150 °C for 12 
hours and the diethylaluminum azide shows is stable under these conditions. 
 
 
 
 
 
 
 
 
                                                                                                                                    278 °C 
 
 
 
 
 
 
 
Figure 19. Dynamic DSC of Et2AlN3 
 
 
 
 
 
 
                                                                                                                                           288 °C 
 
                                                                   182 °C            247 °C                                   
 
 
 
 
 
 
Figure 20. Dynamic DSC of n-Bu3SnN3 
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1.2.2.  Synthesis of Starting Materials 
 
 
1.2.2.1. Alkyl thiocyanates  
 
Alkyl thiocyanates are important synthetic intermediates for the preparation of 
sulfur-containing organic compounds. For introduction of a thiocyanate group into an 
organic molecule, the most general route is the use of metal thiocyanates such as KSCN 
in a nucleophilic substitution with organic halides (Section 1.1.5.4.2.) 109. Nucleophilic 
substitutions are frequently carried out in two phases system using phase transfer 
catalysis (PTC) 148 to facilitate the reaction between the organic reactant in the organic 
phase and the nucleophile in the aqueous phase as an inorganic salt. 
 
Synthesis of benzylthiocyanate  (16) 
109  
Br
+     KSCN
S
N
H2O, Bu4NBr  5mol%
reflux, 2h
97 %
 
                   68                    16  
Scheme 49. Synthesis of benzylthiocyanate 
 
The synthesis of benzylhiocyanate 16 is carried out at 100 °C with benzylbromide 
and two equivalents of aqueous potassium thiocynate in the presence of  catalytic amount 
of tetrabutylammonium bromide as phase transfer catalyst (5 mol %) (Scheme 49). The 
reaction is stirred for two hours and the product is isolated by extraction with ethyl 
acetate. The crude product is purificated by bulb-to-bulb distillation to give the product as 
a yellow crystalline material in good yield (Experimental part, Section 5.1).  
 
Synthesis of 4’-thiocyanato methyl-biphenyl-2-carbonitrile (70)  
109 
 
The 4’-thiocyanato methyl-biphenyl-2-carbonitrile 70 is prepared by following the 
same procedure used for 16 under PTC conditions.  
 
N
Br
+     KSCN
Bu4NBr (5mol%)
Water, toluene
   reflux, 4h
N
S
N
99 %  
  69                             70  
Scheme 50. Synthesis of 4’-thiocyanato methyl-biphenyl-2-carbonitrile 
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1.2.2.2. Synthesis of nitrile derivatives from malononitrile  
 
Synthesis of 4-(2,2-dicyanoethenyl)- benzoic acid methyl ester  (73)  
 
OO
MeO
ZnCl2
N
N
O
MeO
N
N
100°C, 10 min
+
H
94 %  
            71                             72                                                                    73  
Scheme 51. Synthesis of 4-(2,2-dicyanoethenyl)- benzoic acid methyl ester   
 
Following the procedure reported by Venkataratnam 149 the preparation of 4-(2,2-
dicyanoethenyl)-benzoic acid methyl ester 73 is carried out in the presence of zinc 
chloride as catalyst under solvent free conditions. An equimolar amount of malononitrile 
and methyl-4-formylbenzoate, in the presence of zinc chloride (10 mol %) is warmed at 
100 °C for 15 minutes. The resulting heterogenic mixture is cooled to room temperature, 
washed with aqueous methanol (5 % solution) and filtered to give the pure desired 
product 73 as a yellow crystalline material in very good yield. 
2,2-Dibenzyl-malonitrile (74)  
For symmetric compounds, malononitrile undergoes dialkylation readily by treating 
with an appropriate alkylating agent 150. The treatment of malononitrile with 2.4 
equivalents of DBU and benzyl bromide in DMF at 80 °C for 8 hours (Scheme 52), 
followed by a simple work up procedure, affords the desired 2,2-dibenzyl-malonitrile 74 
with 80 % of yield. 
N
N
Br
N
N
+
DBU
DMF
80°C, 8h
80%  
                                       71                68                                         74  
Scheme 52. Synthesis of 2,2-dibenzyl-malonitrile  
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1.2.3. Synthesis of Tetrazoles with Dialkylaluminum      
Azides 
 
 
A wide variety of  nitrile derivatives in the presence of different functional groups 
are efficiently converted into the corresponding tetrazoles using dialkylaluminum azide 
under mild conditions 141,142. The reaction temperature depends on the reactivity of the 
substrates and can be selected from a range of -40 °C to 120 °C (Scheme 53). The rate of 
the 1,3-cycloaddition generally increases with increase in the electron-withdrawing 
characteristics of the substituent R’ in the nitrile. The dialkylaluminum azide is prepared 
in situ by mixing, under argon or nitrogen in anhydrous conditions, equimolecular 
amounts of dialkylaluminum azide in solution (in hexane, xylene or toluene) and solid 
sodium azide at 0 °C (Experimental Part, Chapter 5.1). During the reaction a suspension 
of NaCl is formed. The starting nitrile is then added to the azide mixture at room 
temperature. In the case of reactive substrate such as cyanopyridines and cyanopyrazines 
low temperatures are required. The reactions are followed by HPLC and TLC and 
generally when the analysis show > 98 % conversion, the mixture is cooled to 0 °C and 
the excess of dialkylaluminum azide used (1 – 3 equivalents) is safely destroyed by 
quenching with sodium hydroxide and sodium nitrite, followed by acidification with 
hydrochloric acid, which destroys the hydrazoic acid formed (Scheme 54). 
 
R2AlCl     +    NaN3 R2AlN3  +   NaCl
Toluene
0°C to r.t.
   4-6h
R' C N
   Toluene
-40 to 120°C
R2AlN3 NHN
N N
R'
 
 
Scheme 53. [2+3] Cycloaddition route to tetrazoles 
 
 
HNO2 + HN3 (g)   →   N2 (g) + N2O (g) + H2O 
Scheme 54. Safe removal of hydrazoic acid during the work-up 
 
Acidification (pH ≤ 2) removes the aluminum salts which are water soluble. Basic 
extraction of the tetrazole derivative separates the starting nitrile into the organic phase 
and then re-acidification affords the pure product.  
All the reaction conditions herein described are not optimized because our scope was first 
prove the compatibility and the application of the dialkylaluminum azide as an azide 
Chapter 1 - Discussion 
 40 
source which reacts with a wide variety of starting nitriles in the presence of different 
functional groups to give the corresponding tetrazole derivative.  
 
1.2.3.1. Synthesis of tetrazoles in the presence of sulfonyl, thio, 
thiocyano functional groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Synthesis of 5-substituted tetrazoles. 
Notes: * Isolated yield after crystallization; [a] Et2AlN3 (2.5 M in toluene); 
[b] i-Bu2AlN3 (1.8 M in toluene); [c] Et2AlN3 (2.7 M in xylene). 
 
Tetrazole derivatives in the presence of sulfonyl, thio, thiocyano functional groups 
are synthesized in good yields under mild reaction conditions (Table 1). The 5-
phenylsulfonylmethyl-tetrazole 75 is prepared in good yield with 1.4 equivalents of 
Et2AlN3 and the reaction mixture stirred for 3 hours at 55 °C (Table 1; entry 1). The same 
experiment is done using i-Bu2AlN3 to obtain the same yield. 5-Benzylthio-tetrazole 17 is 
prepared using 1.4 equivalents of Et2AlN3 at 45 °C for 4 and half hours (Table 1; entry 
2). The desired product 17 is obtained in only 40-50 % yield because of the formation of 
benzyl isothiocyanate derivated from the rearrangement of the starting thiocyanate 151. 
The same result is obtained dropping the substrate in three portions into the azide mixture 
Entry T [°C] Time [h] Product Yield [%] 
 
 
1
[a,b]
 
 
 
55 
 
 
3 
S
O O
N
H
N
NN
 
 75 
 
 
76* 
 
 
2
[a] 
  [b]
 
 
 
45 
60 
 
 
4.5 
1 
S N
H
N
NN
 
17 
 
 
46 
40 
 
 
3
[a]
 
 
 
55 
 
 
24 
S
N
H
N
NN
 
76 
 
 
83* 
 
 
 
4
[c]
 
 
 
 
r.t. 
 
 
 
24 
N
S
NHN
N
N
 
77 
 
 
 
87 
 
 
 
5
[c]
 
 
 
 
110 
 
 
 
72 
S
NHN
N
N NH
NN
N
78 
 
 
 
93 
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over a period of one hour, and a comparable yield is obtained using iBuAlN3 as azide 
source at 60 °C for 1 hour. Interesting to mention that the X-ray structure shows that 
compound 17 crystallized only in the 1H-tautomeric form (Figures 21, 22)(See X-ray 
discussion, Chapter 4). 
N
H
N
NN
S
N NH
NN
S
 
                               1H-Tautomer                2H-Tautomer  
Figure 21. Tautomeric equilibrium of 46 in solution 
 
 
Figure 22. Structure of 5-(benzylthio)-1H-tetrazole 
17 in the crystal with thermal ellipsoids drawn at 
50 % probability level 
 
 
 
Phenylsulfanylmethyl-tetrazole 76 is obtained in very good yield using 1.4 
equivalents of Et2AlN3 at 55 °C for 30 hours (Table 1; entry 3). The mono- and bis-
tetrazoles, respectively 77 and 78, can be selectively obtained depending on the reaction 
conditions (Table 1; entries 4, 5). The mono-tetrazole 77 is obtained with complete 
regioselectivity in good yield using 1.5 equivalents of Et2AlN3 at room temperature in 24 
hours. Trace of byproduct derivated from the rearrangement of the starting material, is 
also observed in this case 151. The bis-tetrazole 78 is obtained using 2.8 equivalents of 
Et2AlN3 starting from 77. The mixture is stirred for 3 days from 90 to 110 °C giving the 
desired product in excellent yield (Table 1). 
 
1.2.3.2. Synthesis of tetrazoles in the presence of double bonds  
 
The reaction of benzylidenemalonitrile with Et2AlN3 gives the corresponding 
tetrazoles 79 or 80 in good yield under mild conditions (Table 2). To obtain the mono-
tetrazole derivative 79, the reaction is stirred for 6 hours at 40 °C with 2 equivalents of 
Et2AlN3 (Table 2; entry 6). The desired tetrazole 79 is obtained in very good yield but 
with a purity of 91 % (HPLC) with the partial formation of the bis-tetrazole derivative 
(Table 2; entry 7). Tetrazole 80 is obtained by treatment of the starting nitrile with 3 
equivalents of Et2AlN3 at 65 °C for 24 hours, yielding the desired pure bis-tetrazole 
derivative in good yield. It is interesting to mention that under these conditions the 
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starting benzylidenemalonitrile gives only the tetrazole derivatives 79 and 80 without any 
conjugate addition of the ethyl residue to the double bond which undergoes in the case of 
Et2AlCl in toluene at -40 °C 152. The five membered nitrogen-containing heterocycles are 
traditional centers for energetic materials 5, for this reason the thermal behavior of 
compound 80, with contains geminal bis-tetrazoles in the structure, was measured with a 
Mettler Toledo 821 calorimeter. The dynamic DSC (heating 4 °C/min) shows the thermal 
stability, under this condition, of 80 until 190 °C. However, at 203 °C a small 
endothermic peak, attributed to the melting point, is followed by a strong exothermic 
decomposition with maximum at 205 °C,  with a measured enthalpy of -1302 kJ Kg-1 and 
this energy corresponds to an adiabatic temperature of ca 868 °C. 
 
Entry T [°C]  Time [h] Product Yield [%] 
 
 
6
[a]
 
 
 
40 
 
 
6 
N
N
N
NHN
 
79 
 
 
97 
 
 
 
7
[b]
 
 
 
 
65 
 
 
 
24 
N
N
NHN
N
N N
NH
 
80 
 
 
 
75 
 
 
8
[a]
 
 
 
90 
 
 
20 
N
H
N
NN
 
81 
 
 
65** 
 
 
9
[b]
 
 
 
60 
 
 
18 
N
N
NHN
 
82 
 
 
97* 
 
 
 
10
[b]
 
 
 
 
r.t. 
 
 
 
2 
N
NH
NN
N
N
HN N  
83 
 
 
 
71 
 
 
Table 2. Synthesis of 5-substituted tetrazoles. 
Notes:* Yield after extractions and crystallization; ** Yield after direct 
crystallization of the crude; [a] Et2AlN3 (2.5 M in toluene), [b] Et2AlN3 (2.7 M 
in xylene)  
 
Alpha,beta-unsaturated vinyl nitriles are relatively good substrates, however  
cyclohexene-1-carbonitrile requires, a higher temperature (Table 2; entries 8, 9). The 
reaction is carried out using 1.4 equivalents of Et2AlN3 at 90 °C for 24 hours to give the 
desired 5-(1-cyclohene-1-yl)-tetrazole 81 in good yield. The reaction does not undergo at 
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T < 50 °C and at 75 °C the reaction requires longer reaction time (36 hours) to give the 
desired product with the same yield. Cinnamonitrile gives the desired 5-styryl-tetrazole 
82 in very good yield using 1.3 equivalents of Et2AlN3 at 50-70 °C for 18 hours. The 
reaction proceed very well without the formation of any byproducts. Fumaronitrile 
provides the corresponding tetrazole 83 after two hours at room temperature (Table 2; 
entry 10). 
 
1.2.3.3. Synthesis of tetrazoles from alkyl nitriles 
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Table 3. Synthesis of 5-alkylsubstituted tetrazoles. 
Notes:*Yield after extractions and crystallization; **Yield after direct crystallization of the 
crude;[a] Et2AlN3 (1.8 M in toluene), [b] Et2AlN3 (2.7 M in xylene), [c] Et2AlN3 (in toluene 2.5 M)  
 
Inactivated and sterically hindered alkyl nitriles require relatively high temperature 
and longer reaction time (Table 3). The trans-cyclobutane-1,2-di-tetrazole 84 (Table 3; 
entry 11), is synthesized from the corresponding dinitrile using 1.33 equivalents of 
Et2AlN3 at 90 °C for 30 hours in relative good yield. Excess of Et2AlN3 does not 
influence the rate of the reacion. The tetrazole 85 is obtained under similar conditions 
using 1.5 equivalents of Et2AlN3 at 70 °C for 49 hours (Table 3; entry 12). Sterically 
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hindered nitriles such as 2-phenyl-propionitrile provides the corresponding tetrazole 86 in 
good yield with 1.33 equivalents of Et2AlN3 at 60 °C for 24 hours and more bulky 2,2-
diphenylpropionitrile require higher temperature to give the corresponding tetrazole 89 
(Table 3; entries 13, 16). The inactivated 1-adamantenecarbonitrile requires longer 
reaction times and provides the corresponding tetrazole 87 with an excess of Et2AlN3 
(2.23 equivalents) at 90-110 °C for three days (Table 3; entry 14). The 5-(2-
trifluoromethyl)-benzyl-tetrazole 88 is prepared in good yield using 1.5 equivalents of  
Et2AlN3 or Me2AlN3 at 65 °C for 17 hours (Table 3; entry 15). Geminal di-nitriles such as 
2,2-dibenzyl-malonitrile require mild reaction conditions. The bis-tetrazole 90 is prepared 
at 75 °C for 18 hours using 1.6 equivalents of Et2AlN3 for each nitrile group (Table 3; 
entry 17). 
 
1.2.3.4. Synthesis of tetrazoles from aromatic nitriles 
 
 
Aromatic nitriles are suitable substrates for this methodology (Table 4). Simple 
benzonitrile requires 1.1 to 1.3 equivalents of Et2AlN3 at 80 °C for 24 hours yielding the 
desired tetrazole 1 in excellent yield (Table 4; entry 18). The corresponding 1,2-
dicyanobenzene requires shorter reaction times and provides the bis-tetrazole 91 in good 
yield using 1.4 equivalents of Et2AlN3 at 90 °C for only 3 hours (Table 4; entry 19). The 
4-cyanophenylacetonitrile requires longer reaction time compared to 1,2-dicyanobenzene 
and the reaction is carried out with an excess of Et2AlN3 (2.1 equivalents) at 75 °C for 24 
hours to give the desired bis-tetrazole 93 in good yield (Table 4; entry 21). Aromatic 
nitro-nitriles such as the 4-nitrobenzonitrile are very reactive and the nitro-group may 
react with the Et2AlN3 instead of the cyano group. In this case the reaction is very 
exothermic with gas evolution even at 0 °C and only 15 % of the desired tetrazole 94 is 
isolated under these conditions (Table 4; entry 22). At a given temperature some hetero-
substituted aromatic nitriles require shorter reaction times than benzonitrile, for example 
2-hydroxybenzonitrile is converted to the corresponding tetrazole 95 in two hours at 80 
°C instead twenty-four hours (Table 4; entry 23). The hydroxyl group is rotected in situ 
with triethylaluminum (Section 1.2.3.5.). Para-substituted halogen benzonitriles undergo 
the cycloaddition (Table 4; entries 28, 29). The 5-(4-chloro-phenyl)-tetrazole 2 is 
obtained in very good yield using 1.57 equivalents of Et2AlN3 at 90 °C for 24 hours and 
the 5-(4-fluoro-phenyl)-tetrazole 99 using 1.5 equivalents of Et2AlN3 at 130 °C for 15 
hours.  
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Table 4. Synthesis of 5-arylsubstituted tetrazoles. 
Notes: * Yield after extractions and crystallization; [a] Et2AlN3 (2.7 M in xylene),[b] Et2AlN3 
(1.8 M in toluene), [c] Me2AlN3 (1 M in hexane/toluene), [d] Et2AlN3  (2.5 M in toluene) 
 
The reaction proceeds well in the case of ortho-substituted aryl nitriles where steric 
hindrance might be anticipated to reduce yield (Table 4; entries 20, 23, 25-27). In 
comparison with the methodology proposed by Sharpless 63,78,79 we have been able to 
achive conversion of aromatic nitriles bearing an sp3-hybridized substituent in ortho 
position (Table 4; entry 20) at relative high temperature and long reaction time.  
5-Ortho-methylphenyl-tetrazole 92 is prepared in good yield using one equivalent of 
Et2AlN3 at 80 °C for 25 hours (Table 4; entry 20). Ortho-halogen substituted aromatic 
nitriles (Table 4; entries 24-27) reach to completion at 50 °C within approxymately 30 
hours of reaction. The reactivities of each o-halogen benzonitrile was checked by parallel 
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reactions at 50 °C mixing equimolar amounts of o-fluoro and o-bromobenzonitrile, 
equimolar amounts of o-fluoro and o-chlorobenzonitrile and finally equimolar amounts of 
o-fluoro and o-iodobenzonitrile and following the respective conversions by HPLC. 
Ortho-fluoro, -chloro and –bromobenzonitrile have comparable reactivity, but o-
iodobenzonitrile provides complete conversion after three days. An approximate 
explanation can be given looking the steric hinderance of iodine in o-position and the 
relative electronic effect in the aromatic ring attached to the nitrile (Figures 23, 24). The 
ortho-halogen influences the electronic properties of the aromatic ring and indirectly the 
activation of the nitrile group though the cycloaddition. The molecules were built and 
optimized using Syayl software (Tripos) (Figure 23). The charges were calculated using 
Gasteiger-Marsili method and the electrostatic potential was mapped with Molcad on the 
Connoly surface of each molecule (Figure 24). Corey–Pauling–Koltun (CPK) models are 
the simplest type of representation of the surface of small molecules. In these space-
filling models, the atoms are represented as spheres whose radii are proportional to the 
atom's van der Waals radius (Figure 23). Figure 24 shows the effect in the aromatic ring 
of the presence of halogen atoms compared to the simple benzonitrile. In the case of o-
iodobenzonitrile, the aromatic ring is probably more electron-rich because of the major 
mesomeric effect of iodo compared to the halogens series (Figure 24). The total surface 
of the simple benzonitrile and o-fluorobenzonitrile are comparable (respectively 114.8 Å2 
and 118.8 Å2) as well as the total van der Waals surface of o-bromo and o-
chlorobenzonitrile (respectively 128.4 Å2 and 132.8 Å2). The van der Waals surface of o-
iodobenzonitrile is bigger compared to the above mentioned series (141.5 Å2) because of 
the bigger size of the iodine atom (Figure 23). 
 
Figure 23. 3D Representation of CPK model of ortho-halogenbenzonitriles and benzonitrile 
 
X=Br 
X=I 
X=F 
X=H 
X=Cl 
X 
N 
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 Figure 24. 3D Representation of electrostatic potential on van der Waals surface for 
ortho-halogenbenzonitriles and benzonitril 
 
 
1.2.3.5. Synthesis of tetrazoles in the presence of hydroxy group  
 
Alkyl and aryl nitriles with an alpha-hydroxyl group react at a lower temperature, 
although it is necessary to protect the hydroxyl group with triethyl aluminum, which is 
removed during the conventional workup procedure (Table 4; entry 23; Table 7; entries 
30-33). The protection of the hydroxyl group is done in situ mixing 1.2 equivalents of 
triethyl aluminum in toluene with the starting hydroxy nitrile derivative at 0 °C and 
stirring the resulting mixture for two hours (Scheme 55). 
 
R'
OH
CN R'
O
CN
AlEt3
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OH
N N
N
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N
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1.  R2AlN3
2. H+
 
Scheme 55. Protection in situ of the hydroxyl group and cycloaddition  
 
Tetrazole 100 is synthesized in relative good yield using 1.3 equivalents of 
diethylaluminum azide from 0 °C to room temperature in 24 hours (Table 5; entry 30). 
The reaction was  done only once without any optimization for safety reasons because of 
the risk of HCN formation from the starting nitrile. Mandelonitrile and R-mandelonitrile 
provide the corresponding tetrazoles 101 and 102 in very good yield using 1.5 
equivalents of Et2AlN3 at 40 - 45 °C in around one hour (Table 5; entries 31, 32).  
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Entry T [°C]  Time [h] Product Yield [%] 
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Table 5. Synthesis of 5-substituted tetrazoles. 
Notes:* Yield after crystallization; [a] Et2AlN3 (2.7 M in 
xylene) 
 
1.2.3.6. Synthesis of 5-substituted heteroaromatic tetrazoles  
 
Heteroaromatic nitriles such as pyridinecarbonitriles and cyanopyrazine give the 
corresponding tetrazoles in a few hours at low temperature with good yields (Table 6; 
entries 33-37) ; they require shorter reaction times and lower reaction temperature than 
benzonitrile (Table 4; entry 18). The main problem of these substrates is the high 
hydrophilicity of the corresponding product which makes difficult the purification with 
the common extraction procedure. In all these cases the reaction mixture is quenched 
with HCl (2 M), the pH adjusted with potassium carbonate to isoelectric point at 6.5, the 
aqueous phase is then saturated with solid NaCl and the product extracted with ethyl 
acetate ; some of the product can be lost in the aqueous phase. Ortho-, meta- and para-
cyanopyridine have similar reactivity and give the corresponding tetrazole derivative, 
respectively 103, 104, 105 using 1.3 equivalents of Et2AlN3 at 0 °C for 3 hours (Table 6; 
entries 33-35). The 2,6-pyridinedicarbonitrile gives the desired tetrazole 106 (Table 6; 
entry 36) using 3 equivalents of Et2AlN3 at 0 °C for one hour and is more reactive that 
the analogue 1,2 dicyanobenzene (Table 4; entry 19). The pyrazinecarbonitrile is too 
reactive with Et2AlN3 (reaction very exothermic) and the use of i-Bu2AlN3 is more 
appropriate (Table 6; entry 37). The reaction undergoes with stoichiometric amount of 
azide from –40 to 0°C in three hours to give the desired product 107 in good yield. 
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Table 6. Synthesis of heteroaromatic tetrazoles 
Notes:* Yield after crystallization; [a] Et2AlN3 (2.7 M in xylene); [b] i-Bu2AlN3 (1.8 M in 
toluene) 
 
2-Furanonitrile, 2-thiophenecarbonitrile and pyrrole-2-carbonitrile have similar reactivity 
(Table 6; entries 38 - 40). 2-Furanonitrile and 2-thiophene-carbonitrile give the 
corresponding tetrazole, respectively 108 and 109, in good yield using 1.2 equivalents of 
Et2AlN3 at 55 °C for 12 hours and the purification was done using the conventional work-
up procedure (Table 6; entries 38, 39). The pyrrole-2-carbonitrile is converted into the 
corresponding tetrazole 110 using an excess of Et2AlN3 (2.3 equivalents) because of the 
presence of the NH in the pyrrole ring and the reaction is carried out from 0 °C to room 
temperature in 24 hours (Table 6; entry 40). X-Ray structure analysis of 108, which 
contains an heteroatom near the tetrazole ring, shows that this compound crystallized 
exclusively in the 1H-tautomeric form as in the case of compound 17 (See X-ray 
discussion, Chapter 4)(Scheme 56, Figure 25). 
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N
 
                                               1H-Tautomer                      2H-Tautomer 
Scheme 56. Tautomeric equilibrium of 109 in solution 
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Figure 25. Structure of 5-thiophen-2-yl-1H-
tetrazole 109 in the crystal with thermal ellipsoids 
drawn at 50 % probability level 
 
 
 
 
 
1.2.3.7. Synthesis of tetrazoles in the presence of amides, amines, esters 
and ethers  
 
 Nitriles containing amido, ester and ether functional groups require mild reaction 
conditions (Table 7). Both enantiomers of 2-tetrazol-pyrrolidine-1-carboxylic acid benzyl 
ester 112 and 113 (Table 7,  entries 42, 43)  are  prepared  for  the  first  time  under  very  
mild conditions in 9 hours at 55 °C in high yield 142. The preparation of the (R)-
enantiomer 113 was also increased to 1.5 kg with very good reproducibility. The 
cycloaddition proceeds well using 1.3 - 1.5 equivalents of Et2AlN3 or Me2AlN3 142. The 
Boc analogue 111 is formed under the same reaction conditions (Table 7; entry 41),142 
but the necessary acidic work-up partially cleaves the Boc group giving the unprotected 
pyrrolidine tetrazole 114. To avoid the cleavage of the Boc-group, the reaction mixture 
was directly quenched with a solution of KHSO4 (10 %) at pH 5, but afforded 57 % of 
the desired product. The aqueous phase after the work-up is evaporated and stirred 4 
hours in ethanol, filtered and delivered 25 % of the unprotected pyrrolidine tetrazole 114. 
The tetrazoles 112 and 113 are of interest because they are the precursors of the tetrazol-
5-yl pyrrolidine 114 and 115 respectively, which are interesting alternative to proline 153 
as an organocatalyst for a variety of reactions including: aldol reactions,154,155 Mannich 
reactions,156,157 Diels-Alder reactions 158,159 and Michael additions 160. 
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   Table 7.  
Notes: * Yield after crystallization; [a] Et2AlN3 (2.5 M in toluene); [b] i-Bu2AlN3 (1.8 M in toluene); 
[c] Et2AlN3 (2.7 M in xylene); [d] Me2AlN3 (1 M in hexane); [e] H2, Pd/C 10 % in EtOH; [f] excess 
Et2AlN3 (2.5 M in toluene or 2.7 M in xylene); [g] i) Et2AlN3 (2.7 M in xylene) for 8h at 50 °C, ii) 
HCl (6M) for 8 h at r.t.; [h] Et2AlN3 (1.8 M in toluene) 
 
 
The pyrrolidine tetrazole in both enantiomeric forms, can be directly obtained in a one-pot 
reaction from the starting nitrile with an excess of dialkylaluminum azide to provide first 
the cycloaddition (T ≤ 55 °C) and then the cleavage reaction (T ≥ 65 °C) (Scheme 57) 142. 
Although purity of 114 obtained under these conditions is high according to NMR, but 
broad peaks by IR suggests the presence of some water soluble inorganic materials that 
are difficult to remove. 
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Scheme 57. One pot reaction for the preparation of 1H-tetrazol-5-yl 
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We were the first to solve the X-ray structure of the 2(R)-tetrazol-5-yl-pyrrolidine. 
According to X-ray analysis, the compound 115 crystallized as hydrate and is existing in 
zwitterionic form (Figure 26; See X-ray discussion, Chapter 4). 
 
 
Figure 26. Structure of 2(R)-tetrazol-5-yl-
pyrrolidine 115 in the crystal with thermal 
ellipsoids drawn at 50 % probability level 
 
 
 
 
 
Because of the possible application in organocatalysis, the thermal behavior was 
measured for tetrazoles 112 and 114 (Figures 27-30). All calorimetric scans were 
performed with a Mettler Toledo 821 calorimeter. The dynamic DSC (heating 4 °C/min) 
shows the relative thermal stability of 112 until 200 °C (Figure 27). A peak at 86 °C, with 
a measured endothermy of 74 kJkg-1, is attributed to the melting point. The exothermic 
decomposition starts at 254 °C with an measured enthalpy of –391 kJKg-1and this energy 
correspond to an adiabatic temperature of ca 260 °C (Figure 27). The (S)-2-(tetrazol-5-
yl)-pyrrolidine 114 is thermally stable until 260 °C (Figure 29). A small endothermic 
peak at 168 °C is attributed to the melting point, with a measured endothermy of 25 kJkg-
1 and is followed by an highly spontaneous exothermic decomposition with maximum at 
275 °C, with a measured enthalpy of -1182 kJkg-1 which corresponds to an adiabatic 
temperature of ca 290 °C (Figure 29). The isothermal DSC was also measured at 90 °C 
for 12 hours and both compounds 112 and 114 showed to be stable under these 
conditions (Figures 28, 30). 
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Bemerkungen: Tiegel, Stahl vergoldet (unter Argon verschlossen)
Probe: 4.20 mg (dyn)
DSC-821/180
Experiment: 051091;Valsartan/129/VAD.34.05  (180), 11.02.2005 10:17:16
Integral 1640.29 mJ
  normalis. 390.55 Jg^-1
Onset 223.66 °C
Peakhöhe 0.77 Wg^-1
Peak 254.47 °C
Extrapol. Peak 253.15 °C
Peakweite 32.40 °C
Linke Grenze 204.44 °C
Rechte Grenze 291.38 °C
Heizrate 4.00 °Cmin^-1
Integral -311.41 mJ
  normalis. -74.15 Jg^-1
Onset 80.29 °C
Peakhöhe 0.64 Wg^-1
Peak 85.89 °C
Extrapol. Peak 86.30 °C
Peakweite 6.53 °C
Linke Grenze 69.12 °C
Rechte Grenze 99.33 °C
Heizrate 4.00 °Cmin^-1
Wg^-1
2
min
°C0 20 40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380
0 10 20 30 40 50 60 70 80 90
^exo 051091/dyn 15.02.2005 11:01:28
 SW 8.10eRTASNOVARTIS PHARMA, Safety Labs: WSJ-145.8.65  
 
Figure 27. Differential scanning calorimetry (DSC) for (S)-2-(tetrazol-5-yl)-pyrrolidine-
1-carboxylic acid benzyl ester 112 
 
 
Bemerkungen: Tiegel, Stahl vergoldet (unter Argon verschlossen)
Probe: 4.26 mg (tiso = 12h  Tiso = 90°C)
DSC-820/18
Experiment: 051091;Valsartan/129.VAD.34.05 (18), 11.02.2005 10:26:01
Wg^-1
1
min0 50 100 150 200 250 300 350 400 450 500 550 600 650
^exo 051091/iso90°C 15.02.2005 10:48:09
 SW 8.10eRTASNOVARTIS PHARMA, Safety Labs: WSJ-145.8.65  
 
Figure 28. Isothermic differential scanning calorimetry (DSC) at 90 °C for 12 hours for 
(S)-2-(tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 112 
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Bemerkungen: Tiegel, Stahl vergoldet (unter Argon verschlossen)
Probe: 4.49 mg (dyn)
DSC-821-875
Experiment: 051090;100/101/103;VAD.12B.H2.C1   (875), 11.02.2005 08:55:34
Integral -108.96 mJ
  normalis. -25.22 Jg^-1
Onset 266.76 °C
Peakhöhe 0.98 Wg^-1
Peak 268.47 °C
Extrapol. Peak 268.53 °C
Peakweite 1.56 °C
Linke Grenze 261.08 °C
Rechte Grenze 268.73 °C
Heizrate 4.00 °Cmin^-1
Integral 5106.92 mJ
  normalis. 1182.16 Jg^-1
Onset 269.30 °C
Peakhöhe 5.95 Wg^-1
Peak 275.35 °C
Extrapol. Peak 273.64 °C
Peakweite 9.68 °C
Linke Grenze 269.37 °C
Rechte Grenze 365.18 °C
Heizrate 4.00 °Cmin^-1
Integral -231.66 mJ
  normalis. -53.63 Jg^-1
Onset 99.64 °C
Peakhöhe 0.21 Wg^-1
Peak 112.75 °C
Extrapol. Peak 104.42 °C
Peakweite 17.00 °C
Linke Grenze 83.27 °C
Rechte Grenze 126.21 °C
Heizrate 4.00 °Cmin^-1
Wg^-1
5
min
°C-0 20 40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380
0 10 20 30 40 50 60 70 80 90
^exo 051090/dyn 15.02.2005 12:56:05
 SW 8.10eRTASNOVARTIS PHARMA, Safety Labs: WSJ-145.8.65  
Figure 29. Differential scanning calorimetry (DSC) for (S)-2-(tetrazol-5-yl)-pyrrolidine 114 
  
Bemerkungen: Tiegel, Stahl vergoldet (unter Argon verschlossen)
Probe: 4.85 mg (tiso = 12h  Tiso = 90°C)
DSC-25/758
Experiment: 051090;100/101/103.VAD.12B:H2.C1    (25), 11.02.2005 09:06:10
Wg^-1
1
min0 50 100 150 200 250 300 350 400 450 500 550 600 650
^exo 051090/iso90°C 15.02.2005 12:57:43
 SW 8.10eRTASNOVARTIS PHARMA, Safety Labs: WSJ-145.8.65  
Figure 30. Isothermic differential scanning calorimetry (DSC) at 90 °C for 12 hours for (S)-
2-(tetrazol-5-yl)-pyrrolidine 114 
 
 
Dimethylcyanide provides the corresponding tetrazole 116 in good yield using 1.5 
equivalents of Et2AlN3 at room temperature for 2 hours (Table 7; entry 46). The ester 
groups are stable at room temperature in the presence of dialkylaluminum azides (Table 
7; entries 47, 48). For example, ethyl-tetrazole-5-carboxylate 117 (Table 7; entry 47) is 
efficiently prepared using 1.3 equivalents of  Et2AlN3 at room temperature in one hours 
and the mono-tetrazole 118 is prepared using 1.6 equivalents of Et2AlN3 at room 
temperature for 3 days (Table 7; entry 48). In this case the reaction was stopped before 
the complete conversion to be able to isolate only the mono-tetrazole derivative. 
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2(R)-Cyano-tetrahydrofurane is efficiently converted into the corresponding tetrazole 119 
using 1.3 equivalents of Et2AlN3 at 40 °C for 3 hours (Table 6; entry 49). The (R)-5-
(tetrahydro-furan-2-yl)-tetrazole 119, similarly to 46 and 109, crystallized exclusively in 
the 1H-tautomeric form (Scheme 58, Figure 31; See X-ray discussion, Chapter 4). 
 
O
N
H
N
N
N
H
O
N N
NH
N
H
 
                                               1H-Tautomer                      2H-Tautomer 
Scheme 58. Tautomeric equilibrium of 119 in solution 
 
 
 
Figure 31. Structure of (R)-5-(tetrahydro-
furan-2-yl)-1H-tetrazole 119 in the crystal 
with thermal ellipsoids drawn at 50 % 
probability level 
 
 
 
1.2.3.8. Synthesis of tetrazoles in the presence of carbonyl groups 
 
In analogy with DIBAH and TIBA 161 (Figure 32), aldehyde and ketone functional 
groups are reduced to the corresponding alcohols with Et2AlN3 (Table 8; entries 50-52). 
 
Al H Al
DIBAH                         TIBA
iC4H9 iC4H9
iC4H9 iC4H9
iC4H9
 
Figure 32. 
 
The mechanism may involve a hydride shift from the β-carbon on the residue of the 
diethylaluminum azide to the carbonyl group (Scheme 59) with the formation of one 
molecule of ethylene which derives from the organoaluminum. 
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Entry Starting material T [°C]  Time [h] Product Yield  [%] 
 
 
 
 
50[a,b] 
 
 
O
O
CN
 
           121 
 
 
 
 
r.t. 
 
 
 
 
 
24 
O
O N N
NH
N
122 
O
O N N
NH
N
123 
 
 
57* 
 
 
 
37* 
 
 
 
 
 
51[b] 
 
 
 
CN
O
H  
124 
 
 
 
 
 
50 
 
 
 
 
 
24 
N
N
NHN
HO
Et  
125 
N
N
NHN
HOH2C  
126 
 
 
36** 
 
 
 
 
 
50* 
 
 
52[b] 
CN
O
 
127 
 
 
r.t. 
 
 
14 
N NH
N
N
OH
 
128 
 
 
38 
 
Table 8.  
Notes: * Yield after chromatography; ** Yield after extractions and crystallization; 
[a] Et2AlN3 (2.5 M in toluene), [b] Et2AlN3 (2.7 M in xylene) 
 
O
R"R'
Al
CH2
H
O
R"R'
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H
+ H2C CH2
OH
R"R'
H
H+
 
Scheme 59.  Proposed mechanism for the carbonyl reduction with Et2AlN3 
 
The treatment of 6-isopropyl-4-oxo-4H-chromene-3-carbonitrile with 2.8 
equivalents of Et2AlN3 at room temperature for 24 hours gives a mixture of tetrazoles 122 
and 123 in very good yield (95 %) in ratio ca 3:2 (Table 8; entry 50). The two tetrazole 
derivatives are then isolated by chromatography. The α-β-unsaturated bond in the 6-
isopropyl-4-oxo-4H-chromene-3-carbonitrile could be activated by the coordination of 
the aluminum species with the carbonyl group and the alkyl residue of the 
dialkylaluminum azide may migrate to the β-position of the double bond. The system 
then, probably during the work-up, restabilizes the aromaticity by oxidation (Scheme 60). 
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The tetrazole ring may be already formed or can be formed simultaneously to the alkyl 
migration.  
 
O
O
X
O
O
X
X = tetrazole, CN
Et2AlN3
Et
Al
Et
O
O
X
Et
Al Et
O
OH
X
Et
work-up
-H+
123 
Scheme 60. Proposed mechanism for the formation of 123 
 
The 4-cyanobenzaldehyde reacts with 3 equivalents of Et2AlN3 to give a mixture 
of tetrazole 125 and 126 in good yield (85 %) in ratio ca 2:1 (Table 8; entry 51). The 
reaction probably proceed via an alkoxyaluminum intermediate which undergoes the 
ethyl migration 162 or hydride shift to give respectively 125 (Scheme 61) and 126 
(Scheme 62). The tetrazole ring may be already formed or can be formed simultaneously 
to the alkyl or the hydride migration.   
 
O
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X = CN, tetrazole                                                                               125
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Et OH
H
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Scheme 61. Proposed mechanism for the formation of 125 
 
The product 126 is formed by the hydride shift from the β-carbon on the alkyl residue of 
the diethylaluminum azide to the carbonyl group (Scheme 62) with the formation of one 
molecule of ethylene which derives from the alkylaluminum residue.  
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H H
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                                                                                                                           126 
 
Scheme 62. Proposed mechanism for the formation of 126 
 
According to Scheme 105, the tetrazole 128 could be also formed by the migration of the 
hydride group to the carbonyl (Table 8; entry 52). 
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1.2.3.9. Synthesis of triazoles 
 
 
 
 
 
 
 
 
 
 
Table 9. Synthesis of triazoles. [a] Et2AlN3 (1.8 M in toluene), [b] Et2AlN3 (2.7 
M in xylene) 
 
We only started to investigate the triazoles formation using dialkylaluminum azides 
with alkynes. First experiments show that the cycloaddition occurs under mild conditions 
(Table 9). For example triazole 130 is prepared in a relative good yield with 
equimolecular amount of Et2AlN3 starting at – 50 °C and warming the reaction mixture to 
0 °C in five hours (Table 9; entry 53). Methyl phenylpropiolate  requires longer reaction 
time compared to but-2-ynedioic acid methyl ester and triazole 132 is prepared in good 
yield in three days at room temperature (Table 9; entry 54).  
 
 
1.2.3.10. Synthesis of alternative azides 
 
 
During the course of the studies, we have investigated the [1,3,2]-
benzodioxaborole-2-azido 134 and the diisopropoxyde aluminum azide 139 as novel 
azide sources for the synthesis f tetrazoles, but, unfortunately without any success. Boron 
azides were already reported in the 1960s 163,164 but never used for the preparation of 
tetrazole rings. 
 
1.2.3.10.1. [1,3,2 ] Benzodioxaborole-2-azido (134)  
 
O
B
O
Cl
Me3SiN3
CH2Cl2, -78°C O
B
O
N N N
 
                                      133                                                                134 
Scheme 63. Synthesis of [1,3,2]-benzodioxaborole-2-azido 134 
 
Entry Starting material T [°C] Time [h] Product Yield [%] 
 
 
53[a] 
 
 
CO2MeMeO2C  
129 
 
 
-50 to 0 
 
 
5 
N
N
HN
O
O
O OH3C CH3  
130 
 
 
72 
 
 
54[b] 
 
CO2Me  
131 
 
 
r.t. 
 
 
72 
NH
N
N
O
O
CH3  
132 
 
 
57 
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The [1,3,2]-benzodioxaborole-2-azido 134 is prepared following the procedure 
reported by Klapötke and co-workers 165. Beta-chloro- or bromo-catecholborane dissolved 
in dichloromethane is treated, at -78°C, with 1.5 equivalents of trimethylsilylazide. The 
resulting solution is gradually warmed to room temperature and stirred for two hours. The 
solvent and the excess of trimethylsilylazide are removed by evaporation to give the 
product as a white crystalline material, which is hydrolyzed after few minutes. 
The reaction was furthermore followed by FT-IR spectroscopy and the spectra measured 
every two minutes for a period of 20 hours. The temperature was also monitored 
internally (Figures 33, 34). The trimethylsilylazide has a characteristic absorption band 
caused by asymmetric stretching vibration of the azide group at 2138 cm-1. After the 
addition of β-chloro-catecholborane this peak decreases and a new strong absorption 
band appears at 2169 cm-1, characteristic of the stretching vibration of the boron-azide 
group ν(B-N3). The desired [1,3,2]-benzodioxaborole-2-azido 134 hydrolyzed after 
crystallization, while we tried to prepare in situ 1.5 equivalents of 134 and use it toward 
cycloaddition for the synthesis of tetrazoles. Unfortunately, no tetrazoles are isolated 
using reactive starting nitriles under different reaction conditions (Scheme 66, Table 10). 
In some cases (Table 10; entries 1, 3), 4 % of desired product is detected by HPLC but 
probably because of the cycloaddion with the trimethylsilyl azide species. 
 
 
 
 
 
  
 
 
 
 
Figure 33. Decrease of signal at 2138 (s, ν(Si-N3)), increase of signal at 2169 (s, ν(B-N3)) cm
-1 
(3D picture) 
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Figure 34. Decrease of signal at 2138 (s, ν(Si-N3)), increase of signal at 2169 (s, ν(B-N3)) cm
-1  
 
 
 
Scheme 64. Synthesis of tetrazoles with [1,3,2]-benzodioxaborole-2-azido 
 
Entry Starting material T [°C] Time [h] Conversion [%] 
 
 
1[a] 
CN
F
 
          135 
 
50 
 
120 
 
24 
 
60 
 
0 
 
4 
 
2[a] 
O CN
O
 
136 
 
55 
 
27 
 
0 
 
3[a] 
N CN
H
Cbz  
120 
 
r.t. to 55 
 
48 
 
4 
 
Table 10. Synthesis of tetrazoles with [1,3,2]-benzodioxaborole-2-azido [a] 
conversion by HPLC 
 
1.2.3.10.2. Diisopropoxyde aluminum azide (139)  
 
We tried to prepare and isolate the diisopropoxyaluminum azide from the reaction 
of diisopropoxyaluminum chloride prepared in situ with sodium azide (Scheme 65). A 
solution of 2 equivalents of aluminum isopropoxyde in toluene is treated, at 0 °C, with 
R
N N
NHNO
B
O
N3
R CN
CH2Cl2, Toluene
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aluminum chloride, warmed at room temperature and stirred over the night. The resulting 
solution is cooled at 0 °C and treated  with 3 equivalents of sodium azide, than gradually 
warmed at room temperature and stirred over the night. The resulting heterogeneous 
mixture is centrifuged to obtain two solid layers and an upper solution which are checked 
separately by IR without detect any characteristic stretching vibration of an 
organoaluminum-azide group around 2150 cm-1. 
 
Al
O
OO
2
AlCl3
Toluene
   r.t.
Al
O
O
Cl
3 NaN3
0°C to r.t.
Al
O
O
N N N +   3  NaCl3
 
       137                                                138                                                    139 
Scheme 65. Synthesis of disopropoxyde aluminum azide 
 
 
 
1.2.3.11. Tetrazolate salts and nucleophilic substitution 
 
Neutralization of tetrazolic acids with metal hydroxides give stable metal tetrazolate 
salts (Section 1.1.1.2.) 1,16 which are reactive toward nucleophilic substitution. 
                                                                         
1.2.3.11.1. 5-(4’-Methyl-biphenyl-2-yl)-tetrazole potassium salt (140) 
 
 
H3C NH
NN
N H3C N
NN
N K
KOH
MeOH, r.t.
 
                                                      22                                            140   
Scheme 66. Preparation of 5-(4’-methyl-biphenyl-2-yl)-1H-tetrazole potassium salt 140 
 
5-(4’-Methyl-biphenyl-2-yl)-tetrazole, dissolved in methanol, is treated with 
equimolar amounts of potassium hydroxide and stirred at room temperature for two 
hours. The solvent is removed to give the desired tetrazolate salt in quantitative yield. 
 
1.2.3.11.2. 5-(4-Chloro-phenyl)-tetrazole cesium salt (2) 
 
The 4-chloro-phenyl-tetrazole 1, dissolved in methanol, is treated with equimolar 
amounts of cesium hydroxide monohydrate and stirred at room temperature for one hour. 
The solvent is removed to give the desired tetrazolate derivative in quantitative yield. 
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                                               Cl
NH
NN
N
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+
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.
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                                                         1                                         2  
Scheme 67. Preparation of 5-(4-chloro-phenyl)-tetrazole cesium salt 2 
  
1.2.3.11.3. Nucleophilic substitution with tetrazoles 
 
O
S O
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O
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O
O
N
N
N
Cl
Cl
N
NKN
N
O
O
N
N
NN
Cl
Acetonitrile
+ +
NO2
60°C, 32 h
N1-Isomer                       N2-Isomer
13.5 %                             81 %  
141                              142                                                   143                            219 
                
Scheme 68. Synthesis of (S)-2-[5-(4-chloro-phenyl)-tetrazol-1-yl]-4-phenyl-buthyric acid ethyl 
ester 143 and (S)-2-[5-(4-chloro-phenyl)-tetrazol-2-yl]-4-phenyl-buthyric acid ethyl ester 219 
 
The 5-(4-chloro-phenyl)-tetrazole potassium salt is prepared by treating the 1.3 
equivalents of 4-chlorophenyltetrazole 1 with equimolar amounts of potassium hydroxide 
in methanol at room temperature for one hour. The solvent is removed and the resulting 
crystalline material added, at room temperature, to a solution of (R)-2-(nitro-
benzenesulfonyloxy)-4-phenyl-butyric acid ethyl ester 141 in acetonitrile. The resulting 
mixture is stirred 32 hours at 60 °C. The product is extracted with ethyl acetate and 
potassium carbonate to remove the excess of tetrazole into the aqueous phase and then 
chromatographed (elution system hexane / ethyl acetate 9:1) to give the two regioisomers 
in good yield with a ratio N1- and N2- of 1 to 6. The reaction is not further investigated 
and should follow an SN2 mechanism. 
Chapter 1 - Conclusion 
 63 
  
1.3.   The 5-Substituted Tetrazoles: Conclusions 
 
 
 
The first reported method to synthesize tetrazoles was the reaction of hydrazoic acid 
(HN3) with organic cyanides in 1932 67. However, this procedure has not found practical 
application on account of the high toxicity, explosive nature and low boiling point (37 °C) 
of hydrazoic acid. Currently, 5-substituted tetrazoles are usually obtained by the addition of 
azide salts to nitriles (typically at 100-150 °C) (Section 1.1.3.). Unfortunately, all of these 
protocols have disadvantages including: the use of toxic metals, expensive reagents, harsh 
reaction conditions, water sensitivity and the presence of dangerous hydrazoic acid. 
Methods that seek to avoid hydrazoic acid liberation during the reaction by avoiding acidic 
conditions require a large excess of sodium azide as well as long reaction times. In 
addition, the majority of methods use dipolar aprotic solvents such as DMF. One of the 
most common methods involves the use of sodium azide in the presence of ammonium 
chloride or tertiary ammonium hydrochloride to form in situ ammonium azide species 
(Section 1.1.3.1.2.1.). The reaction is accompanied by the sublimation of explosive NH4N3, 
which also occurs when aprotic solvents instead of DMF are used for the reaction 166. 
Trimethylsilyl- and trialkyltin- azide are alternative general reagents (Section 1.1.3.1.4.). In 
some cases, full conversion can only be obtained with a large excess of azide and harsh 
reaction conditions. The major drawback of this method is the difficult removal of highly 
toxic residual organotin at the end of the reaction 167. Huff proposed a procedure in 1993 
using equimolar amounts of trimethylsilyl azide activated by triethylaluminum in toluene, 
but highly hindered nitriles resulted in poor conversion (Section 1.1.3.1.4.2.). The 
Sharpless approach utilizing zinc catalysis in aqueous conditions is an improvement over 
previous methods (Section 1.1.3.1.3.), but still requires the tedious removal of zinc salts 
from the final product and additional waste water treatments. Moreover, the reaction rates 
at 100 ° C are often insufficient for bulk intermediates and the process requires higher 
temperature and longer reaction time. 
The application of dialklaluminum azide for the synthesis of 5-substituted tetrazoles is 
a new efficient process and offers several advantages over many of the previously 
published procedures, including a reduced environmental impact resulting from the 
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elimination of toxic waste 141,142. The use of dialkylaluminum azides as an azide source 
greatly reduces the hazard posed by in situ generation of hydrazoic acid and avoids 
ammonium- and alkylammonium- azide formation. The reaction is suitable for use on a 
large scale as special care is not required when recycling waste water because aluminum is 
a non-toxic metal compared to tin organo metallics. As dialkylaluminum chlorides are 
available in large quantities and are relatively inexpensive (they are produced for use in 
Ziegler-Natta catalysis) the reaction is also economically attractive. Dialkylaluminum 
azides are prepared in a short time (4-8 h, r.t.), are soluble in organic solvents, are cheap 
and non-toxic. The cycloaddition occurs under mild conditions and it is possible to 
synthesize a broad variety of tetrazole derivatives in the presence of different functional 
groups including halogens, –sulfonyl, -thioethers, alkenes, esters, and ethers 168. Because of 
the low pKa of 1H-tetrazoles (~3-5) and their highly crystalline nature, a simple work up 
procedure is usually sufficient to provide the pure tetrazoles. In addition we can confirm 
that the general procedure described herein is applicable to a wider range of substrates 
leading to the corresponding tetrazoles in good yields. The high reactivity, low costs and 
the eco-compatibility due to the aluminum make this novel process particularly attractive 
and, in addition, is applicable for large scale preparation. Therefore the discovery and the 
development of this new methodology for the preparation of tetrazoles is significant with 
respect to safety, economy, ecology, diversity of substrates. 
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Chapter 2. 
Alkylation of Tetrazole Ring 
 
 
2.1. Alkylation of Tetrazole Ring: Introduction 
 
 
 
The tetrazole itself is an aromatic nucleus, which may exist in two tautomeric forms 
(Figure 35)1 (See Section 1.1.). 
     
R
N
H
N
NN
R
N NH
NN
 
                 1H                           2H 
Figure 35. Tautomeric forms of 5-substituted tetrazoles 
 
Replacement of the tautomeric ring hydrogen leads to two possible type of disubstituted 
tetrazoles, namely the 1,5- and the 2,5-disubstituted tetrazoles, respectively the 1N and 
2N-alkylated (Scheme 69). The transformation of 5-substituted tetrazoles to N-substituted 
tetrazoles is fundamentally important for the preparative chemistry of tetrazoles.  
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Scheme 69. Structure and numbering of disubstiuted tetrazoles
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2.1.1. Chemical and Physical Proprieties of 
Disubstituted Tetrazoles 
 
 
2.1.1.1. Physical properties 
 
N-Unsubstituted tetrazoles are generally white solids where the hydrogen in the 
tetrazole ring provides intermolecular hydrogen bonding which influences the melting 
point. N-Unsubstituted tetrazoles tend to be moderately high-melting solids due to these 
intermolecular hydrogen bonding. Replacement of the ring NH hydrogen by a methyl 
causes in 1,5- and 2,5-disubstituted tetrazoles a low-melting point except where the 5-
substituent itself is capable of forming hydrogen bonds (e.g., OH or NH) 1. In molecules 
where hydrogen bonding is not possible, for example in the N-methyl disubstituted 
tetrazole series, the more polar 1,5-disubstituted form (high dipole moment) usually has a 
higher melting point or boiling point than the corresponding 2,5-disubstituted isomer 
(lower dipole moment) (Figure 36). In general 1,5-disubstituted tetrazoles have a dipolar 
moment in the range of 5.0-5.90 D and the corresponding 2,5-derivatives have values of 
2.4-2.7 D 1.  
F
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N N
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                   96                        145                           146 
       mp 158-160 °C          mp 74-77 °C            mp 70-74 °C 
 
N
NHN
N N
NN
N
H3C
N
NN
N CH3
ClClCl  
                                              1                        147                           148 
                             mp 255-257 °C          mp 120 °C          mp 108 °C 
 
Figure 36. Examples of melting points of tetrazole series 
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2.1.1.2. Solubility and chromatography 
 
The solubility of tetrazoles is strongly influenced by the effect of carbon or nitrogen 
substituents on the charge distribution in the ring.  In general, 2,5-disubstituted tetrazole, 
with low dipole moments, tend to be soluble in apolar organic solvents 1. The different 
dipole moments usually ensure excellent separation of regio-isomers on silica gel columns 
with normal elution systems such as hexane / ethyl acetate 5:1.  
 
2.1.1.3. Nuclear magnetic resonance spectroscopy  
 
NMR spectroscopy is particularly useful for determing the sustitution pattern in 
tetrazoles. 13C-NMR shifts of the tetrazole C-5 is sensitive to the bonding pattern in the 
ring and allows a distinction of isomers. The chemical shift for 2,5-disubstituted tetrazoles 
are generally 10 ppm deshielded than for the corresponding 1,5-disubstituted isomers 
(Figure 37, see Experimental Part, Section 4.2) 1,169. 
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Figure 37.
 13C-NMR shifts of the C-5 in 1,5- and 2,5-disubstituted tetrazoles 
 
The chemical shifts of carbon atoms in nitrogen heterocycles are generally governed by the 
number and location of nearby nitrogen atoms. The electron densities may be the main 
factors in determining chemical shifts. Tetrazole exhibited abnormal 13C shielding but 
showed 1H shift in agreement with the π-electron densities. 
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2.1.2. Alkylation of Tetrazole Ring with Alkyl Halides 
 
 
Alkylation of 5-substituted tetrazoles is one of the most useful routes for the 
preparation of N-substituted derivatives due to the availability of various starting tetrazoles, 
alkylating agents and to the simplicity of the process 32a,98,170. At the present time, 
introduction of an appropriate N-substituent into an already existing tetrazole cycle is the 
most common synthetic pathway to disubstituted tetrazoles (Section 1.1.4). 
In almost all the cases alkylation of 5-substituted tetrazoles with alkyl halides give rise to 
mixtures of isomeric 1,5- and 2,5-disubstituted tetrazoles 1,171 (Section 2.1). The position of 
substitution has been found to be sensitive to the steric requirements of the alkylating agent 
and to the C-5 substituent of tetrazole 98,172. We report here some example of recent 
reported literatures for the alkylation of 5-substituted tetrazoles. 
 
2.1.2.1. Alkylation of tetrazoles  
 
Triphenylmethyl (trityl) group is one common protecting group for tetrazole rings 173. 
It is demonstrated that the alkylation of tetrazoles with triphenylchloromethane provides 
exclusively the N2-derivatives (Scheme 70) 32a. The reaction is usually carried out in the 
presence of base and it is presumable that tritylation of 5-substituted tetrazoles follows SN1 
mechanism.  
N
NN
H
N
Br
N
NN
N
Br
Ph3CCl
Et3N, CH2Cl2
0°C to r.t., 3h
90%  
      26                                                            151 
Scheme 70. Preparation of N-trityl-tetrazoles 
 
2.1.2.2. Alkylation of tetrazoles with alcohols 
 
The alkylation of tetrazoles with alcohols can be performed under a variety of 
conditions 170. Alcohols readily generate carbenium cations in the presence of acidic 
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catalysts and react with N-unsubstituted tetrazoles yielding mixtures of 1N- and 2N-
regioisomers. The reaction can be carried out in neutral organic solvents (dichloromethane, 
acetonitrile, chloroform) in the presence of catalytic amounts of sulphuric or a Lewis acid 
(Scheme 71). 
 
N N
N
H
NR
N N
N
NR
R'
N N
N
NR
R'
++ R'OH
cat. H+ or Lewis acid
-H2O  
Scheme 71. 
 
Formation of 2N-alkyl derivatives as the sole products has been reported for the 
reaction of 5-substituted tetrazoles with secondary and tertiary aliphatic alcohols such as 
tert-butyl alcohol in sulphuric acid media (Scheme 72) 98,174,175,176. The reaction proceed at 
room temperature in high yields in relative short time (1-3 hours). In this acidic conditions 
the tetrazoles is partailly protonated to form the symmetrical 1H,4H-tetrazolium cation, in 
the latter, only the atoms N2 and N3 are accessible for electrophilic attack whereas both N1 
and N4 are blocked by the attached protons.  
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Scheme 72. 
 
 
2.1.2.3. Alkylation of tetrazoles by addition of C-C multiple bonds 
 
N-Unsbstituted tetrazoles react with vinyl ethers in acidic-catalyzed conditions.  The 
tetrazole forms a bond with the α-carbon atom of the vinyl moiety (Scheme 73). The N2-
alkylated tetrazole is the predominantly formed products. 
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Scheme 73. Addition onto C=C bonds 
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Addition onto the triple bonds in aryl acetilenes yields α-substituted N-vinyltetrazoles, but 
so far, only 5-trifluoromethyltetrazoles has been reported as 5-substituted starting material 
(Scheme 74). 
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                            152                                                         153                           154 
Scheme 74. Addition onto C≡C bonds 
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2.1.3. Methylation of Tetrazole Ring 
 
 
  In the last years a wide variety of N-methyl-tetrazole derivatives has been reported 
from pharmaceutical companies as compounds with biological activities. In medicinal 
chemistry they can find application in the treatment of pain and inflammation 155 177, 
obesity 156 178, HIV 157 179, diabete 180, as anticancer 181 and antimicrobial agents 182. 
More than 600 patent applications including N-methyl-tetrazole derivatives were 
published in the last ten years from pharmaceutical and agricultural companies and some 
example is shown in Scheme 77.  
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Scheme 75. N-Methyl tetrazoles with biological activity 
 
2.1.3.1. Methylation with dimethyl sulfate 
 
Dimethyl sulphate 183 is a well known methylating agent for amines, phenols, 
alcohols, thiols and tetrazoles 184,185. Typically, one methyl is removed more quickly than 
the other methyl group. The mechanism that typically occurs with dimethyl sulfate is an 
SN2 reaction. 
Dimethyl sulfate is carcinogenic and toxic 186. The toxicity of dimethyl sulfate is so 
extreme that some consider it a potential chemical weapon while is absorbed through the 
skin, mucous membranes and gastrointestinal tract. Since dimethyl sulfate is very toxic, 
other methylating reagents are often used. However, it is sometimes more appropriate to 
use dimethyl sulfate due to the effectiveness and affordability. 
 
2.1.3.2. Methylation with methyl iodide 
 
          Methyl iodide is an excellent reagent for SN2 substitution reactions and is a well 
known reagent used for methylation, like dimethyl sulfate, but is less hazardous and more 
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expensive. Methyl iodide is a liquid with low boiling point (42.5 °C) and  there are some 
disadvantages to its use such as its toxic profile 187. The substance can be absorbed into 
the body by inhalation of its vapor, by ingestion and through the skin. It is irritating to the 
eyes, the skin and the respiratory tract and may cause effects on the central nervous 
system.  
Methylation of tetrazoles is normally carried out on the tetrazolate anion generated in situ 
by dissolution in an equimolar quantity of aqueous sodium hydroxide, with 
stoichiometric methyl iodide in acetone followed by heating at reflux for 3 to 18 hours 
(Scheme 76),188,189 or in ethanol-water (1:1) under reflux for 12 hours 12,190 or with NaH 
in THF 191  among others. 
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Scheme 76. Methylation of tetrazole rings with MeI 
 
 
2.1.3.3. Methylation with diazomethane 
 
Diazomethane is a well known methylating agent for carboxylic acids 2,192. It react 
with 5-substituted tetrazoles to yield the corresponding disubstituted derivatives, 1- and 
2N-methyltetrazoles, in ratio close to that observed for alkylation of the respective 
tetrazolates with dimethylsulfate or methyl iodide 98 (Scheme 77).  
 
N N
N
H
NR
N N
N
NR
Me
N N
N
NR
Me
CH2N2 +
 
Scheme 77. Methylation of tetrazole ring with CH2N2 
 
A plausible explanation for such similarity is that the first stage of the process is a fast 
proton transfer from the NH-acidic heterocycles to a diazomethane molecule. Then, at the 
rate limiting step, the tetrazolate anion and protonated diazomethane form an ion pair 98. 
The methylation of tetrazoles with diazomethane has the tendency to be currently rarely 
used because of its highly toxic and explosive nature. In addition, polyethylene may form 
as a byproduct of diazomethylation 193. 
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2.1.3.4. Methylation with trimethylsilyldiazomethane 
 
Trimethylsilyldiazomethane, 194 a greenish yellow liquid, is stable thermally and 
can be distilled at atmospheric pressure, is commercially available and is a safer 
alternative for diazomethane as methylatig agent. However the industrial use of this 
methylating agent is limitated by cost and by the fact that it forms numerous artifacts 
complicating spectra interpretation. Thus a reaction of this diazoalkane with water-free 
acetic acid in benzene at room temperature gave not only the expected 
trimethylsilylmethyl acetate but also methyl acetate and trimethylsilyl acetate (Scheme 
78) 195. 
 
Me3SiCHN2                       Me3SiCH2N2
+ OAc-                   Me3SiCH2OAc
Me3SiOAc    +     CH3N2
+ OAc-
- N2
CH3OAc
HOAc
HOAc
- N2
 
Scheme 78. 
 
2.1.3.5. O-Alkyl-S-propargyl xanthates (dithiocarbonates) 
 
Zard et al. reported recently esterification reagents capable of reacting with NH-
acids as well 196 to methylate and benzylate 5-substituted tetrazoles (Scheme 79). The 
methylation gives a 1 to 7 mixture of 1N- and 2N-substituted tetrazoles respectively, 
whereas the only reaction product detected in the benzylation is the corresponding 2-alkyl 
derivatives.  
 
N N
N
H
NR
N N
N
NR
R'
N N
N
NR
R'
+R'O
S
S
R' = Me, Bn
+
 
Scheme 79. Alkylation of tetrazoles with dithiocarbonates 
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2.1.3.6. Synthesis of methyl-tetrazoles from imidates 
 
 In an extension work of Zard 96, reaction of imidate hydrochloride salt with methyl 
hydrazine gives compound 159 which could be treated with sodium nitrite in diluted 
hydrochloric acid to give the 1N-methyl-5-phenyltetrazole in good yield. This approach is 
complementary to the direct methylation of the free tetrazole ring which leads to a 
mixture of isomers where the 2N-isomer dominates (Scheme 82). 
 
OEt
NH+
H
Cl- H2N-NHCH3
NH
N
NH2 NaNO2/ HCl
N
N
N
N
Me H2O
Me
 
              158                                                           159                                                     160 
Scheme 80. Synthesis of 1N-methyl-5-phenyltetrazoles from imidates 
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2.2.  Alkylation of Tetrazole Ring:  
Results and Discussion 
 
 
 
In the course of our investigation towards the protection or alkylation of the 
tetrazole moiety, we prepared a variety of N-alkylated tetrazoles including tert-butyl- (See 
Chapter 3), benzyl-, trytil- and methylated derivatives. According to published data for 
numerous 1,5- and 2,5-disubstituted tetrazoles, the 1,5-regioismer are generally more 
polar, they have a higher melting point and the position of the C-5 signal in their 13C 
NMR differs considerably: it is located at about δ 150 ppm and 160 ppm, respectively for 
the 1,5- and the 2,5-regioisomer (Section 2.1.1.). Therefore, the regioisomers can be 
distinguished with a high reliability and, generally, they can be isolated in good yields by 
simple chromatography on silica gel. 
 
Preparation of N-isopropyl-tetrazole rings 
 
The (R)-2-(tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 113 is 
efficiently alkylated at room temperature in acetonitrile under basic conditions using 2 
equivalents of 2-iodopropane (Scheme 83) 142. The two regioisomers are isolated by 
chromatography (elution system: hexane / ethylacetate 3:1). 
 
I
N N N
NH
N
N N N
N
N
N N N
N
N
Cbz
K2CO3
r.t., 3d
+ Acetonitrile +
Cbz
HHH
64%                                28%
Cbz
 
                               113                                                161                                 162 
 
Scheme 81. Synthesis of (R)-2-(isopropyl-tetrazole-5-yl)-pyrrolidine-1-carboxylic acid 
benzyl esters 161 and 162 
 
Tritylation of tetrazole ring 
 
The (R)-2-(tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 113 is also 
efficiently converted into the corresponding trityl derivative using 1.1. equivalent of 
chlorotriphenylmethane in the presence of triethylamine in THF at room temperature for 
2 hours (Scheme 84). The triphenylmethyl (trityl) is a common protecting group for the 
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tetrazoles 173. According to published data, the alkylation of 113 with 
triphenylchloromethane provides exclusively the 2N-derivatives 164 for steric reasons 32a 
and the tritylation presumably follows a SN1 mechanism. 
N N N
NH
N
Cbz
Cl
N N N
NN
Cbz
  THF
 r.t., 2h
+
Et3N
HH
77 % 
              113                                    163                                              164 
 
Scheme 82. Synthesis of (R)-2-(2-trityl-2H-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 
164 
 
Benzylation of tetrazole rings 
 
Tetrazole rings are readily converted into the N-benzyl derivative at room 
temperature using 1.2 equivalents of benzyl bromide in acetone under basic conditions.    
The 4-[2-benzenesulfonyl-2-(benzyl-tetrazol-5-yl)-vinyl]-benzoic acid methyl ester 166 
and 167 are obtained in ratio 1 to 1 (Scheme 83). The two regioisomers have a similar 
polarity and their separation is very difficult by chromatography on silica gel. 
S
O O
N
H
N
NN
COOCH3
+
Br
S
O O
N
N
NN
COOCH3
+
S
O O
N
N
NN
COOCH3
K2CO3
Acetone, r.t.
69 %
 
           165                      68                                       166                                   167 
Scheme 83. Synthesis of 4-[2-benzenesulfonyl-2-(benzyl-tetrazol-5-yl)-vinyl]-benzoic acid methyl 
ester 166 and 167 
 
The starting 4-[2-benzensulfonyl-2-(tetrazol-5-yl)-vinyl]-benzoic acid methyl ester 165 is 
obtained via Knovenagel reaction between the tetrazole 75 and methyl-4-formylbenzoate 
in the presence of 20 % of piperidine in dioxane at reflux for 15 hours yielding only 30 % 
of the desired Knovenagel product 165 (Scheme 84).  
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S
O O
N
H
N
NN
+
CHO
COOCH3
Piperidine 20%
  Dioxane
reflux, 15 h
S
O O
N
H
N
NN
COOCH3
30 %
 
        75                                    72                                                                     165 
Scheme 84. Knovenagel reaction for the synthesis of 4-[2-benzensulfonyl-2-(tetrazol-5-yl)-vinyl]-
benzoic acid methyl ester 165 
 
To improve the yield of this reaction, different reaction parameters were tested but 
dioxane as solvent in the presence of piperidine was found to be the best condition (Table 
11).  
 
Entry Aldehyde [equiv] Solvent Catalyst T [°C] Time [h] Yield [%] 
1 1 i-BuOH β-alanine 100 12 6.5 
2 1 pyridine piperidine 125 18 18 
3 1 dioxane piperidine reflux 15 30 
4 1.5 dioxane piperidine reflux 15 20 
 
Table 11. Screening of reaction conditions for the synthesis of 4-[2-
benzensulfonyl-2-(tetrazol-5-yl)-vinyl]-benzoic acid methyl ester 165 
 
The 2-(tetrazol-5-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester 111 was readily 
converted into the corresponding N-benzylated derivatives 168, 169 under the same 
conditions as 165 (Scheme 85). Fortunately, in this case, the two regioisomers are 
efficiently separated by chromatography on silica gel (elution system: hexane/ethyl 
acetate 3:1)   
 
N
H
N N
N
N
H
N
H
N N
N
N
N
H
N N
N
N
PhCH2Br
K2CO3
Acetone, r.t.
Boc Boc Boc
+
44%                                49%
                 111                                                     168                                    169 
            
Scheme 85. Synthesis of (S)-tert-butyl-2-(benzyl-tetrazol-5-yl)-pyrrolidine-1-carboxylate 
168 and 169 
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2.2.1. Novel Methylation of Tetrazole Rings using  
 1-Methyl-3-p-tolyltriazene as Methylating Agent 
 
 
Methylation of tetrazole rings is normally carried out by using iodomethane, 
diazomethane, dimethylsulfate or trimethylsilyldiazomethane (Section 2.1). All these 
methodologies suffer from several disadvantages such as the high toxic profile and 
thermal instability of the methylating agent, possible presence of byproducts and toxic 
water waste. Therefore, a new and safe methodology for the methylation of tetrazole rings 
is highly desirable. We have found that the 1-methyl-3-p-tolyltriazene is an efficient and 
safer methylating agent for tetrazole ring and overcome the above mentioned 
disadvantages. 1-Alkyl-3-p-tolyltriazenes 197,198,199 are commercially available or can be 
easily prepared 4,200,201. The 1-methyl-3-p-tolyltriazene is a well known alkylating agent 
used for the methylation of carboxylic acids,193,202 but it was never used for the 
methylation of tetrazole rings.  
The methylation of tetrazole rings proceeds nearly quantitatively in an aprotic solvent 
such as dichloromethane at room temperature in a short time and with a wide variety of 
5-substituted tetrazoles in the presence of different functional groups such as halogens, 
double bonds, protecting groups (Boc and Cbz), thio and sulfanyl. The reaction can be 
easily monitored by TLC (typical elution system: ethyl acetate / hexane 1:4) or by HPLC. 
The ratio of the 1,5- and 2,5-regioisomers is between 1:1 to 1:4 depending on the nature 
of the substituent in position C-5 and the isomers are easily separated by simple 
chromatography on silica gel. 
Although the mechanism is not well understood, we suggest that the pathway for the 
carboxylic acids 265,202 can be extended to 5-substituted tetrazoles. The tetrazole ring is 
deprotonated and the resulting tetrazolate attacks the methyl group in a nucleophiic 
substitution SN2 to form the desired N-methyl-tetrazole derivative, aniline and nitrogen ( 
Scheme 86). 
Ar N
H
N N
Me
+ Ar NH2 +  N2Ar N
H2
N N
Me
N
N
N
N
H
R
N
N
N
N
R
N
N
N
N
R
Me
 
Scheme 86. Proposed mechanism for the methylation of N-unsubstituted tetrazoles with methyl-
aryl-triazene 
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2.2.1.1. 1-Methyl-3-p-tolyltriazene  
 
Alkyl-aryl-triazenes exist as a tautomeric mixture of forms 170 and 171  (Figure 38) 
and are already known as methylating agent for carboxylic acids 203. 
 
Ar N N NH R Ar
H
N N N R  
170                                              171 
Figure 38. Tautomeric forms of alkyl-aryl-triezenes 
 
The IR spectra of monoalkyltriazenes generally show two NH stretching vibration bands, 
one at 3480 – 3440 cm-1, assigned to tautomer 170 and the other near 3338 cm-1 assigned 
to tautomer 171 201. From the temperature dependence of the intensity ratio of the IR 
bands, ∆H of the tautomeric equilibrium is estimated to be 0.3 kcal mol-1. 1H NMR 
spectrum of 3-methyl-1-p-tolyltriazene, measured in dichloromethane at –65 °C or in 
chloroform at -55 °C, exhibits only one resonance, a doublet for the N-methyl protons, 
indicating that only tautomer 170 is detectable under these conditions. However, tautomer 
171 of the same p-tolyltriazene has been detected in chloroform by 13C NMR 
spectroscopy 204 and the failure to detect the 1H NMR signals of the form 171 has been 
ascribed to low intensities of these signals which may well be considerably broadened. 
 
2.2.1.1.1. Preparation of 1-methyl-3-p-tolyltriazene 
 
 The 1-methyl-3-p-tolyltriazene can be easily prepared from the corresponding 
diazonium 6,200,201 salt or via the Grignard method 200,201a. 
 
2.2.1.1.1.1.  Preparation via Grignard 
 
The formation of monoalkyltriazene by the reaction of a Grignard reagent with an 
aryl azide was already reported by Dimroth in 1903 (Scheme 87)199,201a. 
 
ArN3   +   RMgX                   ArN(MgX) N=N-R                      ArNH-N=N-R  
Scheme 87. Synthesis of monoalkyl-triazene via Grignard reaction 
 
This methodology can not be used when the aryl group contains substituents which may 
react with the Gignard reagent such as CO2R and CN functional groups. In the majority of 
such instances the diazonium coupling method described below, is a practical alternative. 
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2.2.1.1.1.2. Preparation via diazonium coupling 
 
The monoalkyl-aryltriazenes can be easily prepared with the N-coupling of an aryl 
diazonium salts with primary amines in the presence of sodium carbonate in DMF 
(Scheme 88) 200,201a. 
Me
N2
+
+ MeNH2
Na2CO3
DMF Me
N
N
NHMe
 
                                   172                                                                 173 
 
Scheme 88. Synthesis of 1-methyl-3-p-tolyltriazene via diazonium salt 
 
2.2.1.1.2. Reactions of 1-alkyl-aryltriazene 
 
Synthetic applications of monoalkyltriazenes include esterification, deamination of 
primary amines and the ability to act as bridging agents in coordination chemistry, 
although one could look upon this property as an extension of their nucleophilic character 
201a. 
 
2.2.1.1.2.1.Reaction with acids 
 
Alkyl-aryltriazenes decompose when in contact with acids; consequently, 
purification by standard chromatographic methods is not always possible 201a. For instance 
the reaction of 1-phenyl-3-alkyltriazenes with aluminum trihalides affords N-
alkylanilines, with nitrogen evolution (Scheme 89).  
Ar N N NH R Ar
H
N N N R
LA
Ar N N N R
LA
H
Ar
H
N RLA + N2
ArNH2
ArNHR  
Scheme 89. Degradation of monoalkyl-aryl-triazenes  
 
2.2.1.1.2.2. Methylation of carboxylic acids 
 
1-Alkyl-3-aryltriazenes are known alkylating agent of carboxylic acids because of 
its facility to release the alkyl fragment 193,201c,. The reaction of carboxylic acids with 1-
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methyl-3-p-tolyltriazene, in particular with polymethacrylic acids, is already known for 
several years (Scheme 90) 193,200-202. 
 
R COOH Ar N+ N NH Me Ar NH2 + R CO2Me + N2   
Scheme 90. Methylation of carboxylic acids with 1-methyl-3-p-tolyltriazene 
 
The proposed mechanism for the methylation of carboxylic acids with 1-methyl-
aryltriazene follows a nucleophilic substutution SN2 to give the desired methyl-ester,  
aniline and nitrogen 201a,202 (Scheme 91).  
Ar N
H
N N
Me
OO
H
+ Ar NH2 +  N2R MeO R
O
Ar N
H2
N N
Me
OO
R  
Scheme 91. Proposed mechanism for the methylation of carboxylic acids with methyl-aryltriazene 
 
Contrary to diazomethane, 1-methyl-3-p-tolyltriazene can be purchased and safely stored 
on the shelf to be used as needed and the formation of polyethylene contamination is 
eliminated.  
 
 
2.2.1.1.2.3. Reduction to anilines and primary amines  
 
The alkyl-aryltriazene can also be reduced to aniline and primary amine by using 
nickel/aluminum alloy in base 205. The compound is reduced under mild conditions 
dissolving the triazene in water or alcohol with potassium hydroxide and treating with 
nickel/aluminum alloy at room temperature for twenty hours (Scheme 92). 
 
Ar N N N
Me
Ar NH2 +
H
H3C NH2
Ni-Al alloy
KOH/H2O, MeOH
      r.t., 20h  
Scheme 92. Reduction of 1-methyl-aryltriazene with Ni/Al alloy 
 
 
2.1.1.1.2.2. Nucleophilic attack  
 
The nucleophilic character of monoalkyl-aryltriazenes is at once evident from the 
fact that formation of penta-azadienes often accompanies triazene formation during N-
diazo coupling. Dimroth 199 showed that the same unsymmetrical penta-azadiene arises 
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from two different coupling reactions of diazonium salt with 1-methyl-3-aryltriazene 
(Scheme 93). 
Ar' N N NH MeArN2
+ + N N
N
N N
Me
Ar'Ar Ar N N NH MeAr'N2
+  +  
 
Scheme 93. Formation of penta-azadiene 
 
Significantly, diazo-coupling occurs at the N-atom adjacent to the methyl, not the aryl 
group. The greater nucleophilicity of N-3 is also evident during acetylation with acetic 
anhydride, which affords 3-acyl derivatives 199a,201a. 
Reaction of 1-methyl-3-p-tolyltriazene 173 with thioketene 174 affords the S-aryl 
thioimide 176 via the thioacylated triazene 155 (Scheme 94). 
 
Ar N N N
Me
S
CH(CF3)2Ar N N NH Me
-N2
N
Me
S CH(CF3)2
Ar+  (CF3)2C=C=S
173 174 175 176  
Scheme 94. Reaction of  1-methyl-3-p-tolyltriazene with thioketenes  
 
2.2.1.1.2.5. Complex formation    
 
The nucleophilic character of triazenes leads to the formation of triazenido-metal 
bonds, which offer a variety of bonding arrangements in transition metal complexes 201a. 
Three fundamental coordination modes have been identified: 1) monodentate, with Pt and 
Pd (typical for dialkyltriazenes), 2) bidentate, with Rh and Co, 3) triazenido-group as a 
bridging ligand between two metal atoms, which can also be bonded to each other, with 
Ag, Rh, Ir and Hg (Figure 39) 201a .  
M
N N N
N
M
N
N
N
N
NM
M'
1)                        2)                    3)  
Figure 39. Modes of complexation of triazenes 
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2.2.1.2. Methylation of tetrazole rings with 1-methyl-3-p-tolyltriazene 
 
A series of  tetrazoles with different functional groups at the C-5 position are 
converted into the corresponding N-methyl derivatives in good yield under mild 
conditions. All the N-methyl tetrazoles, with exception of 147 and 148, are unknown 
compounds. The reactions are achieved by dissolving the tetrazole derivative in 
dichloromethane and treating with 1.25-1.5 equivalents of 1-methyl-3-p-tolyltriazene 
from 0 °C to room temperature (Scheme 95). 
 
R N
N
H
NN N N N
H
CH3
H3C
CH2Cl2, r.t.
N
N
NN
R N
N
NN
+
CH3
CH3
N2-Isomer              N1-Isomer
R
 
 
Scheme 95. Methylation of the tetrazole ring 
 
When HPLC and TLC analysis show ≥ 98 % conversion (usually after 20 minutes – 2 
hours), the reaction mixture is cooled at 0 °C and treated with HCl (2 M) to quench the 
excess of 1-methyl-3-p-tolyltriazene which decomposes to aniline, N-methyl-aniline and 
nitrogen (Sectition 5.2.4.). The desired N-methyl-tetrazole is extracted with 
dichloromethane into the organic phase. The two regioisomers are then isolated by 
chromatography on silica gel (typical elution system: hexane/ethyl acetate 4:1) to yield 
the two pure N1- and N2-isomers in ratio between 1:1 to 1:4, depending on the nature of 
the substituent in position C-5 (Table 12). 
All the reaction conditions herein described are not optimized because our first goal was 
to prove the applicability of 1-methyl-3-p-tolyltriazene as a versatile methylating agent 
for tetrazole rings.  
 
According with published data, the N1-regioisomer is more polar compared to the N2 and 
this is confirmed by the melting point and the HPLC analysis (Table 13). The position of 
the C-5 signal in their 13C NMR differs considerably: it is located at about δ 150 ppm for 
the N1-isomer and 160 ppm for the N2-isomer. Therefore, isomeric 1,5- and 2,5-
disubstituted tetrazoles can be distinguished with a high reliability (Introduction, Section 
2.1). 
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Table 12. Synthesis of N-methyl-substituted tetrazoles. 
Notes: [a] reaction performed at r.t.; [b] N2/N1 ratio based on HPLC of the crude; [c] isolated 
yield after chromatography 
 
 
  
 
Yield
[c]
 [%] 
Entry 
Time 
[h] 
Product 
N2/N1-Isomer
[b]
 
[%] N2 N1 
1[a] 2 
 
N N
NN
N N
NN
CH3
CH3F F
 
                   146                        145 
71/29 58  12 
2[a] 2 Cl
N N
NN
Cl
N N
NN
CH3
H3C
 
                  148                        147 
75/25 44 13 
3[a] 0.2 
S
O O
N
N
NN
COOCH3
CH3
S
O O
N
N
NN
COOCH3
CH3
 
                  177                        178 
57/43 66 14 
4[a] 4 
N
NN
NH3COOC CH3N
NN
NH3COOC
H3C
 
                  150                        149 
73/27 53 17 
5[a] 0.3 S
O O
N
N
NN
CH3
S
O O
N
N
NN
CH3
 
                 179                      180 
52/48 38 36 
6[a] 2 N N
N
N
H3C
S
N N
N
N
CH3S
 
                  181                     182 
66/34 55 42 
7[a] 1 S N
N
NN
CH3
S N
N
NN
CH3
 
                    183                     184 
52/48 53 32 
8[a] 1.5 N N
N
N
CH3
N N
N
N CH3
N N
H H
CbzCbz
 
                     185                    186 
75/25 61 31 
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Table 13. Physical properties of  N-methyl-substituted tetrazoles. 
* Rotamers 
 
Aromatic tetrazole derivatives in the presence of halogens are suitable substrates for 
methylation with 1-methyl-3-p-tolyltriazene (Table 12; entries 1, 2). The reaction is 
carried out at room temperature in 2 hours using 1.5 equivalents of 1-methyl-3-p-
tolyltriazene (Table 12; entries 1, 2). The halogen position on the aromatic ring does not 
influence the final ratio of N1- and N2-regioisomer which is around 1 to 2. Starting 
tetrazole derivative which contain aromatic rings, conjugated double bond and sulphonyl 
moiety undergoes the methylation in a very short time (15 minutes) affording the desired 
N-methylated tetrazole 178 and 177 in good yield with a regioselectivity N1 and N2 of 1 
to 4 (Table 12; entry 3). The X-ray structure of 177 was solved and used as additional 
reference to distinguish in all the cases the 1,5- and 2,5-disubstituted tetrazole isomers 
(see X-ray discussion, Chapter 4) (Figure 40). 
 
 
 
Figure 40. Structure of 4-[2-benzene-
sulphonyl-2-(2-methyl-2H-tetrazol-5-yl)-
vinyl]-benzoic acid methyl ester 177 in the 
crystal with thermal ellipsoids drawn at 50 
% probability level 
 
 
Product HPLC 1H NMR  (CH3-N) 
[ppm] 
 
13
C NMR (C-5) 
      [ppm] 
mp 
[°C] 
146 
145 
148 
147 
177 
178 
150 
149 
179 
180 
181 
182 
183 
184 
185 
186 
8.90 
6.37 
8.21 
5.61 
9.54 
9.35 
14.03 
12.02 
4.62 
4.55 
5.75 
3.37 
7.90 
6.54 
8.03 
7.08 
4.45 
4.03 
4.41 
4.15 
4.40 
3.83 
3.86 
3.56 
4.33 
4.12 
4.40 
4.20 
4.33 
3.84 
4.27, 4.30 
3.81, 4.10 
162.1 
153.7 
163.2 
153.2 
156.9 
147.8 
164.2 
154.1 
156.1 
146.5 
160.2 
149.4 
162.4 
153.1 
167.7, 167.9* 
156.3, 156.7* 
70-74 
74-77 
108 
120 
156-158 
158-160 
- 
117-120 
137-139 
182-184 
84-85 
110-111 
- 
- 
- 
- 
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In the case of 2’-(tetrazol-5-yl)-biphenyl-4-carboxylic acid 187, the tetrazole ring and the 
carboxylic acid moieties are simultaneously methylated in good yields using 1-methyl-3-
p-tolyltriazene at room temperature in 4 hours (Table 12; entry 4) (Scheme 96). 
 
N N N
H
CH3
H3C
CH2Cl2, r.t., 4h
N1-Isomer                                N2-Isomer
NH
NN
NHOOC N
NN
NH3COOC CH3 N
NN
NH3COOC
H3C
+
 
                  187                                                                                149                                      150 
Scheme 96. Synthesis of 4-[1-ethylidene-2-(methyl-terazol-5-yl)-penta-
2,4-dienyl]-benzoic acid methyl ester 149 and 150 
 
 
The regioselectivity is lower in the case of sulfur containing tetrazole derivatives (Table 
12; entries 5-7), between 1 to 1 (Table 12; entry 5) up to ca 2 to 3 (Table 12; entry 7) with 
the 2N-methylated tetrazole as the major regio-isomer. 5-Phenylsulfonylmethyl-tetrazole 
75 undergoes the methylation using 1.4 equivalents of 1-methyl-3-p-tolyltriazene at room 
temperature for 20 minutes (Table 12; entry 5). The 5-thiophen-2-yl-tetrazole 109 
provides the corresponding N-methyl-tetrazoles 181 and 182 in high yield using 1.5 
equivalents of 1-methyl-3-p-tolyltriazene at room temperature for 2 hours (Table 12; entry 
6). The 5-benzylsulfanyl-N-methyl-tetrazoles 181 and 182 are obtained in 2 hours in good 
yield using 1.5 equivalents of 1-methyl-3-p-tolyltriazene with a slight higher 
regioselectivity compared to 75 and 17 (Table 12; entries 5-7). 
The (S)-2-(tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 112 is methylated in 
very good yield using 1.5 equivalents of 1-methyl-3-p-tolyltriazene at room temperature 
for 1.5 hours, with a regioselectivity N1 and N2 of 1 to 2 (Table 12; entry 8) 205. The 
resulting (S)-2-(methyl-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl esters 185, 186 
can be considered as precursors of a novel class of N-alkylated-tetrazole-pyrrolidine 
organocatalysts 142 (Organocalysis; Chapter 3) which could be prepared from the cleavage 
of the Cbz protecting group, as shown in Scheme 99. 
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N N N
H
CH3H3C
CH2Cl2, r.t., 1.5hHN N
N
N
N N
N
N
H3C
N N
N
N CH3
+ NNN
HHH
Cbz Cbz Cbz
61%                             31%
N CN
H
Cbz
Et2AlN3
 Toluene 
 50°C, 9h
96%
          H2
EtOH, r.t. 3-4h
N N
N
N
H3C
N N
N
N CH3
N
H
N
H
HH
120 112
186 185
188                           189  
Scheme 97. Proposed synthesis of novel organocatalysts 
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2.3. Alkylation of Tetrazole Rings: 
Conclusions 
 
 
 
The introduction of an appropriate N-substituent into an already existing tetrazole 
cycle is the most common synthetic pathway to disubstituted tetrazoles (Section 1.1.4), 
due to the availability of various starting tetrazoles, alkylating agents and the simplicity of 
the process 32a,98,170. These transformations are fundamentally important therefore in the 
last years a wide range of N-alkyl-tetrazole derivatives has been reported from 
pharmaceutical companies as compounds which present biological activities 177-181. 
Although the disubstituted tetrazoles attract interest, the preparation methods for these 
compounds are not sufficiently developed 37a. Within last decades not a single new 
approach was advanced for building up a tetrazole ring with substituents in position N-1 
or N-2, especially for methylated tetrazole rings. 
We have prepared a wide variety of N-alkylated tetrazoles, including N-isopropyl, -
tert-butyl (See Chapter 3), -trytil, -benzyl and methyl tetrazoles. According to published 
data for numerous 1,5- and 2,5-disubstituted tetrazoles, we were able to isolate and 
distinguish with high reliability the two regioisomers. In almost all the cases, alkylation of 
5-substituted tetrazoles with alkylating agents give rise to mixtures of isomeric 1,5- and 
2,5-disubstituted tetrazoles 1,171 (Section 2.1). The position of substitution has been found 
to be sensitive to the steric requirements of the alkylating agent and to the C-5 substituent 
of tetrazole 98,172. A significant instance are the trytilation and the tert-butylation of 
tetrazole rings which provide exclusively the N2-regiosiomer. 
The general protocols for the methylation of tetrazole rings suffer from several 
disadvantages such as the high toxic profile of the methylating agent, toxic water waste 
and possible presence of byproducts (Section 2.1.3.). Typical examples of methylating 
agents used for tetrazoles are methyl iodide, dimethylsulfate and diazomethane. We have 
found that the 1-methyl-3-p-tolyltriazene is a valuable, safe and efficient alternative for 
the methylation of tetrazole rings, with possible application for large scale process. The 1-
methyl-3-p-tolyltriazene is a well known alkylating agent used for the methylation of 
carboxylic acids 193,202, but never used for the methylation of tetrazoles. The reaction 
occurs rapidly (20 min to 4 hours) at room temperature. A simple work-up procedure 
gives the mixture of 1-5 and 2-5-methyl-tetrazole derivatives which are generally 
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separated by chromatography on silica gel. Contrary to other methylating agents, 1-
methyl-3-p-tolyltriazene can be purchased and safely stored on the shelf to be used as 
needed. The possibility of polyethylene contamination typical in the case of diazomethane 
is eliminated because of the reagent’s stability. The high reactivity, low cost and safe 
storage of 1-methyl-3-p-tolyltriazene make this novel process particularly attractive with 
possible application in an industrial scale. In addition, other alkyl-aryltriazenes could be 
tested and used to introduce different alkyl residues in the tetrazole moiety thanks to their 
high reactivity as an alkyl fragment-donor and their availability. 
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Chapter 3. 
Organocatalysis 
  
 
  
Until a few years ago, it was generally accepted that transition metal complexes and 
enzymes were the two main classes of very efficient asymmetric catalysts. Synthetic 
chemists have scarcely used small organic molecules as catalysts throughout the last 
century, even though some of the very first asymmetric catalysts were purely organic 
molecules. By contrast chemists have focused on transition metal catalysts. A change in 
perception occurred during the last few years when several reports confirmed that 
relatively simple organic molecules can be highly effective and remarkably 
enantioselective catalysts of a variety of fundamentally important transformations 206. 
This rediscovery has initiated an explosive growth of research activities in 
organocatalysis both in industry and in academia. As realization grows that organic 
molecules not only have a "green" advantage but also can be very efficient catalysts, 
asymmetric organocatalysis may begin to catch up with the spectacular advancements of 
enantioselective transition metal catalysis.  
Asymmetric catalysis represents still one of the major challenges in modern 
organic chemistry. Besides the well-established asymmetric metal-complex-catalyzed 
syntheses and biocatalysis, the use of "pure" organic catalysts turned out to be an 
additional efficient tool for the synthesis of chiral building blocks.  
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3.1. Organocatalysis: introduction 
 
 
 
Between the extremes of transition metal catalysis and the enzymatic 
transformations, a third approach to the catalytic production of enantiomerically pure 
organic compounds has emerged: organocatalysis 207. Organocatalysis is the acceleration 
of chemical reaction with substoichiometric amount of an organic compound. 
Organocatalysts are purely “organic molecules” composed of mainly C, H, O, N, S and P 
atoms to accelerate chemical reactions. Organocatalysts have several advantages 
including inertness toward moisture and oxygen, availability, low cost and low toxicity, 
which confers a huge direct benefit in the production of pharmaceutical intermediates 
when compared with transition metal catalysts. 
During the last few years the asymmetric catalysis of carbonyl transformations via 
iminium ion and enamine intermediates using chiral amines as organocatalysts has grown 
most remarkably. The first publications from the groups of MacMillan, List, Denmark, 
and Jacobsen among others paved the way in the years 1990s. These reports introduced 
highly enantioselective transformations that rivaled the metal-catalyzed reactions in both 
yields and selectivity. Once this foundation was laid, mounting interest in organocatalysis 
was reflected in a rapid increase in publications on this topic from a growing number of 
research groups. 
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3.1.1. Catalysts and Mechanism:  
              The Enamine and Iminium Catalysis 
 
 
The majority of organocatalysts are Lewis bases which initiate the catalytic cycle 
via nucleophilic addition to the substrate 208. Two different approaches can be envisaged 
for organocatalyzed reaction 209,210,211 (Scheme 98).  
 
N
EWG
Enamine
N :Nu
   Iminium  
 
Scheme 98. Enamine and iminium organocatlysys approach  
 
 
3.1.1.1. Enamine catalysis  
 
The first mechanism involves the catalytic formation of an enamine intermediate 
with the chiral amine, generally a chiral pyrrolidine derivative. The enamine, which is 
generated from carbonyl compound via iminium ion formation, reacts with an 
electrophile to give an α-modified iminium ion which gives, upon hydrolysis, the α-
modified carbonyl compound 153e,212 (Scheme 99). Examples of enamine catalysis are 
proline-catalyzed aldol reactions, Mannich reactions and Michael additions among 
others207. 
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Scheme 99. Enamine catalysis  
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3.1.1.2. Iminium catalysis 
 
The second approach is based on a chiral iminium ion from an unsaturated carbonyl 
and the chiral amine. The active species is an iminium ion formed by reversible reaction 
of a chiral amine with an α,β-carbonyl substrate (Scheme 98). Example of iminium 
catalysis is the MacMillan’s enantioselective Diels-Alder reaction 213.   
 
3.1.1.3. Organocatalysts 
 
Whereas many metal centers are good Lewis acids, organic catalysts tend to react as 
heteroatom-centered Lewis bases. Novel, previously unexplored catalysts classes are 
emerging. For example, asymmetric catalysis by Brønsted acid is a recent addition to the 
field of organocatalysis. Moreover, the design and use of synergetic systems and 
bifunctional catalysts, which have two distinct functionalities (e.g. a Lewis base and a 
Brønsted acid) within the same molecule, is becoming more and more common 207. A 
selection of typical organocatalysts is shown in Figure 41. Proline 193, a chiral-pool 
compound which catalyzes reactions by iminium ion or enamine pathway, is a 
prototypical example which promotes aldol and related reactions 210,214. The same is true 
for cinchona alkaloids 215 190 and 191. Amino acid derived organocatalysts such as the 
oxazolidinone 192 introduced by MacMillan et al. 213 or the thiourea 199 introduced by 
Jacobsen et al. have enabled excellent enantioselectivity in e.g., Diels-Alder reactions of 
α,β-unsaturated aldehydes (oxazolidinone 192) or hydrocyanation of imines 216 (thiourea 
199). Diamine catalysts such as 195 and 197 introduced respectively by Alexakis 209,217 
and Barbas 218 are versatile organocatalysts for Michael additions as well as tetrazole 
analogues of proline-derivatives 114 219 and 197 153g,160a. 
Chapter 3.    Introduction 
 94 
N
H
COOH
H
190
N
OMe
OH
H
191
193
NH
N
OMe
N
H OH
192
N
H
N
O
CH3Ph-H2C
H CH3
CH3
194
N
H
H
195
Ph
Ph
OTMS
N
H N
N
H
N
N
N
NH
N
H
N
196 197
N
H
H
198
N N
N
H
N
N
H OMe
114
R
H
N N
H
N
H
O
t-Bu H S
N
HO
t-Bu OR
199
 
Figure 41. Selection of organocatalysts 
 
3.1.1.4. Proline 
 
3.1.1.4.1. History 
 
Despite to very recent introduction of this type of catalysis to synthetic chemistry, 
organocatalytic reactions look back on a venerable history. The first example of an 
asymmetric organocatalytic reaction was reported y in 1912, by Bredig and Fiske 220. 
They reported a modestly enantioselective (≤ 10 % ee) alkaloid-catalyzed cyanohydrin 
synthesis. In the 1960s, Pracejus et al. showed that organocatalysts can give significant 
enantioselectivities. Using alkaloids as catalysts, afforded quite remarkable 74 % ee in 
the addition of methanol to phenylmethylketene 221. The 1970s brought a milestone in the 
area of asymmetric organocatalysis, when two industrial groups led by Hajos at Roche 
and Wiechert at Schering published the first highly enantioselective catalytic aldol 
reactions using the simple amino acid proline as catalyst 222, where the resulting ketone is 
an important intermediate in steroid synthesis (Scheme 100). The cinchona alkaloids and 
proline stood as the only familiar organocatalysts for some time. 
H3C
H3C
OO
O
L-Proline (3.47 mol%)
CH3CN
r.t., -80°C
O
OH3C
 
                                          200                                                                    201 
Scheme 100. The Hajos-Parrish-Eder-Sauer-Wiechert-reaction 
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3.1.1.4.2. Reactivity of proline  
 
Proline is capable of promoting a variety of catalytic asymmetric transformations 
153,207,210. It can react as a nucleophile with carbonyl groups or Michael acceptors to form 
iminium ions or enamines (Scheme 103). The use of proline as a catalyst requires 
normally amounts in the range of 10-20 mol % and furthermore, the substrate itself 
(ketone or aldehyde) or DMSO serve as solvents.  
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Scheme 101. The S-proline-mediated enamine catalytic cycle 153d  
 
 
3.1.1.5 Pyrrolidine-tetrazole 
 
Proline-derived compounds have proven themselves to be real workhorse 
organocatalysts. They have been used in a variety of carbonyl compound transformations, 
where the catalysis is believed to involve the iminium form. These catalysts are cheap 
and readily accessible. 
The organocatalysis system that has been studied extensively is the enantioselective 
proline-based one which accelerates a range of transformations including aldol reactions, 
Robinson annulation, Mannich reaction and Michael additions. Although proline is an 
ideal catalyst in terms of price and availability, often encountered drawbacks relates to 
low reactivity and low solubility of the catalyst. In addition, when these reactions are 
highly enantioselective, they require solvent such as DMSO due to the insoluble nature of 
the proline itself. An old “trick” in medicinal chemistry to improve the solubility of a 
carboxylic acid is the  replacement of the acid functionality with a tetrazole moiety. A 
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second generation catalysts, in which the carboxylic acid of proline is replaced by a 
tetrazolic acid have therefore recently emerged and have been proven to show improved 
reactivity and/or selectivity for many organocatalyzed reactions 223.  
3.1.1.5.1. History and synthesis 
Although (S)-5-(pyrrolidine-2-yl)-tetrazole 114 has already been synthetized in 
1971 by Grzonka et al. 224 and the phisico-chemical and biological properties have been 
investigated in the mild 1980s, its potential in asymmetric catalysis has been reported 
only in 2004 by Ley,225 Yamamoto,155 and Arvidsson et al. 226. Starting from the 
commercial available N-benzyloxycarbonyl protected S-proline 202, (S)-5-(pyrrolidine-2-
yl)-tetrazole is obtained in five steps (Scheme 102). 
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    CH2Cl2, r.t.
75%
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N
 
   202                                         120                                        112                                           114 
Scheme 102. Synthesis of (S)-5-(pyrrolidine-2-yl)-tetrazole 114 proposed by Ley 225 
 
 
3.1.1.5.2. Reactions 
 
The use of pyrrolidine-tetrazole as a valuable alternative to proline as 
organocatalyst is increasing since 2004. In this section we present only a brief overview 
of some reported application of pyrrolidine-tetrazole in asymmetric catalysis.  
Proline itself can be regarded as a bifunctional catalyst, with a carboxlic acid and an 
amine moiety, as well as the pyrrolidine-tetrazole (Scheme 103). These two 
functionalities can both  act as acid or base and can also facilitate chemical 
transformations.  
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Scheme 103. Bifunctional sites for S-proline and pyrrolidine-tetrazole 
 
The higher reactivity and enantioselectivity often obtained with (S)-5-(pyrrolidine-
2-yl)-tetrazole catalyst is ascribed to the lower pKa and increased steric bulk of the 
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tetrazole moiety  relative to S-proline. Tetrazole and S-proline have a pKa value of ~ 8 
and ~ 12, respectively in DMSO. The hydrogen bonding interactions in the transition 
state of the same reaction with the two catalysts are likely different and provide different 
levels of enantioselection 223 (Figure 42).  
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                                                     203                        204 
Figure 42. Proposed transition states 203 of S-proline and 
pyrrolidine-tetrazole 204 mediated enamine catalytic cycle 
 
 
3.1.1.5.2.1. Asymmetric Mannich reaction  
 
Barbas et al. recently reported the organocatalytic Mannich reaction of azido 
ketones with imines in the presence of the (S)-5-(pyrrolidine-2-yl)-tetrazole as catalyst to 
afford diamines with excellent yields and enantioselectivities 157. The azido group 
controls the regioselectivity of the reaction providing access to chiral 1,2-diamines from 
azido ketones (Scheme 104). 
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Catalyst Solvent Time Yield dr [syn/anti] ee (syn)[%] 
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DMSO 48 84 51:49 92 
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90 
 
Scheme 104. Organocatalytic asymmetric synthesis of 1,2-azidoamine 
 
 
Ley et al. reported the application of (S)-5-(pyrrolidine-2-yl)-tetrazole to catalyze 
Mannich-type addition of ketones to N-PMP-protected α-imino ethyl glyxalate 225 
(Scheme 105). 
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CH2Cl2 2 65 >19:1 >99 
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CH2Cl2 2 0 - - 
 
Scheme 105. Addition of cyclohexanone into N-PMP-protected α-imino ethyl glyxalate 
 
It is interesting to note that the same reaction conditions with S-proline 227 gave no 
observable product after the same amount of time, indicating that organocatalyst 
solubility is a key in this reaction. 
The proposed hydrogen-bonded transition state is similar to that suggested by Houk and 
Bahmanyar 228 (Figure 43). The PMP group on the imine sits axially to avoid clash with 
the tetrazole, thereby forcing the E-enamine to produce the syn-product. 
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Figure 43. Proposed transition state for the pyrrolidine-tetrazole catalyzed Mannich reaction. 
 
 
3.1.1.5.2.2. Asymmetric Nitro-Michael addition  
 
(S)-5-(Pyrrolidine-2-yl)-tetrazole 114 is a suitable organocatalyst for nitro-Michael 
addition and overcomes the solvent-limits of the S-proline 229. In alcoholic solvent, 
pyrrolidine-tetrazole outperforms the proline, both in terms of yield and 
enantioselectivity (Tables 14, 15).  
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Author Catalyst Solvent T [°C] Yield
[a]
 [%] 
 
dr 
[b]
 
[syn/anti] 
ee  
[c]
 [%] 
Ley 229 
N
H
H
HN N
N
N
 
CH2Cl2 
CH2Cl2 
DMSO 
MeOH 
EtOH 
20 
40 
20 
20 
20 
20 
98 
97 
61 
65 
>15:1 
>15:1 
>15:1 
>15:1 
>15:1 
40 
37 
35 
53 
65 
 
 
 
List 230 
Barbas  218c 
N
H
H
OH
O
 
CH2Cl2 
MeOH 
DMSO 
DMSO 
THF 
40 
20 
20 
20 
20 
0 
37 
93 
94 
7 
- 
>15:1 
>15:1 
>20:1 
48:1 
- 
57 
35 
23 
56 
Barbas  218b 
NH
N
 
THF 20 86 48 :1 86 
Alexakis 209 N
H
N
HCl
 
CHCl3 20 74 94:6 81 
Ley 160a 
NH HN N
N
N
 
IPA-EtOH 
1:1 
20  >19:1 91 
 
Table 14. Michael addition of cyclohexanone to nitrostyrene; [a] isolated yield; [b] based on 1H 
NMR; [c] based on chiral HPLC 
 
Using the pyrrolidine-tetrazole 114 as catalyst, the reaction can be performed with 1.5 
equivalents of ketone 231. The relative configuration of the product has been confirmed by 
X-ray analysis 229. The improvement in enantioselectivity of the pyrrolidine-tetrazole 
catalyst over the proline suggests that there is an inherent difference between the two 
organocatalysts that alters the transition state. The proposed transition states involves the 
participation of the tetrazole in a hydrogen bonded framework as is suggested by Enders 
for proline (Figure 44).  
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Figure 44. Proposed transition state in organocatalyzed asymmetric nitro-Michael addition 
 
The nitro Michael addition of isovaleraldeyde to nitrostyrene is tested with several 
organocatalysts, but never with 114 or 115 (Table 15). 
Cat. 20 mol%
solvent, r.t.
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H
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O
H
NO2  
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Author Cat.  Solvent 
Time 
[h] 
Yield
[a] 
[%] 
dr
[b]
 
[anti/syn] 
ee
[c]
 (syn) 
[%] 
Barbas 218a,218c N
H
H
OH
O
 
THF 72 <5 93 :7 25 
 
NH
N
O
 
THF 72 78 92 :8 72 
 
NH
N
 
THF 72 80 80:20 75 
Alexakis 232 NH
O
N
O
 
CHCl3 72 85 94:6 88 
Palomo 233 
NH
H
N
iPr
iPr
O
 
CH2Cl2 20-24 >99 
[d] 98:2 40 
Ley 160a 
NH HN N
N
N
 
IPA:EtOH 
(1:1) 
24 39-40 >19:1 37 
Table 15. Michael addition of isovaleraldehyde to nitrosyrene. [a] isolated yield; [b] based on 1H 
NMR; [c] based on chiral HPLC; [d] Determined by 1H NMR 
 
3.1.1.5.2.3. Asymmetric addition of malonates to enones  
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                          215                     216                                               217 
Cat. Solvent Conversion
[a]
 [%] ee 
[b] 
[%] 
N
H
H
HN N
N
N
 
CH2Cl2 
CHCl3 
89 
69 
79 
89 
NH HN N
N
N
 
CHCl3 40 0 
N
H
H
OH
O
 
CHCl3 62 38 
 
Table 16. Organocatalyzed addition of malonate to cyclohexanone. [a] 
Estimated by 1H-NMR; [b] Based on chiral HPLC 
 
(S)-5-(Pyrrolidine-2-yl)-tetrazole 114 is an effective catalyst for the asymmetric 
addition of malonates to enones (Table 16). The reaction gives good results for a range of 
substrates providing the product with good enantioselectivities using 1.5 equivalents of 
enone as coupling partner 234. 
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3.1.1.5.2.4. Asymmetric α-amination of aldehydes 
 
Barbas et al. recently reported the application of the pyrrolidin-tetrazole catalyzed 
α-amination of an aldehyde in a total synthesis sequence of the cell adhesion inhibitor 
BIRT-377 223 (Scheme 106). 
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Scheme 106. Synthesis of BIRT-377 
 
3.1.1.5.2.5. Aldol reactions  
 
(S)-5-(Pyrrolidine-2-yl)-tetrazole 114 is a suitable organocatalyst for aldol reaction 
226,235 (Table 17). The direct asymmetric aldol reaction between ketones and aldehydes 
relies on activation of the ketone partner through formation of the corresponding enamine 
as an intermediate through condensation with the secondary amine function of the 
catalyst (Scheme 109). 
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Cat. Solvent Yield  [%] ee [%]  
N
H
H
HN N
N
N
 
DMSO  
Dioxane 
DMF 
93 
88 
93 
76 
66 
70 
N
H
H
OH
O
 
DMSO 
Dioxane  
DMF 
75 
55 
50 
73 
44 
70 
 
Table 17. Organocatalyzed aldol reaction 226 
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Scheme 107. Proposed mechanism for pyrrolidine-tetrazole catalyzed aldol reactions 226 
 
The pyrrolidine-tetrazole is more reactive and sometimes yields higher stereoselectivity 
compared to proline, when employed as organocatalyst. Arviddson et al. suggested that a 
possible explanation is that proline easily engages in bicyclic oxazolidinone formation, 
while pyrrolidine-tetrazole does not 226. Consequently, more catalyst is available for 
forming the enamine intermediate in the aldol reaction in the case of pyrrolidine-tetrazole 
than when proline is used. In addition, factors related to the low solubility of proline 
contribute in reactivity. 
 
3.1.1.5.2.6. O-Nitroso aldol reaction 
 
Yamamoto et al. recently reported the use of the (S)-5-(pyrrolidine-2-yl)-tetrazole 
114 as an efficient catalyst for O-nitroso aldol ractions 236 (Scheme 108). 
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Cat. Time [h] Yield [%] ee [%] 
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1 94 >99 
N
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1 35 >99 
 
Scheme 108. O-Nitroso aldol reaction of cyclohexanone with nitrosobenzene 
 
Using α,β-unsaturated ketones Yamamoto et al. reported the synthesis of a nitroso Diels-
Alder adduct-type via an O-nitroso aldol reaction, followed by a Michael reaction 
(Scheme 109) 159. 
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Scheme 109. Stepwise O-nitroso aldol / Michael reaction  
 
 
3.1.1.6. Homo-proline tetrazole  
The synthesis and application of the homologue of the pyrrolidine-tetrazole has 
been reported by Ley and co-workers (Scheme 110) 160a,219.  
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Scheme 110. Synthesis of the homo-proline tetrazole 
 
Homo-proline tetrazole catalyzes the asymmetric Michael addition of a ketone to a nitro-
olefin. Its use gives improved entioselectivities in the Michael addition of carbonyl 
compounds to nitro olefins (Scheme 111) (Section 3.1.1.6.). 
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   209              211                                                                          212 
Scheme 111. Michael addition of cyclohexanone to nitrostyrene 
Two possible transition states are proposed. Both involve an electrostatic interaction 
between the nitro group and the nitrogen of the pyrrolidine ring (Figure 45).  
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Figure 45. Hydrogen-bonded transition state 232, and steric hindrance of tetrazole 233 
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Screening of different ketones and nitro olefins suggests that the nature of the nitro-
Michael acceptor has less effect on the stereoselectivity of the reaction than the ketone. 
This observation supports the second model of transition state since any electronic 
change of the nitro olefin could lead to a significant change in the interactions in the 
model 332 (Figure 45) 160a.  
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3.2. Organocatalysis: Results and Discussion 
 
 
 
The initial aim in our investigation was to design a novel class of organocatalysts 
which could be used in solvents more commonly used in organic synthesis with highly 
lipophilic substrates. Using our new methodology for the synthesis of tetrazole rings 
starting from the corresponding nitrile with dialkylaluminum azide (Section 1.2.), we 
decided to prepare a variety of compounds based on pyrrolidine-tetrazole skeleton 142 
which could find in the future application as a novel class of organocatalysts (Scheme 
112).   
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Scheme 112. Preparation of oganocatalysts based on pyrrolidine-tetrazole skeleton. a) Et2AlN3, 
xylene, 50 °C, 9 h; b,i) Pd/C (10 % wt), H2, EtOH, r.t., 4 h; c) 2 equiv Et2AlN3, xylene, 55 °C, 9 h, 
then 85 °C, 9 h; d) α-methylstyrene, TFA, CH2Cl2, r.t., 3d; e) t-BuOH, H2SO4, TFA, CH2Cl2, r.t., 8 
h; f,h) i-PrI, K2CO3, MeCN, r.t., 3d; g) Pd/C (10 % wt), H2, EtOH, r.t., 7 h 
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3.2.1. Synthesis of a Novel Class of Organocatalysts 
 
 
3.2.1.1. Synthesis of 5-pyrrolidine-2yl-tetrazole 
 
5-Pyrrolidine-2yl-tetrazole represents a new proline-derived organocatalyst that was 
developed recently by ourself 142 and others 155,225,226. Both the S- and the R-enantiomers 
may be prepared (Figure 46). 
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Figure 46. Structure of (S)-114 and (R)-5-pyrrolidine-2yl-tetrazole 115 
 
The utility of this catalyst has been demonstrated in several types of reactions including 
Mannich and aldol reactions, and Michael additions (Section 3.1.3.1). 
However, all the methods for the preparation of 114 and 115 suffer from some 
disadvantages in the tetrazole-forming step. The general methods to convert the nitrile 
into the corresponding pyrrolidine-tetrazole use ammonium azide 155,225,226 or  
triethylammonium azide 237 as azide sources which can form dangerous sublimates onto 
the side of the reaction vessel (Section 1.1.3.1.2.1.). Furthermore, the reported 
hydrogenation for the final cleavage of the Cbz-group requires the use of 9:1 acetic acid-
water mixture under a hydrogen atmosphere (Scheme 113, Table 18).  
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Scheme 113. General sequence for the preparation of (S)-5-(pyrrolidine-2-yl)-tetrazole 114 from 
the corresponding Cbz-protected nitrile 120 
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STEP 1 
Author Reagent  Solvent Time [h] T [°C] Yield 
Sharpless 238 NaN3, ZnBr2 H2O/i-PrOH 16 reflux 91 
Almquist 239 NaN3, NH4Cl DMF 6 90-95 100 
Yamamoto 155  NaN3, NH4Cl DMF 6 95 95 
Ley 225,229 NaN3, NH4Cl DMF 8 90-95 78 
Ley  237 NaN3, Et3N·HCl Toluene 24 95 95 
Arvidsson 226 NaN3, ZnBr2 H2O/i-PrOH 16 reflux 98 
Sedelmeier, 
Aureggi 142 
R2AlN3 (R=Me, Et) Toluene or xylene 6-9 50 90-96 
 
 
     
STEP 2      
Author Reagent  Solvent Time [h] T [°C] Yield 
Almquist 239 H2, Pd/C 10 % AcOH/H2O 9:1 4 r.t. 68 
Yamamoto 155 H2, Pd/C 10 % AcOH/H2O 9:1 4 r.t. 95 
Ley 229 H2, Pd/C 10 % AcOH/H2O 9:1 4 r.t. 89 
Ley  237 H2, Pd/C 10 % AcOH/H2O/EtOH 1:1:1 - - 98 
Arvidsson 226 H2, Pd/C 10 % No conditions   No yield given 
Sedelmeier, 
Aureggi 142 
H2, Pd/C 10 % EtOH 4 r.t. 90-96 
 
 Table 18. Reported reaction conditions for the preparation of (S)-5-(pyrrolidine-2-yl)-tetrazole 
114 from the corresponding Cbz-protected nitrile 
 
For the first time we report a mild reaction conditions sequence which provides the 
desired tetrazoles 114 and 115 in high yield and high reproducibility proved from the fact 
that this sequence was also scaled-up in 1.5 kg for the preparation of the R-enantiomer 
(Scheme 114). 
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Scheme 114. Sequence for the synthesis of (R)-5-(pyrrolidine-2-yl)-tetrazole 115 
from the corresponding Cbz-protected nitrile 234 
 
 
The formation of the tetrazole ring proceeds well under mild conditions. Using 2.4 
equivalents of Et2AlN3 in toluene at room temperature, the reaction requires longer time 
to reach completion. However, under these condition, after 2 hours the reaction 
conversion observed  by HPLC was 46 % and after 4 hours already 94 %. However, to 
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achieve total conversion (> 98% based on HPLC) the reaction requires 48 hours. 
Decreasing the amount of azide to 1.5 or 1.3 equivalents does not decrease the rate.  
At 50 °C after only 2 hours, 95 % of reaction conversion was observed by HPLC, 
however the reaction reached total conversion after 9-12 hours. Dimethylaluminum azide 
(1M in hexane) was tested as an alternative to diethylaluminum azide, but the reaction 
requires 24 hours to reach completion probably because of the lower concentration of the 
reagent. The (R)- and the (S)-enantiomers of the starting nitrile, provide the 
corresponding tetrazole with the same yield. 
The Cbz group is removed by hydrogenation using 10 % wt Pd/C in ethanol for 3 to 5 
hours at room temperature. We have found that ethanol could be a more appropriate 
solvent 205 compared to the acetic acid-water system previously described by other groups 
282a,293,301. Once that the hydrogenation is completed, the catalyst is removed by filtration 
through celite and acetic acid and water should be used to remove trace of product on the 
celite layer. The filtrate is concentrated and the (R)-5-(pyrrolidine-2-yl)-tetrazole is 
crystallized from a solution of aqueous acetic acid/ ethanol. X-ray analysis of the product 
shows that (R)-5-(pyrrolidine-2-yl)-tetrazole exists as a zwitterionic form in the solid 
state (Figure 47) (See X-ray discussion; Chapter 4) 
 
 
 
Figure 47. Structure of (R)-5-pyrrolidine-2-yl-
tetrazole 115 in the crystal with thermal ellipsoids 
drawn at 50 % probability level 
 
 
 
3.2.1.1.1. One-pot procedure for the synthesis of 5-pyrrolidine-2yl-tetrazole 
 
We observed that the Cbz protecting group can be removed with the 
diethylaluminum azide at temperature higher that 65 °C. The pyrrolidine tetrazole 114 
and 115 can be directly obtained in one-pot 142 by warming the reaction mixture at more 
than 65 °C with an excess of dialkylaluminum azide to provide first the cycloaddition and 
then the cleavage reaction (Scheme 115). Although purity of the 5-pyrrolidine-2-yl-
tetrazole obtained with the one-pot procedure is high according to NMR, broad peaks by 
IR and low optical rotation value may suggests the presence of some water soluble 
inorganic materials that are difficult to remove. 
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Scheme 115. One-pot reaction for the preparation of 5-pyrrolidine-2-yl-tetrazole 114 
 
3.2.1.1.2. Preparation of pyrrolidine tetrazole metal salts  
 
Neutralization of tetrazolic acid with metal hydroxide or analogues gives stable 
metal tetrazolate salts (Section 1.1.1.2.) 142. Sodium, potassium and cesium salts of the 
(R)-5-pyrrolidine-2-yl-tetrazole are prepared mixing 115 with equimolar amounts of 
metal hydroxide in methanol or water at room temperature. Evaporation of the solvent 
leads the desired salt in quantitative yield (Scheme 116).   
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Scheme 116. Preparation of pyrrolidine tetrazole metal salts 239-241 
 
The (R)-5-pyrrolidine-2-yl-tetrazole sodium salt 239 can be also quantitatively prepared 
using sodium methanolate in methanol at room temperature (Scheme 117). 
 
NH
N
H
N
NN
NH
N
N
NN
NaOCH3
Na
CH3OH
H H
 
                                             115                                           239 
Scheme 117. Preparation of (R)-5-pyrrolidine-2-yl-tetrazole sodium salt 239 
 
The (R)-5-pyrrolidine-2-yl-tetrazole palladium (II) complex 242 is prepared in 
aqueous THF with palladium acetate (0.5 equivalents) at 50 °C (Scheme 118). The 
product crystallizes in quantitative yield after standing at room temperature for two hours 
to give a white crystalline material suitable for X-ray analysis (See X-ray discussion; 
Chapter 4). 
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Scheme 118. Preparation and structure of (R)-5-pyrrolidine-2-yl-tetrazole palladium(II) 
complex 242 in the crystal (thermal ellipsoids drawn at 50 % probability level) 
 
 
3.2.1.2. Synthesis of N-alkylated pyrrolidine tetrazoles  
 
3.2.1.2.1. Synthesis of 2-tert-butyl-5-pyrrolidine-2-yl-2H-tetrazole (237, 243) 
 
Both the pure enantiomeric forms of the 2-tert-butyl-5-pyrrolidine-2-yl-2H-
tetrazole, 237 and 243, are efficiently prepared in sulfuric acidic media with tert-
butanol142. According to published data 98,174,175, the 2N-alkyl isomer is the only 
regioisomer obtained 98,142,176 (Section 2.1.). We believe that regioselectivity is due to the 
steric bulk of the alkylating agent. The reaction proceeds at room temperature in the 
presence of trifluoroacetic acid (ten folds excess), sulfuric acid and two equivalents of 
tert-butanol (Scheme 121). Basic extraction with dichloromethane and aqueous 
potassium carbonate or sodium hydroxide provides the free-base product as a brown oil.  
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Scheme 119. Preparation of 2-tert-butyl-5-pyrrolidine-2-yl-2H-tetrazole 243 
 
Brown crystals of (R)-2-(2-tert-butyl-2H-tetrazol-5-yl) pyrrolidinium trifluoro 
acetate 244 suitable for X-ray analysis are obtained by treating the free base with trifloro 
acetic acid in dichloromethane (Scheme 120, Figure 48) (See X-ray discussion; Chapter 
4). 
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Scheme 120. Preparation of (S)-2-(2-tert-butyl-2H-tetrazol-5-yl) pyrrolidinium trifluoro acetate 244 
 
 
 
Figure 48. Structure of (S)-2-(2-tert-butyl-2H-
tetrazol-5-yl) pyrrolidinium trifluoro acetate in the 
crystal with thermal ellipsoids drawn at 50 % 
probability level 
 
 
 
2-tert-Butyl-5-pyrrolidine-2-yl-2H-tetrazole treated with equimolar amount of 
HCl in dichloromethane leads, after evaporation of the solvent, to the (R)-2-(2-tert-
butyl-2H-tetrazol-5-yl) pyrrolidinium chloride 245 as a pink crystalline material 
(Scheme 121). 
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                                     236                                                        245 
Scheme 121. Preparation of (R)-2-(2-tert-butyl-2H-tetrazol-5-yl) pyrrolidinium chloride 245 
 
 
 
3.2.1.2.2. Synthesis of 2-(1-methyl-1-phenyl-ethyl)5-(R)-pyrrolidine-2-yl-2H-
tetrazole  (235) 
 
2-(1-Methyl-1-phenyl-ethyl)5-(R)-pyrrolidine-2-yl-2H-tetrazole 235 is efficiently 
prepared under acidic conditions (Scheme 122)142. Pyrrolidine-tetrazole 115 is first 
dissolved at room temperature in trifluoroacetic acid and dichloromethane, then treated 
with α-methylstyrene and stirred for three days. A basic extraction with aqueous sodium 
hydroxide neutralizes the excess of trifluoroacetic acid. The organic solvent is removed 
to afford a colorless oil which crystallizes upon standing at room temperature. Colorless 
single crystals suitable for X-ray analyses are obtained (Figure 45) by slow evaporation 
of a mixture of methanol / ethyl acetate (See X-ray discussion; Chapter 4). 
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Scheme 122. Synthesis of 2-(1-methyl-1-phenyl-ethyl)-5-(R)-pyrrolidine-2-yl-2H-tetrazole 235 
 
 
 
Figure 49. Structure of 2-(1-methyl-1-phenyl-
ethyl)-5-(R)-pyrrolidine-2-yl-2H-tetrazole 235 in 
the crystal with thermal ellipsoids drawn at 50 % 
probability level 
 
                     
Colorless crystals of 2-[(1-methyl-1-phenyl-ethyl)-2H-tetrazol-5-yl] pyrrolidinium 
saccharinate 248 are obtained by mixing equimolar amount of 235 with o-benzoic acid 
sulfimide in dichloromethane (Scheme 123)142. Single crystals suitable for X-ray analysis 
are obtained by slow evaporation of  the solvent (Figure 50) (See X-ray discussion; 
Chapter 4). 
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Scheme 123. Preparation of 2-[(1-methyl-1-phenyl-ethyl)-2H-tetrazol-5-yl] 
pyrrolidinium saccharinate 248 
 
 
 
 
 
Figure 50. Structure of 2-[(1-methyl-1-phenyl-ethyl)-2H-
tetrazol-5-yl] pyrrolidinium saccharinate 248 in the 
crystal with thermal ellipsoids drawn at 50 % probability 
level 
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3.2.1.2.3. Isopropyl-5-(R)-pyrrolidine-2-yl-tetrazole (237, 238) 
 
The two regioisomers of the (R)-(isopropyl-tetrazol-5-yl)-pyrrolidine-1-
carboxylic acid benzyl ester 237 and 238 are efficiently hydrogenated to provide the 
cleavage of the Cbz protecting group in ethanol at room temperature for 4 to 7 hours  
(Scheme 124) 142. 
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Scheme 124. Preparation of isopropyl-5-(R)-pyrrolidine-2-yl-tetrazole 237 and 238 
 
Yellow single crystals of the 1N-isomer 237 suitable for X-ray analysis are obtained by 
slow evaporation of a mixture of ethanol / dichloromethane (Figure 51; See X-ray 
discussion; Chapter 4). 
 
 
                       
Figure 51. Structure of 1-isopropyl-5-(R)-pyrrolidine-2-yl-
1H-tetrazole 237 in the crystal with thermal ellipsoids 
drawn at 50 % probability level  
 
 
 
 
Brown single crystals of 2-isopropyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole squaric acid salt 
250 suitable for X-ray analysis are obtained by slow evaporation of a solution of 
dichloromethane / THF containing equimolar amounts of 3,4-dihydroxy-3-cyclobutene-
1,2-dione  and 238 (Scheme 125, Figure 52; See X-ray discussion; Chapter 4). 
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Scheme 125. Preparation of 2-isopropyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole-squaric acid salt 250 
 
 
 
  
 
Figure 52. Structure of 2-isopropyl-5-(R)-
pyrrolidine-2-yl-2H-tetrazole-squaric acid salt 
250 in the crystal with thermal ellipsoids drawn 
at 50 % probability level. 
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3.2.2. Enamine  
 
 
There is agreement in the scientific community that the proline- and analogues-
mediated reactions of aldehydes and ketones with electrophiles involves an intermediate 
enamine. The proline-based organocatalyzed Michael addition of aldehyde to nitro 
olefins very likely proceeds via an enamine mechanism with amine-based 
organocatalysts240. Despite the increasing interest on organocatalysis confirmed by the 
increasing number of publications during the last years, there are not really evidences of 
the enamine intermediate in the catalytic cycle (Scheme 126).  
During the course of our studies, we have detected, characterized with spectroscopic 
analysis and, in some cases, isolated a variety of enamine derived from the condensation 
of aldehydes with the 5-pyrrolidine-2yl-tetrazole and its corresponding N-alkylated 
derivatives. 
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Scheme 126. Enamine catalytic cycle of the pyrrolidine-tetrazole mediated reactions 
 
3.2.2.1. Introduction 
 
Seebach et al. reported the diastereoselective Michael-addition of (E)-enamines to 
(E)-nitro olefins 241. The reaction of nitrostyrene 211 with enamines pre-formed from 
ketones and morpholine leads to γ-nitroketones possessing diastereomeric purities of 90-
99 % (Scheme 127). The Michael addition occurs with the (Re*Re*)-approach of the two 
components in the Newman projection with a gauche-relationship of the donor and the 
acceptor π-system in the Michael addition (Figure 53).  
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Scheme 127. Diastereoselective Michael addition of enamine to nitrostyrene 
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Figure 53. (Re*Re*)-Approach 
 
They also reported the chiral version of this Michael reaction pre-forming the enamine 
with a chiral morfoline and cyclohexanone, and treating it with nitrostyrene 242. The X-
ray structure of the resulting enamine intermediate was solved (Scheme 128). 
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Scheme 128. Asymmetric Michael addition and X-ray structure of the enamine-Michael-
intermediate 305   
 
Seebach et al. recently reported the role of the equilibrium between the enamine 
intermediate and the oxazolidinone form in the catalytic cycle of the proline-catalyzed 
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Michael additions (Scheme 129), in which each species involved in the catalytic cycle are 
characterized by spectroscopic studies 243.  
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Scheme 129. Equilibrium between the enamine and oxazolidinone 
 
Barbas et al. reported the detection of enamine formation through UV spectroscopy 
214,218a,c, and Alexakis et al. reported the detection of an enamine intermediate by GC-MS 
244. Jørgensen et al. reported the reaction between a chiral pre-formed enamine with 
methyl vinyl ketone 211 to give the desired product with 72 % ee (Scheme 130). 
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Scheme 130. Michael addition of pre-formed enamine with methyl vinyl ketone 
 
 
3.2.2.2. Enamine formation  
 
We have tested our new catalysts in Michael addition of carbonyl compounds with 
nitrostyrene (Section 3.2.3.). The high syn selectivity we observed is in accordance with 
results obtained in conjugate additions of preformed enamines to nitro olefins mentioned 
above. Key feature of these catalysts are the presence of the secondary amine required for 
enamine formation. Further studies are needed to elucidate the mechanism of these 
Michael additions, which very likely proceed via an enamine mechanism.  
Herein we report an enamine formation study between an aldehyde and our new class of 
organocatalysts based on pyrrolidine-tetrazole skeleton. 
The enamine formation between a selection of aldehydes and ours pyrrolidine-tetrazole  
organocatysts is proven by spectroscopic studies (Scheme 131, Table 19). In a general 
procedure, equimolar amounts of aldehyde and catalyst are dissolved in d6-DMSO. 
Signals corresponding to the enamine structure were detected in all the cases. 1H NMR 
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spectra in d6-DMSO revealed in all the cases a characteristic signal at δ 6.0-6.4 ppm with 
a coupling constant of ca 13.8 Hz (doublet or singlet depending on the starting aldehyde) 
attributed to the vinylic proton α to the nitrogen (hydrogen of the former aldehyde). The 
second characteristic signal of the enamine is the hydrogen at δ 4.0-4.9 ppm (3J = 13.8 
Hz) which corresponds to the β-vinylic proton. 
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Scheme 131. Equilibrium of the enamine formation 245 
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Table 19. Enamine conversion based on 1H NMR analysis 
 
Based on NMR analysis, 5-{1-[-2-phenylprop-1-en-1-yl]-pyrrolidine-2-yl}-tetrazole 259 
is formed after 5 minutes at room temperature with a conversion of 90 % (Table 19; entry 
1). The E-enamine is the major product with a ratio E and Z-enamine of 75 to 25 (Figure 
54). Using the 2-tert-butyl-5-pyrrolidine-2-yl-2H-tetrazole the equilibrium is almost 
shifted to the enamine (98 % conversion) with a ratio E and Z-enamine of 84 to 16 (Table 
19; entry 2).   
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Figure 54. 
1H NMR signal of the enamine 259 
 
Using the (R)-(+)-N-benzyl-α-methylbenzylamine as chiral amine, only 23 % of enamine 
was detected by 1H NMR analysis (Table 19; entry 3). Equimolecular amounts of 
isovaleraldehyde and (S)-5-pyrrolidine-2-yl-tetrazole 114 forms 67-70 % of E-enamine 
formation (Figure 55; Table 19; entry 4). The same experiment using S-proline revealed 
signals which can be attributed to those characteristic of enamines with a δ 3.99 (dd, 3J = 
13.8 Hz, 1H) and a δ 6.04 (d, 3J = 13.8 Hz, 1H) (Figure 56; Table 19; entry 5).  
 
 
 
Figure 55. Enamine formation between isovaleraldehyde and (S)-5-pyrrolidine-2-yl-tetrazole 114 
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Figure 56. Reaction between isovaleraldehyde and S-proline. Characteristic signals of enamine 
formation 
 
Using N-alkylated pyrrolidine tetrazoles (Table 19; entries 5, 6) as chiral amines with 
isovaleraldehyde, the equilibrium is shifted to the enamine formation and the signals of 
the stating amine and aldehyde are disappear. The same NMR experiment performed in 
CDCl3 reveals a conversion of 90-94 %. This difference can be explained by the presence 
of hydrochloric acid in the solvent which could hydrolyze partially the enamine formed.  
Enamine derived from the condensation of isovaleraldehyde (1.6 equivalents) and N-
alkylated-tetrazoles can be isolated and characterized (For examples see Figures 57, 58). 
The reaction is carried out in dichloromethane with an excess of solid potassium 
carbonate to catch the water formed during the condensation to the enamine. The mixture 
is stirred at room temperature for twenty minutes, the potassium carbonate is filtered, the 
solvent and excess of isovaleraldehyde removed to give the product as a colorless oil in 
quantitative yield (Scheme 132). The enamines formed are characterized by spectroscopy 
(NMR, IR, MS; for more details see experimental part; Section 5.3.).  
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Scheme 132. Preparation of enamines  
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Figure 57.
 1H NMR spectrum of the enamine 264 formed from the condensation between 
isovaleraldehyde and 2-tert-butyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole 236 (For more details see the 
experimental part; Section 5.3.) 
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Figure 58. 1H NMR spectrum of the enamine 263 formed from the condensation between 
isovaleraldehyde and 2-(1-methyl-1-phenyl-ethyl)5-(R)-pyrrolidine-2-yl-2H-tetrazole 235 (For 
more details see the experimental part; Section 5.3.) 
 
 
3.2.2.3. Oxazolines formation 
 
The treatment of α,α-diphenylprolinol with isolvaleraldehyde in dichloromethane in 
the presence of potassium carbonate provides to a bicyclic oxazoline compound 345  
(Figure 59). Netherless, the use of cyclohexanone under the same reaction conditions 
does not yield the corresponding oxazoline derivative.  
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Figure 59. (3R,4S)-3-Isobutyl-1,1-diphenyl-tetrahydro-pyrrolo [1,2-c]oxazole 267 (For more details 
see the experimental part; Section 5.3.) 
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3.2.3. Michael Addition 
 
 
Asymmetric C-C bond forming reactions are among the most challenging 
endeavors in organic synthesis. The Michael reaction is generally regarded as one of the 
efficient and effective transformations and studies concerning this reaction have played 
an important role in the development of modern organic chemistry 246.  
In organocatalysis, the most common feature of this reaction is the use of unmodified 
nucleophilic donors that, upon activation by intermediate enamine formation, add 
stereoselectively to the corresponding acceptor electrophiles under very mild conditions.  
Proline was one of the first to be studied and it successfully catalyzed the reaction both in 
DMSO and alcoholic solvents. However, in most cases reported the enatioselectvities 
obtaine are relativly low (See Section 3.1.). 
In order to test the efficacy of our new pyrrolidine-tetrazole based catalysts, the Michael 
addition of a carbonyl with nitrostyrene was selected. 
 
3.2.3.1. Michael addition of isovaleraldehyde and nitrostyrene 
 
The organocatylized Michael additions of isovaleraldehyde with nitrostyrene  
were screened at room temperature in different solvents and catalytic amounts of (R)-
(tetrazol-5-yl)-pyrrolidine 115 (Table 20). The amounts of catalyst plays a role in the rate 
of the reaction and the best results are performed in general with 20 mol % of catalyst. 
The reaction proceeds smoothly in dichloromethane (Table 20; entries 4-7). Different 
amounts of catalyst do not influence the enantioselectivity, while slightly influence the 
diastereoselectivity which is higher with 20-40 mol % of catalyst. Good 
diastereoselectivity are obtained also in ethanol or acetonitrile (Table 20; entries 1-3, 9-
10), although the enatioselectivity is lower. In ionic liquids the reaction is faster, but less 
selective (Table 20; entries 11-16).  
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O
+H
NO2 NH
N
H
N
NNH
solvent, r.t.
H
NO2
O
 
                        213                   211                                                              214 
 
Entry Solvent 
Cat 
[mol%] 
Time 
[h] 
Conversion[a]   
[%] 
dr[b]   
[syn/anti] 
ee [c]   
[%]syn 
1 
2 
3 
CH3CN 
 
5 
10 
20 
43 
23 
19 
36 
>95 
>95 
13:1 
17:1 
19:1 
30 
30 
31 
4 
5 
6 
7 
CH2Cl2 5 
10 
20 
40 
47 
30 
20 
20 
57 
>95 
>98 
>98 
14:1 
15:1 
19:1 
19:1 
49 
52 
56 
55 
8 
9 
10 
EtOH 10 
20 
40 
28 
20 
5 
93 
>99 
>95 
17:1 
17:1 
25:2 
24 
28 
19 
11 
12 
13 
BumiPF6 5 
10 
20 
24 
18 
5 
>95 
>95 
>95 
12:1 
12:1 
12:1 
31 
31 
32 
14 
15 
16 
EtmiBF6 5 
10 
20 
15 
4 
3 
>99 
>99 
>99 
18:1 
18:1 
18:1 
20 
29 
24 
 
Table 20. Michael addition of isovaleraldehyde and nitrostyrene. [a]  based on HPLC 
analysis of the reaction  mixture; [b] based on HPLC analysis of the crude 
product; [c]  based on chiral HPLC of the crude product  
 
A selection of catalysts was tested at room temperature (Scheme 133; Table 23). The S-
proline catalyzes the reaction in a shorter time compare to (R)-(tetrazol-5-yl)-pyrrolidine 
115 (Table 21; entries 1-3; 6-8), while the enantioselectivity is in general lower. The 
diastereoselectivity in ethanol is higher for proline (Table 21; entry 7), while in 
dichloromethane or acetonitrile is lower (Table 21; entries 6,8). N-Alkyl-pyrrolidine-
tetrazoles are not suitable catalysts for the Michael addition under these conditions (Table 
21; entries 4, 5) as well as the L-prolinol (Table 21; entry 9). 
 
O
+H
NO2
solvent, r.t.
H
NO2
O
Cat. 20 mol%
 
                         213                   211                                                          214 
 
Scheme 133. Michael addition of isovaleraldehyde with nitrostyrene 
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Entry Solvent 
Cat 
 
Time 
[h] 
Conversion[a] 
[%] 
dr[b]   
[syn/anti] 
ee [c] 
[%]syn 
1 
2 
3 
CH2Cl2 
EtOH 
CH3CN 
N
H N
N
NHN
 
20 
20 
19 
>98 
>98 
>95 
19:1 
17:1 
19:1 
56 
28 
31 
4 CH2Cl2 
N
H N
N
NN
HCl.  
120 35 
7:1 
 
26 
5 EtOH 
N
H N
N
NN
HCl.
 
76 90 7:1 23 
6 
7 
8 
CH2Cl2 
EtOH 
CH3CN 
N
H OH
O
 
120 
5 
21 
55 
>96 
>96 
6:1 
25:1 
6:1 
- 
19 
10 
 
9 
 
CH2Cl2 
 NH OH  
 
48 
 
20 
 
2:1 
 
 
- 
 
Table 21. Michael addition of isovaleraldehyde and nitrostyrene.  [a]  based on HPLC 
analysis of the reaction  mixture; [b] based on HPLC analysis of the crude product; [c]  
based on chiral HPLC of the crude product  
 
Interesting to note is that the (R)-(tetrazol-5-yl)-pyrrolidine 115 and its N-alkylated 
derivatives give the same enatiomer (enantiomer B: 13.01 min on chiral HPLC), while S-
proline and the (S)-(tetrazol-5-yl)-pyrrolidine 114 the opposite one (enantiomer A: 8.26 
min on chiral HPLC). 
The product obtained from the Michael addition of isovaleraldehyde and nitrostyrene is 
sensitive to racemization on α-position. For this reason, we have found more appropriate 
the direct reduction to the corresponding more stable primary alcohol. However, no 
relevant increase of enantioselectivity was observed. When the Michael reaction reach 
completion, the mixture is cooled to 0 °C and treated with an excess of sodium 
borohydride (Scheme 134).  
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N N
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+
CH2Cl2
r.t., 20 h
0°C to r.t.
2h
NO2
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dr (syn/anty): 19:1
ee: 63%  
   213               211                                                        214                                           268        
Scheme 134. Michael addition followed by reduction to primary alcohol 268 
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3.2.3.2. Michael addition of cyclohexanone and nitrostyrene 
 
O
NO2
O
NO2
Cat. 20 mol%
r.t., solvent
+
 
           209                  211                                                           212 
 
Entry Solvent 
Cat 
 
Time 
[h] 
Conversion[a] 
[%] 
dr[b]   
[syn/anti] 
ee [c] 
[%]syn 
1 
2 
DMSO 
EtOH N
H N N
NH
N
H
 
5-7 
30 
>99 
>99 
17:1 
19:1 
49 
60 
3 
4 
DMSO 
EtOH N
H N N
N
N
H
. HCl  
30 
30 
>95 
>95 
2:1 
4:1 
13 
7 
5 DMSO 
N
H N N
N
N
H
. HCl  
40 >95 2:1 11 
6 
7 
DMSO 
EtOH N
H
O
OH
H
 
5-8 
30 
>99 
>95 
13:1 
20:1 
23 
49 
 
Table 22. Michael addition of cyclohexanone and nitrostyrene. [a] based on HPLC 
analysis of the mixture; [b] based on HPLC analysis of the crude product; [c] based on 
chiral HPLC of the crude product  
 
 
The organocatalyzed Michael addition of cyclohexanone with nitrostyrene was 
screened at room temperature in DMSO and ethanol with different catalysts (Table 22). 
The reaction is performed with stoichiometric amounts of cyclohexanone with 20 mol% 
of catalyst at room temperature. According to published data 229,230 the 2-(R)-(tetrazol-5-
yl)-pyrrolidine gives better diastereo- and enantioselectivity than proline in both DMSO 
and ethanol (Table 22; entries 1-4). The corresponding N-alkyl-tetrazoles catalyze the 
reaction only after the addition of small amount of hydrochloric acid. However the 
diastereoselectivities and the enantioselectivities are not satisfactory.   
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3.3.  Organocatalysis: Conclusions 
 
 
 
The enantioselective organocatalysis in which the reaction is mediated by a 
catalytic amount of chiral organic molecule is an emerging powerful tool in organic 
synthesis. The interest in this field has increased in the last few years, and more reactions 
and more class of organocatalysts are expected in the future. The hope is that 
organocatalysis will find a consistent application outside the academic environment for 
the synthesis of complex molecular structures.  
Proline is one example of a versatile organocatalyst. However there are a number of 
drawbacks in the use of proline including its limited solvent solubility (reactions are often 
performed in DMSO). In addition a relatively high catalyst loading is usually required, 
commonly proline is used at levels of around 20 mol %. To overcome the above 
mentioned disadvantages of proline, the tetrazole analogue, namely the pyrrolidine 
tetrazole, is receiving considerable attention and represents a valuable alternative to 
proline, particularly as it avoids the use of solvent such as DMSO and can also be used in 
smaller quantities without compromising on enantioselectivity 225.  
Taking in account the recently emerging interest in tetrazole analogues of proline, we 
have efficiently prepared a variety of new compounds based on the pyrrolidine-tetrazole 
skeleton which could represent a novel class of organocatalysts in the future 142.  
Despite the considerable progress that has been made in the elucidation of 
mechanism involved in organocatalyzed reactions, we are only beginning to understand 
the basic factors that control the reactivity and selectivity in these reactions. Therefore  
the rational design of novel organocatalysts remains in most cases difficult.  
One mechanism commonly accepted is the enamine-catalytic cycle in which the catalytic 
formation of an intermediate enamine generated from a carbonyl species and the chiral 
organocatalyst reacts with electrophiles. During our investigation we have detected, and 
in some cases isolated, the enamine-intermediates which are supposed to be involved in 
the enamine catatic-cycle. Unfortunately, we were not able to isolate single crystals of 
these compounds suitable for X-ray analysis which could give some additional important 
knowledge for the understanding of the mechanism involved.  
In addition we have selected Michael addition of carbonyl compounds to nitrostyrene to 
test the efficiency of some new pyrrolidine-tetrazole based catalyst. In general the 
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pyrrolidine-tetrazole is superior to proline, and could be used in solvent such as 
dichloromethane where proline fails, and N-alkyl-pyrrolidine tetrazoles are not suitable 
catalysts for these reactions. Further investigations on the new organocatalysts herein 
described should be done in the future.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4.    X-Ray Discussion 
 130 
Chapter  4. 
X-Ray Structures of Tetrazole Derivatives 
 
 
 
 As already discussed in Chapter 1.1, the tetrazole ring exists in two tautomeric 
forms, 1H- and 2H-form (Figure 60) 1. In the gas phase calculations show that the 2H -
tautomer is the favorite and in solution the 1H-form, which has an higher dipole moment, 
is the dominant tautomer. The 1H-tautomer is also the major isomer in the solid state and 
this is supported by X-ray crystallography data where intermolecular hydrogen bonds 
chains have been detected in the crystal structures 247,248,249 between the N-1 and N-4 
atoms of adjacent rings with the proton preferentially located at the N-1 site. 
 
R
N
H
N
NN
R
N NH
NN
1
2
3
4
5
1 2
3
4
5
1H                                  2H  
Figure 60. Tautomeric forms of tetrazole derivatives and numbering of the tetrazole ring 
 
 A variety of X-ray structures of our 5-substituted tetrazoles have been solved. All 
unsubstituted-tetrazoles herein reported (109, 119, 17), with exception of the pyrrolidine 
tetrazole derivative 115 which is present in the zwitterionic form, crystallized as its 1H-
tautomer. Tetrazoles and tetrazolate complexes show the tetrazole ring to be a planar 
resonance hybrid 250. The bond lengths and angles in the tetrazole and aryl rings of the 
structures herein reported are in accordance with literature data and are not discussed 
further 162,247,248,251. Selected bond lengths and angles are listed in tables in this section. 
 
4.1. 5-Thiophen-1H-tetrazole (109) 
 
 Yellow single crystals suitable for X-ray analysis are obtained by slow evaporation 
of an ethyl acetate solution (Figure 61; see Chapter 5.1). This compound crystallizes in 
the monoclinic space group Pc, with a = 9.962(2) Å, b = 9.213(2) Å, c = 7.219(2) Å, β = 
110.516(9), Z = 4, V = 620.5(3) Å3, Dc = 1.629 g/cm3, R1 = 0.0275, wR2 = 0.0748. The 
asymmetric unit has two molecules with the sulfur atoms disordered over two 
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orientations A and B (Figure 62). Molecule 109.II, position A is the major one with a 
ratio 65 : 35 of A to B. Molecule 109.I the position A is also the major one but with a 85 : 
15 A to B.   
 
 
Figure 61. Structure of 5-thiophen-1H-tetrazole 
109 in the crystals with thermal ellipsoids drawn 
at 50 % probability level. Minor orientation 
omitted for clarity 
 
 
 
 
 
Figure 62. Asymmetric unit of 5-thiophen-1H-
tetrazole 109 with the thiophene ring disordered 
over two orientations A and B  
 
 
 
                109.II                        109.I 
 
 
The molecule 109.II has the tetrazole and the thiophene rings twisted with respect to one 
another, with dihedral angles of 29.5(3)° and 31.1(5)° for the minor orientation B. In 
molecule 109.I the two rings are almost planar with respect to one another with dihedral 
angles between the tetrazole and the thiphene rings of 4.5(2)° and 3.8(11)° for the minor 
orientation B. Within the limits of accuracy all bond lengths in the ordered part of the 
structure agree with expected values 251. Further details are given in tables 25-27. 
The tetrazole ring exists in two tautomeric forms N1- and N2 where the N1 and N2 are 
respectively the nitrogen atoms in α and β position to the carbon of the tetrazole ring 
(Introduction, Chapter 1), however the 5-thiophen-1H-tetrazole 109 crystallized 
exclusively in the 1H-tautomeric form. This could be also supported by the presence of a 
heteroatom such as sulphur which could be involved in an intra-molecular hydrogen 
bonds. However the intra-molecular N−H⋅⋅⋅S hydrogen bonds are not observed by X-ray 
analysis. Instead, the 1H-isomer is stabilized by inter-molecular hydrogen bonds with 
adjacent N-atoms (Table 26). The crystal packing is aided by N−H⋅⋅⋅N hydrogen bonds 
which form linear chains along the b-axis (Table 26). 
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Table 23.   Bond lengths [Å] for 5-thiophen-1H-tetrazole 109 
 
Atoms   Bond length  
C1A - S2A   1.711(2) 
S2A - C3A   1.721(3) 
S2B - C3B   1.715(16) 
S2B - C1B                                    1.641(12) 
C11A - S12A   1.676(3) 
S12B - C11B                              1.666(6) 
S12A - C13A   1.519(6) 
S12B - C13B   1.362(11) 
C6 – N10   1.327(3) 
C6 – N7   1.343(3) 
C1 – N20   1.321(3) 
C16 – N17   1.345(3) 
 
             Table 24.  Bond angles [°] for 109                  Table 25.  Torsion angles [°] for 109                  
 
Atoms Angle  Atoms Angle 
C1A - S2A - C3A 91.77(14)  N7 –C6 – N10 – N9 -0.3(3) 
C1B - S2B - C3B                           93.4(10)  N8 – N9 – N10 – C6 0.1(3) 
C13A - S12A - C11A 96.0(3)  N20 – C16 – N17 – N18 -0.7(3) 
C13B - S12B - C11B                       100.9(7)  C16 – N17 – N18 – N19                                                      0.0(3)
 
 
Table 26.  Hydrogen bonds for 5-thiophen-1H-tetrazole 109 [Å and °]   
 
 
Symmetry transformations used to generate equivalent atoms: 
#1 x+1,y-1,z    #2 x,y+1,z 
         
 
4.2. 5-(Benzylthio)-1H-tetrazole (17) 
 
 Yellow single crystals suitable for X-ray analysis are obtained by slow evaporation 
of an ethyl acetate solution (Figure 63; see Chapter 5.1). This compound crystallizes in 
the monoclinic space group P21, with a = 15.323(4) Å, b = 5.761(2) Å, c = 41.875(2) Å, β 
= 100.517(10), Z = 16, V = 3634.4(16) Å3, Dc = 1.405 g/cm3, R1 = 0.0318, wR2 = 0.0832.  
 
 
 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N7 - H7...N20         #1 0.88 1.99 2.858(3) 168.5 
N17 - H17...N10     #2 0.88 2.00 2.865(3) 165.9 
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Figure 63. Structure of 5-(benzylthio)-1H-
tetrazole 17 in the crystal with thermal 
ellipsoids drawn at 50 % probability level 
 
 
 
 
  
The asymmetric unit consists of eight molecules (Figure 64). The 5-(benzylthio)-1H-
tetrazole 17 has the tetrazole ring and the phenyl ring twisted with respect to one another 
(Table 27). The torsion angles described from the representative atoms C5-S6-C7-C8 are 
slightly different in each molecule of the asymmetric unit (Table 30). Within the limits of 
accuracy all bond lengths and angles agree with expected values. The representative 
distances and angles involving the sulfur atom are mentioned in table 8 and further 
representative details are given in tables 27-30. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 64. Crystal packing of 5-(benzylthio)-1H-tetrazole 17 and numbering of tetrazole and 
phenyl rings 
 
 
 
 
 
 
3 
4 5 
6 
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Table 27.  Dihedral angles between tetrazole and phenyl rings 
[°] for 17. The numbering of the rings is shown in Figure  81 
Rings Angle 
1, 2 86,93(17) 
3, 4 80.29(16) 
5, 6 84.63(17) 
7, 8 74.91(17) 
9, 10 81.0617) 
11, 12 86.55(16) 
13, 14 86.29(17) 
15, 16 75.75(16) 
 
             Table 28. Bond lengths [Å]  17                          Table 29.  Bond angles [°] for 17 
Atoms  Bond length  Atoms   Angle  
N1 - C5 1.336(4)  N1 - C5 - S6 123.9(2) 
N4 - C5 1.323(4)  C5 - S6 - C7 100.12(14) 
C5 - S6 1.731(3)  C8 - C7 - S6 106.6(2) 
S6 - C7 1.832(3)    
C7 - C8 1.512(4)    
         
 
Table 30.  Torsion angles [°] for 5-(benzylthio)-1H-tetrazole 17 
 
Atoms Angle  
C5  –  S6 – C7 – C8 170.6(2) 
C105  –  S106 – C107 – C108 162.8(2) 
C205  –  S206 – C207 – C208 164.2(2) 
C305  –  S306 – C307 – C308 153.4(2) 
C405  –  S406 – C407 – C408 162.0(2) 
C505  –  S506 – C507 – C508 171.3(2) 
C605  –  S606 – C607 – C608 154.6(2) 
C705  –  S706 – C707 – C708 162.7(2) 
 
 
The crystal packing is aided by intermolecular N−H⋅⋅⋅N hydrogen bonds which 
form linear chains along the b-axis (Table 31). The 5-(benzylthio)-1H-tetrazole 17 
crystallized exclusively in the 1H-tautomeric form. This fact could be explained looking 
the inter-molecular hydrogen-bonds in the crystal packing. The N−H⋅⋅⋅N hydrogen bonds 
form a linear chain between the N-H of the N1-tautomer of one molecule and the N1 
position of the molecule neighbor. 
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Table 31. Hydrogen bonds for 5-(benzylthio)-1H-tetrazole 17 [Å and °] 
 
Symmetry transformations used to generate equivalent atoms: 
#1 x+1,y,z    #2 x,y+1,z    #3 x,y-1,z 
 
 
4.3. (R)-5-(Tetrahydro-furan)-1H-tetrazole (119) 
 
 
 
 
 
Figure 65. Structure of (R)-5-
(tetrahydro-furan)-1H-tetrazole 119 in 
the crystal with thermal ellipsoids drawn 
at 50 % probability level 
 
 
 
Colorless crystals suitable for X-ray analysis are obtained by slow evaporation of an 
ethyl acetate solution (Figure 65, see Chapter 5). This compound crystallizes in the 
orthorhombic space group P212121, with a = 8.295(2) Å, b = 9.439(2) Å, c = 16.650(3) Å, 
Z = 8, V = 1303.6(5) Å3, Dc = 1.428 g/cm3, R1 = 0.0301, wR2 = 0.0664. The asymmetric 
unit consists of two molecules in which the tetrazole and the hydrofuran rings are twisted 
with respect to one another and the hydrofuran rings have an envelop conformation 
(Figure 66). In the molecule 119.II, the furan ring is disordered over two orientations A 
and B with a ratio of 0.58 : 0.42. The two positions A and B are described with the angle 
O11A-C15-O11B of 17.0(3)° (Table 33). The torsion angle of molecule 119.II in the A 
orientation, described by the atoms N17-C16-C15-O11A, is 18.6(3)° and the 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 - H1...N304             #1  0.88 1.88 2.756(4) 173.7 
N101 - H101...N4         #2 0.88 1.83 2.711(4) 175.1 
N201 - H201...N104 0.88 1.86 2.735(4) 176.2 
N301 - H301...N204     #2 0.88 1.83 2.709(4) 174.9 
N401 - H401...N504     #3 0.88 1.83 2.709(4) 174.9 
N501 - H501...N604 0.88 1.87 2.743(4) 174.5 
N601 - H601...N704     #3 0.88 1.83 2.705(3) 175.0 
N701 - H701...N404     #1 0.88 1.86 2.738(4) 174.5 
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corresponding torsion angle for the B orientation is similar to those of molecule 119.I 
(4.9(3)° and 5.48(18)° respectively, Table 34). 
Within the limits of accuracy all bond lengths and angles in the ordered part of the 
structure agree with expected values 251. Further details are given in tables 32-34. 
  
 
Figure 66. Asymmetric unit of (R)-
5-(tetrahydro-furan-2-yl)-2H-
tetrazole with the tetrahydrofurane 
ring of the molecule 119.II 
disordered over two orientations A 
and B 
 
119.II                              119.I 
 
 
Table 32. Bond lengths [Å]  for 119 
Atoms  Bond length 
O1 - C5 1.4308(17) 
O1 - C2 1.4427(18) 
C5 - C6 1.502(2) 
C15 - C16 1.490(2) 
 
Table 33.  Bond angles [°] for 119                    Table 34. Torsion angles [°] for  119 
Atoms Angle  Atoms Angle   
C5 - O1 – C2 109.24(11)  O1 – C5 – C6 – N7 5.48(18) 
O1 - C5 – C6 107.68(11)   O11A – C15 – C16 – N17 18.6(3) 
O1 - C5 - C4 106.37(11)  O11B – C15 – C16 – N17 4.9(3) 
O11A - C15 - C16                                                 113.2(3) N10 – C6 – N7 – N8 -0.30(14) 
O11A - C15 - O11B 17.0(3)  N7 – N8 – N9 – N10 -0.24(15) 
C16 - C15 - O11B 102.2(3)  N17 – N18 – N19 – N20 -0.26(15) 
O11A - C15 - C14 108.9(3)  N17 – C16 – N20 – N19 0.05(15) 
O11B - C15 - C14 104.0(3)    
 
The crystal packing is aided by N−H⋅⋅⋅N hydrogen bonds (Table 35). The tetrazole ring 
exists in two tautomeric forms N1- and N2 where the N1 and N2 are respectively the 
nitrogen atoms in α and β position to the carbon of the tetrazole ring (Introduction, 
Chapter 1). However the (R)-5-(tetrahydro-furan-2-yl)-2H-tetrazole 119 crystallized 
exclusively in the 1H-tautomeric form. This fact is explained by the presence of an 
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intermolecular hydrogen-bond between the oxygen of one molecule and the N-H of the 
neighboring molecule. 
 
Table 35.   Hydrogen bonds for (R)-5-(tetrahydro-furan-2-yl)-2H-tetrazole 119 [Å and °]   
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N10 – H10...N7       #1 0.854(18) 2.102(18) 2.8981(18) 155.0(13) 
N10 - H10...O1        #1 0.854(18) 2.447(16) 3.0820(17) 131.8(12) 
N20 - H20...N17      #2 0.81(2) 2.07(2) 2.8475(18) 160.0(16) 
N20 - H20...O11B    #2 0.81(2) 2.434(19) 2.997(6) 127.5(14) 
 
Symmetry transformations used to generate equivalent atoms: 
#1 -x,y+1/2,-z+3/2    #2 -x+2,y-1/2,-z+1/2 
 
 
4.4. 4-[2-Benzene-sulphonyl-2-(2-methyl-2H-tetrazol-5-yl)-vinyl]-
benzoic acid methyl ester (177) 
 
 
 
 
Figure 67. Structure of 4-[2-benzene-
sulphonyl-2-(2-methyl-2H-tetrazol-5-yl)-
vinyl]-benzoic acid methyl ester 177 in 
the crystal with thermal ellipsoids drawn 
at 50 % probability level 
 
 
  
 Colorless single crystals suitable for X-ray analysis are obtained by slow 
evaporation of a mixture of ethyl acetate / hexane (Figure 67; Chapter 5.2). This 
compound crystallizes in the monoclinic space group P-1, with a = 7.582(2) Å, b =  
8.425(2) Å, c = 14.912(4) Å, α= 75.784(9)°, β = 87.969(9)° and γ = 72.584(9)°, Z = 2, V 
= 880.3(4) Å3, Dc = 1.450 g/cm3, R1 = 0.0356, wR2 = 0.0882.  
Within the limit of accuracy all bond lengths and angles agree with expected values 251.   
The main distance and angles are mentioned (Tables 36-38). The two phenyl rings are 
almost perpendicular to each other with an angle of 72.83(5)°. The tetrazole and the 
phenyl (C11) rings have a dihedral angle of 27.38(8)° and the tetrazole with the phenyl 
(C18) rings have a dihedral angle of 87.00(5)°. The phenyl ring (C18) and the carbonyl 
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group are in the same plane, while the phenyl ring and the double bond have a torsion 
angle of 4.1(3)° (Table 38). 
The conformation of the molecule in the crystal is stabilized by an intra-molecular H-
bond between O9 of sulphonyl group and N2 of the tetrazole. Analysis of supramolecular 
array reveals the presence of π-stacking between the phenyl rings based on C18, the 
distance between most proximate pairs of such rings in the supramolecular array being 
3.8 Å . 
 
           
 
Figure 68. 4-[2-Benzene-sulphonyl-2-(2-
methyl-2H-tetrazol-5-yl)-vinyl]-benzoic acid 
methyl ester 177 in the crystal  
 
 
 
 
Table 36. Bond lengths [Å] for 177 
 
Table 37. Angles [°] for 177 
Atoms Bonds Length  Atoms Angle 
C1 – N2 1.331(2)  N2 – C1 – N5 112.66(13) 
C1 – N5 1.351(2)  N3 – C6 – H 109.5 
C1 – C7 1.476(2)  C17 – C7 – C1 128.91(14) 
C7 – C17 1.339(2)  C1 – C7 – S8 114.30(11) 
C7 – S8 1.7901(16)  O10 – S8 – O9 119.41(7) 
S8 – O9 1.4379(12)  C11 – S8 – C7 103.64(7) 
S8 – C11 1.766(16)  C7 – C17 – C18 130.07(15) 
 
 
         Table 38. Torsion angles [°] for 177 
  
Atoms Angle  
C1 – N2 – N3 – N4 0.15(16) 
C1 – N2 – N3 – C6 177.78(13) 
C6 – N3 – N4 – N5  -177.55(13) 
N5 – C1 – C7 – S8 -101.96(15) 
C7 – S8 – C11 – C12 101.66(13) 
C7 – S8 – C11 – C16 -75.61(13) 
C1 – C7 – C17 – C18 4.1(3) 
S8 – C7 – C17 – C18 -174.78(12) 
C22 – C21 – C24 – O26 1.2(2) 
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4.5.  (R)-5-Pyrrolidine-2-yl-tetrazole (115) 
 
 
 
 
 
 
Figure 69. Structure of (R)-5-
pyrrolidine-2-yl-tetrazole 115 in the 
crystal with thermal ellipsoids drawn at 
50 % probability level 
 
Colorless single crystals suitable for X-ray analysis are obtained by slow 
evaporation of a mixture of ethanol / water (Figure 69; Chapter 5.3). This compound 
crystallizes in the orthorhombic space group P212121, with a = 10.213(8) Å, b = 11.634(9) 
Å, c = 12.222(9) Å, Z = 8, V = 1452.2(19) Å3, Dc = 1.356 g/cm3, R1 = 0.0275, wR2 = 
0.0684. X-Ray diffraction shows that the (R)-5-pyrrolidine-2-yl-tetrazole 115 crystallizes 
in the hydrate form (Figures 69, 70). The asymmetric unit has two molecules which are 
present in the zwitterionic form. The solvent is coordinated to the nitrogen N11 of the 
pyrrolidine ring of 115.II and the nitrogen N8 of the tetrazole ring in 115.I (Figure 70). 
 
           
Figure 70. (R)-5-Pyrrolidine-2-yl-
tetrazole in the crystal. Hydrogen bonds 
shown as dotted lines 
 
 
     115.II                                          115.I 
The (R)-5-pyrrolidine-2-yl-tetrazole has the tetrazole ring and the pyrrolidine ring twisted 
with respect to one another. The torsion angle between the pyrrolidine and the tetrazole 
rings is 57.54(16)° for molecule 115.I and 138.15(11)° for molecule 115.II (Table 43). 
Within the limits of accuracy all bond lengths agree with expected values 251.  The main 
distances and angles of the tetrazole ring are mentioned (Tables 39-41). The pyrrolidine 
ring has an envelope conformation on C-5 in molecule 115.1 and on C15 in molecule 
115.II. 
The crystal packing is aided by inter-molecular O−H⋅⋅⋅N hydrogen bonds and by inter-
molecular N-H⋅⋅⋅N hydrogen bonds (Table 42). 
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Table 39. Bond lengths [Å] for (R)-5-pyrrolidin-2-yl-tetrazole 115 
 
Atoms     Bond length  Atoms   Bond length 
N1 - C2 1.5109(17)  N11 - C12 1.5072(17) 
N1 - C5 1.50008(17)  C15 – C16 1.4911(18) 
C6 - N10 1.3338(19)  C16 - N20 1.3388(18) 
C6 – N7 1.3304(17)  C16 – N17 1.3289(17) 
C6 – C5 1.4895(18)  N19 - N20 1.344(3) 
N9 - N10 1.3491(18)  C15 – C16 1.4911(18) 
N11 - C15 1.4991(17)    
             
               Table 40.  Bond angles [°] for 115                  Table 41. Torsion angles [°] for 115 
 
Atoms Angle  Atoms Angle 
C2 - N1 - C5 105.38(10)  N1 – C5 – C6 – N7 57.54(16) 
C6 – C5 – N1 113.44(11)  N1 – C5 – C6 – N10 -44.69(13) 
N1 – C5 – C4 101.44(11)  C6 – N7 – N8 – N9 0.05(13) 
N10 – C6 – N7 112.16(11)  N8 – N9 – N10 – C6 -0.10(15) 
C6 - N10 - N9 104.42(11)  N11 – C15 – C16 – N17 138.15(11) 
C12 - N11 - C15 106.16(11)  N11 – C15 – C16 – N20 -126.62(13) 
C16 – C15 –  N11 111.39(11)  C16 – N17 – N18 – N19 0.44(12) 
C14 – C15 – N11 102.43(11)  N17 – C16 – N20 – N19 0.24(13) 
N20 - C16 - C15 124.32(11)    
C16 - N20 - N19 104.79(10)    
 
Table 42.    Hydrogen bonds [Å and °] for the R-5-pyrrolidine-2-yl-tetrazole 115 
 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+2,y-1/2,-z+1/2    #2 x,y,z+1    #3 -x+2,y+1/2,-z+1/2      #4 x+1/2,-y+3/2,-z        
 
                 
D-H···A     d(D-H) d(H···A) d(D···A) <(DHA) 
N1 - H1A...N20         #1 0.913(17) 1.999(17) 2.862(2) 157.0(14) 
N1 - H1B...N18         #2 0.869(18) 1.964(19) 2.827(2) 171.8(15) 
N11 - H11A...O21 0.889(19) 1.855(19) 2.734(2) 169.9(17) 
N11 - H11B...N7       #3 0.908(19) 1.937(19) 2.835(2) 169.7(16) 
N11 - H11B...N8       #3 0.908(19) 2.673(18) 3.476(3) 147.9(14) 
O21 - H21A...N17     #4 0.85(2) 1.98(2) 2.825(2) 170.6(19) 
O21 - H21B...N8 0.83(2) 2.01(2) 2.827(2) 165.9(19) 
O21 - H21B...N9 0.83(2) 2.64(2) 3.301(2) 137.0(17) 
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4.6. (R)-5-Pyrrolidine-2-yl-tetrazole palladium(II) complex (242) 
 
 
 
 
 
 
 
 
 
 
Figure 71. Structure of (R)-5-pyrrolidine-2-yl-tetrazole palladium(II) complex 242 
in the crystal with thermal ellipsoids drawn at 50 % probability level 
 
 
 Colorless crystals suitable for X-ray analysis are obtained by slow evaporation of a 
mixture of THF / water (Figure 71; Chapter 5.3). This compound crystallizes in the 
orthorhombic space group P212121, with a = 8.092(2) Å, b = 8.597(2) Å, c = 20.951(3) Å, 
Z = 4, V = 1457.5(5) Å3, R1 = 0.0152, wR2 = 0.0369. The (R)-5-pyrrolidine-2-yl-tetrazole 
palladium(II) complex crystallizes in a mono-hydrated form and the X-Ray diffraction 
shows that the palladium(II) has a distorted square-planar geometry and its coordination 
sphere is defined by two (R)-5-pyrrolidine-2-yl-tetrazole ligands (Figure 72).  
 
 
 
 
 
 
 
 
 
 
Figure 72. Structure of (R)-5-pyrrolidine-2-yl-1H-tetrazole palladium(II) complex 242 in 
the crystal 
 
In the normal square-planar geometry the angle between the ligands (L) and the 
metal (M) L1-M-L3 and L2-M-L4 should be 180° and the angles defined by L1-M-L2 = L2-
M-L3 = L3-M-L4 = L4-M-L1 = 90° (Figure 73). However, the N20-Pd-N11 and the N10-
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Pd-N1 angles, respectively 81.36(7)° and 80.97(8)°, show the distorted square-planar 
environment at palladium (Figure 72, Table 43). All the five atoms lie within 0.2Ǻ [Pd], 
within a least square plane defined by the four nitrogen atoms N1 N10 N11 N20. 
 
 
 
 
 
 
 
Figure 73. Square-planar geometry  
 
The torsion angles N11-C15-C16-N20 and N1-C5-C6-N10 of 242 (Table 37) are 
different to those found in the X-ray structure of (R)-5-pyrrolidine-2-yl-tetrazole hydrate 
115 (Section 4.3). The (R)-5-pyrrolidine-2-yl-tetrazole palladium(II) complex 242 has the 
two ligands with the tetrazole and the pyrrolidine rings twisted with respect to one 
another and the torsion angels are given in table 43. Based on the method of Cramer and 
Pople, the conformation of the pyrrolidine rings can be described as twisted on C2-C3 
and C12-C13. Within the limits of accuracy all bond lengths agree with expected values. 
The main distances and angles of the tetrazole ring are mentioned (Tables 43-45). The 
planarity and the bond lengths of the tetrazole ring are not influenced by the metal-
coordination and are comparable with the data found for 115 (Section 4.3). 
The crystal packing is aided by inter-molecular O−H⋅⋅⋅N hydrogen bonds which form  
chains along the b-axis and by inter-molecular N-H⋅⋅⋅N hydrogen bonds (Table 46).   
 
       Table 43. Torsion angles [°] for 237 
 
Atoms Angle 
N11 – C15 – C16 – N20 -20.4(3) 
N1 – C5 – C6 – N10 -12.0(3) 
C16 – N17 – N18 – N19 0.0(2) 
N16 – N20 – N19 – N18 0.2(2) 
C6 – N7 – N8 – N9 -0.4(2) 
C6 – N10 – N9 – N8 -0.2(2) 
 
 
 
 
 
M
L
LL
L
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Table 44. Bond lengths [Å] for 237                     Table 45.  Angles [°] for  237 
 
Atoms    Bond length    Atoms    Angle 
Pd1 - N10 1.985(2)   N10 - Pd1 - N20 177.87(8) 
Pd1 - N20  1.995(2)   N10- Pd1 - N11 97.72(8) 
Pd1 - N11  2.0560(18)   N20 - Pd1 - N11 81.36(7) 
Pd1 - N1                          2.0579(18)   N10 - Pd1 - N1                                                80.97(8)
N1 - C2 1.501(3)   N20 - Pd1 - N1 99.94(7) 
N1 - C5 1.507(3)   N11 - Pd1 - N1 178.64(8) 
C6 - N10 1.327(3)   C2 - N1 - C5 106.12(16) 
N9 - N10 1.341(3)   C2 - N1 - Pd1 114.48(13) 
N11 - C12 1.514(3)   C5 - N1 - Pd1 113.20(13) 
N11 - C15 1.514(3)   C6 - N10 - N9 108.00(18) 
C16 - N20 1.329(3)   C6 - N10 - Pd1 117.03(15) 
N19 - N20 1.344(3)   N9 - N10 - Pd1 134.96(14) 
    C12 - N11 - C15 107.37(17) 
    C12 - N11 - Pd1 114.57(14) 
    C15 - N11 - Pd1 112.42(13) 
    N20 - C16 - C15 119.6(2) 
    C16 - N20 - N19 107.73(18) 
    C16 - N20 - Pd1 115.63(14) 
    N19 - N20 - Pd1 135.89(15) 
 
                        Table 46. Hydrogen bonds [Å and °] for 237 complex. 
 
Symmetry transformations used to generate equivalent atoms: 
            #1 -x+2,y+1/2,-z+1/2    #2 -x+1,y+1/2,-z+1/2    #3 x-1/2,-y+5/2,-z     
 
 
4.7. 1-Isopropyl-5-(R)-pyrrolidine-2-yl-1H-tetrazole (237) 
 
 Yellow single crystals suitable for X-ray analyses are obtained by slow evaporation 
of a mixture of ethanol / methylene chloride (Figure 74; Chapter 5.3). This compound 
crystallizes in the monoclinic space group C2, with a = 11.598(5) Å, b = 16.066(7) Å, c = 
11.446(5) Å, β = 103.38(2)°, Z = 8, V = 2074.9(16) Å3, Dc = 1.277 g/cm3, R1 = 0.0270, 
wR2 =  0.0651. 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 – H1...N7             #1 0.88(3) 2.14(3) 2.952(3) 154(2) 
N11 – H11...N8         #2 0.91(3) 2.03(3) 2.899(3) 159(2) 
O21 – H21A...N18    #3 0.79(3) 2.13(3) 2.903(3) 166(3) 
O21 – H21B...N17         0.78(3) 2.18(3) 2.933(3) 161(4) 
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Figure 74. Structure of 1-isopropyl-5-(R )- 
pyrrolidine-2-yl-1H-tetrazole 237 in the 
crystal with thermal ellipsoids drawn at 
50% probability level  
Figure 75. 1-Isopropyl-5-(R)-pyrrolidine- 
2-yl 1H-tetrazole 237 
 
 
 
X-ray diffraction shows that the 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole 237 
exists as hydrochloride (Figures 74, 75) and the hydrochloric acid is an impurity from the 
purification. The asymmetric unit has two 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-
tetrazole molecules and two chloride ions on special positions. Therefore, the ratio of 1-
isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole and chloride ion is 2:1 and only one of the 
two 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole molecules in the asymmetric unit is 
protonated.  
The 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole has the tetrazole ring and the 
pyrrolidine ring twisted with respect to one another but the torsion angles of 237 are 
different to those found in the X-Ray structures of other pyrrolidine-tetrazole derivatives 
(Sections 4.4 - 4.10). Based on the method of Cramer and Pople, the conformation can be 
described as twisted on C2-C3 and C24-C25. Within the limits of accuracy all bond 
lengths agree with expected values. The main distances and angles of the tetrazole ring 
are mentioned (Tables 48-50). 
 
Table 47. Bond lengths [Å]  for 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole 237  
 
Atoms Bond length  Atoms Bond length 
N1 - C2 1.485(2)  N21 – C22 1.499(2) 
N1 - C5 1.5008(19)  N21 – C25 1.484(2) 
C6 - N10 1.342(2)  C25 – C26 1.498(2) 
C6 – N7 1.325(2)  C26 - N27 1.323(2) 
C6 – C5 1.498(2)  C26 – N30 1.339(2) 
N10 – C11 1.481(2)  N30 – C31 1.480(2) 
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Table 48. Bond angles [°] for  237 
 
Atoms Angle  Atoms Angle 
C2 –  N1  – C5 106.56(11)  C12 – C11 –  C13 112.35(14) 
C6 – C5 – N1 109.93(12)  C22 – N21 – C25 108.40(12) 
N10 – C6 – N7 108.52(13)  N21 – C25 – C26 111.47(13) 
C6  –  N10  –  N9 108.16(12)  C26 – N30 – N29 108.36(13) 
N10  – C11  – C12 109.24(14)    
 .  
Table 49. Torsion angles [°] for 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole 237  
 
Atoms   Angle 
N1 – C5 – C6 – N10 -101.74(16) 
C6 – N7 – N8 – N9 -0.15(17) 
N8 – N9 – N10 – C6 -0.52(16) 
N21 – C25 – C26 – N30 -128.55(15) 
C26 – N27 – N28 – N29 0.09(17) 
N30 – C26 – N27 – N28 -0.40(16) 
 
Table 50. Hydrogen bonds [Å and °] for 1-isopropyl-(R)-5-pyrrolidine-2-yl-1H-tetrazole 237 
 
The crystal packing is aided by inter-molecular N−H⋅⋅⋅N and N−H⋅⋅⋅Cl hydrogen bonds 
(Table 50). Four molecules 237 form a layer generating a channel along the c-axis 
where the chloride atoms are in the channels (Figure 76).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 76. Crystal packing of 237 with H-bond interactions shown as dotted lines 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 - H1A...Cl14 0.92 2.24 3.1413(16) 164.7 
N1 - H1B...N21      0.92 1.78 2.6931(19) 174.0 
N21 - H21A...Cl34 0.86(2) 2.53(2) 3.2540(17) 142.6(16) 
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4.8. 2-(1-Methyl-1-phenyl-ethyl)-5-(R)-pyrrolidine-2-yl-2H-
tetrazole (235)     
 
Colorless single crystals of 235 suitable for X-ray analyses are obtained by slow 
evaporation of a mixture of methanol / ethyl acetate (Figure 77; Chapter 5.3). This 
compound crystallizes in the orthorombic space group P212121, with a = 6.140(2) Å, b = 
7.526(2) Å, c = 29.490(4) Å, Z = 4, V = 1362.7(6) Å3, Dc = 1.254 g/cm3, R1 = 0.0362, 
wR2 = 0.0850. 
 
 
Figure 77. Structure of 2-(1-methyl-1-phenyl-
ethyl)-5-(R)-pyrrolidine-2-yl-2H-tetrazole 235 in the 
crystal  with thermal ellipsoids drawn at 50 % 
probability level 
 
 
 
X-ray diffraction shows that 2-(1-methyl-1-phenyl-ethyl)-5-(R)-pyrrolidine-2-yl-2H-
tetrazole 235 has the tetrazole ring and the pyrrolidine ring twisted with respect to one 
another (Table 53), but the torsion angle is different to those found in the X-ray structures 
of other pyrrolidine-tetrazole derivatives (Sections 4.4 - 4.10). Based on the method of 
Cramer and Pople, the conformation of the pyrrolidine ring can be described as twisted 
on C2-C3. Within the limits of accuracy all bond lengths and angles agree with expected 
values. The main distances and angles are mentioned (Tables 51-53).  
 
 
 
 
 
Figure 76. 2-(1-Methyl-1-phenyl-ethyl)-5-
(R)-pyrrolidine-2-yl-2H-tetrazole 235    
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Table 51. Bond lengths [Å] for 2-(1-methyl-1-phenyl-ethyl)-5-(R)-pyrrolidine-2-yl-1H-tetrazole 235 
Atoms    Bond length  Atoms    Bond length 
N1 - C2 1.466(2)  C6 – C5 1.5011(18) 
N1 - C5 1.4909(16)  N8 – C11 1.424(16) 
C4 – C5 1.5521(19)  N7 – N8 1.3336(15) 
C6 - N10 1.3534(18)  N8 – N9 1.3214(16) 
C6 – N7 1.3312(18)  C11 - C14 1.5346(16) 
 
Table 52. Bond angles [°] for 2-(1-methyl-1-phenyl-
ethyl)-5-(R)-pyrrolidine-2-yl-1H-tetrazole 235 
 
Atoms    Angle 
C2 - N1 - C5 105.84(11) 
C6 – C5 – N1 108.53(10) 
N1 – C5 – C4 106.93(10) 
C6 – C5 – C4 112.53(11) 
N10 – C6 – N7 111.86(11) 
N7 – C6 – C5 124.28(11) 
N7 – N8 – N9 113.49(10) 
N8 – C11 – C12 108.14(10) 
N8 – C11 – C13 106.67(10) 
N8 – C11 – C14 108.74(10) 
C15 – C14 – C11 120.08(12) 
 
Table 53. Torsion angles [°] for the 2-(1-methyl-1-phenyl-
ethyl)-5-(R)-pyrrolidine-2-yl-1H-tetrazole 235 
 
Atoms Angles [°] 
N1 – C5 – C6 – N10 73.96(15) 
C6 – N7 – N8 – N9 0.32(12) 
N8 – N9 – N10 – C6 - 0.05(13) 
N9 – N8 – C11 – C14  79.89(14) 
 
The planarity and the bond lengths of the tetrazole ring are not influenced by the presence 
of the cumyl group. The neighboring atoms of C11 form a slightly distorted tetrahedron 
(Table 52). The pyrrolidine ring is farther from the tetrazole ring in comparison to the un-
alkylated (R)-5-pyrrolidine-2-yl-1H-tetrazole 115 (Section 4.4.). The phenyl and the 
tetrazole rings are twisted with respect to one another with a dihedral angle of 42.48(8)°.  
The crystal packing is aided by inter-molecular N−H⋅⋅⋅N hydrogen bonds between the 
pyrrolidine-rings (Table 54).  
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Table 54. Hydrogen bonds [Å and °] for the 2-(1-methyl-1-phenyl-ethyl)-5-(R)-
pyrrolidine-2-yl-1H-tetrazole  312 
 
Symmetry transformation used to generate equivalent atoms: 
#1 x-1/2,-y+3/2,-z+2        
 
 
 
4.9. (S)-2-(2-tert-Butyl-2H-tetrazol-5-yl) pyrrolidinium trifluoro 
acetate (244) 
 
 
Brown single crystals suitable for X-ray analyses are obtained by slow evaporation 
of a methylene chloride solution (Figure 78; Chapter 5.3). Compound 244 crystallizes in 
the monoclinic space group P21, with a = 5.955(2) Å, b = 7.704(2) Å, c = 16.113(4) Å, β 
= 98.457(9)°, Z = 2, V = 731.2(4) Å3, Dc = 1.405 g/cm3, R1 = 0.0310, wR2 = 0.0776. X-
ray diffraction shows that the molecule of trifluoroacetic acid is coordinated to the 
nitrogen N1 of the pyrrolidine ring (Figures 78, 79). The (S)-2-(2-tbutyl-2H-tetrazol-5-yl) 
pyrrolidinium has the tetrazole and the pyrrolidine rings twisted with respect to one 
another but with a torsion angles different to those found in the X-Ray structures of other 
pyrrolidine-tetrazole derivatives (Sections 4.4-4.10). Within the limits of accuracy all 
bond lengths agree with expected values. The main distances and angles are mentioned 
(Tables 55-57). 
 
 
Figure 78. Structure of (S)-2-(2-tert-butyl-
2H-tetrazol-5-yl) pyrrolidinium trifluoro 
acetate 244 in the crystal with thermal 
ellipsoids drawn at 50 % probability level 
 
 
        
 
Figure 79. (S)-2-(2-tert-Butyl-2H-tetrazol-5-yl) 
pyrrolidinium trifluoro acetate 244 
 
 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 – H1...N1      #1 0.89(2) 2.448(19) 3.2658(13) 152.9(16) 
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The pyrrolidine ring has an envelope conformation on C3 and the distance between the 
tetrazole and the pyrrolidine rings is comparable to that found for 115 and 237 (Sections 
4.4, 4.6) but shorter compared to 2-(1-methyl-1-phenyl-ethyl)-5-(R)-pyrrolidine-2-yl-
tetrazole (Section 4.7). In the alkyl residue the environment of C11 is a slightly distorted 
tetrahedron (Table 55). The crystal packing is aided by intra-molecular N−H⋅⋅⋅O and 
N−H⋅⋅⋅F hydrogen bonds and by inter-molecular N-H⋅⋅⋅O hydrogen bonds between the 
pyrrolidine ring and the trifluoroacetic acetate along the a-axis (Table 50).  
 
Table 55. Bond lengths [Å]  for (R)-2-(2-
tert-butyl-2H-tetrazol-5-yl) pyrrolidinium 
trifluoro acetate 244 
 Table 56. Bond angles [°] for (R)-2-(2-tert-
butyl-2H-tetrazol-5-yl) pyrrolidinium 
trifluoro acetate 244 
Atoms    Bond length   Atoms    Angle 
N1 - C2 1.505(2)  C2 – N1 – C5 107.45(13) 
N1 - C5 1.5190(19)  C6 – C5 – N1 109.20(12) 
C4 – C5 1.532(2)  N1 – C5 – C4 105.08(13) 
C6 - N10 1.348(2)  N10 – C6 – N7 112.63(13) 
C6 – N7 1.328(2)  N7 – N8 – C11 122.59(13) 
C6 – C5 1.495(2)  C12 – C11 – C12 107.58(13) 
N8 – N9 1.322(2)    
N8 – N7 1.3292(18)    
C11 – C14 1.515(2)    
  
Table 57. Torsion angles [°] for (R)-2-(2-tert-butyl-2H-
tetrazol-5-yl) pyrrolidinium trifluoro acetate 244 
Atoms   Angle 
N1 – C5 – C6 – N19 -89.33(17) 
N10 – C6 – N7 – N8 0.31(15) 
N8 – N9 – N10 – C6 0.75(15) 
C6 – N7 – N8 – N9 0.19(15) 
N7 – N8 – N9 – N10 -0.61(16) 
 
Table 58. Hydrogen bonds [Å and °] for (R)-2-(2-tert-butyl-2H-tetrazol-5-yl) 
pyrrolidinium trifluoro acetate 244 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 - H1B...O21          0.87(2) 1.88(2) 2.7463(18) 171(2) 
N1 - H1B...F16         0.87(2) 2.62(2) 3.0808(18) 113.9(17) 
N1 - H1A...O20        #1 0.98(2) 1.76(2) 2.7331(19) 174.0(18) 
Symmetry transformation used to generate equivalent atoms: 
#1   x+1,y,z       
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4.10. 2-Isopropyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole-squaric acid 
salt (250) 
 
 
Brown single crystals suitable for X-ray analyses are obtained by slow evaporation 
of a methylene chloride solution (Figure 80; Chapter 5.3). This compound crystallizes in 
the orthorhombic space group P212121, with a = 9.143(2) Å, b = 10.706(2) Å, c = 
13.979(3) Å, Z = 4, V = 1368.3(5) Å3, Dc = 1.433 g/cm3, R1 = 0.0235, wR2 = 0.0576. 
 
 
Figure 80. Structure of 2-isopropyl-5-(R)-
pyrrolidine-2-yl-2H-tetrazole squaric acid salt 
250 in the crystal with thermal ellipsoids 
drawn at 50 % probability level 
 
 
        
 
 
 
Figure 81. 2-Isopropyl-5-(R)-pyrrolidine-2-yl-
2H-tetrazole squaric acid salt 250 
 
 
 
 
 
X-Ray diffraction shows that O19 in the cyclobutene moiety is H-bonded to N1 of the 
pyrrolidine ring (Figure 81). The 2-isopropyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole squaric 
acid salt has the tetrazole and the pyrrolidine rings twisted with respect to one another, 
but the torsion angle is different to those found in the X-ray structures of the other 
pyrrolidine-tetrazole derivatives (Sections 4.4.-4.10)(Table 53). The dihedral angle 
between the squaric acid and the tetrazole ring is 14.42(8)°. Based on the method of 
Cramer and Pople, 314  the pyrrolidine ring has an envelope conformation on C4.  
The distance between the pyrrolidine and the tetrazole rings is comparable to that of the 
(R)-5-pyrrolidine-2-yl-tetrazole 115 (Section 4.4.) and the 1-isopropyl-(R)-5-pyrrolidine-
2-yl-1H-tetrazole 237 (Section 4.7.). Within the limits of accuracy all bond lengths and 
angels agree with expected values. The main distance and angles are mentioned (Tables 
59-61). 
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Table 59. Bond lengths [Å]  for 2-
isopropyl-5-(R)-pyrrolidine-2-yl-2H-
tetrazole squaric acid salt 250 
 Table 60. Bond angles [°] for 2-isopropyl- 
5-(R)-pyrrolidine-2-yl-2H-tetrazole squaric 
acid salt 250 
Atoms     Bond length  Atoms   Angle 
N1 – C2 1.5180(16)  C2 - N1 - C5 107.97(9) 
N1 – C5 1.5235(16)  C6 – C5 – N1 109.17(10) 
C5 – C6 1.4961(16)  N1 – C5 – C4 116.80(10) 
C6 – N7 1.3275(16)  C5 – C6 – N7 122.58(10) 
C6 – N10 1.3470(16)  N7 -  C6 – N10 112.82(10) 
N8 – C11 1.4794(15)  N7 – N8 – N9 114.04(10) 
C11 – C12 1.5193(18)  N8 – C11 – C12 109.21(10) 
C16 – C17 1.4330(17)  C16 – C15 – C18 88.10(9) 
C18 – O19 1.2276(15)  C16 – C18 – C17 88.95(9) 
C16 – O21 1.2944(15)    
C15 – C18 1.5073(17)    
C17 – C18 1.4793(17)    
  
        Table 61. Torsion angles [°] for 250 
 
Atoms Angles [°] 
N1 – C5 – C6 – N10 95.02(13) 
N10 – C6 – N7 – N8 -0.98(12) 
C6 – N7 – N8 – N9 0.88(12) 
N7 – N8 – N9 – N10 -0.47(13) 
C15 – C16 – C17 – C18 -2.14(9) 
C16 – C17 – C18 – C15 2.07(9) 
 
The crystal packing is aided by intra-molecular N−H⋅⋅⋅O hydrogen bonds between the 
pyrrolidine and the cyclobutene rings and by inter-molecular O−H⋅⋅⋅O hydrogen bonds 
between the cyclobutene rings along the b-axis (Table 62). 
 
Table 62. Hydrogen bonds [Å and °] for 2-isopropyl-5-(R)-pyrrolidine-2-yl-2H-
tetrazole squaric  acid salt 250 
 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+1,y+1/2,-z+3/2    #2 -x+2,y-1/2,-z+3/2      
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 - H1A...O19          0.919(18) 1.839(18) 2.7554(15) 175.1(17) 
N1 - H1B...O14        #1 0.909(17) 2.005(17) 2.8487(14) 153.7(13) 
O21 – H21...O20     #2 1.04(2) 1.46(2) 2.4970(12) 173.0(2) 
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4.11. 2-[(1-Methyl-1-phenyl-ethyl)-2H-tetrazol-5-yl] pyrrolidinium 
saccharinate (248) 
 
 
 
Figure 82. Structure of 2-[(1-methyl-1-phenyl-
ethyl)-2H-tetrazol-5-yl] pyrrolidinium 
saccharinate 248 in the crystal with thermal 
ellipsoids drawn at 50 % probability level 
 
 
 
 
 
Figure 83. 
Colorless single crystals suitable for X-
ray analyses are obtained by slow evaporation 
of a dichloromethane solution (Figure 82; 
Chapter 5.3). This compound crystallizes in 
the triclinic space group P1, with a = 9.721(2) 
Å, b = 9.821(3) Å, c = 12.530(3) Å, α = 
99.4521(14)°, β = 91.691(13)°, γ = 112.443(14)°, 
Z = 2, V = 1085.0(5) Å3, Dc = 1.348 g/cm3, R1 
= 0.0553, wR2 = 0.1161. The asymmetric unit 
has two molecules, each molecule has an 
hydrogen bond between the oxygen of the 
saccarinate and the NH of the pyrrolidine ring 
(Figure 83). The X-ray structure analysis of 
the 2-[(1-methyl-phenylethyl)-2H-tetrazol-5-
yl] pyrrolidinium saccharinate 248 shows that 
the tetrazole and the pyrrolidine rings are 
twisted with respect to one another, but the 
torsion angles are different to those found in 
the other pyrrolidine-tetrazole derivatives 
(Sections 4.4.–4.10)(Table 65). The phenyl and tetrazole rings have a dihedral angles of 
89.52(14)° in molecule 248.I and 79.82(15)° in molecule 248.II. The saccarinate moiety 
and the phenyl ring have a dihedral angle of 67.14(13)° in molecule 248.I and 61.56(13)° 
248.I 
248.II 
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in molecule 248.II. The distance between the tetrazole and the pyrrolidine rings are 
comparable to that found for molecule 235 (Table 65). 
Within the limits of accuracy all bond lengths and angles agree with expected values. The 
main distances and angles are mentioned (Tables 63-65). The crystal packing is aided by 
intra-molecular N−H⋅⋅⋅O hydrogen bonds between the pyrrolidine ring and the 
saccarinate and by inter-molecular N−H⋅⋅⋅N hydrogen bonds (Table 66). 
 
 
Table 63. Bond lengths [Å] 248  Table 64. Angles [°] for 248 
Atoms   Bonds Length  Atoms Angle 
N1 – C2 1.497(5)  C2 - N1 - C5 105.9(3) 
N1 – C5 1.482(5)  C6 – C5 – N1 110.8(3) 
C5 – C6 1.486(5)  N1 – C5 – C4 101.9(3) 
N8 – N9 1.329(5)  C6 – C5 – C4 117.7(3) 
N9 – N10 1.333(4)  N10 – C6 – N7 112.5(3) 
N9 – C11 1.484(5)  N7 – C6 – C5 124.6(3) 
C11 – C12 1.531(6)  N7 – N8 – N9 106.1(3) 
C11 – C14 1.534(5)  N9 – C11 – C12 105.3(3) 
C42 – N41 1.504(5)  N9 – C11 – C13 108.2(3) 
N41 – C45 1.494(5)  N9 – C11 – C14 107.8(3) 
C45 – C46 1.497(5)  C45 – N41 – C42 107.8(3) 
N48 – N49 1.320(5)  N41 – C45 – C46 110.2(3) 
N49 – N50 1.334(4)  N41 – C45 – C44 103.8(3) 
N49 – C51 1.488(5)  N47 – N48 – N49 106.2(3) 
C51 – C54 1.528(6)  N49 – C51 – C53 106.4(3) 
C51 – C52 1.522(6)  N49 – C51 – C52 107.8(3) 
   N49 – C51 – C54 108.9(3) 
 
Table 65. Torsion angles [°] for 2-[(1-methyl-1-phenyl-ethyl)-
2H-tetrazol-5-yl] pyrrolidinium saccharinate 248 
  
Atoms Angle [°] 
N1 – C5 – C6 – N10 -169.8(3) 
N10 – C6 – N7 – N8 0.3(4) 
C6 – N7 – N8 – N9 -1.0(4) 
N7 – N8 – N9 – N10 1.4(4) 
N41 – C45 – C46 – N50 151.3(3) 
N50 – C46 – N47 – N48 0.1(4) 
C46 – N47 – N48 – N49 0.2(4) 
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Table 66. Hydrogen bonds [Å and °] for 2-[(1-methyl-1-phenyl-ethyl)-2H-tetrazol-5-yl] 
pyrrolidinium saccharinate 248 
 
Symmetry transformations used to generate equivalent atoms: 
#1   x-1,y,z+1              #2    x+1,y,z-1       
     
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N1 - H1A...O31          0.82(5) 2.07(5) 2.739(4) 139(4) 
N41 – H41A...O71         0.96(5) 1.80(5) 2.650(4) 146(4) 
N1-H1A...N47          #1 0.82(5) 2.59(4) 3.012(5) 113(4) 
N1-H1B...N60          #1 0.89(6) 1.99(6) 2.866(5) 166(5) 
N41-H41B...N20      #2 0.86(5) 1.97(5) 2.773(5) 154(4) 
Chapter 5.    Experimental Part 
 155 
Chapter 5. 
Expermental Part 
 
 
 
 All chemicals were obtained either from commercial suppliers or internal sources 
and used without further purification unless otherwise stated. The reagents and solvents 
are listed in each chapter of the experimental part. All reactions were carried out under an 
atmosphere of nitrogen or argon. All the products were satisfactorily characterized by 
melting point, TLC, UV, IR, 1H and 13C NMR, MS, HR-MS and when possible, 
comparison of their analytical data has been made with available literature data. 
 
Melting points 
 
All melting points were measured in open end glass capillary tubes on a Büchi 535 
melting point apparatus and are uncorrected. 
 
Thin-layer Chromatography 
 
Thin-layer chromatographys were performed on Merck pre-coated glass silica gel 
plates of type 60 F254. Compounds were identified with either ultraviolet light and / or 
iodine on silica gel and / or by treatment of the TLC plate with ninhydrin (5 % solution in 
ethanol) followed by heating.  
 
Flash Chromatography 
 
Compounds were purified on  Merck silica gel 60, particle size 0.040-0.063 mm, at 
room temperature with a pressure of ca. 0.3 bar and eluted with the solvent system 
indicated. 
 
High Performance Liquid Chromatography 
 
HPLC analysis were performed with an Agilent Series 1100. The mobile phase was 
0.5 % H3PO4 in water and acetonitrile, flow: 2 mL/min at 40 °C, injection volume: 5.0 
µL, wavelength 220 nm. Column: Merck, Chromolith Performance RP-18e 100-4.6 mm. 
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UV / Vis Spectrometry 
 
UV / Vis spectra were obtained using a Perkin Elmer Lambda19 UV / VIS / NIR 
spectrometer with the Perkin Elmer UV WinLab-Version 2.80.03 software or using a 
Varian Cary 300 Scan UV / VIS spectrophotometer with the Varian Cary WinUV 3.00 
software. The performance of spectrophotometer in terms of wavelength and absorbance 
accuracy is monitored on a regular basis using reference materials (holmium glass). The 
spectra cover the UV as well as the visible light ranges (210 nm to 400 nm and 400 nm to 
700 nm, respectively). The substance was dissolved in a solvent (methanol, ethanol or 
acetonitrile), measured using UV-transparent quartz cells with a 1 cm pathlengh and 
applying individual solvent-specific baseline correction. For each peak, the molar 
absorption is given in L/mol/cm. 
 
Optical rotation 
 
Optical rotation were measured on a Perkin Elmer polarimeter, Polarimeter 341, at 
the sodium D line (589 nm) at 20 °C. The solvent and concentrations (% m/m) are 
indicated. Optical rotations were obtained by subtracting zero- α-value of the solvent 
from the α-value of the sample solution. Before obtaining the α-value, all solutions 
(sample solutions and zero-value) were equilibrated at 20 °C for 15 minutes. The optical 
rotation value was calculated with the following formula: [ ]Tλα  
 
[ ]
( ))1001
100
LODm
V
s
T
−∗∗
∗∗
=
α
α
λ
 
 
[α]λ
T
   = Specific optical rotation at the wavelength λ and temperature T;  
α = Measured angle of rotation minus the zero value, with the corresponding 
sign in degrees; V  =  Volume of sample solution (mL); ms   =  Mass (g) of 
sample; 1 =  Path length of the cell (dm); LOD   = Loss on drying of the sample 
in percent (if not determined: to be set to zero) 
 
Infra-red spectrometry (IR) 
 
Infrared spectra were measured as a solid film on a Bruker Hyperion microscope 
coupled with a Bruker TENSOR 27 FTIR spectrometer over a wave number range of 
4000 - 600 cm-1. Each sample was scanned 32 times with a 2 cm-1 resolution.  
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FT-IR spectrometry 
 
FT-IR spectra were measured in solution on a Mettler Toledo ReactIR 4000 with a 
K6 conduit Dicomp probe over a wave number range of 4000 - 650 cm-1. Each sample 
was scanned 128 times every 2 minutes. 
 
Raman spectrometry 
 
The FT-Raman spectrum were measured as solid on a Bruker RFS 100 FT Raman 
spectrometer equipped with a liquid nitrogen cooled germanium detector. The resolution 
was 4 cm-1 and 250 scans were accumulated by using a laser output of 250, 275 or 300 
mW. The spectrum was corrected for instrumental response. 
 
Nuclear magnetic resonance spectrometry (NMR) 
 
NMR spectra were recorded on a Bruker dpX400 (operating at 400.13 MHz for 1H 
and 100 Mz for 13C) or a Bruker dpX500 (operating at 500.00 MHz for 1H and 125 Mz 
for 13C) or a Brukner dpX600 ( operating at 600.00 MHz for 1H and 150 Mz for 13C ) in 
the solvents indicated at 300 K and chemical shifts (in ppm) were referenced to residual 
solvent peaks (CDCl3: 7.27 ppm for 1H, 77.2 ppm for 13C ; d6-DMSO: 2.50 ppm for 1H, 
39.5 ppm for 13C). Multiplicities are given as s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, sep = septet and br = broad signal.  
 
Mass spectral data (MS)   
 
Mass spectral data were recorded on a Water ZQ2000 Quadruple, electrospray mass 
spectrometer  operating  in  positive  or  negative  ion  mode as  indicated,  or with a    
Varian 1200L Triple Quadrupole mass spectrometer. 
 
High resolution (HR-MS) and high accuracy mass spectra 
 
  High resolution and high accuracy mass spectra were acquired on a 9.4 Tesla 
Bruker APEXIII Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (FT / 
ICR -MS) equipped with an electrospray ion source operated in both positive and 
negative ion mode; 32 spectra were accumulated and internally calibrated using the 
signals from the Agilent ES tune mix solution.  
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X-Ray analyses 
 
Diffraction data for all compounds were collected at 100 K with a Bruker AXS 
SMART 6000 CCD detector on a three-circle platform goniometer with Cu(Kα) radiation 
from a fine-focus sealed tube generator equipped with a graphite monochromator or a 
microfocus rotating anode equipped with multilayer optics. A semi-empirical absorption 
correction was applied, based on the intensities of symmetry-related reflections measured 
at different angular settings.(1) The structure was solved and refined on F2 with the 
SHELXTL suite of programs.(2) Non-hydrogen atoms were refined with anisotropic 
displacement parameters, hydrogen atoms were located in DF maps and refined 
isotropically or in idealized positions using a riding model. Figures were generated with 
PLATON (3) or Mercury.(4) 
 
Numeration of the structures 
 
In most cases, the numbering of the structure is in agreement with the IUPAC name 
generated by the Autonom® program. In some cases, we have used arbitrary numbering, 
which is independent from the IUPAC name of the molecule. 
 
 
 
 
 
 
 
 
 
 
                                                 
(1) G. M. Sheldrick, SADABS, version 2004/1, University of Göttingen, Göttingen, Germany. 
(2) G. M. Sheldrick, SHELXTL, version 6.12, Bruker AXS inc. Madison, Wisconsin, USA. 
(3) A. L. Spek, PLATON, a Multi-Purpose Crystallographic Tool; Utrecht University: Utrecht, The 
Netherlands (http://www.cryst.chem.uu.nl/platon). 
(4) C.F. Macrae, P.R. Edgington, P. McCabe, E. Pidcock, G.P. Shields, R. Taylor, M. Towler, J. van de 
Streek, J. Appl. Cryst. 2006, 39, 453. 
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5.1.  Novel Click Chemistry for the Synthesis 
of 5-Substituted Tetrazoles from 
Organoaluminumazides and Nitriles  
Experimental part 
 
 
5.1.1. Reagents and Solvents 
 
 
All chemicals were obtained either from commercial suppliers or internal sources 
and used without further purification unless otherwise stated. The diethyl aluminum 
chloride was purchased from Sigma-Aldrich or Chemtura Organometallics (formerly 
Crompton GmbH). All reactions were carried out under an atmosphere of nitrogen or 
argon. All the products were satisfactorily characterized by melting point, TLC, UV, IR, 
1H and 13C-NMR, MS, HR-MS and when possible, comparison of their analytical data 
has been made with available literature data. 
 
5.1.1.1. Reagents 
Reagent Molecular 
Formula 
MW 
(g/mol) 
Quality 
Acetic Acid C4H4O2 60.05 Fluka ; ≥96 % 
1-Adamantane carbonitrile C11H15N 161.25 Aldrich ; 97 % 
Aluminum chloride anhydrous AlCl3 133.34 Fluka ; ≥ 99 % (AT) 
Aluminum isopropoxide C9H21AlO3 204.25 Fluka ; > 98 % (Al) 
Benzonitrile C7H5N 103.13 Aldrich ; ≥ 99%  
Benzylbromide C7H7Br 171.04 Fluka ; ≥ 98 % (GC) 
Benzylidenemalonitrile C10H6N2 154.17 Across ; 98 % 
Bicyclo[4.2.0]-octa-1,3-triene-7- 
carbonitrile 
C9H7N  129.16 Novartis ; 87 % (HPLC) 
2-Bromo-1,3,2-benzodioxaborole C6H4BBrO2 198.82 Fluka ; ≥ 98 % (AT)  
2-Bromobenzonitrile C7H4BrN 182.03 Fluka ; ≥ 99 % (GC) 
4’-Bromomethyl-biphenyl-2- 
carbonitrile 
C14H10BrN 272.15 Novartis Production 
But-2-ynedioic acid methyl ester C6H6O4 142.11 SEAC Lot2 
ß-Chlorocatecholborane C6H4BClO2 154.36 Aldrich ; 97 & 
2-Chlorobenzonitrile  C7H4ClN 137.57 Fluka ; ≥ 97 % (GC) 
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4-Chlorobenzonitrile C7H4ClN 137.57 Fluka ; ≥ 97 % (Cl) 
Cesium hydroxide Monohydrate CsHO.H2O 167.93 Fluka ; ≥ 95.0 % (T) 
Cinnamonitrile C9H5N 129.16 Fluka ; ≥ 97 % (GC) 
4-Cyanobenzaldehyde C8H5NO 131.14 Fluka ; ≥ 97 % (T) 
4-Cyanobenzophenone C14H9NO 207.23 Lancaster ; 98 % 
4-Cyanophenyl-acetonitrile C9H6N2 142.16 Aldrich ; 97 % 
2-Cyanopyridine C6H4N2 104.11 Aldrich ; 99 % 
3-Cyanopyridine C6H4N2 104.11 Fluka ; ≥ 97 % (GC) 
4-Cyanopyridine C6H4N2 104.11 Fluka ; ~ 98 % (GC) 
 (S)-2-Cyano-pyrrolidine-1- 
carboxylic acid benzyl ester 
C13H14N2O2 230.27 Novartis 
(R)-2-Cyano-pyrrolidine-1- 
carboxylic acid benzyl ester 
C13H14N2O2 230.27 Novartis 
(S)-2-Cyano-pyrrolidine-1- 
carboxylic acid tert-butyl ester 
C10H16N2O2 196.25 Novartis 
(R)-2-Tetrahydrofuran-2-carbonitrile C5H7NO 97.15 Jülich Chemical Fine 
Lot H40183.01 
Cyclohexene-1-carbonitrile C7H9N 107.16 Lancaster ; 98 % 
1,8-Diazabicyclo[5.4.0]undec-7-ene C9H16N2 152.24 Fluka ; ≥ 99.0 % (GC) 
1,2-Dicyanobenzene C8H4N2 128.13 Aldrich ; 98 % (GC) 
2,6-Pyridinedicarbonitrile C7H3N3 129.12 Aldrich ; 97 %  
Diethylaluminum chloride C4H10 AlCl 120.56 Aldrich ; 1.8 M  in toluene 
Chemtura Organometallics 
Diisobutylaluminum chloride C8H18AlCl 176.67 Aldich ; 97 % 
Dimethylaluminum chloride C2H6 AlCl 92.51 Aldrich ; 1.0 M in Hexane 
Dimethylcyanamide C3H6N2 70.09 Across ; 97 % 
2,2-Diphenylpropionitrile C15H13N 207.28 Alfa Aesar ; 97 % 
Ethyl cyanoformate C4H5NO2 99.09 Fluka ; ≥ 98 % (GC) 
2-Fluorobenzonitrile C7H4FN 121.12 Fluka ; ≥ 98 % (GC) 
4-Fluorobenzonitrile C7H4FN 121.12 Merck ; > 99 % (GC) 
Fumaronitrile C4H2N2 78.07 Lancaster ; 98+ % 
2-Furonitrile C5H3NO 93.09 Lancaster ; 98+ % 
Hydrochloric acid HCl 36.46 Fluka ; 2N standard solution 
Fluka ; ≥ 36.5 % (T) 
2-Hydroxybenzonitrile C7H5NO 119 Fluka ; ≥ 99 % (NT) 
2-Iodobenzonitrile C7H4NI 229.02 Trans World Chemicals 98% 
6-Isopropyl-4-oxo-4H-chromene-3- 
carbonitrile 
C13H11NO2 213.24 Novartis 
DL-Lactonitrile C3H5NO 71.08 Fluka ; > 97.0 % (T) 
Mandelonitrile C8H7NO 133.15 Aldrich ; Tech. 
(R)-(+)-Mandelonitrile C8H7NO 133.15 Aldrich ; 97 % 
Malononitrile C3H2N2 66.06 Fluka ; ≥ 98.0 % (GC) 
5-(4’-Methyl-biphenyl-2yl)-1H- 
tetrazole 
C14H12N4 236.27 Novartis 
Chapter 5.    Experimental Part 
 161 
Methyl-4-formylbenzoate C9H8O3 164.16 Fluka ; ~95 % (HPLC) 
α-Methylphenylacetonitrile C9H9N 131.18 Alfa Aesar ; 97 % 
Methyl phenylpropionate  C10H8O2 160.17 Aldrich ; 97 % 
Ninhydrin C9H6O4 178.14 Fluka ; ≥ 95.0 % (UV) 
R-2-(4-Nitrobenezene- sulfonyloxy)- 
4-phenyl-butyrric acid ethyl ester 
C18H19NO7S 393.42 Novartis 
4-Nitrobenzonitrile C7H5N2 148.12 Lancaster ; 97 % 
Palladium on carbon Pd 106.4 Engelhard 4505 ; Pd/C 10% 
α-Methylbenzyl cyanide C9H9N 131.17 Aldrich ; 96 % 
Phenylsulphonyl acetonitile C8H7NO2S 181.22 Lancaster ; 98 % 
Phenylthio-acetonitrile C8H7NS 149.22 Fluka ; ≥ 95 % (GC) 
Potassium carbonate K2CO3 138.27 Fluka ; ≥ 99 % (AT) 
Potassium hydrogen sulfate KHSO4 136.17 Riedel-deHaen ; Puriss.p.a. 
Potassium hydroxide KOH 56.11 Fluka ; ≥ 86 % (T) 
Potassium thiocyanate CKSNS 97.18 Fluka ; ≥ 99 % (AT) 
Pyrazinecarbonitrile C5H3N3 105.1 Aldrich ; 99 % 
2,6-Pyridine-dicarbonitrile C7H3N3 129.12 Aldrich ; 97 % 
Pyrrole-2-carbonitrile C5H4N2 92.10 Lancaster ; 99 % 
Sodium azide NaN3 65.01 Aldich ; 99 % 
Sodium hydroxyde NaOH 40.00 Fluka ; ≥ 97.0 % (T)  
Fluka ; p.a. ≥ 98 % (T) 
Sodium nitrite  NaNO2 69.00 Aldrich ; 99.5 % 
Tetrabutylammonium bromide C16H13BrN 322.38 Fluka ; ≥ 99 % (Br) 
Thiophene-2-carbonitrile C5H3NO 109.15 Lancaster ; 99 % 
o-Tolunitrile C8H7N 117.15 Merck ; For synthesis 
trans-Cyclobutane-1,2-dicarbonitrile C6H6N2 106.13 Fluka ; ≥ 97 % (GC) 
Triethyl aluminum C6H15Al 114.17 Fluka ; ~1.8 M in toluene  
2-Trifluoromethyl-phenyl-acetonitrile C9H6F3N 185.15 Lancaster ; 97 % 
Trimethylsilylazide C3H9N3Si 115.21 Fluka ; ~ 97 % (GC) 
Zinc chloride ZnCl2 136.29 Fluka ; ≥ 98.0 % (AT) 
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5.1.1.2. Solvents 
 
Solvents Quality 
Acetonitrile  Merck ; for LC 
ARMAR Chemicals ;  d3-Acetonitrile 99.5 Atom % D 
1-Butanol Aldrich ; ≥ 99.5 % 
Dichloromethane Merck ; for analysis  
Fluka ; 99.5 % (GC) 
Diethyl ether Fluka; puriss. over molecular sieves 
Dimethylformamide Fluka; puriss. p.a., ≥ 99.8 % 
Ethanol Fluka ; absolute, ≥ 99.8 % (V/V) (GC) 
Ethyl acetate Fluka ; 99.5 % 
Methanol Fluka ; for analysis 
Dichloromethane Fluka; puriss. over molecular sieves 
Toluene Fluka ; puriss. over molecular sieve (H2O ≤ 0.005 %) 
Fluka ; absolute, over sieve, ≥ 99.5 % (GC) 
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5.1.2. Synthesis of the Starting Material 
 
 
Benzylthiocyanate  (16) 
Br
+     KSCN
S
N
H2O, Bu4NBr  5%
reflux, 2h
 
                                 68                                                                            16 
CAS Registry Number 3012-37-1 
Molecular Formula   C8H7NS 
Molecular Weight    149.22 g/mol 
Methodology Ref. 
W. P. Reeves, M. R. White, R. G. Hilbrich, L. L. Biegert, Synth.  
Commun. 1977, 6, 509 
Analysis Ref. 
a) C. R. Harrison, P. Hodge, Synthesis 1980, 4, 299; b) P. Molina, 
M. Alajarin, A. Ferao, M. J. Lidon, P. H. Fresneda, M. J. Vilarlana, 
Synthesis 1982, 6, 472; c) H. R. Snyder, J. C. Speck, J. Am. Chem. 
Soc. 1939, 61, 668; d) S. D. Ross, M. Finkelstein, R. C. Petersen, J. 
Am. Chem. Soc. 1961, 83, 4853; e) P.-Y. Renard, H. Schweber, P. 
Vayron, L. Josien, A. Valleix, C. Mioskowki,Chem. Eur. J. 2002, 8, 
2910; f) H. L. Wheeler, H. F. Merraam, J. Am. Chem. Soc. 1901, 23, 
283; g) J. F. King, T. Y. Tsang, M. M. Sbdel-Malik, N.C. Payne, J. 
Am. Chem. Soc. 1985, 107, 3224; h) Y. Yamamoto, Y. Morita, 
Chem. Pharm. Bull. 1984, 32, 2957; i) H. Maeda, T. Kawaguchi, M. 
Masaui, H. Ohmori, Chem. Pharm. Bull. 1990, 38, 1389; l) N. 
Iranpoor, H. Firouzabad, H. Shaterian, Syn. Lett. 2000, 1, 65  
 
A 100 mL, three necked round bottomed flask, equipped with an overhead mechanical 
stirrer, is charged, at r.t., with benzylbromide (11.88 mL, 100 mmol), potassium 
thiocynate (38.88 g, 200 mmol, solution 50 % in water), and tetrabutyl ammonium 
bromide (1.611 g, 5 mmol). The resulting mixture is refluxed at 110 °C for two hours. 
The mixture is cooled down at r.t., and the product is extracted three times with ethyl 
acetate (20 mL portion). The combined organic phase is washed twice with water (30 mL 
portion). The solvent is removed, and the crude is subjected to bulb-to-bulb distillation 
(110-115 °C at 5.0 • 10-1 mbar) to give the product as a yellow crystalline material (14.44 
g, 97 % of yield). 
 
Compound characterization data:  
S
N
1
2
3
4
6
 
mp: 37-40 °C; TLC: Rf (hexane / AcOEt 8:1) = 0.3; HPLC: 7.98 min; UV (EtOH): λmax, 
nm (ε): 222 (8000), 201 (1690); IR: ν 3063 (w, ע(C-H)), 2962 (w, ע(C-H)), 2147 (s, 
ע(C≡N)), 1493 (w, ע(C=C)), 1455 (s, ע(C=C)), 1427 (s, ע(C=C)), 769 (s, γ(C-H, Ph)), 698 
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(s, γ(Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 4.35 (s, 2H, H-C5), 7.35 (m, 1H, H-
C4 ), 7.38 (m, 2H, H-C3), 7.40 (m, 2H, H-C2); 13C NMR (125 MHz, d6-DMSO): δ = 37.4 
(CH2, C5), 113,4 (CN, C6), 128.7 (CH, C4), 129.2 (CH, C2), 129.5 (CH, C3), 136.6 (Cq, 
C1); MS: m/z 149 [M]+, 129 [M-HCN]+, 91 [M-SCN]+. 
 
 
4’-Thiocyanato methyl-biphenyl-2-carbonitrile (70) 
N
Br
+     KSCN
Bu4NBr (5%)
Water, toluene
   reflux, 4h
N
S
N
 
                        69                                                                                                70 
Molecular Formula   C15H10N2S 
Molecular Weight    250.32 g/mol 
Methodology Ref. 
W. P. Reeves, M. R. White, R. G. Hilbrich, L. L. Biegert, Synth.  
Commun. 1977, 6, 509 
 
A 100 mL, three necked round-bottomed flask, is chaged, at r.t., with 4’-bromomethyl-
biphenyl-2-carbonitrile (6.804 g, 25 mmol), dissolved in toluene (20 mL), potassium 
thiocynate (9.8 mL, 50 mmol, solution 50 %), and tetrabutyl ammonium bromide (403 
mg, 1.25 mmol). The mixture is refluxed at 110 °C for four hours. The mixture is cooled  
to room temperature and the organic phase is separated, and washed twice with water (15 
mL portion). The combined aqueous phase is extracted twice with toluene (10 mL  
portion). The solvent is removed, and the product is crystallized from ethyl acetate and 
diethyl ether to give the product as a yellow crystalline material  (6.27 g, 99 % yield). 
 
Compound characterization data: 
N
S
N
13
1
2
3
4
5
6
7
8
9
10
11
12
 
mp: 88-90 °C; TLC: Rf (EtOAc / hexane 1:3) = 0.4; HPLC: 10.10 min; UV (EtOH): 
λmax, nm (ε): 287 (5700), 255 (14340), 205 (4120); IR: ν 3037 (w, ע(C-H)), 2218 (vs, 
ע(Ar-C≡N), 2150 (m, ע(C≡N, -SCN)), 1595 (w, ע(C=C)), 1478 (s ע(C=C)), 851 (m, γ(C-
H, Ph)), 773 (s, γ(C-H, Ph)) cm -1; 1H NMR (400 MHz, d6-DMSO): δ = 4.40 (s, 2H, H-
C11), 7.55 (m, 2H, H-C9), 7.57 (m, 1H, H-C3), 7.61 (m, 2H, H-C8), 7.64 (m, 1H, H-C5), 
7.78 (dt, 3J = 7.8 Hz, 4J = 1.3 Hz, 1H, H-C4), 7.94 (m, 3J = 7.7 Hz, 1H, H-C2); 13C NMR 
Chapter 5.    Experimental Part 
 165 
(125 MHz, d6-DMSO): δ = 36.6 (CH2, C11), 110.1 (Cq, C1), 113.1 (Cq, C12), 118.6 (Cq, 
C13), 128.3 (CH, C3), 129.2 (CH, C9), 129.4 (CH, C8), 130.1 (CH, C5), 133.4 (CH, C4), 
133.8 (CH, C2), 136.8 (Cq, C10), 137.8 (Cq, C7), 144.0 (Cq, C6); HR-MS: calc’d for 
[MNH4]+ = 268.0903, found 268.0902 (∆M (ppm) = 0.2), calc’d for [MNa]+ = 273.0457, 
found 273.0456 (∆M (ppm) = 0.4), calc’d for [MK]+ = 289.0196, found 289.0197 (∆M 
(ppm) = 0.2). 
 
 
4-(2,2-Dicyanoethenyl)- benzoic acid methyl ester  (73) 
OO
O
CH3
ZnCl2
N
N
O
O
CH3
N
N
100°C, 10 min
+
H
 
           71                           72                                                                      73 
CAS Registry Number 3129-16-6 
Molecular Formula   C12H8N2O2 
Molecular Weight    212.21 g/mol 
Methodology Ref. P. S. Rao, R. V. Venkataratnam, Tetrahedron Lett. 1991, 32, 5821 
Analysis Ref. 
T. B. Posner, C. D. Dennis, J. Chem. Soc.Perkin Trans. 2, 1976, 6, 
729 
 
A 25 mL, three necked round bottomed flask is charged at room temperature, with 
malonitrile (1.980 g, 30 mmol), methyl-4-formylbenzoate (4.923 g, 30 mmol) and zinc 
chloride (403 mg, 3 mmol). The mixture is warmed and kept at 100 °C for fifteen 
minutes. The resulting heterogenic mixture is cooled to room temperature, washed once 
with aqueous methanol (40 mL, 5 % solution) and filtered to give the product as a yellow 
crystalline material (5.99 g, 94 % yield). 
  
Compound characterization data: 
O
O
CH3
N
N
1
2 3
45
6
7
8 9
 
mp: 152-160 °C; TLC: Rf (toluene / EtOAc 3:1) = 0.68; HPLC: 7.66 min; UV (MeOH): 
λmax, nm (ε): 306 (25700); IR: ν 3080 (w, ע(C-H)), 3038 (w, ע(C-H)), 2960 (w, ע(C-H)), 
2231 (s, ע(C≡N)), 1714 (vs, ע(C=O)), 1591 (m, ע(C=C)), 1561 (s, ע(C=C)), 1432 (m, 
ע(C=C)), 1291 (s, ע(C-O)), 1118 (m, ע(C-O)), 823 (w, γ(C-H, Ph) cm-1; 1H NMR (400 
MHz, d6-DMSO): δ = 3.69 (s, 3H, H-C6), 8.04 (d, 3J2,3 = 6.9 Hz, 2H, H-C3), 8.14 (d, 3J2,3 
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= 6.9 Hz, 2H, H-C2), 8.65 (s, 1H, H-C7); 13C NMR (125 MHz, d6-DMSO): δ = 52.6 
(CH3, C6), 84.3 (Cq, C8), 112.8 (Cq, CN), 113.9 (Cq, CN), 129.8 (CH, C3), 130.5 (CH, 
C2), 133.6 (Cq, C1), 135.1 (Cq, C4), 160.3 (CH, C7), 165.2 (Cq, C5); MS: m/z 212 [M]+, 
181 [M-OCH3]+, 153 [M-COOCH3]+. 
 
 
2,2-Dibenzyl-malonitrile (74) 
N
N
Br
N
N
+
DBU
DMF
 
                                     71             68                                              74 
CAS Registry Number 3779-31-5 
Molecular Formula   C17H14N2 
Molecular Weight    246.31 g/mol 
Methodology Ref. T.-Y. Tsai, K.-S. Shia, H.-J. Liu, Synlett  2003, 1, 97 
Analysis Ref. 
a) J. J. Bloomfield, J. Org. Chem. 1961, 26, 4112; b) H. Normant, T. 
Cuvigny, Bull. Soc. Chim. Fr. 1965, 1881; c) R. Sommer, W. P. 
Neumann, Angew. Chem. 1966, 78, 546; d) K. Friedrich, J. Rieser, 
Synthesis 1970, 2, 479; e)  E. Diez-Barra, A. De la Hoz, A. Moreno, 
P. Sanchez-Verdu, J. Chem. Soc., Perkin Trans. 1, 1991, 10, 2589; 
f) E. Diez-Barra, A. De la Hoz, A. Moreno, P. Sanchez-Verdu, J. 
Chem. Soc., Perkin Trans. 1, 1991, 10, 2589 
 
A 25 mL, three necked round-bottomed flask, is charged at room temperature, with 
malononitrile (330 mg, 5 mmol) dissolved in DMF (5 mL), 1.643 ml of DBU (1.643 mL, 
12 mmol)(exothermic from 20 to 40 °C) and benzylbromide (1.3 mL, 11 mmol). The 
mixture is stirred height hours at 80 °C. The mixture is added, at 0 °C, drop wise to a 
solution of HCl (1 M) to give an heterogeneous brown mixture. The product is extracted 
three times with ethyl acetate (15 mL portion). The combined organic phase is washed 
wice with HCl (1 M,  15 mL portion). The solvent is removed to give the product as a 
brown oil which solidificates at room temperature (1.32 g, 80 % yield). 
 
Compound characterization data: 
N
N
12
3
4
5 6
7
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mp: 118-121 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.84; HPLC: 11.08 min;  
UV (EtOH): λmax, nm (ε): 350 (570), 264 (790), 258 (850), 205 (15440); IR: ν 3080 (w, 
ע(C-H)), 309 (w, ע(C-H)),  2935 (w, ע(CH2)), 2192 (w, ע(C≡N)), 1587 (w, ע(C=C)), 1497 
(s, ע(C=C)), 1457 (m, ע(C=C)), 762 (s, γ(C-H, Ph)), 702 (s, γ(Ph)) cm-1; 1H NMR (500 
MHz, d6-DMSO): δ = 3.49 (s, CH2, H-C5), 7.43 (m, 10H, H-C2-4); 13C NMR (125 MHz, 
d6-DMSO): δ = 41.4 (CH2, C5), 41.9 (Cq, C6), 115.4 (Cq, C7), 128.0 (CH, C4), 128.3, 
130.3 (CH, C2,3), 133.5 (Cq, C1); MS: m/z 246 [MH]+, 91 [PhCH2]+.   
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5.1.3. Synthesis of Tetrazoles and Triazoles with  
               Dialkylaluminum Azides 
 
 
5.1.3.1. Typical procedures for the syntesis of 5-substituted 
tetrazoles 
 
5.1.3.1.1. Typical procedure for the preparation of dialkylaluminum azide 
 
R2AlCl   +   NaN3 R2AlN3  +   NaCl
Toluene
0°C to 25°C
    4-6h  
Scheme 137. Preparation of the dialkylaluminum azide 
 
Notes: diethylaluminum chloride can be used in different solvents and molarities by 
following the same general procedure. For example solutions of diethylaluminum 
chloride were used in 1.8 M in toluene, in 2.5 M in toluene, in 2.7 M in xylene. 
 
A 100 ml, four-necked, oven dried round-bottomed flask equipped with an overhead 
mechanical stirrer, is charged, at 0 °C, under an atmosphere of argon, with of sodium 
azide (5.46 g, 84 mmol). Diethylaluminum chloride (46.7 mL, 84 mmol, 2.7 M in 
toluene) are added with a syringe. After 15 minutes, the white heterogeneous mixture is 
gradually warmed to room temperature, and stirred for four to six hours. During the 
formation of the reagent, a suspension of sodium chloride is formed. 
 
5.1.3.1.2. TP1: Typical procedure for 1-3 dipolar cycloadditions between 
dialkylaluminum azide and nitriles for the tetrazole ring formation  
 
Cycloaddition: 
R' C N
   Toluene
-40 to 120°C
R2AlN3 NH
N
N N
R'
 
Scheme 138. Synthesis of 5-substituted tetrazole 
 
A 100 ml, four-necked, oven dried round-bottomed flask equipped with an 
overhead mechanical stirrer, containing a white suspension of diethylaluminum azide  (84 
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mol, 2.7 M in toluene) is charged, at room temperature, under atmosphere of argon, with 
phenylsulphonyl acetonitrile (10.87 g, 60 mmol) in two equal portions in intervals of five 
minutes. The mixture is gradually heated to 55 °C (external temperature) and stirred for 
two hours.  
 
Work up: 
HNO2 + HN3 (g)   →   N2 (g) + N2O (g) + H2O 
 
Equation 1. Safe removal of hydrazoic acid 
 
When the HPLC and the TLC analysis show >98 % conversion the reaction mixture 
is cooled to 0 °C and, to destroy the excess of azide, added to a solution of NaOH (15 %, 
67 mL, 252 mmol), containing sodium nitrite (17.38 g, 252 mmol) (pH 13.5) (Equation 
1). The pH is adjusted to 1.5 with 6M HCl . The biphasic mixture is transferred to a 
separatory funnel,  and the product is extracted three times with ethyl acetate (20 mL 
portion); the combined organic phase is washed once with water (20 mL), and then 
concentrated by rotary evaporation (45 °C, 210 to 50 mbar) to afford 13.0 g of crude 
product which is re-dissolved in ethyl acetate (30 mL), transferred to a separatory funnel, 
and extracted  three times with potassium carbonate (10 % solution, 25 mL portion) to the 
aqueous phase as the potassium salt (pH 11). The combined basic aqueous phase is 
cooled to 0 °C under stirring and carefully treated with 6M HCl to adjust the pH to 2.5, 
monitored with pH-paper or electrode. The product is extracted three times with ethyl 
acetate (20 ml portion). The combined organic phase is washed once with water (30 ml). 
The solvent is removed to give the tetrazole 75 as a yellow crystalline material which is 
crystallized from ethyl acetate / toluene (10.23 g, 76 %). 
 
5.1.3.1.3. TP2: Typical procedure for  the  protection  of  the hydroxyl  group  
for  synthesis of the compounds 95, 100, 101 and 102 
 
A 25 mL, two necked, oven dried round bottomed flask equipped with a stirring 
bar, is charged, under atmosphere of argon, with triethylaluminum (5 mL, 9 mmol, 1.8 M 
in toluene). The solution is cooled to 0 °C and the mandelonitrile (0.88 mL, 7 mmol) is 
carefully added over 15 minutes (exothermic from 0 to 40 °C). The mixture is stirred two 
hours from 0 °C to room temperature. 
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5.1.3.2. Synthesis of tetrazoles in the presence of sulfony, thio, 
thiocyano functional groups  
 
5-Phenylsulfonylmethyl-1H-tetrazole (75) 
 
S
NO O
Et2AlN3
 Toluene
r.t. to 55°C
S
O O
N
H
N
NN
 
                                       269                                                           75 
CAS Registry Number 54971-66-3 
Molecular Formula   C8H8N4O2S 
Molecular Weight    224.24 g/mol 
Analysis Ref. J. Polanski, K. Jarzembeck, Pure Appl. Chem. 2002, 74, 1227 
 
TP1: 1.4 equivalent of diethylaluminum azide (2.5 M in toluene) are used in a 60 mmol 
scale experiment. The reaction is heated for three hours at 55 °C to give 10.23 g of 
product as a yellow crystalline material after crystallization from toluene (76 % yield). 
The same reaction was done with 1.4 equivalent of diisobutylaluminum azide to obtain 
the same yield. 
 
Compound characterization data:  
S
O O
N
H
N
NN
1
23
4
5
6
 
mp: 172-174 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.44; HPLC: 3.60 min; 
UV (acetonitrile): λmax, nm (ε): 271 (ε = 1610), 264 (1870), 217 (17520), 194 (39300); 
IR: ν 3000 (m, ע(C-H)), 2700-2500 (brm, ע(N-H)), 1555 (w, tetrazole), 1447 (m, 
ע(C=C)), 1401 (m, δsim (CH2)), 1297 (s, עasim(SO2)), 1151 (s, עsim(SO2)) cm-1; 1H NMR 
(500 MHz, d6-DMSO): δ = 5.22 (s, 2H, H-C2), 7.64 (dd, J = 8.8, 7.0 Hz, 2H, H-C5), 7.77 
(m, 3H, H-C4,6), 17.05 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 50.3 (CH2, C2), 
128.0 (CH, C4), 129.5 (CH, C5), 134.5 (CH, C6), 137.9 (Cq, C3), 148.5 (Cq, C1); MS: m/z 
223 [M-H-], 141 [M-CH2CN4H]-.  
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5-(Benzylthio)-1H-tetrazole (17) 
Et2AlN3
 Toluene
r.t. to 50°C
S N
H
N
NN
S
N
 
                                           16                                                             17 
CAS Registry Number 21871-47-6 
Molecular Formula   C8H8N4S 
Molecular Weight    192.24 g/mol 
Analysis Ref. 
a) W. G. Finnegan, R. A. Henry, R. Lofquist, J. Am. Chem. Soc. 
1958, 80, 3908; b) E. B. W. LeBlanc, B. S. Banko, Synth. Commun. 
1998, 28, 3591; c) Lieber Z. P. Demko, K. B. Sharpless, J. Org. 
Chem. 2001, 66, 7945, T. Enkoji, J. Org. Chem. 1961, 26, 4472 
 
TP1: 1.5 equivalent of dithylaluminum azide (2.5 M in toluene) are used in a 20 mmol 
scale experiment. The reaction is heated for four hours and 30 min at 45 °C to give the 
product as a yellow crystalline material (1.77 g, 46 % yield). 
 
Compound characterization data: 
 
S N
H
N
NN
1
2
3
4
5
6
  
mp: 134-136 °C; TLC: Rf  (toluene / EtOAc / AcOH 20:20:1) = 0.28; HPLC: 6.28 min; 
UV (acetonitrile): λmax, nm (ε): 201 (30190); IR: ν 3050 (w, ע(C-H)), 2800-2200 (brm, 
ע(N-H)), 1532 (m, tetrazole), 1493 (m, ע(C=C)), 1454 (m, ע(C=C)), 1433 (m, ע(C=C)) cm-
1; 1H NMR (500 MHz, d6-DMSO) δ = 4.50 (s, 2H, H-C5), 7.26 (t, 3J3,4 = 7.3 Hz, 1H, H-
C4), 7.31 (t, 3J3,4 = 3J2,3 = 7.3 Hz, 2H, ArH), 7.39 (d, 3J2,3 = 7.3 Hz, 2H, ArH), 16.59 (br, 
NH); 13C NMR (125 MHz, d6-DMSO) δ = 36.4 (CH2, C5), 128.1 (CH, C4), 129.0 (CH, 
C2), 129.3 (CH, C3), 137.1 (Cq, C1), 153.7 (Cq, C6); MS: m/z 193 [M+ H]+, 191 [M-H]-, 
91 [M-SCN4H]+; X-Ray: the structure was confirmed by X-ray analysis (See X-ray 
discussion; Section 4).  
 
 
Phenylsulfanylmethyl-1H-tetrazole (76) 
S
N
H
N
NN
S
N
Et2AlN3
     Toluene
r.t. to 55°C, 30h  
                                    270                                                               76 
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CAS Registry Number 18527-28-1 
Molecular Formula   C8H8N4S 
Molecular Weight    192.24 g/mol 
Analysis Ref. 
a) R. L. Buchman, R. A. Portyka, Bristol-Myers Co. U.S. 1967, US 
3337576; b) R. L. Buchman, V. Spancmanis, R. A. Portyka, J. Med. 
Chem. 1969, 12, 1001; c) G. Sedelmeier, Novartis Pharma AG, 
2005, WO2005/14602 A1 
 
TP1: 1.4 equivalent of diethylaluminum azide (2.5 M in toluene) are used in a 6 mmol 
scale experiment. The reaction is heated for thirty hours at 55 °C to give the product as a 
yellow solide after crystallization from toluene (990 mg, 86 % yield ). 
 
Compound characterization data: 
 
S
N
H
N
NN
1
2
3
4
5
6
 
mp: 106-108 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.26; HPLC: 5.14 min; 
UV (EtOH): λmax, nm (ε): 251 (3570); IR: ν 3100-2400 (brs, ע(N-H)), 3100 (s, ע(C-H)), 
2974 (s ע(C-H), 1950-1750 (w, overtones γ(C-H, Ph)), 1571 (s, ע(C=C)), 1471 (w, 
ע(C=C)), 1439 (s, ע(C=C)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 4.54 (s, 2H, H-C5), 
7.21  m, 1H, H-C4), 7.30 (m, 2H, H-C3), 7.34 (m, 2H, H-C2), 16.40 (br, NH); 13C NMR 
(125 MHz, d6-DMSO): δ = 24.8 (CH2, C5), 126.7 (CH, C4), 128.9 (CH, Ar), 129.2 (CH, 
Ar), 134.0 (Cq, C1), 155.0 (Cq, C6); MS: m/z 191 [M-H]-. 
 
 
4’-(1H-Tetrazol-5-yl-sulfanylmethyl)-biphenyl-2-carbonitrile (77)  
N
S
N
Et2AlN3
Xylene, r.t., 24h
N
S
NN
N
N
H
 
                                     70                                                                        77               
Molecular Formula   C15H11N5S 
Molecular Weight    293.35 g/mol 
 
TP1: 1.5 equivalent of diethylaluminum azide (2.7 M in xylene) are used in a 3 mmol 
scale experiment. The reaction is stirred for twenty four hours at room temperature to give 
the product as an off white crystalline material (768  mg, 87 % yield). 
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Compound characterization data: 
N
S
NHN
N
N
12
3
4
5
67
8
9
10
11
12 13
  
mp: 157-160 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.22; HPLC: 7.88 min; 
UV (MeOH): λmax, nm (ε): 287 (5600), 254 (13570); IR: ν 3100-2400 (s, ע(N-H)), 3062 
(s, ע(C-H)), 2923 (s, ע(C-H)), 2226 (s, ע(C≡N)), 1521 (s, ע(C=C)), 1482 (s, ע(C=C)), 838 
(m, γ(C-H, Ph)), 763 (s, γ(C-H, Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 4.59 ( s, 
2H, H-C11), 7.54 (m, 2H, H-C9), 7.55 (m, 2H, H-C8), 7.57 (m, 1H, H-C4), 7.61 (m, 1H, H-
C6), 7.76 (dt, 3J = 7.8, 4J3,5 = 1.3 Hz, 1H, H-C5), 7.93 (dd, 3J3,4 = 8.6, 4J3,5 = 1.3 Hz, 1H, 
H-C3), 17.10 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 35.4 (CH2, C11), 110.1 (Cq, 
C1), 118.5 (Cq, C13), 128.3 (CH, Ar), 128.9 (CH, Ar), 129.3 (CH, Ar), 130.1 (CH, Ar), 
133.5 (CH, C6), 133.9 (CH, C4), 137.1 (Cq, C7), 137.5 (Cq, C10), 144.0 (Cq, C2), 153.8 
(Cq, C12); MS: m/z 294 [M+H]+, 292 [M-H]-; HR-MS: calc’d for [M+H]+ = 294.0808 
found 294.0807 (∆M (ppm) = 0.3), calc’d for [M+Na]-+ = 316.0627 found 316.0627 (∆M 
(ppm) = 0.1). 
 
 
 
5-{4'-[(1H-Tetrazol-5-ylthio)methyl]biphenyl-2-yl}-1H-tetrazole  (78)  
 
Et2AlN3
Xylene, 100°C, 64h
S
NN
N
N
H
N
S
NN
N
N
H
NH
NN
N
 
                               77                                                                                 78                
Molecular Formula   C15H12N8S 
Molecular Weight    336.38 g/mol 
 
TP1: 2.8 equivalents of diethylaluminum azide (2.7 M in xylene) are used in a 1.73 mmol 
scale experiment. The reaction is stirred for three days from 90 to 110 °C to give the 
product as a yellow crystalline material (540 mg, 93 % yield). 
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Compound characterization data: 
S
NHN
N
N NH
NN
N
12
3
4
5
678
9
10
11
12 13
 
mp: 180-182 °C; TLC: Rf (toluene / EtOAc / AcOH 10:20:2) = 0.30; HPLC: 6.24 min; 
UV (MeOH): λmax, nm (ε): 203 (3480); IR: ν 3200-2350 (brs, ע(N-H)), 3060 (s, ע(C-H)), 
3031 (s, ע(C-H)), 2906 (s, ע(C-H)), 1607 (m, ע(C=C)), 1572 (w, tetrazole), 1534 (w, 
tetrazole), 1487 (s, ע(C=C)), 1427 (m, ע(C=C)), 1487s ע(C=C), 840 (m, γ(C-H, Ph)), 747 
(s, γ(C-H, Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 4.5 (s, 2H, H-C11), 7.03 (d, 
3
J8,9 = 8.2 Hz, 2H, H-C8), 7.34 (d, 3J8,9 = 8.2 Hz 2H, H-C9), 7.63 (m, 4H, H-C3-6 ), 16.50 
(br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 35.5 (CH2, C11), 123.1 (Cq, C1), 127.9 
(CH, Ar), 128.9 (CH, Ar), 129.0 (CH, Ar), 130.6 (CH, Ar), 131.1 (CH, C4), 136.0 (Cq, 
C10), 138.5 (Cq, C7), 141.0 (Cq, C2), 153.7 (Cq, C13), 154.4 (Cq, C12); MS: m/z 337 
[MH]+, 335 [M-H]-; HR-MS: calc’d for [MH]+ = 337.0978, found 337.0978 (∆M (ppm) 
< 0.1), calc’d for [M+Na]+ = 359.0798, found 359.0798 (∆M (ppm) < 0.1). 
 
 
5.1.3.3. Synthesis of tetrazoles in the presence of double bonds 
 
(E)-3-Phenyl-2-(2H-tetrazol-5-yl)acetonitrile (79) 
N
N
Et2AlN3
 Toluene
40°C, 6h N
N
N
NHN
 
                                    33                                                             79               
Molecular Formula   C10H7N5 
Molecular Weight    197.20 g/mol 
 
TP1: 2 equivalents of diethylaluminum azide (2.5 M in toluene) are used in a 2 mmol 
scale experiment. The reaction is stirred six hours at 45 °C  to give the product as a white 
crystalline material (381 mg, 97 % yield). 
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Compound characterization data: 
N
N
N
NHN
12
3
4
5
6
7
8
 
mp: 189-192 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.20; HPLC: 5.87 min; 
UV (MeOH): λmax, nm (ε): 305 (15550), 225 (7590); IR: ν 3100-2500 (brs, ע(N-H)), 
3109 (m, ע(C-H)), 3055 (s, ע(C-H)), 2991 (s, ע(C-H)), 2229 (m, ע(C≡N)), 1614 (s, 
ע(C=C)), 1589 (s, ע(C=C)), 1555 (m, tetrazole), 1454 (m, ע(C=C)), 771 (m, γ(C-H, Ph)), 
688 (m, γ(Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 7.60 (m, 3H, H-C3,4), 8.01 (m, 
2H, H-C2), 8.39 (s, 1H, H-C5), 16.80 (br, NH); 13C NMR (150 MHz, d6-DMSO) 97.2 
(Cq, C6), 115.6 (Cq, C7), 128.8, 129.3 (CH, C3,4), 129.8 (CH, C2), 132.2 (Cq, C1), 148.1 
(CH, C5), 155.2 (Cq, C8); MS: m/z 236 [M+K]+, 198 [M+H]+, 196 [M-H]-; HR-MS: 
calc’d for [M-H]- = 196.0629 found 196.0629 (∆M (ppm) = 0.2). 
 
 
5-[(Z)-2-Phenyl-1-(2H-tetrazol-5-yl)vinyl]-1H-tetrazole (80) 
   
N
N
Et2AlN3
 Toluene
60°C, 53h
N
N
NHN
N
N N
NH
 
                                      33                                                                 80             
Molecular Formula   C10H8N8 
Molecular Weight    240.23 g/mol 
 
TP1: 3 equivalents of diethylaluminum azide (2.7 M in xylene) are used in a 10 mmol 
scale experiment. The reaction is stirred for twenty four hours at 65 °C  to give the 
product as a off white crystalline material (1.8 g, 75 % yield). 
 
Compound characterization data: 
N
N
NHN
N
N N
NH
1
2
3
4
5 6
7
7'
 
mp: 203 °C, onset of exothermic decomposition: 204-368 °C with maximum at 211.5 °C; 
TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.04; HPLC: 4.04 min; UV (MeOH): λmax, 
nm (ε): 289 (1410), 220 (860); IR: ν 3100-2500 (brs, ע(N-H)), 3088 (s, ע(C-H)), 3007 (s, 
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ע(C-H)), 1638 (s, ע(C=C)), 1568 (s, ע(C=C)), 1568 (s, tetrazole), 1453 (w, ע(C=C)), 761 
(s, γ(C-H, Ph)), 690 (m, γ(Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 7.07 (m, 2H, 
H-C2), 7.35 (m, 3H, H-C3,4), 8.15 (s, 1H, H-C5), 17.00 (br, NH); 13C NMR (125 MHz, d6-
DMSO): δ = 110.9 (Cq, C6), 128.1 (CH, C2), 129.3 (CH, C3), 130.0 (CH, C5), 133.3 (Cq, 
C1), 140.8 (Cq, C7,7’); MS: m/z 241 [MH]+, 239 [M-H]-. 
 
 
5-(1-Cyclohexen-1-yl)-1H-tetrazole (81) 
Et2AlN3
  Toluene 
 90°C, 20h
N
N
H
N
NN
 
                                            271                                            81 
CAS Registry Number 188890-71-3 
Molecular Formula   C7H10N4 
Molecular Weight    150.18 g/mol 
Ref. 
O. Kazuyuki, T. Makoto, M. Tohru, O. Hiroyuki, Ono Pharmaceutical 
Co., Ltd., Japan, 1997,  EP  761680  A2 
 
TP1: 1.4 equivalents of diethylaluminum azide (2.5 M in toluene) are used in a 7 mmol 
scale experiment. The reaction is heated for twenty hours at 90 °C to give the product as a 
white crystalline material after direct crystallization of the crude from a mixture of ethyl 
acetate / toluene 1:1 ( 680 mg, 65 % yield ). 
 
Compound characterization data: 
 
N
H
N
NN
1
2
3
4
5
6 7
   
mp: 151-153 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.32; HPLC: 4.43 min; 
UV (MeOH): λmax, nm (ε):  230 (1100); IR: ν 3100-2600 (brs, ע(N-H)), 3108 (m, ע(C-
H)), 2972-2931 (s, ע(C-H)), 1651 (s, ע(C=C)), 1556 (s, tetrazole), 1410 (s, tetrazole) cm-1; 
1
H NMR (500 MHz, d6-DMSO): δ = 1.61 (m, 2H, H-C4), 1.70 (m, 2H, H-C5), 2.21 (m, 
2H, H-C3), 2.45 (m, 2H, H-C6), 6.77 (m, 1H, H-C2), 16.20 (br, NH); 13C NMR (125 
MHz, d6-DMSO): δ = 21.1 (CH2, C4), 21.5 (CH2, C5), 24.8 (CH2, C3), 24.9 (CH2, C6), 
122.7 (Cq, C1), 132.7 (CH, C2), 155.5 (Cq, C7); MS: m/z 151 [MH]+, 108 [MH-HN3]+, 
149 [M-H-N2]-; HR-MS: calc’d for [M-H]- = 149.0833, found 149.0833 (∆M (ppm) = 
0.1). 
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5-Styryl-1H-tetrazole (82) 
N
N
N
NHN
Et2AlN3
  Xylene
60°C, 18h  
                                              272                                              82 
CAS Registry Number 220429-71-0 
Molecular Formula   C9H8N4 
Molecular Weight    172.19 g/mol 
Analysis Ref. 
a) H. Detert, D. Schollmeier, Synthesis 1999, 6, 999; b) Z. P. 
Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 7945; c) G. 
Sedelmeier, Novartis Pharma AG, 2005, WO2005/14602 A1 
 
TP1: 1.3 equivalents of diethylaluminum azide (2.7 M in xylene) are used in a 10 mmol 
scale experiment. The reaction is stirred for 18 hours from 50 to 70 °C to give the product 
as an off white crystalline material obtained after crystallization from ethyl acetate (1.667 
g, 97 % yield).  
 
Compound characterization data: 
N
N
NHN
1
2
3
4
5
6 7
 
mp: 158-160 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.46; HPLC: 6.26 min; 
UV (EtOH): λmax, nm (ε): 284 (24660), 221 (12940), 208 (10160); IR: ν 3100-2400 (brs, 
ע(N-H)), 3062 (m, ע(C-H)), 3032 (m, ע(C-H)), 1960-1800 (w, overtones γ(C-H, Ph)), 
1650 (vs, ע(C=C)), 1559 (s, tetrazole), 1420 (s, ע(C=C)), 974 (s, δ(C-H, C=C trans), 776 
(s, γ(C-H, Ph)), 688 (m, γ(Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 7.35 (d, 3J5,6 = 
16.6 Hz, 1H, H-C6), 7.44 (m, 3H, H-C3,4), 7.66 (d, 3J5,6 = 16.6 Hz, 1H, H-C5), 7.74 (m, 2H, 
H-C2), 16.50 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 110.5 (CH, C6), 127.5 (CH, 
C2), 129.0 (CH, C3), 129.6 (CH, C4), 134.9 (Cq, C1), 137.8 (CH, C5), 154.1 (Cq, C7); 
MS: m/z 173 [MH]+, 130 [MH-HN3]+, 186 [MH-HN3]+; HR-MS: calc’d for [M-H]- = 
171.0676, found 171.0676 (∆M (ppm) = 0.1). 
 
 
Fumaryl-2H-tetrazole (83) 
Et2AlN3
N
N
N
NH
NN
N
N
HN N
     Xylene 
r.t., 1 h 30 min  
                                         273                                                                 83 
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CAS Registry Number 18733-24-9 
Molecular Formula   C4H4N8 
Molecular Weight    164.13g/mol 
Analysis Ref. Z. P. Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 7945 
 
TP1: 1.6 equivalents of diethylaluminum azide (2.7 M in xylene) are used in a 6 mmol 
scale experiment. The reaction is stirred for two hours at room temperature to give the 
product as a light brown crystalline material (700 mg, 71 % yield).  
 
Compound characterization data: 
N
NH
NN
N
N
HN N
1
2
 
mp: 275 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.04; HPLC: 2.10 min; UV 
(EtOH): λmax, nm (ε): 261 (1520); IR: ν 3200-2800 (brs, ע(C-H), ע(N-H)), 3098 (s, ע(C-
H)), 3043 (s, ע(C-H)), 1548 (s, tetrazole), 1427 (m, ע(C=C)) cm-1; 1H NMR(500 MHz, 
d6-DMSO): δ = 7.69 (s, 2H, H-C1), 17.00 (br, NH); 13C NMR(125 MHz, d6-DMSO): δ = 
119.1 (CH, C1), 152.9 (Cq, C2); MS: m/z 165 [MH]+, 163 [M-H]-, 136 [MH-N2]+, 108 
[MH-N2-N2]+; HR-MS: calc’d for [M-H]- = 163.0486, found 163.0486 (∆M (ppm) < 
0.1). 
 
 
5.1.3.4. Synthesis of tetrazoles from alkylnitriles 
 
trans-Cyclobutane-1,2-di-1H-tetrazole (84) 
NN
N N
+ Et2AlN3
 Toluene
90°C, 30h
+
N
NHN
N
N
N N
NHHN
N N
N
N
NHN
N
(R,R)              (S,S)  
                                       274                                                                   84 
Molecular Formula   C6H8N8  
Molecular Weight    192.16 g/mol 
 
TP1: 1.33 equivalents of diethylaluminum azide (1.8 M in toluene) are used in a 30 
mmol scale experiment. The reaction is stirred for thirty hours at 90 °C to give the 
product as a white crystalline material after crystallization from ethyl acetate (3.47 g, 
60% yield). 
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Compound characterization data: 
HN
N N
N
N
NHN
N
1
23
4
5
6
Racemic
  
mp: 233-236 °C, onset of exothermic decomposition: 235-315 °C with maximum at 265 
°C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1, I2) = 0.19; IR: ν 3250-2400 (brs, ע(N-
H)), 2958 (s, ע(C-H)), 2921 (s, ע(N-H)), 1564 (s, tetrazole), 1446 (m, tetrazole), 1425 (s, 
tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 2.42 (m, 4H, H-C4,3), 4.12 (m, 2H, 
H-C1,2), 16.45 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 24.4 (CH2, C4,3), 34.2 
(CH, C1,2), 157.1 (Cq, C5,6); MS: m/z 193 [M+H]+, 191 [M-H]-, 148 [M-H-HN3]; HR-
MS: calc’d for [M-H]- = 190.0799 found 191.0800 (∆M (ppm) = 0.4).  
 
 
5-Bicyclo [4.2.0] octa-1,3,5-trien-7-yl-1H-tetrazole (85) 
N
Et2AlN3
  Toluene
70°C, 49 h
NH
N
N
N
 
                                         275                                                85 
CAS Registry Number 188890-75-7 
Molecular Formula   C9H8N4 
Molecular Weight    172.19 g/mol 
Ref. 
O. Kazuyuki, T. Makoto, M. Tohru, O. Hiroyuki, Ono Pharmaceutical 
Co., Ltd.,  Japan, 1997, EP  761680  A2 
 
TP1: 1.5 equivalenst of diethylaluminum azide (1.8 M in toluene) are used in a 10 mmol 
scale experiment. The reaction is heated for forty nine hours at 70 °C to give the product 
as a white crystalline material after direct crystallization of the crude from ethyl acetate / 
toluene (2.53 g, 64 % yield). 
 
Compound characterization data: 
 
N
H
N
N
N
1
6
5
4
3 2
7
8
9
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mp: 154-156 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.24; HPLC: 4.72 min; 
UV (EtOH): λmax, nm (ε):  271 (1550), 265 (1720), 259 (1230); IR: ν 3053 (m, ע(C-H)), 
3000-2400 (brs, ע(N-H)), 2998 (s, ע(C-H)), 1575 (m, tetrazole), 1457 (s, ע(C=C)), 1435 
(w, ע(C=C)), 751 (s, γ(C-H, Ph) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 3.65 (m, 2H, 
H-C7), 5.05 (m, 1H, H-C8), 7.21 (m, 2H, C-H3,6), 7.28 (m, 2H, H-C3,4), 16.30 (br, NH); 
13
C NMR (125 MHz, d6-DMSO): δ = 35.7 (CH, C8), 36.2 (CH2, C7), 122.7, 123.2 (CH, 
C3, 6), 127.5, 128.4 (CH, C4, 5), 143.4 (Cq, C2), 143.6 (Cq, C1), 156.4 (Cq, C9); MS: m/z 
171 [M-H]-. 
 
 
5-(1-Phenyl-ethyl)-2H-tetrazole (86) 
CH3
N
Et2AlN3
CH3
N N
NH
N
Xylene, 55°C
   
                                             276                                                   86                                            
Molecular Formula   C9H10N4 
Molecular Weight    174.21 g/mol 
 
TP1: 1.33 equivalenst of diethylaluminum azide (2.7 M in xylene) are used in a 30 mmol 
scale experiment. The reaction is heated for twenty four hours at 60 °C to give the product 
as a white crystalline material (4.22 g, 81 % yield). 
 
Compound characterization data: 
CH3
N N
NH
N
1
2
3
4
5
6
7
  
mp: 98-99 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.44; HPLC: 4.39 min; UV 
(EtOH): λmax, nm (ε): 258 (23); IR: ν 3200-2500 (brs, ע(N-H)), 3104 (s, ע(C-H)), 2977 (s, 
ע(CH3)), 2937 (s, ע(C-H)), 1967-1670 (w, overtones γ(C-H, Ph)), 1555 (s, tetrazole), 1491 
(s, ע(C=C)), 1453 (s, ע(C=C)), 755 (s, γ(C-H, Ph), 706 (s, γ(Ph)) cm-1; 1H NMR (500 
MHz, d6-DMSO): δ = 1.65 (d, 3J5,6 = 7.2 Hz, 3H, H-C6), 4.53 (q, 3J5,6 = 7.2 Hz, 1H, H-
C5), 7.25 (m, 3H, ArH), 7.32 (m, 2H, ArH), 16.18 (br, NH); 13C NMR (125 MHz, d6-
DMSO): δ = 20.3 (CH3, C6), 34.6 (CH, C5), 127.1 (CH, C2,4), 128.8 (CH, C3), 142.0 (Cq, 
C1), 158.6 (Cq, C7); MS: m/z 175 [M-H]+, 173 [M-H]-, 145 [M-H-N2]-, 132 [MH-NH3]+; 
HR-MS: calc’d for [M-H]- = 173.0833, found 173.0833 (∆M (ppm) = 0.1). 
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5-(1-Adamantyl)-1H-tetrazole (87) 
NH
NN
NN
Et2AlN3
 toluene
90°C, 3d  
                                                            277                                  87 
CAS Registry Number 60798-89-2 
Molecular Formula   C11H16N4 
Molecular Weight    204.27g/mol 
Ref. 
a) T. J. Bleisch, S. A. Filla, P. L. Ornstein, Eli Lilly and Company, 
USA, 2002, WO 2002053556 A2; b) C. P. Hegarty, H. C. Pietryk, 
American Home Products Corp., USA, 1977, US  4032659. 
 
TP1: 2.23 equivalents of diethylaluminum azide (2.5 M in toluene) are used in a 3 mmol 
scale experiment. The reaction is stirred for three days at 90-110 °C to give the product as a 
white crystalline material (500 mg, 82 % yield). 
 
Compound characterization data: 
NH
NN
N
1
2
3
4
 
mp: 250-253 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1, I2) = 0.38; IR: ν 3100-2500 
(brm, ע(N-H)), 2989 (s, ע(C-H)), 2934 (s, ע(C-H)), 2909 (s, ע(C-H)), 1560 (w, tetrazole), 
1409 (w, tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 1.75 (brm, 6H, H-C3), 1.98 
(brm, 6H, H-C1), 2.05 (brm, 3H, H-C2), 16.10 (br, NH); 13C NMR (125 MHz, d6-
DMSO): δ = 27.3 (CH2, C3), 32.0 (Cq, C4), 35.7 (CH2, C1), 40.4 (CH, C2), 162.0 (Cq, C5); 
MS: m/z 205 [MH]+, 203 [M-H]-; HR-MS: calc’d for [M+H]+ = 205.1448, found 
205.1447 (∆M (ppm) = 0.5), calc’d for [M+Na]+ = 227.1267, found 227.1266 (∆M (ppm) 
= 0.4). 
 
 
5-(2-Trifluoromethyl) benzyl-1H-tetrazole (88) 
FF
F
N
Et2AlN3
Xylene HN N
N
N
FF
F
65°C, 17h  
                                               278                                               88   
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CAS Registry Number 220429-74-3 
Molecular Formula   C9H7N4F3 
Molecular Weight    228.17g/mol 
Ref. 
T. Utsunomiya et. all, Nissan Chem. Industries, 1999, Patent written 
in Japanese, WO9906380 A1 
 
TP1: 1.5 equivalents  of diethylaluminum azide  (2.5 M in toluene) or dimethylaluminum 
azide (1 M in hexane) are used in a 4 mmol scale experiment. The reaction was heated 
for seventeen hours at 65 °C to give the product as a yellow crystalline material (730 mg, 
80 % yield).  
 
Compound characterization data: 
HN N
N
N
FF
F
12
3
4
5
6
7 8 9
 
mp: 135-137 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.38; HPLC: 6.51 min; 
UV (EtOH): λmax, nm (ε): 271 (120), 264 (135), 257 nm (130); IR: ν 3134 (w, ע(C-H)), 
3000-2450 (brs, ע(N-H)), 1586 (w, ע(C=C)), 1569-1547 (w, ע(C=C), tetrazole), 1428 (w, 
ע(C=C)), 1109 (s, ע(CF3)), 771 (s, δ(Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 4.45 
(s, 2H, H-C8 ), 7.49 (d, 3J5,6 = 7.6 Hz, 1H, H-C6), 7.54 (t, 3J4,5 = 7.6, 3J3,4 = 7.8 Hz, 1H, H-
C4), 7.69 (t, 3J  = 7.6 Hz, 1H, H-C5), 7.77 (d, 3J3,4 = 7.8 Hz, 1H, H-C3), 16.20 (br, NH); 
13
C NMR (125 MHz, d6-DMSO): δ = 26.3 (CH2, C8), 124.4 (Cq, C7), 126.1 (CH, C3), 
127.2 (Cq, C2), 128.0 (CH, C4), 132.3 (CH, C6), 132.9 (CH, C5), 133.6 (Cq, C1), 154.5 
(Cq, C9); MS: 229 [MH]+, 209 [M-HF]+, 186 [MH-HN3]+; HR-MS: calc’d for [M-H]- = 
227.0550, found 227.0550 (∆M (ppm) = 0.2), calc’d for [M+CF3COO]- = 341.0479, 
found 341.0480 (∆M (ppm) = 0.3). 
 
 
5-(1,1-Diphenylethyl)-2H-tetrazole (89) 
N
CH3 Et2AlN3
N N
NH
N
CH3
      xylene
85-120°C, 18h
 
                                          279                                                       89 
CAS Registry Number 132979-90-9 
Molecular Formula   C15H14N4 
Molecular Weight    250.30 g/mol 
Analysis Ref. 
J. V. Duncia, M. E. Pierce, J. B. Santella, III, J. Org. Chem. 1991, 
56, 2395 
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TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for heighteen hours from 85 to 120 °C to give 
the product as a white crystalline material (550 mg, 45 % yield). 
 
Compound characterization data: 
N N
NH
N
CH3
1
2
3
4
56
7
 
mp: 138-140 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.54; HPLC: 8.70 min; 
UV (EtOH): λmax, nm (ε): 259 (520), 196 (52820); IR: ν 3091 (m, ע(C-H)), 3062 (w, ע(C-
H)), 3025 (m, ע(C-H)), 2800-2350 (brm, ע(N-H)), 2918 (m, ע(CH3)), 1900-1700 (w, 
overtones γ(C-H, Ph)), 1549 (m, tetrazole)), 1494 (s, ע(C=C)), 1447 (m, ע(C=C)), 1410 
(m, ע(C=C)), 761 (s, γ(C-H, Ph)), 698 (s, γ(Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ 
= 2.18 (s, 3H, H-C2), 7.07 (m, 4H, ArH), 7.30 (m, 6H, ArH), 16.20 (br, NH); 13C NMR 
(125 MHz, d6-DMSO): δ = 28.2 (CH3, C2), 45.9 (Cq, C1), 126.6 (CH, C6), 127.1 (CH, 
Ar), 127.9 (CH, Ar), 144.7 (Cq, C3); MS: m/z 251 [MH]+; HR-MS: calc’d for [M-H]- = 
173.0833, found 173.0833 (∆M (ppm) = 0.1). 
 
 
1,3-Diphenyl-2,2-bis-(5-tetrazoyl) propane (90) 
Et2AlN3
Xylene
N
N
NH
NN
N
N
NN
N
N
H
NH
NN
N
Et2AlN3
Xylene
r.t. to 75 °C
     18 h
 
            74                                                           280                                                      90                                                                  
CAS Registry Number 66012-54-2 
Molecular Formula   C17H16N8 
Molecular Weight    332.36 g/mol 
Analysis Ref. H. Illy, Ciba-Geigy AG., Switz., Ger. Offen. 1978, DE  2731323 (A1) 
 
TP1: 1.6 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 1.88 
mmol scale experiment. The reaction is stired for eighteen hours from room temperature 
to 75 °C to give the product as a brown crystalline material (488 mg, 87 % yield). 
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Compound characterization data: 
NN
N
N
H
NH
NN
N
1 2
3
4
5
6
7
 
mp: 217-220 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.6 ; HPLC: 7.69 min; 
UV (EtOH): λmax, nm (ε): 259 (71); IR: ν 3200-2400 (brs, ע(N-H)), 3089 (s, ע(C-H)), 
3028 (s, ע(C-H)), 3007 (s, ע(C-H)), 2962 (s, ע(C-H)), 1951-1740 (w, overtones γ(C-H, 
Ph), 1563 (m, tetrazole), 1497 (m, ע(C=C)), 1456 (s, ע(C=C)), 747 (m, γ(C-H, Ph), 700 (s, 
γ(Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 3.69 (s, 4H, H-C5), 6.56 (m, 4H, H-C2), 
7.05 (m, 6H, H-C3,4), 16.29 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 44.8 (Cq, 
C6), 45.2 (CH2, C5), 126.5 (CH, C4), 127.6 (CH, C2), 129.2 (CH, C3), 134.6 (Cq, C1), 
153.0 (Cq, C7); MS: 331 [M-H]-, 333 [M-H]-.   
 
 
5.1.3.5. Synthesis of tetrazoles from aromatic nitriles 
 
5-Phenyl-1H-tetrazole (11) 
Et2AlN3
  Xylene 
 80°C, 24h
N
N
H
N
NN
 
                                             10                                               11              
CAS Registry Number 18039-42-4 
Molecular Formula   C7H6N4 
Molecular Weight    146.15 g/mol 
Analysis Ref. 
a) J. S. Mihina, R. M. Herbst, J. Org. Chem. 1950, 15, 1082; b) K. 
Sisido, K. Nabika, I. Tyuzo, S. Kozima, J. Organomet. Chem. 1971, 
33, 337; c) J. Kaczmarek, Z. Grzonka, Pol. J. Chem. 1980, 54, 
1297; d) B. S. Jursic, B. W. Leblanc, J. Heterocycl. Chem. 1998, 35, 
405; e) Z. P. Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 
7945; f) J.-J. Shie, J.-M. Fang, J. Org. Chem. 2003, 68, 1158; g) D. 
Amantini, R. Beleggia, F. Fringuelli, F. Pizzo, L. Vaccaro, J. Org. 
Chem. 2004, 69, 2896 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for twenty four hours at 80 °C to give the 
product as a white crystalline material obtained after crystallization from ethyl acetate 
(730 mg, 99 % yield). 
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Compound characterization data: 
N
N
NHN
1
2
3
4
5
 
mp: 214-216 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.6; HPLC: 4.40 min; 
UV (EtOH): λmax, nm (ε): 239 (14710), 199 (29680); IR: ν 3078 (m, ע(C-H)), 3056 (m, 
ע(C-H)), 3000-2400 (brs, ע(N-H)), 1609 (s, ע(C=C)), 1565 (s ,tetrazole or ע(C=C)), 1487 
(s, ע(C=C)), 1466 (s, ע(C=C)), 688 (s, γ(Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ 
= 7.58 (m, 3H, H-C3,4), 8.03 (m, 2H, H-C2), 16.80 (br, NH); 13C NMR(125 MHz, d6-
DMSO): δ = 123.8 (Cq, C1), 126.6 (CH, Ar), 129.0 (CH, Ar), 130.8 (CH, C4), 154.7 (Cq, 
C7); MS: m/z 147 [MH]+, 104 [MH-HN3]+, HR-MS: calc’d for [M-H]- = 145.0520, found 
145.0520 (∆M (ppm) = 0.1). 
 
 
5,5’-(1,2-Phenylene) bis -2H-tetrazole (91) 
N
N
Et2AlN3 N
NH
NN
N
N
H
N
N  Xylene
90°C, 3h
 
                                        281                                                       91 
CAS Registry Number 73096-43-2 
Molecular Formula   C8H6N8 
Molecular Weight    214.19 g/mol 
Analysis Ref. 
a) J. Kaczmarek, Z. Grzonka, Pol. J. Chem. 1980, 54, 1297; b) W. 
Ried, S. Aboul-Fetouh, Tetrahedron 1988, 44, 3399; c) Z. P. 
Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 7945; d) A. 
Fleming, F. Kelleher, M. F. Mahon, J. McGinley, V. Prajapati, 
Tetrahedron  2005, 61, 7002 
 
TP1: 1.4 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for three hours at 90 °C to give the product as an 
off white crystalline material (800 mg, 75 % yield). 
 
Compound characterization data: 
N
NH
NN
12
3 4
N NH
N
N
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mp: 225-227 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.07; HPLC: 3.09 min; 
UV (EtOH): λmax, nm (ε): 206 (21950); IR: ν  3200-2400 (brs, ע(N-H)), 3114 (s, ע(C-H)), 
3054 (s, ע(C-H)), 1957-1780 (w, overtones γ(C-H, Ph)), 1606 (m, ע(C=C)), 1592 (m, 
ע(C=C)), 1556 (s, tetrazole), 1481 (s, ע(C=C)), 1453 (s, ע(C=C)) cm-1; 1H NMR (500 
MHz, d6-DMSO): δ = 7.80 (m, 2H, H-C2), 7.89 (m, 2H, H-C3), 16.60 (br, NH); 13C NMR 
(125 MHz, d6-DMSO): δ = 124.1 (Cq, C1), 130.3 (CH, C3), 130.9 (CH, C2), 154.3 (Cq, 
C4); MS: m/z 215 [MH]+; HR-MS: calc’d for [M-H]- = 213.0643, found 213.0643 (∆M 
(ppm) < 0.1).  
 
 
5-(o-Methylphenyl)-2H-tetrazole (92) 
N
CH3 Et2AlN3
N
N
H
N
N
CH3
Xylene
80°C, 25h  
                                                58                                          92 
CAS Registry Number 51449-86-6 
Molecular Formula   C8H8N4 
Molecular Weight    160.07 g/mol 
Analysis Ref. 
a) J. S. Mihina, R. M. Herbst, J. Org. Chem. 1950, 15, 1082; b) R. 
N. Butler, V. C. Garvin, J. Chem. Soc., Perkin Trans. 1:  Organic 
and Bio-Organic Chemistry (1972-1999), 1981, 2, 390; c) L. A. 
Flippin, Tetrahedron Lett. 1991, 32, 6857; d) K. Koguro, T. Oga, S. 
Mitsui, R. Orita, Synthesis 1998, 6, 910; e) B. S. Jursic, B. W. 
LeBlanc, J. Heterocycl. Chem. 1998, 35, 405 
 
TP1: One equivalent of diethylaluminum azide  (2.7 M in xylene) are used in a 7 mmol 
scale experiment. The reaction is stirred for twenty five hours at  80 °C to give the 
product as a white crystalline material (670 mg, 83 % yield). 
 
Compound characterization data: 
N
NN
H
N
CH3
1 2
3
4
5
6
7 8
 
mp: 150-151 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.46; HPLC: 4.43 min; 
UV (EtOH): λmax, nm (ε): 273 (776), 234 (9330), 205 (23790); IR: 3105 (w, ע(C-H)), 
3062 (m, ע(C-H)), 3000-2300 (brs, ע(N-H)), 2970 (s, עasim(CH3)), 2843 (s, ע(C-H)), 1608 
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(m, ע(C=C)), 1563 (s, tetrazole), 1490 (s, ע(C=C)), 746 (s, γ(C-H, Ph) cm-1; 1H NMR(500 
MHz, d6-DMSO): δ = 2.50 (s, 3H, H-C8), 7.38 (m, 1H, H-C5), 7.43 (m, 1H, H-C3), 7.48 
(m, 1H, H-C4), 7.68 (m, 1H, H-C6), 16.65 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 
20.5 (CH3, C8), 123.8 (Cq, C2), 126.3 (CH, C5), 129.4 (CH, C3), 130.7 (CH, C4), 131.3 
(CH, C6), 137.0 (Cq, C1), 155.0 (Cq, C7); MS: m/z 159 [MH]+, 131 [M-H-N2]-; HR-MS: 
calc’d for [M-H]- = 159.0676, found 159.0676 (∆M (ppm) = 0.2). 
 
 
5-[4-(1H-tetrazol-5-yl-methyl)-phenyl]-1H-tetrazole (93) 
Et2AlN3
N
N
NH
NN
N
N
N
N
H
N
Xylene
75°C, 24h
 
                                                282                                                 93 
CAS Registry Number 66012-62-2 
Molecular Formula   C9H8N8 
Molecular Weight    228.22 g/mol 
Analysis Ref. H. Illy, Ciba-Geigy A.-G., Switz., Ger. Offen. 1978, DE  2731323 A1 
 
TP1: 2.1 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 1.4 mmol 
scale experiment. The reaction is stirred for twenty four hours at 75 °C to the product as a 
white crystalline material (305 mg, 95 % yield). 
 
Compound characterization data: 
N
N
NH
N
NH
NN
N
1
2
3
4
5 6
7
 
mp: up to 250 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.24; HPLC: 3.44 min; 
UV (MeOH): λmax, nm (ε): 243 (14580); IR: 3200-2300 (brs, ע(N-H)), 3091 (w, ע(C-H)), 
3018 (m, ע(C-H)), 2988 (m, ע(C-H)), 2931 (m, ע(C-H)), 1577 (m, tetrazole), 1509 (m, 
ν(C=C)), 1451 (m, ע(C=C)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 4.41 (s, 2H, H-C5), 
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7.51 (d, 3J2,3  = 8.3 Hz, 2H, H-C3), 8.02 (d, 3J2,3  = 8.3 Hz, 2H, H-C2), 16.60 (br, NH); 13C 
NMR(125 MHz, d6-DMSO): δ = 28.4 (CH2, C5), 127.3 (CH, Ar), 127.5 (Cq, Ar), 129.8 
(CH, Ar), 139.1 (Cq, Ar), 155.0 (Cq, C6,7); MS: m/z 227 [M-H]-. 
 
 
5-(4-Nitrophenyl)-1H-tetrazole (94) 
Et2AlN3
N
NH
NN
N
NO2
Xylene
0°C, 5min
NO2  
                                                           283                                      94 
CAS Registry Number 16687-60-8 
Molecular Formula   C7H5N5O2 
Molecular Weight    191.15 g/mol 
Analysis Ref. 
a) Z. P. Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 7945; b) 
E. H. Master, S. I. Khan, K. A. Poojary, Bioorg. Med. Chem. 2005, 
13, 4891 
 
TP1: 1.5 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred five minutes at 0 °C (addition of the starting 
nitrile very exhothermic with gas evolution) to give the product as a brown crystalline 
material (140 mg, 15 % yield).  
 
Compound characterization data: 
O2N
N
H
N
NN
1
3
2
4
5
 
mp: 194-196 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.16; HPLC: 4.34 min; 
UV (EtOH): λmax, nm (ε): 280 (11830); IR: ν 3250-2400 (brm, ע(N-H)), 3105 (m, ע(C-H)), 
3079 (m, ע(C-H)), 1606 (m, ע(C=C)), 1553 (m, tetrazole), 1526 (s, ע(NO2)), 1339 (s, 
ע(NO2)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 8.30 (d, 3J2,3 = 12.0 Hz, 2H, H-C2), 
8.43 (d, 3J2,3 = 12.0 Hz, 2H, H-C3), 16.30 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 
124.2 (CH, C2), 127.8 (CH, C3), 130.5 (Cq, C4), 148.2 (Cq, C1), 152.9 (Cq, C5); MS: m/z 
190 [M-H]-, 162 [M-H-N2]-, 134 [M-H-N2-N2]-. 
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5-(2-Hydroxy-phenyl)-1H-tetrazole (95) 
N
OH
AlEt3
   Toluene
0°C to r.t., 2h
N
OAlEt2
Et2AlN3
     Xylene
80°C, 2h 30min
OH
NH
NN
N
 
            284                                                285                                                        95 
CAS Registry Number 51449-77-5 
Molecular Formula   C7H6N4O 
Molecular Weight    162.15 g/mol 
Analysis Ref. 
a) J. Kaczmarek, Z. Grzonka, Polish J. Chem. 1980, 54, 1297; b) A. 
Kumar, R. Narayanan, H. Shechter, J. Org. Chem. 1996, 61, 4462; 
c) K. Koguro, T. Oga, S. Mitsui, R. Orita, Synthesis 1998, 6, 910; d) 
G. Sedelmeier, Novartis Pharma AG, 2005, WO2005/014602 A1 
 
Protection of the hydroxyl group: TP2, Cycloaddition: TP1: 
1.1 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 4 mmol scale 
experiment. The reaction is stirred for two hours and thirty minutes at 80 °C to give the 
product as a white crystalline material (628 mg, 97 % yield). The same experiment is done 
at room temperature for four hours to obtain the same yield . 
 
Compound characterization data: 
 
OH
NH
NN
N
1
2
35
6
7
4  
mp: 220-222 °C; TLC: Rf (toluene / AcOEt / AcOH) = 0.46; HPLC: 3.67 min; UV 
(EtOH): λmax, nm (ε): 298 (516), 253 (843), 244 (1190), 208 (2710); IR: ν 3254 (s, 
ע(OH)), 3300-2500 (brs, ע(N-H)), 3065 (s, ע(C-H)), 1964-1600 (w, overtones γ(C-H, 
Ph)), 1615 (vs, ע(C=C)), 1548 (s, tetrazole), 1487 (s, ע(C=C)), 1466 (vs, ע(C=C)), 748 (s, 
γ(CH, Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 7.01 (m, 3J = 8.0 Hz, 1H, H-C5), 
7.14 (d, 3J = 8.2 Hz, 1H, H-C3), 7.41 (dt, 4J4,6 = 1.5 Hz, 3J =  8.0 Hz, 1H, H-C4), 8.00 (dd, 
4
J4,6 = 1.5 Hz, 3J = 8.0 Hz, 1H, H-C6), 11.00 (br, OH), 16.00 (br, NH); 13C NMR (125 
MHz, d6-DMSO): δ = 110.4 (Cq, C1), 116.3 (CH, C5), 119.7 (CH, C3), 129.0 (CH, C6), 
132.6 (CH, C4), 151.6 (Cq, C7), 155.3 (Cq, C2); MS: m/z 161 [M-H]+, 163 [M+H]+.   
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5-(2-Fluoro-phenyl)-2H-tetrazole (96) 
F
N
Et2AlN3
Toluene
90°C, 7h
F
N
NHN
N
 
                                              135                                                96 
CAS Registry Number 50907-19-2 
Molecular Formula   C7H5N4F 
Molecular Weight    164.14  g/mol 
Analysis Ref. 
a) E. F. George, W. R. Riddell, Imperial Chemical Industries Ltd., 
UK, 1975, US  3865570; b) R. K. Russell, W. V. Murray, J. Org. 
Chem. 1993, 58, 5023; c) P. Malladi, S. Kantevari, C. K. S. Nair, 
(Council of Scientific and Industrial Research, India) 2001, US 
6326498 B1; d) K. Srinivas, C. K. S. Nair, S. Ramesh, M. 
Pardhasaradh, Org. Prep. Proc. Int. 2004, 36, 69; e) G. Sedelmeier, 
Novartis Pharma AG, 2005, WO2005/14602 A1 
 
TP1: 1.3 equivalents of diethylaluminum azide (1.8 M in toluene) are used in a 15 mmol 
scale experiment. The reaction is stirred seven hours at 90 °C  to give the product as a 
white crystalline material (2.348 g, 95 % yield). The same experiment was done at 55 °C 
stirring the reaction for 39 hours with the same yield. 
 
Compound characterization data: 
F
N
NHN
N
1
2
3
4
5
6
7
 
mp: 158-160 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.45; HPLC: 3.79 min.; 
UV (EtOH): λmax, nm (ε): 275 (1610), 236 (12850), 197 (25630); IR: ν 3100-2400 (brs, 
ע(N-H)), 3063 (m, ע(C-H)), 3023 (s, ע(C-H)), 1900-1750 (w, overtones γ(C-H)), 1622 (s, 
ע(C=C)), 1587 (m, tetrazole), 1494 (s, ע(C=C)), 1234 (s, ע(C-F)), 752 (s, γ(C-H, Ph) cm-1; 
1
H NMR (500 MHz, d6-DMSO): δ = 7.45 (m, 1H, H-C5), 7.50 (m, 1H, H-C3), 7.68 (m, 
1H, H-C4), 8.06 (m, 1H, H-C6), 16.5 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 
112.5 (Cq, C1), 116.6 (CH, C3), 123.4 (CH, C5), 130.2 (CH, C6), 133.5 (CH, C4), 158.1 
(Cq, C7), 159.8 (Cq, C1); MS: m/z 165 [MH]+, 163 [M-H]-, 135 [MH-N2]-, 122 [MH-
HN3]+. 
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5-(2-Chloro-phenyl)-2H-tetrazole (97) 
N
Cl
Et2AlN3 N
HN
N N Cl
  Xylene
50°C, 27h  
                                                    286                                            97 
CAS Registry Number 50907-46-5 
Molecular Formula   C7H5ClN4 
Molecular Weight    180.60 g/mol 
Analysis Ref. 
a) R. M. Herbst, K. R. Wilson, J. Org. Chem. 1957, 22, 1142; b) E. 
F. George, W. R. Riddell, Imperial Chemical Industries Ltd., UK, 
1975 US  3865570; c) R. N. Butler, V. C. Garvin, J. Chem. Soc., 
Perkin Trans. 1, 1981, 2, 390; d) K. Srinivas, C. K. S. Nair, S. 
Ramesh, M. Pardhasaradhi, Org. Prec. Proc. Int. 2004, 36, 69; e) 
G. Sedelmeier, Novartis A.-G., Switz. 2005, WO 2005014602  A1   
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 4 mmol 
scale experiment. The reaction is stirred for twenty seven  hours at 50 °C to give the 
product as a white crystalline material (680 mg, 95 % yield).  
 
Compound characterization data: 
N
NHN
N
Cl1 2
3
4
5
6
7
 
mp: 173-175 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.48; HPLC: 4.28 min; 
UV (EtOH): λmax, nm (ε):  235 (6770), 204 (2439); IR: ν 3200-2400 (sbr, ע(N-H)), 3108 
(w, ע(C-H)), 3061 (m, ע(C-H)), 3034 (m, ע(C-H)), 3004 (m, ע(C-H)), 1603 (s, ע(C=C)), 
1564 (s, tetrazole), 1472 (m, ע(C=C)), 748 (s, γ(C-H, Ph) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 7.55 (m, 1H, H-C5), 7.63 (m, 1H, H-C4), 7.71 (m, 1H, H-C3), 7.80 (m, 1H, 
H-C6), 16.90 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ =  124.1 (Cq, C2), 127.8 (CH, 
C5), 130.4 (CH, C4), 131.7 (CH, C3), 131.9 (Cq, C1), 132.6 (CH, C6); MS: m/z 181 
[MH]+, 179 [M-H]-, 151 [M-H-N2]-. 
 
5-(2-Bromo-phenyl)-1H-tetrazole (26) 
R2AlN3
Br
N
Br
NH
NN
N
Xylene
50°C, 58H  
                                                25                                             26 
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CAS Registry Number 73096-42-1 
Molecular Formula   C7H5N4Br 
Molecular Weight    225.5 g/mol 
Analysis Ref. 
a) S. J. Wittember, B. G. Donner, J. Org. Chem. 1993, 58, 4139; b) 
J. W. Ellingboe, M. Antane, T. T. Nguyen, M. D. Collini, A. Schuyler, 
D. Hartupee, V. White, J. McCallum, J. Med. Chem. 1994, 37, 542; 
c) J. Boivin, S. Husinec, S. Z. Zard, Tetrahedron 1995, 51, 11737 
 
TP1: 1.5 equivalents  of diethylaluminum azide (2.7 M in xylene), or 1.5 equivalents  of 
dimethylaluminum azide (1 M in hexane) are used in a 3 mmol scale experiment. The 
reaction is stirred for thirty  hours at 50 °C to give the product as a white crystalline 
material (480  mg, 71 % yield). 
 
Compound characterization data: 
Br
NH
NN
N
1
2
3
4
5
6
7
 
mp: 174-176 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.4; HPLC: 4.14 min; 
UV (EtOH): λmax, nm (ε): 203 (27320); IR: ν 3100-2400 (brs, ע(N-H)), 3068 (m, ע(C-H)), 
3035 (m, ע(C-H)), 1988-1700 (w, overtones γ(C-H, Ph), 1605 (s, ע(C=C)), 1476 (s, 
ע(C=C)), 1447 (s, tetrazole), 749 (s, γ(C-H, Ph) cm-1; 1H NMR (500 MHz, d6-DMSO): δ 
= 7.55 (m, 3J = 8.0 Hz, 2H, H-C4,5), 7.7 (dd, 3J3,4 = 8.0, J = 4.0 Hz, 1H, H-C3), 7.85 (dd, J 
= 8.0, 4.0 Hz, 1H, H-C6), 16.70 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 121.4 
(Cq, C1), 126.1 (Cq, C2), 127.7 (CH, C5), 131.6 (CH, C4), 132.2 (CH, C3), 133.1 (CH, 
C6), 154.2 (Cq, C7); MS: m/z 225 [MH]+, 197 [M-H-N2]-, 182 [MH-HN3]+. 
 
 
5-(2-Iodo-phenyl) -2H-tetrazole (98) 
N
I
N
NN
H
N
IEt2AlN3
Xylene
50°C, 5d  
                                                   286                                         98 
CAS Registry Number 73096-40-9 
Molecular Formula   C7H5N4I 
Molecular Weight    272.05 g/mol 
Analysis Ref. 
a) J. Kaczmarek, H. Smagowski, Z. Grzonka, J. Chem. Soc., Perkin 
Trans. 2:  Physical Organic Chemistry (1972-1999) 1979, 12, 1670; 
b) J. Kaczmarek, Z. Grzonka, Pol. J. Chem. 1980, 54, 1297; c) J. 
Boivin, S. Husinec, S. Z. Zard, Tetrahedron 1995, 51, 11737 
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TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 3 mmol 
scale experiment. The reaction is stirred for three days at 50 °C to give the product as a 
white crystalline material (690 mg, 85 % yield). 
 
Compound characterization data: 
N
NHN
N
I1 2
3
4
5
6
7
 
mp: 214-216 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.42; HPLC: 4.75 min; 
UV (EtOH): λmax, nm (ε): 204 (20180); IR: ν 3027 (w, ע(C-H)), 3000-2300 (brs, ע(N-H)), 
2996 (w, ע(C-H)), 1601 (s, ע(C=C)), 1569 (w, tetrazole), 1473 (s, ע(C=C)), 747 (s, γ(C-H, 
Ph) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 7.34 (m, 3J3,4 = 8.03 Hz, 1H, H-C4), 7.59 
(m, 2H, H-C5,6), 8.09 (d, 3J3,4 = 8.03 Hz, 1H, H-C3), 17.00 (br, NH); 13C NMR (125 MHz, 
d6-DMSO): δ = 97.6 (Cq, C2), 128.4 (CH, C4), 130.5 (Cq, C1), 131.2 (CH, C5), 132.4 
(CH, C6), 139.7 (CH, C3), 155.8 (Cq, C7); MS: m/z 273 [M+H]+, 271 [M-H]-, 243 [M-H-
N2]-; HR-MS: calc’d for [M+H]+ = 272.9632, found 272.9630 (∆M (ppm) = 0.5), calc’d 
for [M+Na]+ = 294.9451, found 294.9450 (∆M (ppm) = 0.3). 
 
 
5-(4-Chloro-phenyl)-1H-tetrazole (1) 
N
Et2AlN3
     Toluene
    90°C, 24h
NH
NN
N
ClCl  
                                                287                                              1 
CAS Registry Number 16687-61-9 
Molecular Formula   C7H5N4Cl 
Molecular Weight    180.59  g/mol 
Analysis Ref. 
a) E. F. George, W. R. Riddell, Imperial Chemical Industries Ltd., 
UK, 1975, US  3865570; b) A. Antonowa, S. Hauptmann, Zeitschrift 
fuer Chemie 1976, 16, 17; c) J. Kaczmarek, Z. Grzonka, Pol. J. 
Chem. 1980, 54, 1297; d) N. Sadlej-Sosnowska, W. P. Oziminski, 
A. Krowczynski, Chem. Phys. 2003, 294, 65; e) F. Lenda, F. 
Guenoun, B. Tazi, N. BenIarbi, H. Allouchi, J. Martinez, F. Lamaty, 
Eur. J. Org. Chem. 2005, 2, 326; f) G. Sedelmeier, Novartis Pharma 
AG, 2005, WO2005/14602 A1 
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TP1: 1.57 equivalents  of diethylaluminum azide (2.5 M in toluene) are used in a 40 
mmol scale experiment. The reaction is stirred twenty four hours at 90 °C  to give the 
product as a off white crystalline material (7.09 g, 97 % yield). 
 
Compound characterization data: 
N
NHN
N
Cl
1
2
3
4
5
 
mp: 255-257 °C; TLC: Rf (toluene / EtOAc / AcOEt / AcOH 20:20:1) = 0.40; HPLC: 
5.86 min.; UV (EtOH): λmax, nm (ε): 248 (34480); IR: ν 3200-2400 (brs, ע(N-H)), 3096 
(m, ע(C-H)), 3071 (m, ע(C-H)), 3000 (m, ע(C-H)), 1900-1750 (w, overtones γ(C-H, Ph)), 
1611 (s, ע(C=C)), 1566 (w, tetrazole), 1488 (s, ע(C=C)), 1436 (s, ע(C=C)), 1096 (s, ע(Ph-
Cl)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 7.69 (m, 3J2,3 = 8.8 Hz, 2H, H-C2), 8.04 
(d, 3J2,3 = 8.8 Hz, 2H, H-C3), 17.00 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 123.1 
(Cq, C1), 128.7 (CH, C3), 129.6 (CH, C2), 135.9 (Cq, C4), 154.8 (Cq, C5); MS: m/z 179 
[M-H]-. 
 
 
5-(4-Fluoro-phenyl)-1H-tetrazole (99) 
N
Et2AlN3
  Toluene
130°C, 15h
N
NHN
N
FF  
                                                  288                                           99 
CAS Registry Number 50907-21-6   
Molecular Formula   C7H5FN4 
Molecular Weight    164.14 g/mol 
Analysis Ref. 
a) E. F. George, W. R. Riddell, Imperial Chemical Industries Ltd., 
UK, 1975, US  3865570; b) N. E. Takach, E. M. Holt, N. W. Alcock, 
R. A. Henry, J. H. Nelson, J. Am. Chem. Soc. 1980, 102, 2968; c) 
B. Verheyde, W. Dehaen, J. Org. Chem. 2001, 66, 4062   
 
TP1: 1.5 equivalents  of diethylaluminum azide (1.8 M in toluene) are used in a 5 mmol 
scale experiment. The reaction is stirred fifteen four hours at 130 °C  to give the product 
as an off white crystalline material after crystallization from toluene (720 mg, 88 % 
yield). 
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Compound characterization data: 
N
NHN
N
F
1
2
3
4
5
 
mp: 209-211 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.41; HPLC: 4.73 min; 
UV (EtOH): λmax, nm (ε): 240 (5440); IR: ν 3091 (w, ע(C-H)), 3073 (w, ע(C-H)), 3000-
2300 (brs, ע(N-H)), 1900-1750 (w, overtones γ(C-H, Ph)), 1611 (s, ע(C=C)), 1572 (w, 
tetrazole), 1501 (s, ע(C=C)), 1446 (s, ע(C=C)), 843 (s, γ(C-H, Ph)) cm-1; 1H NMR (500 
MHz, d6-DMSO): δ = 7.55 (m, 3J2,3 = 8.8 Hz, 2H, H-C2), 8.10 ( m, 3J 2,3 = 8.8 Hz, 2H, H-
C3), 17.00  (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 116.6 (CH, C2), 121.0 (Cq, 
C1), 129.4 (CH, C3), 154.7 (Cq, C5), 162.7 (Cq, C4); HR-MS: calc’d for [M-H]- = 
163.0426, found 163.0425 (∆M (ppm) = 0.1).   
 
 
5.1.3.6. Synthesis of tetrazoles in the presence od hydroxy group 
 
1H-Tetrazole-5-methanol-α-methyl (100) 
H3C
OH
N H3C
OH
NH
N
N
N
Et2AlN3
Xylene
0°C to r.t., 24h  
                                             289                                                   100 
CAS Registry Number 155471-60-6 
Molecular Formula   C3H6N4O 
Molecular Weight    114.05 g/mol 
Analysis Ref. 
B. E. Fisher, A. J. Tomson, J. P. Horwitz, J. Org. Chem. 1959, 24, 
1650 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 10 mmol 
scale experiment. The reaction is stirred for twenty four hours from 0 °C to room 
temperature to give the product as a white crystalline material (780 mg, 65 % yield). 
 
Compound characterization data: 
H3C
OH
NH
N
N
N1
2
3
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mp: 120-122 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1, CPS) = 0.2; UV (EtOH): 
λmax, nm (ε): 273 (ε = 3); IR: ν 3382 (s, ע(O-H)), 3000-2400 (brs, ע(N-H)), 2987 (s, ע(C-
H)), 2978 (s, ע(C-H)), 2950 (m, ע(C-H)), 1580 (m, (tetrazole)), 1463 (w, (tetrazole)), 1445 
(m, (tetrazole)), 1256 (s, ע(C-O)), 1246 (s, ע(C-O)) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 1.48 (d, 3J1,2 = 6.5 Hz, 3H, H-C1), 5.08 (q, 3J1,2 = 6.5 Hz, 1H, H-C2), 6.01 
(br, OH), 16.15 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 22.6 (CH3, C1), 60.6 
(CH, C2), 144.0 (Cq, C3);  MS: m/z 115 [MH]+, 113 [M-H]-; HR-MS: calc’d for [M-H]- 
= 113.0469, found 113.0469 (∆M (ppm) = 0.1), calc’d for [M+Cl]- = 149.0236, found 
149.0236 (∆M (ppm) = 0.1). 
 
 
Phenyl (2H-tetrazol-5-yl)-methanol (101) and (R)-enantiomer (102) 
OH
N
OH
N
H
N
N
N
Et2AlN3
xylene, 45 °C
 
                                        290                                                         101 
CAS Registry Number 40060-76-2 (racemic) 
Molecular Formula   C8H8N4O 
Molecular Weight    176.18 g/mol 
Analysis Ref. Z. P. Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 7945 
        
Protection of the hydroxyl group: TP2, Cycloaddition: TP1 
1.5 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 7 mmol scale 
experiment. The reaction is stirred for one hour twenty minutes at 45 °C to give the 
product as a white crystalline material obtained after crystallization from ethyl acetate 
(1.04 g, 82.4 % yield). The same experiment is done with the pure (R)-enantiomer in a 3.5 
scale experiment at 40 °C for one hour to give 610 mg of product with 99 % of yield after 
extractions. 
 
Compound characterization data: 
 OH
NH
N
N
N
12
3
4
5
6
 
mp: 157-159 °C; HPLC: 2.428 min; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.23; 
Optical rotation: (R)-enantiomer: [ ]25Dα  = -1.0 (in MeOH, c = 0.70); UV (EtOH): λmax, 
nm (ε): 258 (ε = 25); IR: ν 3426 (brs, ע(O-H)), 3092 (s, ע(C-H)), 3066 (s, ע(C-H)), 3000-
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23000 (brs, ע(N-H)), 2950 (s, ע(C-H)), 1495 (w, ע(C=C)), 1456 (w, ע(C=C)), 1434 (w, 
ע(C=C)), 1059 (s, ע(C-O)), 1041 (m, ע(C-O)), 754 (m, γ(C-H, Ph)), 696 (s, γ(Ph)) cm-1; 
1
H NMR (500 MHz, d6-DMSO): δ =  6.11 (d, J = 4 Hz, 1H, H-C5), 6.75 (br, 1H, OH), 
7.30 (m, 1H, H-C4), 7.35 (m, 2H, H-C3), 7.41 (m, 2H, H-C2), 16.40 (br, NH); 13C NMR 
(125 MHz, d6-DMSO): δ = 66.3 (CH, C5), 126.3 (CH, C2), 128.0 (CH, C4), 128.4 (CH, 
C3), 140.9 (Cq, C1), 158.8 (Cq, C6); MS: m/z 177 [MH]+, 175 [M-H]-, 159 [MH-H2O]+, 
131 [MH-H2O-N2]+; HR-MS: calc’d for [M-H]- = 175.0625, found 175.0625 (∆M (ppm) 
= 0.1). 
 
 
5.1.3.7. Synthesis of 5-substituted heteroaromatic tetrazoles  
 
2-(2H-Tetrazol-5yl)-pyridine (103) 
N
N
Et2AlN3
N
N
NH
NN
Xylene
0°C to r.t., 3h  
                                         291                                              103 
CAS Registry Number 33893-89-9 
Molecular Formula   C6H5N5 
Molecular Weight    147.14 g/mol 
Analysis Ref. 
a) J. M. McManus, R. M. Herbst, J. Org. Chem. 1959, 24, 1462; b)   
Z. P. Demko, K. B. Sharpless, J. Org. Chem. 2001, 66, 7945; c) J.-
J. Shie, J.-M. Fang, J. Org. Chem. 2003, 68, 1158 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for three hours from 0°C to room temperature. 
The mixture is quenched with HCl (2 M) and the pH adjusted with potassium carbonate 
to pH 6, the aqueous phase is saturated with solid NaCl and extracted with ethyl acetate 
to give  the product as a white crystalline material (490, mg 67 % yield). 
 
Compound characterization data: 
N
N
NH
NN
1
2
3
4
5
6
7
 
mp: 210-212 °C; TLC: Rf (toluene / EtOAc / AcOH 10:20:1) = 0.07; HPLC: 2.23 min; 
UV (EtOH): λmax, nm (ε): 273 (6450), 233 (11490); IR: ν 3092 (s, ע(C-H)), 3065 (s, ע(C-
H)), 3032 (s, ע(C-H)), 3000-2400 (brs, ע(N-H)), 1640 (w, ע(C=C)), 1603 (s, ע(C=C)), 
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1558 (s, tetrazole), 796 (s, δ(pyrindine), 744 (s, δ(pyrindine) cm-1; 1H NMR (500 MHz, 
d6-DMSO): δ = 7.62 (ddd, 3J5,6 = 4.8, 3J4,5 = 7.7, 4J3,5 = 1.3 Hz, 1H, H-C5), 8.07 (dt, 3J = 
7.7, 4J4,6 = 1.7 Hz, 1H, H-C4), 8.21 (ddd, 3J3,4 = 7.8, 4J3,5 = 1.3, 5J3,6 = 1.0 Hz, 1H, H-C3), 
8.77 (ddd, 3J5,6 = 4.8, 4J4,6 = 1.7, 5J3,6 = 1.0 Hz, 1H, H-C6), 17.15 (br, NH); 13C NMR 
(125 MHz, d6-DMSO): δ = 122.2 (CH, C5), 125.7 (CH, C4), 137.8 (CH, C ), 143.2 (Cq, 
C2), 149.6 (CH, C6), 154.3 (Cq, C7); MS: m/z 148 [MH]+, 146 [M-H]-, 120 [MH-N2]+, 
118 [M-H-N2]-; HR-MS: calc’d for [M-H]- = 146.0472, found 146.0472 (∆M (ppm) = 
0.1). 
 
 
3-(2H-Tetrazol-5yl)-pyridine (104) 
N
N
Et2AlN3
N
N
NH
NN
Xylene
0°C to r.t., 3h  
                                          292                                             104 
CAS Registry Number 3250-74-6 
Molecular Formula   C6H5N5 
Molecular Weight    147.14 g/mol 
Analysis Ref. 
a) J. M. McManus, R. M. Herbst, J. Org. Chem. 1959, 24, 1462; b) 
M. Alterman, A. Hallberg, J. Org. Chem. 2000, 65, 7984; c) D. 
Amantini, R. Beleggia, F. Fringuelli, F. Pizzo, L. Vaccaro, J. Org. 
Chem. 2004, 69, 2896; d) T. T. Denton, X. Zhang, J. R. Cashman, 
J. Med. Chem. 2005, 48, 224 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for three hours from 0 °C to room temperature. 
The mixture is quenched with HCl (2 M) and the pH adjusted with potassium carbonate 
to pH 6, the aqueous phase is saturated with solid NaCl and extracted to give  the product 
as a white crystalline material after crystallization from a mixture of ethyl acetate / 
ethanol (570 mg, 78 % yield). 
 
Compound characterization data: 
N
N
NH
NN
1
2
3
4
5
6
7
 
mp: 226-228 °C; TLC: Rf (toluene / AcOEt / AcOH 10:20:2) = 0.04; HPLC: 1.72 min; 
UV (EtOH): λmax, nm (ε): 272 (2190), 266 (2190), 233 (7650); IR: ν 3200-2400 (brs, 
ע(N-H)), 3086 (s, ע(C-H)), 3063 (s, ע(C-H)), 3036 (s, ע(C-H)), 1610 (s, ע(C=C)), 1583 
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(m, ע(C=C)), 1528 (m, tetrazole), 1485 (m, ע(C=C)) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 7.69 (ddd, 3J5,6 = 4.9, 3J4,5 = 7.9 Hz, 1H, H-C5), 8.51 (m, 3J4,5 = 7.9, 4J4,6 = 
1.7 Hz, 1H, H-C4), 8.77 (dd, 3J5,6 = 4.9, 4J4,6 = 1.7 Hz, 1H, H-C6), 9.28 (m, 1H, H-C2), 
16.70 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 121.2 (Cq, C3), 124.6 (CH, C5), 
135.3 (CH, C4), 147.1 (CH, C2), 151.1 (CH, C6), 153.6 (Cq, C7); MS: m/z 148 [MH]+, 
146 [M-H]-, 105 [MH-HN3]+; HR-MS: calc’d for [M-H]- = 146.0472, found 146.0472 
(∆M (ppm) = 0.1). 
 
 
4-(2H-Tetrazol-5yl)-pyridine (105) 
N
N
Et2AlN3
N
N
NH
NN
    Xylene 
0°C to rt, 3h  
                                            293                                            105 
CAS Registry Number 14389-12-9 
Molecular Formula   C6H5N5 
Molecular Weight    147.14 g/mol 
Analysis Ref. 
a) J. M. McManus, R. M. Herbst, J. Org. Chem. 1959, 24, 1462; b)   
H. Detert, D. Schollmeier, Synthesis 1999, 6, 999 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for three hours from 0 °C to room temperature. 
The mixture is quenched with HCl (2 M), and the pH adjusted with potassium carbonate 
to pH 6, the aqueous phase is saturated with solid NaCl and extracted to give the product 
as a white crystalline material obtained after crystallization from ethanol (700 mg, 95 % 
yield). 
 
Compound characterization data: 
N
N
NH
NN
1
2
3
4
5
 
mp: 255-258 °C; TLC: Rf (toluene / EtOAc / AcOH 10:20:1) = 0.04; HPLC: 1.38 min; 
UV (EtOH): λmax, nm (ε): 253 (234); IR: ν 3200-3000 (brs, ע(N-H)), 3040 (m, ע(C-H)), 
1619 (s, ע(C=C)), 1580 (s, tetrazole), 1448 (s, ע(C=C)) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 7.78 (d, 3J2,3  = 6.0 Hz, 2H, H-C3), 8.51 (d, 3J2,3  = 6.0 Hz, 2H, H-C2), 16.30 
(br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 120.9 (CH, C3), 139.4 (Cq, C4), 149.8 
(CH, C2), 158.9 (Cq, C5); MS: m/z 146 [M-H]-, 118 [M-H-N2]+. 
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2,6-Bis-(2H-tetrazol-5-yl)-pyridine (106) 
N
NN
N
N
HN
N N N NH
N
N
Et2AlN3
 Xylene
0°C, 1h
 
                                          294                                                        106 
CAS Registry Number 68790-48-7 
Molecular Formula   C7H5N9 
Molecular Weight    215.18 g/mol 
Analysis Ref. 
a) J. M. McManus, R. M. Herbst,  J. Org. Chem. 1959, 24, 1462; b) 
M. Duati, S. Tasca, F. C. Lynch, H. Bohlen, J. G. Vos, S. Stagni, M. 
D. Ward, Inorg. Chem. 2003, 42, 8377 
 
TP1: 3 equivalents of diethylaluminum azide (2.7 M in xylene) are used in a 2 mmol 
scale experiment. The reaction is stirred for one hour at 0 °C. The mixture reaction is 
quenched with HCl (2 M) and the pH adjusted with potassium carbonate to pH 6, the 
aqueous phase is saturated with solid NaCl and extracted to give the product as an off 
white crystalline material (360 mg, 84 % yield).   
 
Compound characterization data: 
 
N
N
HN
N N N NH
N
N
1
2
3
4
 
mp: up to 260 °C; TLC: Rf (toluene / EtOAc / AcOH 10:20:1) = 0.03; UV (MeOH): λmax, 
nm (ε): 281 (3360), 273 (3500), 266 (3170), 221 (9380); HPLC: 3.61 min; IR: ν 3200-
2600 (brs, ע(N-H)), 3119 (s, ע(C-H)), 3092 (s, ע(C-H)), 3080 (s, ע(C-H)), 3043 (s, ע(C-
H)), 3015 (s, ע(C-H)), 1557 (s, tetrazole), 1455 (s, (C=C)) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 8.33 (m, 3H, H-C1-3), 16.80 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 
132.6 (CH, C2), 133.8 (Cq, C1), 140.3 (CH, C3), 162.0 (Cq, C4); MS: m/z 214 [M-H]-. 
 
 
2-(1H-Tetrazol-5-yl)-pyrazine (107) 
N
N
N
H
N
NN
N
N
N
Et2AlN3
    toluene
-40 to 0°C 3h  
295                                            107 
CAS Registry Number 16289-54-6 
Molecular Formula   C5H4N6 
Molecular Weight    148.13 g/mol 
Analysis Ref. a) G. F. Holland, J. N. Pereira, J. Med. Chem. 1967, 10, 149; b) G. 
Chapter 5.    Experimental Part 
 201 
A. Wächter, M. C. Davis, A. R. Martin, S. G. Franzblau, J. Med. 
Chem. 1998, 41, 2436; c) Z. P. Demko, K. B. Sharpless, J. Org. 
Chem. 2001, 66, 7945 
 
TP1: One equivalent of diisobutylaluminum azide (1.8 M in toluene) are used in a 4 
mmol scale experiment. The reaction is stirred for three hours from - 40 to 0 °C. The 
mixture reaction is quenched with HCl (2 M) and the pH adjusted with potassium 
carbonate to pH 6, the aqueous phase is saturated with solid NaCl and the product 
extracted to give to give the product as an off white crystalline material obtained after 
crystallization from ethyl acetate (380 mg, 64 % yield). 
 
Compound characterization data: 
N
N
N
H
N
NN1
2
3
4
5
6 7
 
mp: 178-180 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.06; HPLC: 2.00 min; 
UV (EtOH): λmax, nm (ε): 276 (9940), 227 (9800); IR: ν 3139 (w, ע(C-H)), 3097 (w, ע(C-
H)), 3075 (m, ע(C-H)), 3000-2300 (brm, ע(N-H)), 1603 (w, ע(C=C)), 1572 (w, tetrazole), 
1572 (w, pyridine) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 8.87 (m, J = 4.0 Hz, 1H, 
H-C3), 9.39 (d, J = 4.0 Hz, 2H, H-C5,6), 17.50 (br, NH); 13C NMR (125 MHz, d6-
DMSO): δ = 139.7 (Cq, C2), 142.9 (CH, Ar), 144.4 (CH, Ar), 146.3 (CH, Ar), 153.2 (Cq, 
C7); MS: m/z 147 [M-H]-; HR-MS: calc’d for [M-H]- = 147.04247, found 147.04247 
(∆M (ppm) = 0.3). 
 
 
5-Furan-2-yl-1H-tetrazole (108) 
O
N
O
HN N
N
NEt2AlN3
      Xylene
r.t. to 55°C, 12h  
                                          296                                                 108 
CAS Registry Number 23650-33-1 
Molecular Formula   C5H4N4O 
Molecular Weight    136.11 g/mol 
Analysis Ref. 
a) E. F. George, W. R. Riddell, Imperial Chemical Industries Ltd., 
UK 1975, US  3865570; b) A. Antonowa, S. Hauptmann,  Zeitschrift 
fuer Chemie 1976, 16, 17; c) J.-J. Shie, J.-M. Fang, J. Org. Chem. 
2003, 68, 1158; d) D. Amantini, R. Beleggia, F. Fringuelli, F. Pizzo, 
L. Vaccaro, J. Org. Chem. 2004, 69, 2896; e) F. Lenda, F. 
Guenoun, B. Tazi, N. Ben Iarbi, H. Allouchi, J. Martinez, F. Lamaty, 
Eur. J. Org. Chem.  2005, 2, 326 
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TP1: 1.2 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for twelve hours at 55 °C to give the product as a 
yellow crystalline material (591 mg, 87 % yield).  
 
Compound characterization data: 
1
23
4
5
O
N N
NH
N
 
mp: 198-200 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.31; HPLC: 2.86 min; 
UV (EtOH): λmax, nm (ε): 255 (14490); IR: ν 3108 (s, ע(C-H)), 3073 (w, ע(C-H)), 3022 
(m, ע(C-H)), 3000-2300 (brs, ע(N-H)), 1642 (s, ע(C=C)), 1541 (s, tetrazole)), 1488 (w, 
ע(C=C)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 6.70 (dd, 3J2,3 = 3.5 Hz, 1H, H-C3), 
7.26 (dd, 3J2,3 = 3.5, 4J2,4 = 1.7 Hz, 1H, H-C2), 8.02 (dd, J = 1.7 Hz, 1H, H-C4), 17.10 (br, 
NH); 13C NMR (125 MHz, d6-DMSO): δ = 112.1 (CH, C3), 112.6 (CH, C2), 139.5 (Cq, 
C1), 145.6 (CH, C4), 154.2 (Cq, C5); MS: m/z 137 [MH]+, 135 [M-H]-, 94 [MH-HN3]+; 
HR-MS: calc’d for [M-H]- = 135.0312, found 135.0312 (∆M (ppm) < 0.1). 
 
 
5-Thiophen-2-yl-1H-tetrazole (109) 
S
N
S
HN N
N
NEt2AlN3
      Xylene
r.t. to 55°C, 12h  
                                           297                                                   109 
CAS Registry Number 59541-58-1 
Molecular Formula   C5H4N4S 
Molecular Weight    152.18 g/mol 
Analysis Ref. 
a) B. Decroix, P. Dubus, J. Morel, P. Pastour, Bull. Soc. Chim. Fr. 
1976, 621; b) A. Antonowa, S. Hauptmann,  Zeitschrift fuer Chemie 
1976, 16, 17; c) J.-J. Shie, J.-M. Fang, J. Org. Chem. 2003, 68, 
1158; d) F. Lenda, F. Guenoun, B. Tazi, N. Ben Iarbi, H. Allouchi, J. 
Martinez, F. Lamaty, Eur. J. Org. Chem.  2005, 2, 326 
 
TP1: 1.2 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for twelve hours at 55 °C to give the product as a 
yellow crystalline material obtained after crystallization from a mixture of ethyl acetate / 
toluene (616 mg, 81 % yield). 
 
Compound characterization data: 
S
HN N
N
N
1
23
4 5
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mp: 206-207 °C; TLC: Rf (toluene / EtOAc /AcOH 20:20:1) = 0.40; HPLC: 3.73 min; 
UV (EtOH): λmax, nm (ε): 266 (237); IR: ν 3110 (m, ע(C-H)), 3076 (s, ע(C-H)), 3030 (m, 
ע(C-H)), 3000-2300 (brs, ע(N-H)), 1594 (s, ע(C=C)), 1507 (m, tetrazole), 1410 (s, 
ע(C=C)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 7.28 (dd, 3J2,3 = 3.7, 3J3,4 = 5.0 Hz, 
1H, H-C3), 7.79 (dd, 3J2,3 = 3.7, 4J2,4 = 1.2 Hz, 1H, H-C2), 7.86 (dd, 3J3,4 = 5.0, 4J2,4 =  1.2 
Hz, 1H, H-C4), 16.90 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 125.4 (Cq, C1), 
128.6 (CH, C3), 129.1 (CH, C2), 130.4 (CH, C4), 151.3 (Cq, C5); MS: m/z 153 [MH]+, 
151 [M-H]-, 110 [MH-HN3]+, X-Ray: the structure was confirmed by X-ray analysis (See 
X-ray Discussion; Chapter 4).  
 
 
5-(1H-Pyrrol-2-yl)-2H-tetrazole (110) 
N
H
Et2AlN3
 Xylene 
 r.t., 10h
N
H N N
NH
N
N
 
                                       298                                               110 
CAS Registry Number 31602-66-1 
Molecular Formula   C5H5N5 
Molecular Weight    135.13 g/mol 
Analysis Ref. 
a) A. Antonowa, S. Hauptmann, Zeitschrift für Chemie, 1976, 16, 
17; b) F. Lenda, F. Guenoun, B. Tazi, N. BenIarbi, H. Allouchi, J. 
Martinez, F. Lamaty, Eur. J. Org. Chem. 2005, 2, 326 
 
TP1: 2.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 3 mmol 
scale experiment. The reaction is stirred for twenty four hours from 0 °C to room 
temperature to give the product as an off white crystalline material (670 mg, 82 % yield). 
 
Compound characterization data: 
N
H N N
NH
N1
23
4
5
 
mp: 230-232 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.41; HPLC: 2.26 min; 
UV (MeOH): λmax, nm (ε): 262 (4850); IR: ν 3300 (s, ע(N-H, pyrrole)), 3072 (w, ע(C-
H)), 3015 (m, ע(C-H)), 3000-2300 (brm, ע(N-H, tetrazole), 1636 (s, ע(C=C)), 1540 (m, 
tetrazole), 1469 (s, tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 6.23 (m, 1H, H-
C3), 6.81 (m, 1H, H-C2), 7.01 (m, 1H, H-C4), 12.00 (br, NH), 16.50 (br, NH);  13C 
NMR(125 MHz, d6-DMSO): δ = 109.6 (CH, C3), 111.0 (CH, C2), 115.5 (Cq, C1), 122.5 
(CH, C4), 149.0 (Cq, C5); MS: m/z 136 [MH]+, 134 [M-H]-, 106 [M-H-N2]-. 
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5.1.3.8. Synthesis of tetrazoles in the presence of amides, amines, 
esters and ethers 
 
2-(2H-Tetrazol-5-yl)-pyrrolidine-1- carboxylic acid tert-butyl ester (111) 
N CN
H
O
O
Et2AlN3
 Toluene 
50°C, 30h
N
H
O
O
N N
NH
N
 
                                         299                                                   111 
CAS Registry Number 867326-86-1 
Molecular Formula   C10H17N5O2 
Molecular Weight    239 g/mol 
Analysis Ref. 
a) T. Nowak, A. P. Thomas, Astrazeneca, 2005, WO  2005040159  
A1; b) M. G. Palermo, S. K. Sharma, C. Straub, R.-M. Wang, L. 
Zawel, Y. Zhang, Z. Chen, Y. Wang, F. Yang, W. Wrona, G. Liu, M. 
G. Charest, F. He, Novartis AG, 2005, WO  2005097791  A1; c) V. 
Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
TP1: 1.2 equivalents  of diethylaluminum azide (2.5 M in toluene) are used in a 5 mmol 
scale experiment. The reaction is stirred for thirty hours at 40 °C. The workup is done by 
using directly a solution of KHSO4 (10 % solution) to pH 5 instead HCl, to avoid the 
cleavage of the Boc group to give the product as a white crystalline material (680 mg, 57 
% yield). 
The aqueous phase after work-up is evaporated and stirred 4h with ethanol. The 
suspension is filtered and the solvent removed to give the deprotected 2(S)-(1H-tetrazol-
5-yl)-pyrrolidine as a white crystalline material (139 mg, 25 % yield). 
 
Compound characterization data: 
N
H
O
O
N N
NH
N1
23
4
6
5
7
8  
mp: 122 °C; TLC: Rf (toluene / etylacetate / AcOH 20:20:1) = 0.22; Optical rotation: 
[α]D = -75.68 ° (in MeOH, c = 0.63); IR: ν 3416 (w, ע(N-H)), 2977 (s, ע(C-H)), 1669 (vs, 
ע(C=O)), 1553 (m, tetrazole), 1423 (vs, ע(C-N)), 1372 (m, δ(-CH3)), 1160 (s, ע(C-O)) cm-
1; 1H NMR (500 MHz, d6-DMSO, 300 K) Rotamers (1:1): δ = 1.12, 1.37 (s, 9H, H-C8), 
1.90 (m, 2H, H-C3), 2.1 (m, 1H, H-C2), 3.40 (m, 2H, H-C4), 5.08 (m, 1H, H-C1), 16.37 
(br, NH); (500 MHz, d6-DMSO, 393 K): δ = 1.29 (s, 9H, H-C8), 1.91 (m, 3H, H-C2,3), 
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2.34 (m, 1H, H-C2), 3.49 (m, 2H, H-C4), 5.10 (m, 1H, H-C1); 13C NMR (150 MHz, d6-
DMSO, 300 K) Rotamers (1:1): δ = 23.0, 23.1 (CH2, C3), 27.7, 28.1 (CH3, C8) 31.7, 32.9 
(CH2, C2), 46.2, 46.4 (Cq, C7), 51.3, 51.6 (CH2, C4), 79.1, 78.8 (CH, C1), 152.8, 153.5 
(Cq, C5), 158.6, 159.3 (Cq, C6); MS: m/z 240 [MH]+, 238 [M-H]-, 140 [MH-Boc]+. 
 
 
(R)-2-(2H-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester (113) and (S-
enantiomer-112) 
N
OO
CN
H
Et2AlN3
  Xylene
50 °C, 9h
N
OO
H
N N
N
H
N
 
                                             120                                                   112 
CAS Registry Number 
(R) enantiomer: 839711-73-8 
(S)-enantiomer: 33876-20-9 
Molecular Formula   C13H15N5O2 
Molecular Weight    273.30 g/mol 
Analysis Ref. 
a) R. G. Almquist, W. R. Chao, C. Jennings-White, J. Med. Chem. 
1985, 28, 1067; b) Z. P. Demko, K. B. Sharpless, Org. Lett. 4, 2002, 
2525; c) N. Momiyama, H. Torii, S. Saito, H. Yamamoto, Proc. Natl. 
Acad. Sci. U.S.A. 2004, 101, 5374; d) A. J. A. Cobb, D. M. Shaw, D. 
A. Longbottom, J. B. Gold, S. V. Ley, Org. Bio. Chem. 2005, 3, 84; 
e) V. Franckevicius, K. R. Knudsen, M. Ladlow, D. A. Longbottom, 
S. V. Ley, Synlett  2006, 6, 889; f) V. Aureggi, G. Sedelmeier, 
Novartis Pharma AG, 2007, WO 2007/009716 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 50 mmol 
scale experiment. The reaction is stirred for nine hours at 50 °C to give the product as a 
white crystalline material (13.9 g, 96 % yield ). The (R)- and the (S)-enantiomers gave the 
same yield. 
 
Compound characterization data: 
N
OO
H
N N
N
H
N
123
4
5
6
7
8
9 10
11
 
mp: 84-86 °C, onset of exothermic decomposition: 204-291.38 °C with maximum at 253 
°C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.22; HPLC: 5.46 min; Optical 
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rotation: R-enantiomer: [ ]25Dα  = +50.1 ° (in MeOH, c = 1.00), +49.7 ° (in EtOH, c = 1), 
+85.3 ° (in CHCl3, c = 1.00), +41.8 ° (in DMSO, c = 1.00), +65.4 ° (in DMF, c = 0.99); 
S-enantiomer: [ ]25Dα  = -89.0 ° (in CHCl3, c = 1.00); UV (acetonitrile): λmax, nm (ε): 258 
(23); IR: ν 3074 (w, ע(C-H)), 3035 (w, ע(C-H)), 3000-2300 (brm, ע(N-H)), 2973 (w, ע(C-
H)),  2944 (w, ע(C-H)), 1694 (vs, ע(C=O)), 1552 (m, tetrazole), 1499 (w, ע(C=C)), 1443 
(s, ע(C=C)), 1404 (s, ע(C-N)), 1132 (s, ע(C-O)),  693 (w, γ (Ph)) cm-1; 1H NMR (500 
MHz, d6-DMSO, 300 K) Major rotamer: δ = 1.95 (m, 3H, H-C2,3), 2.33 (m, 1H, H-C3),  
3.51 (m, 2H, H-C4), 4.98 (m, 2H, H-C7), 5.18 (m, 1H, H-C1), 7.32 (m, 5H, H-C9-11), 16.20 
(br, NH); (500 MHz, d6-DMSO, 394 K): δ = 1.95 (m, 3H, H-C2,3), 2.33 (m, 1H, H-C3),  
3.51 (m, 2H, H-C4), 4.98 (m, 2H, H-C7), 5.18 (m, 1H, H-C1), 7.32 (m, 5H, H-C9-11), 16.20 
(br, NH); 13C NMR (125 MHz, d6-DMSO, 300 K) Rotamers (1:1): δ = 24.2 (CH2, C3), 
32.0, 33.1 (CH2, C2), 46.7, 47.21 (CH2, C4), 52.2 (CH, C1), 66.3, 66.6 (CH2, C7), 127.3 
(CH, Ar), 127.9 (CH, Ar), 128.8 (CH, Ar), 137.0 (Cq, C8), 153.9 (Cq, C6), 154.5 (Cq, 
C5); MS: m/z 274 [MH]+, 272 [M-H]-. 
 
 
2(S)-(Tetrazol-5-yl)-pyrrolidine (114) and ((R)-enatiomer-115) 
N
H
PG
N N
NH
N
N
H
H
N N
NH
N
 
                                                                                                   114 
CAS Registry Number 
(S)-enantiomer: 33878-70-5 
(R)-enantiomer: 702700-79-6 
Molecular Formula   C5H9N5 
Molecular Weight    139.16 g/mol 
Analysis Ref. 
a) R. G. Almquist, W.-R. Chao, C. Jennigs-White, J. Med. Chem. 
1985, 28, 1067; b) N. Momiyama, H. Torii, S. Saito, H. Yamamoto, 
PNAS 2004, 101, 5374; c) A. Cobb, D. M. Shaw, D. A. Longbottom, 
J. B. Gold, S. V. Ley, Org. Biom. Chem. 2005, 3, 84; d) A. Hartikka, 
P. I. Ardvisson, Eur. J. Org. Chem. 2005, 20, 4287; e) V. 
Franckevicius, K. R. Knudsen, M. Ladlow, D. A. Longbottom, S. V. 
Ley Synlett. 2006, 6, 889; f) V. Aureggi, G. Sedelmeier, Novartis 
Pharma AG, 2007, WO 2007/009716 
 
Method 1 :                                             
 
N
H
N N
NH
N
N
H
H
N N
NH
N
O O
H2,Pd/C 10%
  EtOH
r.t., 3-4h
114
112
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(S)-2-(Tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester (15.33 g, 56.1 mmol) and 
palladium on carbon (150 g, 10 wt %) in ethanol (250 mL) are stirred under hydrogen at 
room temperature for four to six hours at room temperature. The catalyst is removed by 
filtration through celite, and the celite is washed sequentially twice with ethanol  (15 mL 
portion), twice with acetic acid (8 mL portion), and twice with water (10 mL portion). 
The filtrate is concentrated under reduced pressure with a rotary evaporator to give the 
product (7.56 g, 97 % yield). The product is crystallized from acetic acid / ethanol (15 
mL, 1:2) to give the pure product as a white crystalline material (7.3 g, 94 % of yield). 
The (R)- and (S)-enatiomers gave the same yield. 
 
Method 2:                                          
N
H
N N
NH
N
N
H
H
N N
NH
N
O O
1 equiv.Et2AlN3
   Xylene
  85°C, 9h
1 equiv.Et2AlN3
   Xylene
  55°C, 9h
N CN
H
O O
 
    120                                                           112                                                                 114 
 
TP1: 2 equivalents  of diethylaluminum azide (2.5 M in toluene, or 2.7 M in xylene) are 
used in a 10 mmol scale experiment. The reaction is stirred for nine hours at 55 °C, then 
is warmed at 85 - 90 °C and stirred for additional nine hours. The mixture is quenched 
with HCl (2 M), the pH adjusted with potassium carbonate to pH 6.5 and the solvent is 
removed. Ethanol is added and the mixture is stirred for two to six hours. The mixture is 
filtered and the solvent removed. The crude is crystallized from ethanol to give 1.4 g of  
product as a white crystalline material in ≥ 98 % yield. The product contains some 
inorganic material. 
 
Method 3:   
 
N
H
N N
NH
N
N
H
H
N N
NH
N
O O
1. Et2AlN3
2. HCl (6N)
 
                                       111                                                        114 
 
TP1:1.4 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 20 mmol 
scale experiment. The reaction is stirred for eight hours at 50 °C. The mixture is 
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quenched at 0° C with HCl (6 M) to pH 1 and stirred over the night. The pH is adjusted 
with solid potassium carbonate to pH 6.5 and the solvent is removed. Ethanol is added 
and the mixture is stirred for two to six hours. The mixture is filtered and the solvent 
removed to give 2.8 g of product. The crude is crystallized from ethanol to give the 
product as a white crystalline material (2.26 g, 81 % yield). The product contains some 
inorganic material. 
 
Compound characterization data: 
N
H
H
N N
NH
N
1
2
34
5
6
       
Exothermic range: 269-365 °C (maximum: 275 °C); TLC: Rf (nBuOH / water / AcOH 
3:3:1, ninhydrin) = 0.25; Optical rotation: (S)-enantiomer: [ ]25Dα  = -10.5 ° (in MeOH, c 
= 0.63), (R)-enantiomer: [ ]25Dα  = -2.6 ° (in water, c = 1.00), [ ]
25
Dα  = +11.0 ° (in MeOH, c = 
1.00), [ ]25Dα  = +18.5 ° (in DMSO, c = 1.00), [ ]
25
Dα  = -13.2 ° (in AcOH, c = 1.00); IR: ν 
3000-2600 (brs, ν(NH)), 2768 (s, ν(CH)), 1557 (w, tetrazole) 1462 (w, tetrazole) cm-1; 1H 
NMR (500 MHz, d6-DMSO): δ = 2.05 (m, 3H, H-C3,4), 2.33 (m, 1H, H-C4), 3.26 (m, 2H, 
H-C5), 4.77 (dd, 3J2,3 = 8.2, 7.3 Hz, 1H, H-C2), 9.19 (NH2: zwitterionic form confirmed 
by X-ray); 13C NMR (125 MHz, d6-DMSO): δ = 23.2 (CH2, C4), 29.9 (CH2, C3), 44.3 
(CH2, C5), 54.2 (CH, C2), 171.1 (Cq, C6); MS: m/z 139 [M]+, 111 [M-N2]+, 83 [CH2CN4 
H]+, 70 [CHN4 H]+, 43 [NHCNH2]+; X-Ray: zwitterionic form confirmed by X-ray 
analysis (See X-ray Discussion; Chapter 4).  
 
 
N,N-Dimethyl- 2H-tetrazol-5-amine (116) 
CH3
N
H3C
N
Et2AlN3
N
N
NHN
N
H3C
CH3
Xylene
r.t., 2h  
                                                300                                         116 
CAS Registry Number 5422-45-7 
Molecular Formula   C3H7N5 
Molecular Weight    113.12 g/mol 
Analysis Ref. 
a) W. G. Finnegan, R. A. Henry, E. Lieber, J. Org. Chem. 1953, 18, 
779; b) N. Sadlej-Sosnowska, J. Phys. Org. Chem. 2004, 17, 303   
 
TP1: 1.5 equivalents  of diethylaluminum azide  (2.7 M in xylene) are used in a 5 mmol 
scale experiment. The reaction is stirred for two hours at room temperature. The mixture 
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is quenched with HCl (2 M), the pH adjusted to 6 with potassium carbonate (10 % 
solution) and the aqueous phase saturated with solid sodium chloride. The product is 
extracted with ethyl acetate to give the product as a white crystalline material (400 mg, 
71 % yield). 
 
Compound characterization data: 
N
N
NHN
N
H3C
CH3
1 2
 
mp: 206-208 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1, ninhydrin) = 0.06; UV 
(MeOH): λmax, nm (ε): 228 (1430); IR: ν 3000-2400 (brs, ע(N-H)), 2933 (s, ע(C-H)), 
1555 (w, tetrazole), 1492 (w, tetrazole), 1427 (s, tetrazole), 1343 (w, δ(CH3))  cm-1; 1H 
NMR (500 MHz, d6-DMSO): δ = 2.96 (s, 6H, H-C1), 16.0 (br, NH); 13C NMR(125 
MHz, d6-DMSO): δ =  39.6 (CH3, C1), 163.6 (Cq, C2);  MS: m/z 114 [MH]+, 112 [M-H]-. 
 
 
Ethyl-2H-tetrazole-5-carboxylate (117) 
Et2AlN3
Toluene
 r.t., 1h
O
O
N
O
O
N NH
N
N
 
                                         136                                                            117 
CAS Registry Number 55408-10-1 
Molecular Formula   C4H6N4O2 
Molecular Weight    142.09 g/mol 
Analysis Ref. 
a) E. Olivieri-Mandala, Gazz. Chim. Ital. 1911, 41, 59; b) M. S. 
Poonian, E. F. Nowoswiat, J. F. Blount, T. H. Williams, R. G. 
Pitcher, M. J. Kramer, J. Med. Chem. 1976, 19, 286; c) J. Diago-
Meseguer, A. L. Palomo-Coll, J. R. Fernandez-Lizarbe, A. Zugaza-
Bilbao, Synthesis 1980, 7, 547; d) P. M. O’Brien, D. R. Slislovich, J. 
A. Picard, H. T. Lee, C. F. Purchase, B. D. Roth, A. D. White, M. 
Anderson, S. B. Muller, J. Med. Chem. 1996, 39, 2354; e) N. 
Nazaré, V. Laux, A. Bauer, M. Wagner, Aventis Pharma, 2004 
EP1479679 A1 
 
TP1: 1.3 equivalents  of diethylaluminum azide (2.5 M in toluene) are used in a 10 mmol 
scale experiment. The reaction is stirred one hours at room temperature to give the 
product as an off white crystalline material (1.33 g, 94 % yield). 
 
 Compound characterization data: 
O
O
N NH
N
N1
2
3
4
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mp: 92-94 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.19; HPLC: 1.98 min; IR: 
ν 3000-2400 (brm, ע(N-H)), 2948 (w, ע(C-H)), 2916 (w, ע(C-H)), 2882 (w, ע(C-H)), 2844 
(m, ע(C-H)), 1750 (vs, ע(C=O)), 1543 (m, tetrazole), 1470 (w, tetrazole), 1455 (w, 
tetrazole), 1445 (w, tetrazole), 1223 (s, ע(C-O)) cm-1; 1H-NMR (500 MHz, d6-DMSO): δ 
=  1.35 (t, 3J3,4 = 7.1 Hz, 3H, H-C4), 4.41 (q, 3J3,4 = 7.1 Hz, 2H, H-C3), 16.5 (br, NH); 13C 
NMR(125 MHz, d6-DMSO): δ =  13.9 (CH3, C4), 62.3 (CH2, C3), 150.7 (Cq, C1), 156.6 
(Cq, C2); MS: m/z 142 [M]+, 127 [M-CH3]+, 115 [MH-N2]+, 97 [M-OC2H5]+, 69 
[CN4H]+; HR-MS: calc’d for [M-H]- = 141.0418 found 141.0418 (∆M (ppm) < 0.1). 
 
 
4-[(E)-2Cyano-2-(1H-tetrazol-5-yl)-vinyl]-benzoic acid methyl ester (118) 
MeO2C
N
N MeO2C
N
N
N
N
HN
Xylene
r.t., 3d
Et2AlN3
 
                                        73                                                              118                        
Molecular Formula   C12H9N5O2 
Molecular Weight    255.24 g/mol 
 
TP1:  1.6 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 10 mmol 
scale experiment. The reaction is stirred for three days at room temperature to give the 
product after crystallization from toluene as an off white crystalline material (1.38 g, 54 % 
yield).  
 
Compound characterization data: 
O
O
CH3
N
N N
NHN
1
4 5
6
7 8
9
2 3
10  
mp: 204-206 °C; TLC: Rf (toluene / EtOAc / AcH 20:40:1) = 0.23 ; HPLC: 6.30 min; 
UV (MeOH): λmax, nm (ε): 312 (21010); IR: ν 3270 (s, ע(NH)), 3089 (w, ע(C-H)), 2224 
(w, ע(C≡N)), 1715 (vs, ע(C=O)), 1615 (m, ע(C=C)), 1565 (w, tetrazole), 1434 (s, ע(C=C)), 
1291 (s, ע(C-O)), 1114(s, ע(C-O)) cm-1; 1H-NMR (400 MHz, d6-DMSO): δ = 3.89 (s, 3H, 
H-C10), 8.11 (m, 4H, H-C2,3), 8.41 (s, 1H, H-C5), 16.50 (br, NH); 13C-NMR (150 MHz, 
d6-DMSO): δ = 52.5 (CH3, C10), 101.0 (Cq, C6), 115.7 (Cq, CN), 129.7 (CH, ArH), 129.8 
(CH, ArH), 131.6 (Cq, C1), 136.9 (Cq, C4), 144.8 (CH, C5), 156.0 (Cq, C8), 165.5 (Cq, 
Chapter 5.    Experimental Part 
 211 
C9); MS: m/z 256 [MH]+, 254 [M-H]-; HR-MS: calc’d for [M-H]- = 254.06835 found 
254.06832 (∆M (ppm) = 0.1). 
  
 
(R)-5-(Tetrahydro-furan-2-yl)-2H-tetrazole (119)  
 
O CN
H Et2AlN3
 Toluene 
 40°C, 3h
O
H
N N
NH
N
 
                                            301                                              119               
Molecular Formula   C5H8N4O 
Molecular Weight    140.15 g/mol 
 
TP1:1.3 equivalents  of diethylaluminum azide (1.8 M in toluene) are used in a 10 mmol 
scale experiment. The reaction is stirred for three hours at 40 °C. The crude was directly 
crystallizated from ethyl acetate to give the product as a white crystalline material (1.28 
g, 92 % yield). 
 
Compound characterization data: 
 
O
H
N N
NH
N
1
23
4
5
 
mp: 108-109 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1, CPS) = 0.16; Optical 
rotation: [ ]25Dα  = -9.0 ° (in MeOH, c = 0.96); UV (acetonitrile): λmax, nm (ε): 279 (3); IR: 
ν 3200-2400 (sbr, ν(N-H)), 2979 (s, ν(C-H)), 1559 (w, tetrazole), 1538 (m, tetrazole), 
1086 (s, ν(C-O)) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 1.95 (m, 2H, H-C3), 2.20 (m, 
2H, H-C2), 3.86 (m, 2H, H-C4), 5.24 (dd, 1H, H-C1), 16.22 (br, NH); 13C NMR (125 
MHz, d6-DMSO): δ = 25.4 (CH2, C3), 31.4 (CH2, C2), 68.4 (CH2, C4), 70.8 (CH, C1), 
157.5 (Cq, C6); MS: m/z 141 [MH]+, 139 [M-H]-; X-Ray: the structure was confirmed by 
X-ray analysis (See X-ray Discussion; Chapter 4). 
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5.1.3.9. Synthesis of tetrazoles in the presence of carbonyl groups 
 
6-Isopropyl-3-(1H-tetrazol-5-yl)-chromen-4-one (122) and 2-ethyl-6-isopropyl-3-(1H-
tetrazol-5-yl)-chroman-4-one (123)  
 
O
O
CN
Et2AlN3
O
O N N
NH
N
O
O N
H N
N
N
Toluene
 r.t., 30h
+
 
               121                                                            122                                               123 
CAS Registry Number 122:    50743-59-4       
Molecular Formula   122:    C13H12N4O2 123:    C15H16N4O2 
Molecular Weight    122:    256.26 g/mol 123:    284.32 g/mol 
Analysis Ref. 
122:   A. Nohara, H. Kuriki, T. Saijo, H. Sugihara, M. Kanno, Y. 
Sanno, J. Med. Chem. 1977, 20, 141 
 
TP1: 2.8 equivalents  of diethylaluminum azide (2.5 M in toluene) or diethylaluminum 
azide (2.7 M in xylene) are used in a 4 mmol scale experiment. The reaction is stirred for 
twenty four hours at room temperature. The product after extraction is chromatographed 
(elution system: toluene / EtOAc / AcOH 50:10:1) to give 1.026 g of product (95 % 
yield) as a yellow crystalline materials (589 mg of P1, and 425 mg of P2) with P1 / P2 in 
ratio 3:2.   
The same experiment was done with 1.3 equivalents  of diethylaluminum azide (in 
xylene 2.7 M) in a 6 mmol scale experiment to obtain 1.54 g of product (96 % yield) as a 
yellow crystalline material with P1 / P2 in ratio 2:1.  
 
Compound characterization data  
6-Isopropyl-3-(1H-tetrazol-5-yl)-chromen-4-one 122: 
 
O
O HN N
N
N
1
234
5
6
7
8
9
1011
12  
mp: 210-214 °C; TLC: Rf (toluene / AcOEt / AcOH 50:10:1) = 0.3; HPLC: 7.57 min; 
UV (MeOH): λmax, nm (ε): 307 (5570), 244 (21620); IR: ν 3221 (s, ע(N-H)), 3103 (w, 
ע(C-H)), 3027 (w, ע(C-H)), 2963 (m, עasim(CH3)), 2927 (w, ע(C-H)), 2869 (w, ע(C-H)), 
1644 (vs, ע(C=O)), 1538 (s, ע(C=C)), 1480 (s, ע(C=C)), 1458 (s, ע(C=C)), 1298 (m, 
δ(CH3)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 1.30 (d, 3J11,12 = 6.9 Hz, 6H, H-C12), 
3.10 (sep, 3J 11,12 =  6.9 Hz, 1H, H-C11), 7.75 ( d, 3J 5,6 = 8.6 Hz, 1H, H-C6), 7.85 (m, 1H, 
H-C5), 8.02 (d, 4J3,5 = 2.2 Hz, 1H, H-C3), 9.22 (s, 1H, H-C9), 16.60 (br, NH); 13C NMR 
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(150 MHz, d6-DMSO): δ =  23.7 (CH3, C12), 33.0 (CH, C11), 110.1 (Cq, C8), 118.9 (CH, 
C6), 121.7 (CH, C3), 122.9 (Cq, C2), 133.9 (CH, C5), 147.0 (Cq, C4), 154.2 (Cq, C1), 
158.4 (CH, C9), 173.4 (Cq, C7); MS: m/z 257 [M+H]+, 255 [M-H]-. 
 
2-Ethyl-6-isopropyl-3-(1H-tetrazol-5-yl)-chroman-4-one  123: 
 
O
O N
H N
N
N
1
234
5
6
7
8
9
1011
12
13
14
 
mp: 190-194 °C; TLC: Rf (toluene / AcOEt / AcOH 50:20:1) = 0.5; HPLC:  9.42 min; 
IR: ν 3262 (s, ע(N-H)), 3063 (w, ע(C-H)), 2775 (w, ע(C-H)), 2958 (m, ע(C-H)), 2933 (m, 
ע(C-H)), 2873 (w, ע(C-H)), 1632 (vs, ע(C=O)), 1573 (m, ע(C=C)), 1523 (s, ע(C=C)), 1483 
(s, ע(C=C)), 1306 (m, δ(CH3)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 1.25 (d, 3J11,12  
= 6.9 Hz, 6H, H-C12), 1.32 (t, 3J13,14 = 7.0 Hz, 3H, H-C14), 2.95 (q, 3J13,14 = 7.0 Hz, 2H, 
H-C13), 3.10 (sep, 3J11,12 = 6.9 Hz, 1H, H-C11), 7.69 (d, 3J5,6 = 8.8 Hz, 1H, H-C6), 7.8 (dd, 
3
J5,6 = 8.8, 4J3,5 = 2.3 Hz, 1H, H-C5), 7.92 (d, 4J3,5 = 2.3 Hz, 1H, H-C3), 16.50 (br, NH); 
13
C NMR (150 MHz, d6-DMSO): δ = 11.5 (CH3, C14), 23.2 (CH3, C12), 23.7 (CH3, C12), 
26.5 (CH3, C13), 32.9 (CH, C11), 118.0 (CHq, C8), 118.4 (CH, C6), 121.5 (Cq, C2), 121.6 
(CH, C3), 133.8 (CH, C5), 146.7 (Cq, C4), 153.8 (Cq, C1), 159.2 (Cq, C10), 172.6 (Cq, 
C9), 174.3 (Cq, C7); MS: m/z 285 [M+H]+, 283 [M-H]-.  
 
 
1-[4-(2H-Tetrazol-5-yl)-phenyl]-propan-1-ol (125) and 4-(1H-tetrazol-5-yl)-
benzenemethanol (126) 
N
O
H
N
N
N
H
N
OH
N
N
N
H
N
OHXylene
Et2AlN3
+
50 °C, 24 h
 
                        124                                                   125                                     126 
CAS Registry Number 126: 501126-02-9 
Molecular Formula   125: C10H12N4O         126: C8H8N4O 
Molecular Weight    125: 204.23g/mol      126: 176.07g/mol 
Ref. 
126: C. Betschart, K. Hayakawa, O. Irie, J. Sakaki, G. Iwasaki, R. 
Lattmann, M. Missbach, N. Teno, Novartis A.-G., Switz., Novartis 
Pharma G.m.b.H, 2003, WO 2003020721  A1 
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TP1: 3 equivalents  of diethylaluminum azide (2.7 M in xylene) are used in a 10 mmol 
scale experiment. The reaction is stirred for twenty four hours at 50 °C to give a mixture 
of products 125 and 126 (1.68 g, 85 % yield), in ratio 125 : 126 of ca 7:3. The product  P1 
is isolated via crystallization of the crude from ethyl acetate / toluene 1:1 (710 mg, 35 % 
yield; pure 92 % based on HPLC). The mother liquor is chromatographed to isolate 880 
mg of product 126 (elution system:  toluene / ethyl acetate / AcOH  40:20:1)(50 % yield). 
 
Compound characterization data: 
1-[4-(2H-Tetrazol-5-yl)-phenyl]-propan-1-ol (125) 
OH
N
H
N
NN
12
3
4
6
5
7
8
 
mp: 153-154 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.18; HPLC: 4.40 min; 
UV (MeOH): λmax, nm (ε): 246 (18420); IR: ν 3334 (brs, ע(O-H)), 3100-2300 (brs, ע(N-
H)), 3063 (m, ע(C-H)), 2974 (s, ע(C-H)), 2934 (s, ע(C-H)), 2873 (s, ע(C-H)), 1618 (m, 
ע(C=C)), 1569 (m, tetrazole), 1505 (m, ע(C=C)), 1052 (s, ע(C-O)), 750 (m, γ(C-H, Ph) 
cm-1; 1H NMR (600 MHz, d6-DMSO): δ = 0.84 (t, 3J6,7 = 7.3 Hz, 3H, H-C7), 1.64 (q, 3J6,7 
= 7.3 Hz, 2H, H-C6) 4.54 (m, 1H, H-C5), 5.31 (m, 1H, OH), 7.54 (d, 3J2,3 = 8.2 Hz, 2H, H-
C3), 7.99 (d, 3J2,3 = 8.2 Hz, 2H, H-C2), 16.40 (br, NH); 13C NMR (150 MHz, d6-DMSO): 
δ = 9.6 (CH3, C7), 31.9 (CH2, C6), 73.0 (CH, C5), 126.6 (CH, C2), 126.8 (CH, C3), 149.6 
(Cq, C8); MS: m/z 205 [MH]+, 203 [M-H]-, 203 [M-H- CH3OH]-; HR-MS: calc’d for 
[M-H]- = 203.0938, found 203.0938 (∆M (ppm) < 0.1).  
 
4-(2H-Tetrazol-5-yl)-benzenemethanol (126) 
N
N
N
H
N
OH
1
2
3
4
5
6
 
mp: 197-200 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.11; HPLC: 3.01 min; 
UV (MeOH): λmax, nm (ε): 245 (13620); IR: ν 3228 (brs ע(O-H)), 3099 (s, ע(C-H)), 3064 
(s, ע(C-H)), 3027 (s, ע(C-H)), 3000-2450 (brs, ע(N-H)), 2925 (s, ע(C-H)), 1619 (s, 
ע(C=C)), 1583 (m, ע(C=C)), 1436 (m, ע(C=C)), 1017 (s, ע(C-O)),  740 (m, γ(C-H, Ph) cm-
1; 1H NMR (500 MHz, d6-DMSO): δ = 4.59 (s, 2H, H-C5), 5.37 (br, 1H, OH), 7.54 (d, 
3
J2,3 = 8.2 Hz, 2H, H-C3), 8.02 (d, 3J2,3 = 8.2 Hz, 2H, H-C2), 16.83 (br, NH); 13C NMR 
Chapter 5.    Experimental Part 
 215 
(125 MHz, d6-DMSO): δ = 62.4 (CH2, C5), 122.4 (Cq, C1), 126.8 (CH, C2), 127.1 (CH, 
C3), 146.1 (Cq, C4), 155.1 ( Cq, C7); MS: m/z 175 [M-H]-, 147 [M-H-N2]-. 
 
 
Pheny-l-[4-(1H-tetrazol-5-yl)phenyl] methanol (128) 
 
N N
H
N
N
OHO
N
     Xylene 
   0°C to r.t.
       15 h
Et2AlN3
127                                                                   128
 
Molecular Formula   C14H12N4O 
Molecular Weight    204.56 g/mol 
 
TP1: 1.1 equivalents  of diethyl aluminum azide (2.7 M in xylene) are used in a 2 mmol 
scale experiment. The reaction is stirred over the night from 0 °C to room temperature to 
give the product as a light brown crystalline material (190 mg, 38 % yield).  
 
Compound characterization data: 
OH
N N
NH
N
1
2 3 4
5
6
7
8
9
10
 
mp: up to 250 °C; TLC: Rf (toluene / EtOAc / AcH 20:20:1) = 0.45; HPLC: 6.22 min; 
UV (EtOH): λmax, nm (ε): 250 (400); IR: ν 3473 (brm, ע(O-H)), 3100-2500 (brs, ע(N-H)), 
3087 (m, ע(C-H)), 3027 (s, ע(C-H)), 1655 (m, ע(C=C)), 1577 (w, tetrazole), 1496 (m, 
ע(C=C)), 1438 (s, ע(C=C)), 1024 (m, ע(C-O)), 762 (m, γ(C-H, Ph)), 701 (s, γ(Ph) cm-1; 1H 
NMR (400 MHz, d6-DMSO): δ = 5.79 (s, 1H, H-C1), 6.08 (br, 1H, OH), 7.24 (m, 1H, H-
C9), 7.32 (m, 2H, ArH), 7.41 (m, 2H, ArH), 7.60 (d, 3J3,4 = 8.2 Hz, 2H, H-C3), 8.00 (d, 
3
J3,4 = 8.2 Hz, 2H, H-C2), 16.90 (br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 73.6 
(CH, C1), 122.2 (Cq, C5), 125.9 (CH, Ar), 126.5 (CH, Ar), 126.6 (CH, C9), 126.7 (CH, 
Ar), 127.8 (CH, Ar), 144.7 (Cq, C6), 148.4 (Cq, C2), 154.3 (Cq, C10); MS: m/z 251 [M-
H]-. 
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5.1.3.10. Synthesis of triazoles 
 
1H-[1,2,3]-triazole-4,5-dicarboxylic acid methyl ester  (130) 
Et2AlN3
      Toluene 
 -50°C to r.t, 5h
O
O
O
OH3C CH3
N
N
HN
O
O
O OH3C CH3  
                                           129                                                              130                                                              
CAS Registry Number 707-94-8 
Molecular Formula   C6H7N3O4 
Molecular Weight    185.14 g/mol 
Analysis Ref. 
a) J. J. Looker, J. Org. Chem. 1965, 30, 638; b) L. Fisera, F. 
Povazanec, P. Zalupsky, J. Kovac, D. Pavlovic, Collect. Czech. 
Chem. Commun.  1983, 48, 3144; c) K. Harju, M. Vahermo, I. 
Mutikainen, J. Yli-Kauhaluoma, J. Comb. Chem. 2003, 5, 826 
 
TP1: One equivalent of diethylaluminum  azide (1.8 M in toluene) are used in a 3 mmol 
scale experiment. The reaction is stirred for five hours from – 50 to 0 °C to give the 
product as a yellow crystalline material (400 mg, 72 % yield).  
 
Compound characterization data: 
 
N
N
HN
OO
O OH3C CH3
1
2
3  
mp: 121-123 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.28; HPLC: 2.90 min; 
UV (MeOH): λmax, nm (ε): 215 (674); IR: ν 3240 (sbr, ע(N-H)), 2968 (w, ע(CH3)), 1741 
(vs, ע(C=O)) cm-1; 1H NMR(500 MHz, d6-DMSO) 3.86 (s, 6H, H-C3), 16.27 (br, NH); 
13
C NMR (125 MHz, d6-DMSO): δ = 52.7 (CH3, C3), 138.6 (Cq, C2), 160.3 (Cq, C1); 
MS: m/z 184 [M-H]-; HR-MS: calc’d for [M-H]- = 184.0364, found 184.0364 (∆M 
(ppm) = 0.1). 
 
 
 
5-Phenyl-1H-[1,2,3]triazole-4-carboxylic acid methyl ester (132) 
NH
N
N
O
O
CH3
O
O CH3
XN3
Solvent
 
                                                 131                                                  132 
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CAS Registry Number 40235-35-6 
Molecular Formula   C10H9N3O2 
Molecular Weight    203.20 g/mol 
Analysis Ref. 
a) G. Beck, Gerhard, D. Guenther, Farbwerke Hoechst A.-G. Ger. 
Offen.  1973, DE  2138522; b) G. Beck, D. Guenther, Chem. Ber. 
1973, 106, 2758 
 
Method 1:       
NH
N
N
O
O
CH3
O
O CH3
Et2AlN3
Xylene
 
                                                131                                                   132 
TP1: 1.1 equivalents  of diethylaluminum azide (2.7 M in xylene) is used in a 2 mmol 
scale experiment. The reaction is stirred for three days at room temperature to give the 
product as a yellow crystalline material (230 mg, 57 % yield).  
 
Method 2:       
NH
N
N
O
O
CH3
O
O CH3
NaN3
DMF
 
                                                131                                                   132 
TP1: 1.1 equivalents  of sodium azide in DMF is used in a 4 mmol scale experiment. The 
reaction is stirred for one and half hour at 70 °C to give the product as a yellow crystalline 
material (570 mg, 70 % yield).  
 
Compound characterization data: 
N
N
HN
O
H3C
O
1 2
3 4
5
6
7
8  
mp: 106-108 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.52; HPLC: 3.62 min; 
UV (MeOH): λmax, nm (ε): 243 (990); IR: ν 3460 (w, overtones ester), 3300-2900 (brs, 
ע(N-H)), 3037 (m, ע(C-H)), 2967 (m, ע(C-H)), 1743 (s, ע(C=O)), 1533 (w, ע(C=C)), 1480 
(s, ע(C=C)), 1275 (m, ע(C-O)), 755 (s, γ(CH, Ph)), 684 (m, γ(Ph)) cm-1; 1H NMR (400 
MHz, d6-DMSO): δ = 3.81 (s, 3H, H-C8), 7.43 (m, 3H, H-C5,6), 7.73 (m, 2H, H-C4), 15.85 
(br, NH); 13C NMR (125 MHz, d6-DMSO): δ = 51.7 (CH3, C8), 118.8 (Cq, C3), 127.9 
(CH, Ar), 128.6 (CH, Ar), 128.9 (CH, C6), 161.0 (Cq, C7); MS: m/z 202 [M-H]-. 
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5.1.3.11. Synthesis of alternative azides 
 
[1,3,2 ] Benzodioxaborole-2-azido (134) 
O
B
O
Cl
Me3SiN3
CH2Cl2, -78°C O
B
O
N N N
 
                                      133                                                              134 
CAS Registry Number 258331-21-4 
Molecular Formula   C6H4BN3O2 
Molecular Weight    160.93 g/mol 
Analysis Ref. 
W. Fraenk, T. Habereder, H. Nöth, K. Polborn, T. M. Klapötke, J. 
Chem. Soc. Dalton Trans. 1999, 23, 4283 
 
A 5 mL, one necked round-bottomed flask, is charged with ß-chloro-catecholborane (462 
mg, 3 mmol) dissolved in dichloromethane (1 mL) and treated, at -78°C, with 
trimethylsilylazide (0.6 mL, 4.5 mmol). The solution is gradually warmed to room 
temperature, and stirred for two hours. The solvent and the excess of trimethylsilylazide 
are removed to give 950 mg of white crystalline material. The product is hydrolyzed after 
few minutes. The same experiment was done with the 2-bromo-1,3,2-benzodioxaborole to 
obtain the same result. 
 
Compound characterization data: 
 
mp: 68-69 °C; FT-IR: ν 2169s ν(B-N3) cm –1. 
 
 
Diisopropoxyde aluminum azide (139) 
Al
O
OO
2
AlCl3
Toluene
   r.t.
Al
O
O
Cl
3 NaN3
0°C to r.t.
Al
O
O
N N N +   3  NaCl3
 
         137                                           138                                                    139 
A solution of aluminum isopropoxyde (4.085 g, 20 mmol) in toluene (11 ml) is treated, at 
0 °C, with aluminum chloride (1.33 g, 10 mmol). The mixture is warmed at room 
temperature and stirred over the night. The mixture is treated  with granular sodium azide 
(1.95 g, 30 mmol) at  0 °C , and than gradually warmed at room temperature and stirred 
over the night. The with suspension is centrifuged to obtain an upper solution and two 
solid layers. 
 
NO PRODUCT ISOLATED!! 
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5.1.3.12. Tetrazolate salts 
                                                                         
5-(4’-Methyl-biphenyl-2-yl)-tetrazole potassium salt (140) 
 
H3C NH
NN
N H3C N
NN
N K
KOH
MeOH, r.t.
 
                                                           22                                               140     
CAS Registry Number 860644-27-5 
Molecular Formula   C14H11N4K 
Molecular Weight    274.36 g/mol 
Ref. 
M. Lusina, T. Cindric, J. Tomaic, M. Peko, L. Pozaic, N. Musulin, J. 
Pharm. 2005, 291, 127 
 
 
5-(4’-Methyl-biphenyl-2-yl)-1H-tetrazole (4.725 g, 20 mmol), KOH (1.122 g, 20 mmol) 
are dissolved in methanol (26 mL) and stirred two hours at room temperature. The 
solvent is removed to give 5.44 g of product in ≥ 99 % yield. 
 
Compound characterization data: 
 
H3C N
NN
N K
1
1'
2'
3'
4'
6'
2
3
4
5
6
7
 
mp: up to 260 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.7; HPLC: 7.19 min.; 
UV (MeOH): λmax, nm (ε): 249 (1290), 202 (3810); IR: ν 3052 (w, ע(C-H)), 3025 (m, 
ע(C-H)), 2919 (w, ע(C-H)), 2863 (m, ע(C-H)), 1505 (m, ע(C=C)), 1458 (s, ע(C=C)), 1422 
(m, ע(C=C)), 826 (s, γ(C-H, Ph)), 765 (s, γ(C-H, Ph))  cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 2.25 (s, 3H, H-C6’), 6.95 (m, 4H, H-C2’,3’), 7.32 (m, 3H, H-C4,5,6), 7.49 (m, 
1H, H-C3); 13C NMR (125 MHz, d6-DMSO): δ = 20.6 (CH3, C6’), 126.4 (CH, C2’), 
127.58 (CH, C3'), 128.0 (CH, C4), 128.9 (CH, C6), 129.9 (CH, C3), 130.5 (CH, C5), 132.0 
(Cq, C2), 135.1 (Cq, C1’), 138.8 (Cq, C1), 140.5 (Cq, C4), 160.4 (Cq, C7); MS: m/z 235 
[M-K]-, 207 [M-K-N2]- 
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5-(4-Chloro-phenyl)-tetrazole cesium salt (2) 
                                               Cl
NH
NN
N
Cl
N
NN
N [Cs]
+
CsOH.H2O
MeOH
r.t.
 
                                                         1                                2  
Molecular Formula   C7H4ClN4Cs 
Molecular Weight    312.49 g/mol 
 
A 25 ml, one necked round-bottomed flask is charged, at room temperature, with 4-
chloro-phenyltetrazole 1 (542 mg, 3 mmol) and cesium hydroxide monohydrate (504 mg, 
3 mmol) in methanol (5 mL). The mixture is stirred at room temperature for one hour. 
The solvent is removed and the product is dried in vacuum for four hours at  30 °C to 
give a white crystalline material in ≥ 99 % yield (940 mg). 
 
Compound characterization data: 
Cl
N
NN
N [Cs]
+
1
2
3
4
5
 
mp: up to 250 °C; TLC: Rf (toluene / AcOEt / AcOH 20:20:1) = 0.39;  HPLC: 5.12 min; 
UV (MeOH): λmax, nm (ε): 248 (9650); IR: ν 3262 (brs, ע(C-H)), 1439 (s, ע(C=C)), 1422 
(s, ע(C=C)), 1093 (s, ע(C-Cl)), 841 (s, γ(C-H, Ph) cm-1; 1H NMR (500 MHz, d6-DMSO): 
δ = 7.41 (d, 3J2,3 = 8.6 Hz, 2H, H-C2), 7.96 (d, 3J2,3 = 8.6 Hz, 2H, H-C3); 13C NMR (125 
MHz, d6-DMSO): δ = 127.3 (CH, C2), 128.4 (CH, C3), 131.2 (Cq, C4), 131.5 (CH, C1), 
159.7 (Cq, C5); MS: m/z 181 [MH-Cs]+.  
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5.1.3.13. Nucleophilic substitution with tetrazoles 
 
(S)-2-[5-(4-Chloro-phenyl)-tetrazol-2-yl]-4-phenyl-buthyric acid ethyl ester (143) and 
(S)-2-[5-(4-Chloro-phenyl)-tetrazol-1-yl]-4-phenyl-buthyric acid ethyl ester (144) 
 
O
S O
O
O
O
N
O
O
N
N
N
Cl
Cl
N
NKN
N
O
O
N
N
NN
Cl
Acetonitrile
+ +
NO2
60°C, 32 h
N1-Isomer                       N2-Isomer
141                    142                                                      143                              144
 
Molecular Formula   143:       C19H19ClN4O2  144:      C19H19ClN4O2 
Molecular Weight    143:       370.84 g/mol  144:      370.84 g/mol  
 
 A 25 mL, three necked round bottomed flask, is charged, at room temperature, with 5-(4-
chloro-phenyl)-1H-tetrazole 1 (722 mg, 4 mmol), methanol (10 mL) and potassium 
hydroxide (225 mg, 4 mmol). The mixture is stirred one hour at room temperature. The 
solvent is removed, the resulting crystalline material is dried one hour in vacuum and 
added at room temperature to a solution containing (R)-2-(nitro-benzenesulfonyloxy)-4-
phenyl-butyric acid ethyl ester 141 (1.179 g, 3 mmol) in acetonitrile (7 mL). The reaction 
is stirred thirty two hours at 60 °C. The solvent is removed to give the crude (2.05 g) 
which is re-dissolved in ethyl acetate (30 mL) and extracted twice with potassium 
carbonate (10 % solution, 20 mL portion). The solvent is removed  to give 1.01 g of  a 
colorless oil which is chromatographed (elution system: hexane / ethyl acetate 9:1) to give 
the pure N1-isomer 143 (150 mg, 13 % yield) and the N2-isomer 144 (900 mg, 79 % 
yield) as oils. 
 
Compound characterization data: 
N1-Isomer (143) 
O
O
N
N
NN
Cl
H
1
23
4
5
6
7
8
9
10
11
12
1314
15
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TLC: Rf (hexane / EtOAc 9:1) = 0.06; HPLC: 11.53 min; 1H NMR (500 MHz, d6-
DMSO) Major rotamer (ratio 1:6) δ = 1.11 (t, 3J9,10 = 7.06 Hz, 3H, H-C10), 2.61 (m, 4H, 
H-C3,4), 4.21 (q, 3J9,10 = 7.1 Hz,  2H, H-C9), 5.49 (dd, 3J2,3 = 7.1, 7.3 Hz, 1H, H-C2), 7.01 
(m, 2H, H-C6), 7.18 (m, 3H, H-C7,8), 7.63 (m, 3J13,14 = 8.8 Hz, 4H, H-C13,14); 13C NMR 
(125 MHz, d6-DMSO): δ = 13.7 (CH3, C10), 30.8 (CH2, C3), 31.9 (CH2, C4), 59.5 (CH2, 
C9), 62.4 (CH, C2), 122.0 (Cq, C5), 126.3 (CH, C8), 128.2 (CH, C6), 128.5 (CH, C7), 129.5 
(CH, C13), 130.8 (CH, C14), 136.5 (Cq, Ar), 139.6 (Cq, Ar), 154.4 (Cq, C11), 167.6 (Cq, 
C1); MS: m/z 371 [MH]+.  
 
N2-Isomer (144) 
N
O
O
N
N
N
Cl
H
1'
2'3'
4'
5'6'
7'
8'
9'
10'
11' 12' 13'
14'
15'
 
TLC: Rf (hexane / EtOAc 9:1) = 0.18; HPLC: 13.38 min; UV (MeOH): λmax, nm (ε): 248 
(2210); IR: ν 3063 (w, ע(C-H)), 3028 (w, ע(C-H)), 2982 (m, ע(C-H)), 2937 (m, ע(C-H)), 
1749 (vs, ע(C=O)), 1607 (s, ע(C=C)), 1497 (w, ע(C=C)), 1456 (s, ע(C=C)), 1204 (s, ע(C-
O)), 1092 (s, ע(Ph-Cl)), 758 (s, γ(C-H, Ph)), 701 (s, γ(Ph)) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ = 1.15 (t, 3J9’,10’ = 7.3 Hz, 3H, H-C10’), 2.60 (m, 4H, H-C3’,4’), 4.18 (q, 3J9’,10’ = 
7.3 Hz, 2H, H-C9’), 5.99 (m, 1H, H-C2’), 7.14 (m, 3H, H-C6’,8’), 7.25 (m, 2H, H-C7’), 7.62 
(d, 3J13’,14’ = 9.0 Hz,  2H, H-C14’), 8.08 (d, 3J13’,14’ = 9.0 Hz, 2H, H-C13’); 13C NMR (125 
MHz, d6-DMSO): δ = 13.9 (CH3, C10’), 31.3 (CH2, C3’), 31.8 (CH2, C4’), 62.5 (CH2, C9’), 
64.9 (CH, C2’), 125.2 (Cq, C5’), 126.2 (CH, C8’), 128.3 (CH, C6 ), 128.4 (CH, C7’), 128.6 
(CH, C13’), 129.4 (CH, C14’), 135.4 (Cq, Ar), 139.8 (Cq, Ar), 163.4 (Cq, C11), 167.3 (Cq, 
C1); MS: m/z 371 [MH]+.  
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5.2. Alkylation of Tetrazole Rings 
 
5.2.1. Reagents and solvents 
 
 
 All chemicals were obtained either from commercial suppliers or internal sources 
and used without further purification unless otherwise stated. All reactions were carried 
out under an atmosphere of nitrogen or argon. All the products were satisfactorily 
characterized by melting point, TLC, UV, IR, 1H and 13C-NMR, MS, HR-MS and when 
possible, comparison of their analytical data has been made with available literature data. 
 
5.2.1.1. Reagents 
 
Reagent Molecular 
Formula 
MW 
(g/mol) 
Quality 
Benzhydryl bromide C13H11Br 247.1 Lancaster ; 95 % 
Benzylbromide C7H7Br 171.04 Fluka ; ≥ 98 % (GC) 
Chlorotriphenylmethane C19H15Cl 278.78 Lancaster ; 98+ % 
Hydrochloric acid HCl 36.5 Fluka ; 2N standard solution 
Fluka ; ≥ 32 % (T) 
2-Iodopropane C3H7I 169.99 Fluka ; ≥ 97 % (GC) 
Methyl-4-formylbenzoate C9H8O3 164.16 Fluka ; ~95 % (HPLC) 
3-Methyl-1-p-tolyltriazene C8H11N3 149.19 Aldrich ; 98 % 
Piperidine C5H11N 85.16 Fluka ; ~98 % (GC) 
Potassium hydrogen carbonate KOH 56.11 Fluka ; ≥ 86 % (T) 
Potassium carbonate K2CO3 138.27 Fluka ; ≥ 99 % (AT) 
Triethylamine C6H15N 101.19 Fluka ; ≥ 99.5 %  
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5.2.1.2. Solvents 
 
Solvents Quality 
Acetone Fluka ; ≥ 99.5 % (GC) 
Acetonitrile Merck ; for LC 
ARMAR Chemicals ; d3-Acetonitrile 99.5 Atom % D 
Chloroform Fluka ;  ≥ 99.5 % (GC) 
ARMAR Chemicals; CDCl3 100 Atom % D, stab. with Ag 
Dichloromethane Merck ; for analysis  
Fluka ; 99.5 % (GC) 
Dimethylsulfoxide ARMAR Chemicals ; d6-DMSO 99.9 Atom % D 
1,4-Dioxane Fluka; puriss. p.a., ≥ 99.5 % 
Ethyl acetate Fluka ; 99.5 % 
Heptane Fluka ; ≥ 99.0 % (GC) 
Hexane Fluka ; ≥ 99.0 % (GC) 
Isopropyl acetate Fluka ; ≥ 99.0 % (GC) 
Methylen chloride Fluka; puriss. over molecular sieves 
Tetrahydrofuran Fluka; puriss. p.a., ≥ 99.5 % (GC) 
Toluene Fluka ; absolute over molecular sieves, ≥ 99.5 % (GC) 
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5.2.2. Synthesis of the Starting Materials  
 
 
4-[2-Benzensulfonyl-2-(1H-tetrazol-5-yl)-vinyl]-benzoic acid methyl ester (165) 
 
S
O O
N
H
N
NN
+
CHO
COOCH3
Piperidine 20%
  Dioxane
reflux, 15 h
S
O O
N
H
N
NN
COOCH3
     75                                72                                                            165
 
Molecular Formula   C17H14N4O4S 
Molecular Weight    370.39 g/mol 
 
A 200 mL four necked bottomed-flask, equipped with an overhead mechanical stirrer and 
a water removed system, is charged at room temperature, with 5-phenylsulfonylmethyl-
1H-tetrazole 75 (6.727 g, 30 mmol), methyl-4-formyl benzoate (7.387 g, 45 mmol) and 
piperidine (511 mg, 6 mmol) dissolved in dioxane (90 mL). The mixture is gradually 
warmed to refluxing 130 °C (external temperature) and stirred 15 hours. The solution is 
cooled to room temperature and the solvent is removed to give 21.8 g of crude as a brown 
oil. The crude is dissolved with a solution of ethyl acetate and toluene (1:1) and washed 
three times with HCl (2 M) to remove the piperidine in the aqueous phase. The collective 
aqueous phase is washed twice with ethyl acetate (30 mL portion). The solvent is 
removed, the brown oil is re-dissolved in ethyl acetate (40 mL) and the product is 
extracted three times with a solution of KHCO3 (15 % solution, 30 mL portion). The 
combined aqueous phase is washed twice with ethylacetate (30 mL portion). The basic 
aqueous phase is cooled to 0 °C and treated with HCl (6 M) to pH 2.5 monitored with an 
electrode or a pH paper. The product is extracted four times with ethyl acetate (30 mL 
portion). The solvent is removed and the product is crystallized from ethyl acetate to give 
3.4 g, with 30 % of yield. 
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Compound characterization data: 
S
O O
N
H
N
NN
COOCH3
1
2
3
4
5
6
7
8
9
10
11
12 13  
mp: 180-182 °C; TLC: Rf (toluene / EtOAc / AcOH 20:20:1) = 0.16; HPLC: 11.26 min 
UV (acetonitrile): λmax, nm (ε): 286 (2180); IR: ν 3100-2400 (brw, ע(N-H)), 3069 (w, 
ע(C-H)), 1724 (vs, ע(C=O)), 1631(s, ע(C=C)), 1434 (s, ע(C=C)), 1308 (s עasim(SO2)), 1291 
(s, ע(C-O)), 1152 (s, עsim(SO2)), 1085 (s, ע(C-O)) cm-1; 1H NMR (500 MHz, d6-DMSO): 
δ = 3.81 (s, 3H, H-C13), 7.21 (m, 2H, H-C9), 7.63 (m, 2H, H-C3), 7.76 (m, 1H, H-C4), 7.77 
(m, 2H, H-C2), 7.86 (m, 2H, H-C10), 8.44 (s, 1H, H-C7), 16.80 (br, NH); 13C NMR (125 
MHz, d6-DMSO): δ = 52.6 (CH3, C13), 128.7 (CH, C2), 129.9 (CH, C10), 130.1 (CH, C3), 
130.6 (Cq, C5), 130.7 (CH, C9), 132.0 (Cq, C11), 134.9 (CH, C4), 136.1 (Cq, C8), 138.4 
(Cq, C1), 144.9 (CH, C7), 165.8 (C=O, C12); MS: m/z 369 [M-H]-, 141 [PhSO2]-; HR-
MS: calc’d for [MH]+ = 371.0809, found 371.0809 (∆M (ppm) < 0.1), calc’d for 
[M+Na]+ = 393.0628, found 393.0628 (∆M (ppm) < 0.1). 
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5.2.3. Alkylation of the Tetrazole Ring 
 
 
(R)-2-(Isopropyl-tetrazole-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester (161, 162) 
I
N
N
N
NHN
O
O
N
N N
N
N
N
N N
N
N
O O
K2CO3
r.t., 3d
+
Acetonitrile +
O O
HH
H
 
              302              113                                                   161                                162 
CAS Registry Number N1-isomer: 920748-49-8   N2-isomer: 920748-47-6 
Molecular Formula   C16H21N5O2 
Molecular Weight    315.17 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
A 200 mL, three necked bottomed flask, is charged at room temperature with (R)-2-(1H-
tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester (12.3 g, 45 mmol), in acetonitrile 
(130 mL) and potassium carbonate (24.84 g, 180 mmol). After five minutes 2-
iodopropane is added (9.28 mL, 90 mmol) and the mixture is stirred for three days. The 
mixture is transferred into a 500 mL flask and the acetonitrile is removed with the rotary 
evaporator. Water (40 mL) is added (pH 8.5) and the product is extracted four times with 
ethyl acetate (50 mL portion). The combined organic phase is washed once with water 
(40 mL). The solvent is removed to give an orange oil which contains both the N1- and 
the N2-isomers (N2/N1-isomer 72:28 based on HPLC analysis). The crude is 
chromatographed (eluent: ethyl acetate / hexane 1:3) to give 9.163 g of pure N2-
regioisomer 161 (65 % yield) and N1-isomer 162 (28 % yield) as colorless oils. 
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Compound characterization data: 
N1-Isomer (162) 
12 13
1
23
4
5
6
7 8
9
10
11
N N N
N
N
O O
H
 
TLC: Rf (hexane / EtOAc 3:1) = 0.12; HPLC: 8.53 min; UV (EtOH): λmax, nm (ε): 258 
(22), 205 (1010); IR: ν 3064 (w, ν (C-H)), 3034 (w, ν (C-H)), 2984 (w, ν (C-H)), 1704 (s, 
ν (C=O)), 1447 (m, ν (C=C)), 1415 (s, ν (C-N)), 1357 (s, δ(CH3)), 1123 (s, ν(C-O)), 699 
(w, γ(Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO, 300 K) Rotamers (1:1): δ = 1.30, 1.53 ( 
dd, 3J12,13 = 6.5 Hz, 6H, H-C13), 1.90 (m, 2H, H-C3), 2.2 (m, 2H, H-C2), 3.58 (m, 2H, H-
C4), 4.90 (m, 3H, H-C7,12), 5.31 (dd, 3J1,2 = 8.0, 8.1 Hz, 1H, H-C1), 6.97 (m, 1H, H-C11), 
7.35 (m, 4H, H-C9,10); (400 MHz, d6-DMSO, 394 K): δ = 1.45 (d, 6H, H-C13), 1.95 (m, 
2H, H-C3), 2.25 (m, 2H, H-C2), 3.58 (m, 2H, H-C4), 4.80 (m, 1H, H-C12), 4.93 (s, 1H, H-
C7), 5.25 (m, 1H, H-C1), 7.12 (m, 2H, ArH), 7.28 (m, 3H, ArH); 13C NMR (125 MHz, d6-
DMSO, 300 K) Rotamers (1:1): δ = 21.7, 22.2 (CH3, C13), 22.5, 23.9 (CH2, C3), 31.4, 32.3 
(CH2, C2), 46.3, 46.8 (CH2, C4), 49.9, 50.1 (CH2, C7), 50.1, 50.3 (CH, C12), 66.2, 66.3 
(CH, C1), 127.4, 127.5 (CH, Ar), 127.8, 127.9 (CH, C11),  128.3, 128,4 (CH, Ar), 136.2, 
136.7 (Cq, C8), 153.2, 153.9 (Cq, C5), 155.5, 155.9 (Cq, C6); MS: m/z 316 [MH] +; HR-
MS: calc’d for [MH]+ = 316.1768, found 316.1767 (∆M (ppm) = 0.2); calc’d for [M+Na]+ 
= 338.1588, found 338.1586 (∆M (ppm) = 0.4). 
 
N2-Isomer (161) 
N N N
N
N
O O
H
2'3'
4'
5'6'
7' 8' 9'
10'
11'
1'
12'
13'
 
TLC: Rf (hexane / EtOAc 3:1) = 0.25; HPLC: 7.65 min; UV (EtOH): λmax, nm (ε): 205 
(1321); IR: 3064 (w, ν (C-H)), 3033 (w, ν (C-H)), 2984 (w, ν (C-H)), 2955 (w, ν (C-H)), 
1707 (s, ν (C=O)), 1448 (m, ν (C=C)), 1412 (s, ν (C-N)), 1356 (s, δ(CH3)), 1116 (s, ν(C-
O)), 698 (w, γ(Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO, 300 K) Rotamers (1:1): δ = 
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1.45, 1.51 (dd, 3J12’,13’  = 6.5 Hz, 6H, H-C13’), 1.95 (m, 3H, H-C2’,3’), 2.33 (m, 1H, H-C2’), 
3.53 (m, 2H, H-C4’), 4.95 (m, 3H, H-C7’,12’), 5.18 (dd, 3J1’,2’ = 8.0 Hz, 1H, H-C1’), 7.02 (m, 
1H, H-C11’), 7.29 (m, 4H, H-C9’,10’); (400 MHz, d6-DMSO, 394 K): δ =  1.51 (dd, 6H, H-
C13’), 1.98 (m, 3H, H-C2’,3’), 2.35 (m, 1H, H-C2’), 3.53 (m, 2H, H-C4’), 4.97 (m, 3H, H-
C7’,12’), 5.18 (m, 1H, H-C1’), 7.18 (m, 2H, ArH), 7.25 (m, 3H, ArH); 13C NMR (125 MHz, 
d6-DMSO, 300 K) Rotamers (1:1): δ = 21.7, 21.8 (CH3, C13’), 23.5, 23.7 (CH2, C3’), 31.9, 
32.8 (CH2, C2’), 46.2, 46.7 (CH2, C4’), 52.5, 53.1 ( CH2, C7’), 55.9 (CH, C12’), 65.7, 65.9 
(CH, C1’), 126.8, 127.4 (CH, Ar), 127.6, 127.8 (CH, C11’), 128.1, 128,4 (CH, Ar), 136.7, 
136.9 (Cq, C8’), 153.6, 153.8 (Cq, C5’), 167.2, 167.6 (Cq, C6’); MS: m/z 316 [MH]+, 272 
[MH-CO2]+; HR-MS: calc’d for [MH]+ = 316.1768, found 316.1768 (∆M (ppm) = 0.1); 
calc’d for [M+Na]+ = 338.1588, found 338.1587 (∆M (ppm) = 0.3). 
 
 
 (R)-2-(2-Trityl-2H-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester (164) 
N N N
NH
N
Cl N N N
NN
OO THF
 r.t.,2h
O O
+ Et3N
HH
 
              113                                  163                                                       164 
Molecular Formula   C32H29N5O2   
Molecular Weight    515.62 g/mol 
 
A 25 mL, three necked round-bottomed flask, is charged at room temperature, with (R)-2-
(1H-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 113 (546 mg, 2 mmol) and 
chlorotriphenylmethane (613 mg, 2.2. mmol) in THF (8 mL). The solution is then treated 
with triethyl amine (0.362 mL, 2.6 mmol) and stirred at room temperature for two hours. 
The mixture is filtered, the solvent is removed and the crude (1.15 g, colorless gel) is 
chromatographed (elution system: heptane / ethyl acetate 5:1) to give the product 164 as a 
colorless oil (1.03 g, 77 % of yield). 
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Compound characterization data: 
N N N
N
N
O O
H
23
4
56
7 8 9
10
11
1
12
13
14
15
16
       
TLC: Rf (heptane / EtOAc 5:1) = 0.1; HPLC: 12.72 min; UV (MeOH): λmax, nm (ε): 259 
(76); IR: ν 3090 (w, ע(C-H)), 3062 (w, ע(C-H)), 3033 (w, ע(C-H)), 2978 (w, ע(C-H)), 
2953 (w, ע(C-H)), 1960-1800 (w, overtones γ(C-H, Ph)), 1703 (s, ע(C=O)), 1494 (m, 
ע(C=C)), 1448 (s, ע(C=C)), 1414 (s, ע(C-N)), 748 (s, γ(C-H, Ph)), 699 (s, γ(Ph)) cm-1; 1H 
NMR (400 MHz, d6-DMSO) Major rotamers (ratio 2:3): δ = 1.93 (m, 3H, H-C2,3), 2.34 
(m, 1H, H-C2), 3.48 (m, 2H, H-C4), 4.98 (m, 2H, H-C7), 5.22 (dd, 3J1,2 = 6.8, 7.0 Hz, 1H, 
H-C1), 6.95 (m, 6H, ArH), 7.30 (m, 14H, ArH); 13C NMR (125 MHz, d6-DMSO) 
Rotamers (ratio 2:3): δ = 22.7, 23.5 (CH2, C3), 31.9, 32.8 (CH2, C2), 46.2, 46.8 (CH2, C4), 
52.5, 53.1 (CH, C1), 65.8, 65.9 (CH2, C7), 82.2 (Cq, C12), 126.8 (CH, ArH), 124.4, 127.5 
(CH, Ar), 127.9 (CH, ArH), 128.1, 128.3 (CH, ArH), 129.5, 129.6 (CH, C14), 136.6, 
136.9 (Cq, C8), 140.9, 140.9 (Cq, C13), 153.5, 153.8 (Cq, C6), 166.8, 167.1 (Cq, C5); MS: 
m/z 538 [M+Na]+; HR-MS: calc’d for [M+Na]+ = 538.2214, found 538.2212 (∆M (ppm) 
= 0.3); calc’d for [M+K]+ = 554.1953, found 554.1953 (∆M (ppm) = 0.1 ). 
 
 
5.2.3.1. Benzylation of the tetrazole ring 
 
4-[2-Benzenesulfonyl-2-(benzyl-tetrazol- 5-yl) -vinyl]-benzoic acid methyl ester (166, 
167) 
S
O O
N
H
N
NN
COOCH3
+
Br
S
O O
N
N
NN
COOCH3
+
S
O O
N
N
NN
COOCH3
N2-Isomer                      N1-Isomer
K2CO3
Acetone, r.t.
 
             165                        68                                               166                           167 
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Molecular Formula   C24H20N4O4S 
Molecular Weight    460.51 g/mol 
 
A 25 mL, three necked round bottomed flask, is charged at room temperature, with  4-[2-
benzensulfonyl-2-(1H-tetrazol-5-yl)-vinyl]-benzoic acid methyl ester 165 (741 mg, 2 
mmol), dissolved in acetone (7.5 mL). The solution is treated with potassium carbonate 
(553 mg, 4 mmol) and benzyl bromide (410 mg, 2.4 mmol). The mixture is stirred over 
the night. The acetone is removed by rotary evaporator, water is added (10 mL) and the 
product is extracted three times with isopropyl acetate (15 mL portion). The collective 
organic phase is washed once with water (15 mL). The solvent is removed to give 1.06 g 
of crude. The product is flash chromatographed (toluene / ethyl acetate 14:1) to give 640 
mg as a mixture of N1 and N2-isomers in ratio 1:1 with 69 % of yield.  
 
Compound characterization data: 
S
O O
N
N
NN
COOCH3
S
O O
N
N
NN
COOCH3
N2-Isomer                                         N1-Isomer
2
1
3
4
5
6
7
8
9
10
11 12
13
14
15
16 17
18
 
mmp: 53-55 °C; TLC: Rf (toluene / EtOAc 5:1) = 0.23; HPLC: 16.07; 16.34 min; UV 
(EtOH): λmax, nm (ε): 289 (25650), 201 (41850); IR: ν 3419 (w overtones (C=O)), 3100 
(w, ע(C-H)), 2855 (w, ע(C-H)), 1724 (s, ע(C=O)), 1631 (s ע(C=C)), 1434 (s, ע(C=C, Ph)), 
1308 (s, עasim(SO2)), 1291 (s, ע(C-O)), 1152 (s, עsim(SO2)), 1085 (s, ע(C-O)) cm-1; 1H 
NMR (500 MHz, d6-DMSO): δ =  3.86 (s, 3H, H-C12, N1-isomer), 3.87 (s, 3H, H-C12, N2-
isomer), 5.23 (br, 1H, H-C14, N1-isomer), 5.53 (br, 1H, H-C14, N1-isomer), 5.94 (s, 2H, 
H-C14, N2-isomer), 7.1 (m, 6H, H-C8,16, N1- and N2-isomers), 7.40 (m, 1H, ArH, N1-
isomer), 7.58 (m, 1H, ArH, N2-isomer), 7.75 (m, 6H, ArH, N1- and N2-isomers), 8.46 ( s, 
1H, H-C6, N2-isomer B), 8.57 (s, 1H, H-C6, N1-isomer); (500 MHz, d6-DMSO, 353 
K) 3.86 (s, 3H, H-C12, N1-isomer), 3.87 (s, 3H, H-C12, N2-isomer), 5.21 (br, 2H, H-C14, 
N1-isomer), 5.96 (s, 2H, H-C14, N2-isomer), 7.1 (m, 6H, H-C8,16, N2- and N2-isomers), 
7.40 (m, 1H, ArH, N1-isomer), 7.58 (m, 1H, ArH, N2-isomer), 7.75 (m, 6H, ArH, N1- and 
N2-isomers), 8.45 (s, 1H, H-C6, N2-isomer), 8.57 (s, 1H, H-C6, N1-isomer); 13C NMR 
(125 MHz, d6-DMSO) More relevant data: δ =  51.9 (CH3, C12, N1-and N2-isomers), 50.8 
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(CH2, C14, N1-isomer), 56.7 (CH2, C14, N2-isomer), 128.2 (CH, Ar), 128.5 (CH, Ar), 
129.3 (CH, Ar), 130.0 (CH, Ar), 130.4 (CH, Ar), 130.8 (CH, Ar), 131.4 (CH, Ar), 134.4 
(CH, Ar), 135.1 (Cq, Ar), 145.0 (CH, C6, N2-isomer), 148.0 (CH, C6, N1-isomer), 165.6 
(Cq, C11); MS: m/z 369 [M-H]-, 141 [PhSO2]-; HR-MS: calc’d for [MH]+ = 371.0809, 
found 371.0809 (∆M (ppm) < 0.1), calc’d for [M+Na]+ = 393.0628, found 393.0628 (∆M 
(ppm) < 0.1). 
 
 
 (S)-tert-butyl-2-(benzyl-tetrazol-5-yl)-pyrrolidine-1-carboxylate (168, 169) 
N
H
O
O
N N
N
N
N
H
O
N N
N
N
N1-Isomer                       N2-Isomer
+N
H
O
O
N N
N
H
N
PhCH2Br
K2CO3
Acetone, r.t.
 
            111                                                            168                                 169 
Molecular Formula   C17H23N5O2 
Molecular Weight    329.19 g/mol 
 
A 25 mL, three necked round-bottomed flask, is charged, at room temperature, with the 
boc-pyrrolidine tetrazole 111 (956 mg, 4 mml) in acetone (9 mL), benzyl bromide (820 
mg, 4.8 mmol) and potassium carbonate (1.106 g, 8 mmol). The mixture is stirred over the 
night at room temperature. The mixture is quenched with water (20 mL) and the product 
extracted four times with ethyl acetate (25 mL portion). The solvent is removed to give 
1.320 g  of crude which is chromatographed (elution system: hexane / ethyl acetate 3:1) to 
afford the the 650 mg of N2-isomer 169 (49 % yield) and 580 mg of N1-isomer 168 (44 % 
yield) as yellow oils. 
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Compound characterization data: 
N1-Isomer (168) 
N
H
O
O
N N
N
N1
23
4
6
5
7
8
9
10
11
12
13
 
TLC: Rf (hexane / EtOAc 3:1) = 0.6; HPLC: 9.56 min; UV (MeOH): λmax, nm (ε): 257 
(342); IR: ν 3066 (w, ע(C-H)), 3034 (w, ע(C-H)), 2977 (m, עasim(CH3)), 2930 (w, ע(C-H)), 
1696 (vs, ע(C=O)), 1456 (s, ע(C=C)), 1396 (vs, ע(C-N)), 1367 (s, δ (CH3)3), 1163 (s, ע(C-
O)) cm-1; 1H NMR(500 MHz, d6-DMSO, 394 K): δ = 1.27 (s, 9H, H-C8), 1.85 (m, 1H, H-
C3), 1.90 (m, 1H, H-C3), 2.05 (m, 1H, H-C2), 2.18 (m, 1H, H-C2), 3.48 (m, 2H, H-C4), 5.17 
(m, 1H, H-C1), 5.66 (m, 2H, H-C9), 7.28 (m, 2H, H-C11), 7.34 (m, 3H, H-C12,13); 13C NMR 
(150 MHz, d6-DMSO, 300 K) Major rotamer: δ = 22.8 (CH2, C3), 27.7 (CH3, C8), 32.0 
(CH2, C2), 46.2 (CH2, C4), 50.0 (CH, C1), 50.9 (CH2, C9), 79.9 (Cq, C7), 128.0 (CH, C11), 
128.5 (CH, C13), 128.9 (CH, Ar), 134.5 (Cq, C10), 157.2 (Cq, C6), 168.7 (Cq, C5); MS: m/z 
330 [MH]+, 230 [MH-Boc]+; HR-MS: calc’d for [MH]+ = 330.1925, found 330.1925 (∆M 
(ppm) = 0.1), calc’d for [M+Na]+ = 352.1744, found 352.1744 (∆M (ppm) = 0.1).  
 
N2-Isomer (169) 
N
H
O
O
N N
N
N1'
2'3'
4'
6'
5'
7'
8'
9'
10'
11' 12'
13'
 
TLC: Rf (hexane / EtOAc 3:1) = 0.75; HPLC: 10.38 min; IR: ν 3067 (w, ע(C-H)), 3035 
(w, ע(C-H)), 2977 (m, ע(C-H)), 1698 (vs, ע(C=O)), 1456 (m, ע(C=C)), 1395 (s, ע(C-N)), 
1367 (s, δ(CH3)3), 1163 (s, ע(C-O)) cm-1; 1H NMR (400 MHz, d6-DMSO) Major 
rotamer: δ = 0.98 (s, 9H, H-C8’), 2.05 (m, 4H, H-C2’,3’), 3.45 (m, 2H, H-C4’), 4.95 (m, 1H, 
H-C1’), 5.90 (s, 2H, H-C9’), 7.34 (m, 5H, H-C11’-13’); 13C NMR (150 MHz, d6-DMSO) 
Major rotamer: δ = 22.9 (CH2, C3’), 27.6 (CH3, C8’), 32.8 (CH2, C2’), 46.2 (CH2, C4’), 
52.5 (CH, C1’), 55.7 (CH2, C9’), 78.4 (Cq, C7’), 128.4 (CH, Ar), 128.5 (CH, C13’), 129.2 
(CH, Ar), 134.2 (Cq, C10’), 157.8 (Cq, C6’), 168.7 (Cq, C5’); MS: m/z 330 [MH]+, 230 
[MH-Boc]+ 
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5.2.4. Methylation of the Tetrazole Ring 
 
 
5.2.4.1. TP3: Typical procedure for the methylation of the tetrazole 
ring 
R N
N
H
NN N N N
H
CH3
H3C
CH2Cl2, r.t., 2h
N
N
NN
R N
N
NN
+
CH3
CH3
N2-Isomer              N1-Isomer
R
 
Scheme 139. Methylation of the tetrazole ring 
 
A 25 mL, three necked round bottomed flask, is charged at 0 °C, under 
atmosphere of argon, with 2-fluoro-phenyl-tetrazole (821 mg, 5 mmol) dissolved in 
dichloromethane (10 mL) and  treated with 3-methyl-1-p-tolyltriazene (1.119 g, 7.5 
mmol). The mixture is gradually warmed at room temperature and stirred for two hours. 
When the HPLC and the TLC analysis show > 98 % conversion the reaction mixture is 
cooled to 0 °C and quenched with HCl (2 M, 10 mL). The biphasic mixture is transferred 
to a separatory funnel and the product is extracted three times with dichloromethane (10 
mL portion) ; the combined organic phase is washed three times HCl (2 M, 10 mL 
portion). The solvent is removed to give 740 mg of a pink crystalline material and the 
crude is chromatographed (elution system: hexane / ethyl acetate 3:1) to give the N2-
isomer (520 mg, 82.5 % yield) and the N1-isomer (110 mg, 17.5 % yield). 
 
5-(2-Fluoro-phenyl)-N-methyl-tetrazole (145, 146) 
N
NHN
N
F
N N N
H
CH3
H3C
CH2Cl2, r.t., 2h
N
NN
N
F
N
NN
N
F
+
H3C
CH3
N2-Isomer              N1-Isomer  
                      96                                                                    146                      145 
Molecular Formula   C8H7FN4 
Molecular Weight    178.17 g/mol 
 
TP3: 1.5 equivalents  of 3-methyl-1-p-tolyltriazene are used in a 5 mmol scale 
experiment. The reaction is stirred two hours at room temperature to give 740 mg of pink 
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crystalline material (N2/N1-isomer = 71:29 based on HPLC analysis). The crude is 
chromatographed to give 520 mg of  N2-isomer 146 as an orange solid (58 % yield) and 
110 mg of N1-isomer 145 as an orange oil (12 % yield).  
 
Compound characterization data: 
N1-Isomer (145) 
N
NN
N
F
CH3
1
2
3
4
5
6
7
8
 
mp: 74-77 °C; TLC: Rf (hexane / AcOEt 3:1) = 0.16; HPLC: 6.37 min; UV (EtOH): 
λmax, nm (ε): 269 (1250), 224 (8570); IR: ν 3073 (w, ע(C-H)), 2961 (w, ע(CH3)), 1623 (m, 
ע(C=C)), 1585 (w, tetrazole), 1480 (s, ע(C=C)), 1436 (s, ע(C=C)), 1223 (s, ע(C-F)) cm-1; 
Raman: 3080 (w, ע(C-H)), 2961 (w, עsim(-CH3)), 1526 (m, tetrazole), 1223 (w, ע(C-F)) 
cm-1; 1H NMR (500 MHz, d6-DMSO): δ =  4.03 (s, 3H, H-C8), 7.46 (m, 2H, H-C4,6), 7.72 
(m, 2H, H-C3,5); 13C NMR (125 MHz, d6-DMSO): δ =  34.0 (CH3, C8), 113.2 (Cq, C2), 
117.3 (CH, C6), 126.2 (CH, C4), 129.5 (CH, C3), 132.8 (CH, C5), 153.7 (Cq, C7), 160.7 
(Cq, C1); MS: m/z 179 [MH]+;  
 
N2-Isomer (146) 
N
NN
N
F
CH3
1'
2'
3'
4'
5'
6'
7'
8'
 
mp: 70-74 °C; TLC: Rf (hexane / AcOEt  3:1) = 0.37; HPLC: 8.90 min; UV (EtOH): 
λmax, nm (ε): 283 (1400), 275 (1880), 234 (14450); IR: ν 3068 (w, ע(C-H), 2961 (w, 
ע(CH3), 2000-1700 (w, overtones γ(CH, Ph)), 1546 (w, tetrazole), 1482 (s, ע(C=C)), 1436 
(s, ע(C=C)), 1219 (s, ע(C-F)) cm-1; Raman: 3070 (w, ע(C-H), 2964 (w, עsim (-CH3)), 1545 
(w, tetrazole)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ =  4.45 (s, 3H, H-C8’), 7.38 (m, 
2H, H-C4’,6’), 7.58 (m, 1H, H-C5’), 8.03 (dt, J = 1.7, 7.5 Hz, 1H, H-C3’); 13C NMR (125 
MHz, d6-DMSO): δ =  38.3 (CH3, C8’), 113.5 (Cq, C2’), 117.2 (CH, C6’), 126.0 (CH, C4’), 
132.1 (CH, C3’), 134.0 (CH, C5’), 162.1 (Cq, C7’), 163.3 (Cq, C1); MS: m/z 179 [MH]+; 
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HR-MS: calc’d for [MH]+ = 179.07275, found 179.0727 (∆M (ppm) = 0.6), calc’d for 
[M+Na]+ = 201.0547, found 201.0546 (∆M (ppm) = 0.7).  
 
 
5-(4-Chloro-phenyl)-N-methyl-tetrazole (147, 148) 
N N N
H
CH3
H3C
CH2Cl2, r.t., 2h
N1-Isomer                                N2-Isomer
N
H
N
NN
N
N
NN
CH3
N
N
NN
CH3
+
ClClCl
 
           1                                                                              147                                      148 
CAS Registry Number 147: 77455-52-8;       148:  69746-35-6 
Molecular Formula   C8H7ClN4 
Molecular Weight    194.62 g/mol 
Analysis Ref. 
a) C. W. Roberts, G. F. Fanta, J. D. Martin, J. Org. Chem. 1959, 24, 
654; b) R. N. Butler, V. C. Garvin, J. Chem. Soc., Perkin Trans.1: 
Organic and Bio-Organic Chemistry 1981, 2, 390 
 
TP3: 1.5 equivalents  of 3-methyl-1-p-tolyltriazene are used in a 4 mmol scale 
experiment. The reaction is stirred two hours at room temperature to give 600 mg of 
brown crystalline material (N2/N1-isomer = 75:25 based on  HPLC analysis). The crude 
is chromatographed (elution system hexane / ethyl acetate 5 : 1) to give 340 mg of N2-
isomer 148 (44 % yield) and 100 mg of N1-isomer 147 (13 % yield).  
 
Compound characterization data: 
N1-Isomer (147) 
N
N
NN
CH3Cl
1
2
3
4
5
6  
mp: 120 °C; TLC: Rf (hexane / AcOEt 4:1)= 0.08; HPLC: 5.61 min; UV (MeOH): λmax, 
nm (ε): 234 (1570); IR: ν 3100 (w, ע(C-H)), 3076 (w, ע(C-H)), 3036 (w, ע(C-H)), 3016 
(w, ע(C-H)), 3100 (w, ע(C-H)), 2962 (w, ע(CH3)), 1604 (s, ע(C=C)), 1470 (s, ע(C=C)), 
1454 (s, ע(C=C)), 1094 (s, ע(Ph-Cl)) cm-1; Raman: 1535 (w, tetrazole) cm-1; 1H NMR 
(500 MHz, d6-DMSO): δ = 4.15 (s, 3H, H-C6), 7.68 (d, 3J2,3 = 8.4 Hz, 2H, H-C3), 7.86 ( d, 
3
J2,3
 = 8.4 Hz, 2H, H-C2); 13C NMR (125 MHz, d6-DMSO) 35.1 (CH3, C6), 122.7 (Cq, 
C4), 129.3 (CH, C3), 130.6 (CH, C2), 136.1 (Cq, C1), 153.2 (Cq, C5); MS: m/z 195 
[MH]+, 138 [MH-HN3]-. 
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N2-Isomer (148) 
N
N
NN
CH3
Cl
1'
2'
3'
4'
5'
6'
                                              
mp: 108 °C; TLC: Rf (hexane / AcOEt 4:1) = 0.31; HPLC: 8.21 min; UV (MeOH): λmax, 
nm (ε): 201 (3000), 246 (2030); IR: ν 3062 (w, ע(C-H)), 3035 (w, ע(C-H)), 2953 (w, 
ע(CH3)), 2925 (w, ע(CH3)), 2855 (w, ע(CH3)),  1607 (m, ע(C=C)), 1466 (s, ע(C=C)), 1452 
(s, ע(C=C)), 1089 (s, ע(Ph-Cl)) cm-1; Raman: 1526 (w, tetrazole) cm-1; 1H NMR (500 
MHz, d6-DMSO): δ = 4.41 (s, 3H, H-C6’), 7.61 (d, 3J2’,3’ = 8.5 Hz, 2H, H-C3’), 8.03 (d, 
3
J2’,3’
 = 8.5 Hz, 2H, H-C2’); 13C NMR (125 MHz, d6-DMSO): δ = 40.1 (CH3, C6’), 125.8 
(Cq, C4’), 128.1 (CH, C3’), 129.5 (CH, C2’), 135.2 (Cq, C1’), 163.2 (Cq, C5’); MS: m/z 
195[MH]+. 
 
 
4-[2-Benzene-sulphonyl-2-(-methyl-tetrazol-5-yl)-vinyl]-benzoic acid methyl ester 
(177, 178) 
S
O O
N
H
N
NN
COOCH3
N N N
H
CH3
H3C
CH2Cl2, r.t., 15 min
N1-Isomer                              N2-Isomer
S
O O
N
N
NN
COOCH3
CH3 +
S
O O
N
N
NN
COOCH3
CH3
 
            165                                                                    178                                   177 
Molecular Formula   C8H7FN4 
Molecular Weight    384.39 g/mol 
 
TP3: 1.3 equivalents of 3-methyl-1-p-tolyltriazene are used in a 3 mmol scale 
experiment. The reaction is stirred fifteen minutes at room temperature to give 1.09 g of 
brown crystalline material (N2/N1-isomer = 57:43 based on HPLC analysis). The crude 
is chromatographed to give 757 mg of N2-isomer 177 (66 % yield) and 161 mg of N1-
isomer 178 (14% yield).  
 
 
 
 
Chapter 5.    Experimental Part 
 238 
Compound characterization data: 
N1-Isomer (178) 
S
O O
N
N
NN
COOCH3
CH3
1
2
3
4
5
6
7
8
9
10
11 12
13
14
 
mp: 158-160 °C; TLC: Rf (hexane / AcOEt 3:2) = 0.26; HPLC: 9.35 min; UV (EtOH): 
λmax, nm (ε): 288 (27890); IR: ν 3050 (w, ע(C-H)), 2950 (w, ע(-CH3)), 2000-1750 (w, 
overtones γ(C-H, Ph)), 1727 (vs, ע(C=O)), 1641(s, ע(C=C)), 1446 (s, ע(C=C)), 1321 (s, 
עasim(SO2)), 1285 (s, ע(C-O)), 1148 (s, עsim(SO2)) cm-1; Raman: ν 1720 (w, ע(C=O)), 
1642 (s, ע(C=C)), 1610 (s, ע(C=C)), 1517 (w, tetrazole) cm-1; 1H NMR (500 MHz, d6-
DMSO): δ =  3.75 (s, 3H, H-C12), 3.83 (s, 3H, H-C14), 7.19 (d, 3J8,9 = 8.4 Hz, 2H, H-C8), 
7.67 (dd, 3J = 7.7 Hz, 2H, H-C3), 7.81 (m, 3H, H-C2,4), 7.91 (d, 3J8,9 = 8.4 Hz, 2H, H-C9), 
8.60 (s, 1H, H-C6); 13C NMR (125 MHz, d6-DMSO): δ =  40.5 (CH3, C14), 52.8 (CH3, 
C12), 127.2 (CH, C2), 128.8 (CH, C9), 130.3 (CH, Cq, C3,5), 130.6 (CH, C8), 132.5 (Cq, 
C10), 135.3 (CH, C4), 135.4 (Cq, C7), 137.9 (Cq, C1), 147.2 (CH, C6), 147.8 (Cq, C13), 
165.7 (Cq, C11); HR-MS: calc’d for [MH]+ = 385.0965, found 385.0967 (∆M (ppm) = 
0.4), calc’d for [M+Na]+ = 407.0785, found 407.0786 (∆M (ppm) = 0.4). 
 
N2-Isomer (177) 
S
O O
N
N
NN
COOCH3
CH3
1'
2'
3'
4'
5'
6'
7'
8'
9'
10'
11' 12'
13'
14
 
mp: 156-158 °C; TLC: Rf (hexane / AcOEt 3:2) = 0.19; HPLC: 9.54 min.; UV (EtOH): 
λmax, nm (ε): 286 (25620); IR: ν 2951 (w, ע(C-H)), 2000-1800 (w, overtones γ(C-H, Ph)), 
1715 (s, ע(C=O)), 1639 (m, ע(C=C)), 1447 (w, ע(C=C)), 1326 (s, עasim(SO2)), 1287 (s, 
ע(C-O)), 1158 (s, עsim(SO2)) cm-1; Raman: 1718 (w, ע(C=O)), 1641 (s, ע(C=C)), 1639 (s, 
(C=C)), 1509 (w, tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ =  3.83 (s, 3H, H-
C12’), 4.40 (s, 3H, H-C14’), 7.31 ( d, 3J8’,9’ = 8.4 Hz, 2H, H-C8’), 7.65 (dd, 3J = 7.7, 8 Hz, 
2H, H-C3’), 7.75 (t, 3J = 7.7 Hz, 1H, H-C4’), 7.86 (m, 4H, H-C2’,9’), 8.43 (s, 1H, H-C6’); 
Chapter 5.    Experimental Part 
 239 
13
C NMR (125 MHz, d6-DMSO): δ =  34.4 (CH3, C14’), 52.9 (CH3, C12’), 128.8 (CH, 
C2’), 129.8 (CH, C9’), 130.0 (CH, C3’), 130.9 (CH, C8’), 131.7 (Cq, C10’), 131.8 (Cq, C5’), 
134.8 (CH, C4’), 136.3 (Cq, C7’), 138.8 (Cq, C1’), 144.8 (CH, C6’), 156.9 (Cq, C13’), 165.9 
(Cq, C11’); HR-MS: calc’d for [MH]+ = 385.0965, found 385.0965 (∆M (ppm) < 0.1), 
calc’d for [M+Na]+ = 407.0785, found 407.0785 (∆M (ppm) < 0.1); X-Ray: the structure 
of the N2-isomer was confirmed by X-ray analysis (See X-ray discussion; Chapter 4).  
 
 
4-[1-Ethylidene-2-(N-methyl-terazol-5-yl)-penta-2,4-dienyl]-benzoic acid methyl 
ester (149, 150) 
N N N
H
CH3
H3C
CH2Cl2, r.t., 15 min
N1-Isomer                                N2-Isomer
NH
NN
NHOOC N
NN
NH3COOC CH3 N
NN
NH3COOC
H3C
+
 
                  187                                                                               149                                    150  
Molecular Formula   C16H14N4O2 
Molecular Weight    294.26 g/mol 
 
TP3: 1.25 equivalents  of 3-methyl-1-p-tolyltriazene are used in a 4 mmol scale 
experiment. The reaction is stirred four hours at room temperature to give 1.03 g of 
brown crystalline material (N2/N1-isomer = 73:27 based on HPLC analysis). The crude 
is chromatographed to give 620 mg of N2-isomer 150 as a brown oil (53 % yield), and 
200 mg of N1-isomer 149  as a white crystalline material (17 % yield).  
 
Compound characterization data: 
N1-Isomer (149) 
N
NN
NH3COOC CH3
1
2
3
4
5
6
7
8
9
10
11
121314
 
mp: 117-120 °C; TLC: Rf (hexane / EtOAc 3:2) = 0.20; HPLC: 12.02; UV (MeOH): 
λmax, nm (ε): 260 (1790), 200 (3640); IR: ν 3100 (w, ע(C-H)), 2950 (w, ע(C-H)), 2000-
1800 (w, overtones γ(C-H, Ph)), 1725 (vs, ע(C=O)), 1610 (m, ע(C=C)), 1545 (w, 
tetrazole), 1282 (vs, ע(C-O)), 776 (m, δ(C-H, Ph)) cm-1; Raman: ν 1719 (w, ע(C=O)), 
1610 (s, ע(C=C)), 1543 (w, tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 3.56 (s, 
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3H, H-C12), 3.85 (s, 3H, H-C14), 7.24 (d, 3J2,3 = 8.5 Hz, 2H, H-C3), 7.74  (m, 4H, H-
C6,7,8,9), 7.90 (d, 3J2,3 = 8.5 Hz, 2H, H-C2); 13C NMR (125 MHz, d6-DMSO): δ =  33.8 
(CH3, C12), 52.3 (CH3, C14), 122.3 (CH, C3), 128.7 (CH, Ar), 128.8 (CH, Ar), 128.9 (CH, 
Ar), 129.4 (Cq, C1), 130.4 (CH, Ar), 131.1 (CH, C2), 131.8 (Cq, C5), 140.6 (Cq, C10), 
143.6 (Cq, C4), 154.1 (Cq, C11), 165.8 (Cq, C13); MS: m/z 295 [MH]+; HR-MS: calc’d 
for [MH]+ = 295.1190, found 95.1190 (∆M (ppm) < 0.1), calc’d for [M+Na]+ = 317.1009, 
found 317.1009 (∆M (ppm) = 0.1).  
 
N2-Isomer (150) 
N
NN
NH3COOC
CH3
14' 13'
1'
2'
3'
4'
5'
6'
7'
8'
9'
10'
11'
12'
 
TLC: Rf (hexane / EtOAc 3:2) = 0.35; HPLC: 14.03 min.; UV (MeOH): λmax, nm (ε):  
259 (1270), 233  (2100), 200 (3870); IR: ν 3060 (w, ע(C-H)), 2953 (w, ע(-CH3)), 2000-
1900 (w, overtones γ(C-H, Ph)), 1721 (vs, ע(C=O)), 1610 (m, ע(C=C)), 1526 (w, 
tetrazole), 1281 (vs, ע(C-O)), 756 (s, δ(C-H, Ph)) cm-1; Raman: ν 1721 (w, ע(C=O)), 
1610 (s, ע(C=C)), 1526 (w, tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 3.86 (s, 
3H, H-C12’), 4.29 (s, 3H, H-C14’), 7.29 (d, 3J2’,3’ = 6.5 Hz, 2H, H-C3’), 7.53 (m, 1H, H-
C6’), 7.64 (m, 3J8’,9’ = 7.5 Hz, 2H, H-C7’,8’), 7.81 (m, 3J8’,9’ = 7.5 Hz, 1H, H-C9’), 7.90  (d, 
3
J2’,3’ = 6.5 Hz, 2H, H-C2’); 13C NMR (125 MHz, d6-DMSO): δ =  48.6 (CH3, C12’), 52.2 
(CH3, C14’), 127.7 (CH, C3’), 128.3 (CH, Ar), 128.5 (CH, Ar), 128.9 (CH, Ar), 129.4 (Cq, 
C1’), 130.4 (CH, Ar), 130.5 (CH, C2’), 130.7 (Cq, C5’), 140.2 (Cq, C10’), 145.2 (Cq, C4’), 
164.2 (Cq, C11’), 166.1 (Cq, C13’); MS: m/z 295 [MH]+;  
 
 
5-Benzenesulphonylmethyl)-N-methyl-tetrazole (179, 180) 
N N N
H
CH3
H3C
CH2Cl2, r.t., 20 min
N1-Isomer                                N2-Isomer
S
O O
N
H
N
NN
S
O O
N
N
NN
CH3
S
O O
N
N
NN
CH3
+
 
                 75                                                                      180                                    179 
Molecular Formula   C9H10N4O2S 
Molecular Weight    238.24  g/mol 
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TP3: 1.4 equivalents  of 3-methyl-1-p-tolyltriazene are used in a 10 mmol scale 
experiment. The reaction is stirred twenty minutes at room temperature to give 2.78 g of 
brown crystalline material (N2/N1-isomer = 52/48 based on HPLC analysis). The crude 
is chromatographed (elution system toluene / ethyl acetate 3:1) to give 907 mg of N2-
isomer 179 (52 % yield) and 855 mg of N1-isomer 180 (48 % yield).  
 
Compound characterization data: 
N1-Isomer (180) 
S
O O
N
N
NN
CH3
1
23
4
5
6 7
 
mp: 182-184 °C; TLC: Rf (toluene / EtOAc 3:1) = 0.21; HPLC: 4.55 min; UV 
(acetonitrile): λmax, nm (ε): 273 (1080), 266 (1290), 259 (918), 219 (12810), 194 (39970); 
IR: ν 3095 (w, ע(C-H)), 3072 (w, ע(C-H)), 3006 (m, ע(C-H)), 2954 (m, ע(C-H)), 2000-
1750 (w, overtones γ(C-H, Ph), 1584 (w, ע(C=C)), 1522 (w, tetrazole), 1466 (m, ע(C=C)), 
1448 (s, ע(C=C)), 1315 (s, עasim(SO2)), 1159 (s, עsim(SO2)) cm-1; Raman: 1522 (w, 
tetrazole), 1160 (m, עsim(SO2)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 4.12 (s, 3H, H-
C7), 5.48 (s, 2H, C-H2), 7.73 (m, 2H, H-C4), 7.86 (m, 3H, H-C5,6); 13C NMR (125 MHz, 
d6-DMSO): δ = 34.2 (CH3, C7), 49.0 (CH2, C2), 128.2 (CH, C4), 129.5 (CH, C5), 134.7 
(CH, C6), 137.6 (Cq, C3), 146.5 (Cq, C1); MS: m/z 239 [MH]+, 237 [M-H]-; HR-MS: 
calc’d for [MH]+ = 239.05972, found 239.0596 (∆M (ppm) = 0.3), calc’d for [MNH4]+ = 
256.0863, found 256.0862 (∆M (ppm) = 0.2), calc’d for [MNa]+ = 261.047, found 
261.0416 (∆M (ppm) = 0.2). 
 
N2-Isomer (179) 
S
O O
N
N
NN
CH3
1'
2'3'
4'
5'
6'
7'
 
mp: 137-139 °C; TLC: Rf (toluene / EtOAc 3:1) = 0.35; HPLC: 4.62 min.; UV 
(acetonitrile): λmax, nm (ε): 272 (1190), 265 (1410), 259 (990), 216 (16890), 194 (41680); 
IR: ν 3098 (w, ע(C-H)), 3061 (w, ע(C-H)), 2995 (s, ע(C-H)), 2936 (m, ע(C-H)), 2000-
1750 (w, overtones γ(C-H, Ph), 1584 (w, ע(C=C)), 1494 (w, tetrazole), 1445 (s, ע(C=C)), 
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1319 (s, עasim(SO2)), 1160 (s, עsim(SO2)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 4.33 
(s, 3H, H-C7’), 5.13 (s, 2H, C-H2’), 7.62 (m, 2H, H-C4’), 7.73 (m, 3H, H-C5’,6’); 13C NMR 
(125 MHz, d6-DMSO): δ = 39.5 (CH3, C7’), 51.6 (CH2, C2’), 128.1 (CH, C4’), 129.3 (CH, 
C5’), 134.2 (CH, C6’), 138.2 (Cq, C3’), 156.1 (Cq, C1’); MS: m/z 239 [MH]+, 237 [M-H]-; 
HR-MS: calc’d for [MH]+ = 239.05972, found 239.0596 (∆M (ppm) = 0.5), calc’d for 
[MNH4]+ = 256.0863, found 256.0862 (∆M (ppm) = 0.4), calc’d for [MNa]+ = 261.047, 
found 261.0415 (∆M (ppm) = 0.6). 
 
 
N-Methyl-5-thiophen-2-yl-tetrazole (181, 182) 
 
HN N
N
N
S
N N
N
N
H3C
S
N N
N
N
CH3S
N N N
H
CH3
H3C
CH2Cl2, r.t., 1h 30min
N1-Isomer                     N2-Isomer
+
 
         109                                                                           182                                 181                                                                             
 
Molecular Formula   C6H6N4S 
Molecular Weight    166.21 g/mol 
 
TP3: 1.5 equivalents of 3-methyl-1-p-tolyltriazene are used in a 0.86 mmol scale 
experiment. The reaction is stirred two hours at room temperature to give 300 mg of a 
yellow solid (N2/N1-isomer = 66:34 based on HPLC analysis). The crude is 
chromatographed (elution system hexane / ethyl acetate 5:1) to give 78 mg of N2-isomer  
181 (55 % yield) and 60 mg of N1-isomer 182 (42 % yield) as an off white cristalline 
materials. 
 
Compound characterization data: 
N1-Isomer (182) 
N N
N
N
CH3
S 1
2
4 5
3
6  
mp: 110-111 °C; TLC: Rf (hexane / AcOEt 5:1) = 0.05; HPLC: 3.37 min; UV UV 
(MeOH): λmax, nm (ε): 271 (8130), 254 (7900); IR: ν 3089 (s, ע(C-H)), 3079 (w, ע(C-H)), 
2960 (w, ע(CH3), 1575 (s, thiophene), 1489 (s, tetrazole), 1448 (s, thiophene) cm-1;  1H 
NMR (400 MHz, d6-DMSO): δ = 4.20 (s, 3H, H-C6), 7.29 (dd, 3J3,4 = 5.0 Hz, 1H, H-C3), 
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7.81 (d, 3J2,3 = 3.8 Hz, 1H, H-C2), 7.92 (d, 3J3,4 = 5.0 Hz, 1H, H-C4); 13C NMR (100 
MHz, d6-DMSO): δ = 35.2 (CH3, C6), 124.0 (Cq, C1), 128.8 (CH, C3), 130.4 (CH, C2), 
131.2 (CH, C4), 149.4 (Cq, C5); HR-MS: calc’d for [M+H]+ = 167.0386, found 167.0386 
(∆M (ppm) = 0.2), calc’d for [M+Na]+ = 189.0205, found 189.0205 (∆M (ppm) = 0.3). 
 
N2-Isomer (181) 
N N
N
N
CH3S 1'
2'3'
4'
5'
6'
 
mp: 84-85 °C; TLC: Rf (hexane / AcOEt 5:1) = 0.22; HPLC: 5.75 min; UV (MeOH): 
λmax, nm (ε): 268 (11120), 255 (10620); IR: ν 3119 (s, ע(C-H)), 3096 (w, ע(C-H)), 3077 
(w, ע(C-H)), 2957 (w, ע(CH3), 1573 (s, thiophene), 1478 (s, tetrazole) cm-1;1H NMR (400 
MHz, d6-DMSO): δ = 4.40 (s, 3H, H-C6’), 7.25 (dd, 3J = 5.02 Hz, 1H, H-C3’), 7.78 (d, 
3
J2’,3’ = 3.3 Hz, 1H, H-C2’), 7.80 (d, 3J3’,4’ = 5.02 Hz, 1H, H-C4’); 13C NMR (100 MHz, 
d6-DMSO): δ = 36.2 (CH3, C6’), 127.7 (CH, C3’), 128.3 (Cq, C1’), 128.4 (CH, C2’), 129.0 
(CH, C4’), 160.2 (Cq, C5’); HR-MS: calc’d for [M+H]+ = 167.0386, found 167.0386 (∆M 
(ppm) = 0.1), calc’d for [M+Na]+ = 189.0205, found 189.0205 (∆M (ppm) = 0.3). 
 
 
5-Benzylsulfanyl-N-methyl-tetrazole (183, 184) 
N N N
H
CH3CH3
S N
H
N
NN
S N
N
NN
CH3
S N
N
NN
CH3
CH2Cl2, r.t., 20 min
N1-Isomer                                N2-Isomer
+
 
                 17                                                                               184                                   183 
Molecular Formula   C9H10N4S 
Molecular Weight    206.27  g/mol 
 
TP3: 1.5 equivalents of 3-methyl-1-p-tolyltriazene are used in a 1.87 mmol scale 
experiment. The reaction is stirred one hour at room temperature to give 400 mg of an 
orange oil (N1/N2-isomer = 52:48 based on HPLC analysis). The crude is 
chromatographed (elution system hexane / ethyl acetate 5:1) to give 205 mg of N2-
isomer 183 (53 % yield) and 125 mg of N1-isomer 184 (32 % yield).  
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Compound characterization data: 
N1-Isomer (184) 
S N
N
NN
CH3
1
2
3
4
5
6
7  
TLC: Rf (Hexane / EtOAc 5:1) = 0.06; HPLC: 6.54 min; IR: ν 3086 (w, ע(C-H)), 3062 
(w, ע(C-H)), 3030 (w, ע(C-H)),  2949 (w, ע(C-H)), 1958-1813 (w, overtones γ(C-H, Ph)), 
1585 (w, ע(C=C)), 1495 (s, ע(C=C)), 1455 (w, ע(C=C)), 700 (w, γ(Ph) cm-1; 1H NMR 
(400 MHz, d6-DMSO): δ = 3.84 (s, 3H, H-C7), 4.52 (s, 2H, C-H5), 7.31 (m, 3H, H-C3,4), 
7.40 (m, 2H, H-C2); 13C NMR (100 MHz, d6-DMSO): δ = 33.5 (CH3, C7), 36.7 (CH2, 
C5), 127.7 (CH, C4), 128.5 (CH, C3), 128.9 (CH, C2), 136.5 (Cq, C1), 153.1 (Cq, C6); 
HR-MS: calc’d for [M+H]+ = 207.0699, found 207.0698 (∆M (ppm) = 0.5), calc’d for 
[M+Na]+ = 229.0518, found 229.0517 (∆M (ppm) = 0.4). 
 
N2-Isomer (183) 
S N
N
NN
CH3
1'
2'
3'
4'
5'
6'
7'
 
TLC: Rf (Hexane / EtOAc 5:1) = 0.20; HPLC: 7.90 min; UV (MeOH): λmax, nm (ε): 243 
(2900); IR: ν 3063 (w, ע(C-H)), 3030 (w, ע(C-H)), 2956 (w, ע(C-H)), 2930 (w, ע(C-H)), 
1954-1808 (w, overtones γ(C-H, Ph)), 1602 (w, ע(C=C)), 1496 (m, ע(C=C)), 1454 (s, 
ע(C=C)), 702 (w, γ(Ph) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 4.33 (s, 3H, H-C7’), 
4.45 (s, 2H, C-H5’), 7.29 (m, 3H, H-C3’,4’), 7.40 (m, 2H, H-C2’); 13C NMR (100 MHz, d6-
DMSO): δ = 35.4 (CH3, C7’), 39.8 (CH2, C5’), 127.4 (CH, C4’), 128.4 (CH, C3’), 128.9 
(CH, C2’), 137.0 (Cq, C1’), 162.4 (Cq, C6’); HR-MS: calc’d for [M+H]+ = 207.0699, 
found 207.0697 (∆M (ppm) = 0.9), calc’d for [M+Na]+ = 229.0518, found 229.0518 (∆M 
(ppm) = 0.3). 
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(S)-2-(N-Methyl-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester (185, 186) 
N N N
H
CH3
H3C
CH2Cl2, r.t., 1h 30min
N1-Isomer                     N2-Isomer
N
H
N
NN
N
N
NN
CH3
N
N
NN
CH3
+
NNN
HHH
O
O O
O
O
O
 
         112                                                                           186                                            185 
CAS Registry Number 920748-45-4 
Molecular Formula   C14H17N5O2 
Molecular Weight    287.32 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
TP3: 1.5 equivalents of 3-methyl-1-p-tolyltriazene are used in a 8 mmol scale 
experiment. The reaction is stirred one and half hour at room temperature to give 2.61 g 
of a brown oil (N2/N1-isomer = 75:25 based on HPLC analysis). The crude is 
chromatographed (elution system hexane / ethyl acetate 3 : 1) to give 1.4 g of N2-isomer 
185 (61 % yield) and 710 mg of N1-isomer 186 (31 % yield) as colorless oils. 
 
Compound characterization data: 
N1-Isomer (186) 
N
N
NN
CH3N
H
O
O
1
2
3
4 5
6
7
8 9
10
11 12
 
TLC: Rf (hexane / AcOEt 4:1) = 0.08; HPLC: 7.08 min; UV (EtOH): λmax, nm (ε): 258 
(21); IR: ν 3056 (w, ע(C-H)), 3034 (w, ע(C-H)), 2996 (w, ע(C-H)), 2960 (w, ע(CH3)), 
1703 (s, ע(C=O)), 1468 (w, ע(C=C)), 1414 (s, ע(C-N)), 1110 (m, ע(C-O)), 751 (m, γ(C-H, 
Ph), 704 (w, γ(Ph)) cm-1; 1H NMR (400 MHz, d6-DMSO, 300 K) Rotamers (4:3): δ = 
2.02 (m, 2H, H-C3), 2.17 (m, 1H, H-C2), 2.32 (m, 1H, H-C2), 3.54 (m, 2H, H-C4), 3.81 (s, 
3H, H-C12, rotamers 4:3, minor rotamer), 4.10 (s, 3H, H-C12, major rotamer), 4.90 (m, 
2H, H-C6, minor rotamer), 5.01 (m, 2H, H-C6, major rotamer), 5.21 (m, 1H, H-C1), 6.99 
(m, 2H, Ar), 7.33 (m, 3H, Ar); (400 MHz, d6-DMSO, 394 K): δ =  2.02 (m, 2H, H-C3), 
2.18 (m, 1H, H-C2), 2.37 (m, 1H, H-C2), 3.60 (m, 2H, H-C4), 3.96 (br, 3H, H-C12), 4.96 
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(m, 2H, H-C6), 5.19 (m, 1H, H-C1), 7.18 (br, 2H, Ar), 7.29 (m, 3H, Ar); 13C NMR (125 
MHz, d6-DMSO, 300 K) Rotamers: δ = 23.1, 24.1 (CH2, C3), 31.1, 32.2 (CH2, C2), 33.3, 
33.7 (CH3, C12), 46.3, 46.8 (CH2, C4), 49.7, 50.2 (CH, C1), 66.2, 66.3 (CH2, C6), 127.5, 
127.9 (CH, Ar), 127.9 (CH, C10), 128.3, 128.4 (CH, Ar), 136.3, 136.7 (Cq, C7), 153.2, 
154.0 (Cq, C5), 156.3, 156.7 (Cq, C11); MS: m/z 288 [MH]+. 
 
N2-Isomer (185) 
N
N
NN
CH3
N
H
O
O
1'
2'
3'
4' 5'
6'
7' 8'
9'
10'
11'
12'
 
TLC: Rf (hexane / AcOEt 4:1)= 0.31; HPLC: 8.03 min; UV (MeOH): λmax, nm (ε): 258 
(6), 205  (418); IR: ν 3064 (w, ע(C-H)), 3033 (w, ע(C-H)), 2957 (w, ע(C-H)), 2881 (w, 
ע(C-H)), 1704 (s, ע(C=O)), 1586 (w, ע(C=C)), 1498 (w, ע(C=C)), 1447 (m, ע(C=C)), 1412 
(s, ע(C-N)),  1116 (s, ע(C-O)), 741 (w, γ(C-H, Ph)), 699 (w, γ(Ph) cm-1; 1H NMR (400 
MHz, d6-DMSO, 300 K) rotamers (1:1): δ =  1.85 (m, 1H, H-C2’), 1.92 (m, 2H, H-C3’), 
2.30 (m, 1H, H-C2’), 3.50 (m, 2H, H-C4’), 4.27, 4.30 (s, 3H, H-C12’), 4.95 (m, 2H, H-C6’), 
5.17 (m, 3J1’,2’ = 8.0 Hz, 1H, H-C1’), 7.01 (m, 1H, H-C10’), 7.30 (m, 4H, H-C8’,9’); (400 
MHz, d6-DMSO, 394 K): δ = 1.97 (m, 3H, H-C2’,3’), 2.33 (m, 1H, H-C2’), 3.54 (m, 2H, H-
C4’), 4.23 (s, 3H, H-C12’),  5.00 (m, 2H, H-C6’), 5.18 (br, 1H, H-C1’), 7.21 (m, 5H, H-
C8’,9’,10’); 13C NMR (125 MHz, d6-DMSO, 300 K) rotamers (1:1): δ = 22.7, 23.5 (CH2, 
C3’), 31.8, 32.8 (CH2, C2’), 39.5 (CH3, C12’), 46.2, 46.7 (CH2, C4’), 52.5, 53.0 (CH, C1’), 
65.5, 65.9 (CH2, C6’), 127.0, 127.5 (CH, Ar), 127.6, 127.8 (CH, C10’), 128.2, 128.4 (CH, 
Ar), 136.8, 136.9 (Cq, C7’), 153.5, 153.8 (Cq, C5’), 167.7, 167.9 (Cq, C11’); MS: m/z 288 
[MH] +, 244 [MH-CO2] +. 
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5.3. Organocatalysis 
 
5.3.1. Reagents and Solvents 
 
 
 All chemicals were obtained either from commercial suppliers or internal sources 
and used without further purification unless otherwise stated. All reactions were carried 
out under an atmosphere of nitrogen or argon. All the products were satisfactorily 
characterized by melting point, TLC, UV, IR, 1H and 13C NMR, MS, HR-MS and when 
possible, comparison of their analytical data has been made with available literature data. 
 
5.3.1.1. Reagents  
 
Reagent Molecular 
Formula 
MW 
(g/mol) 
Quality 
Acetic acid C4H4O2 60.05 Fluka ; ≥ 96 %  
(R)-(+)-N-Benzyl-α- 
methylbenzylamine  
C15H17N 211.30 Aldrich ; 98 % 
Cesium hydroxide Monohydrate CsHO.H2O 167.93 Fluka ; ≥ 95.0 % (T) 
Cyclohexanone C6H10 O 98.15 Fluka ; ≥ 99.5 % (GC) 
3,4-Dihydroxy-3-cyclobutene-1,2- 
dione  
C4H2O4 114.6 Fluka ; ≥ 97.0 % (NT) 
(s)-(-)-α,α-Diphenylprolinol C17H19NO 253.35 Lancaster ; 98 % 
Hydrochloric acid HCl 36.45 Fluka ; 2N standard solution 
Isovaleraldehyde C5H10O 86.14 Fluka ; ≥ 98 % 
α-Methylstyrene C9H10 118.18 Fluka ; ≥ 98 % (GC) 
Ninhydrin C9H6O4 178.14 Fluka ; ≥ 95.0 % (UV) 
trans-β-Nitrostyrene  C8H7NO2 149.15 Fluka ; ≥ 98.0 % (GC) 
Palladium on carbon Pd 106.4 Engelhard 4505 ; Pd/C 10% 
Palladium acetate (CH3CO2)2Pd 224.51 Aldrich ; 99.98% 
2-Phenylpropionaldehyde C9H10O 134.18 Aldrich ; 98 % 
Potassium carbonate K2CO3 138.27 Fluka ; ≥ 99 % (AT) 
Potassium hydroxide KOH 56.11 Fluka ; ≥ 86 % (T) 
D-Proline C5H9NO2 115.13 Fluka ; ≥ 99 % (NT) 
L-Proline C5H9NO2 115.13 Fluka ; ≥ 99.5 % (NT) 
Saccharin C7H5NO3S 183.18 Fluka ; ≥ 99.0 % (T) 
Sodium hydroxyde NaOH 40.00 Fluka ; ≥ 98 % (T)  
Fluka ; solution 2N 
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Sodium methylate CH3ONa 54.02 Fluka ; 95 % 
Sulfuric acid H2SO4 98.08 Fluka ; 95/97 % (T) 
Trifluoroacetic acid C2F3O2H 114.09 Fluka ; ≥ 98.0 % (T) 
 
5.3.1.2. Solvents  
 
Solvents Quality 
Acetonitrile Merck ; for LC 
ARMAR Chemicals ;  d3-Acetonitrile 99.5 Atom % D 
n-Butanol Aldrich ; ≥ 99.5 % 
tert-Butanol Fluka ; ≥ 99 % (GC) 
Chloroform Fluka ;  ≥ 99.5 % (GC) 
ARMAR Chemicals; CDCl3 100 Atom % D, stab. with Ag 
Dichloromethane Merck ; for analysis  
Fluka ; 99.5 % (GC) 
Diethyl ether Fluka; puriss. over molecular sieves 
Dimethylsulfoxide Fluka ; 99.5 % (GC) 
ARMAR Chemicals ; d6-DMSO 99.9 Atom % D 
Ethanol Fluka ; absolute, ≥ 99.8 % (V/V) (GC) 
Ethyl acetate Fluka ; 99.5 % 
Hexane Fluka ;  ≥ 99.0 % (GC) 
Methanol Fluka ; for analysis 
Dichloromethane Fluka; puriss. over molecular sieves 
Tetrahydrofuran Fluka; puriss. p.a., ≥ 99.5 % (GC) 
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5.3.2. Synthesis of Pyrrolidine-Tetrazole Derivatives 
 
 
5.3.2.1. Synthesis of N-alkylated pyrrolidine tetrazoles and their salts 
 
2-t-Butyl-5-(S)-pyrrolidine-2-yl-2H-tetrazole (243) and  (R)-enantiomer (236) 
                      
N
H
N
N
N
H
NH
CH2Cl2 NH
N N
NN
H
   tBuOH
   H2SO4
CF3COOH
 
                            114                                                     243 
CAS Registry Number 920748-18-1 
Molecular Formula   C9H17N5 
Molecular Weight    195.26 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
A 100 mL, three necked-round bottomed flask, is charged at 0 °C with (S)-5-pyrrolidine-
2-yl-1H-tetrazole 114 (5.56 g, 40 mmol) and trifluoroacetic acid (34.2 mL, 444 mmol). 
Then sulfuric acid (2.6 mL, 95 - 97 %) and tert-butanol (5.92 g, 80 mmol) in 
dichloromethane (8 mL) are added. The mixture is stirred at room temperature over the 
night. The mixture is quenched with ice-water (20 mL), and the product is extracted three 
times with dichloromethane (20 mL portion). The aqueous phase is treated with solid 
potassium carbonate until pH 8.5 and re-extracted twice with dichloromethane (20 mL 
portion). The combined organic phase is washed three times with NaOH (0.5 N, 25 mL 
portion). The solvent is removed to give 7.34 g of the pure product as a yellow oil (94 % 
yield). The reaction gave the same yield also with the (R)-enantiomer. 
 
Compound characterization data: 
N
H
N N
NN
H
1
2
3
4 5
6
7
 
pKa = 8.1; TLC: Rf (nBuOH / H2O / AcOH 3:3:1, ninhydrin) = 0.44; Optical rotation: 
(R)-enantiomer: [ ]25Dα  = +7.2 ° (in MeOH, c = 1.08); IR: ν 2982 (s, עasim(CH3)), 2960 (s, 
ע(C-H)), 1500 (w, tetrazole)), 1478 (s, tetrazole)), 1461 (w, tetrazole)), 1372 (s, δ(CH3)) 
cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.69 (s, 9H, H-C7), 1.9 (m, 3H, H-C2,3), 2.22 (m, 
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1H, H-C2), 2.39 (br, NH), 2.97 (m, 1H, H-C4), 3.15 (m, 1H, H-C4), 4.45 (dd, 3J1,2 = 7 Hz, 
1H, H-C1,); 13C NMR (125 MHz, d6-DMSO): δ = 25.2 (CH2, C3), 28.7 (CH3, C7), 31.8 
(CH2, C2), 46.3 (CH2, C4), 53.1 (CH, C1), 63.1 (Cq, C6), 168.5 (Cq, C5); MS: m/z 218 
[M+Na]+, 196 [MH]+, 70 [C4H8N]+; HR-MS: calc’d for [MH]+ = 196.1557, found 
196.1557 (∆M (ppm) = 0.1), calc’d for [M+Na]+ = 218.1376, found 218.1376 (∆M (ppm) 
= 0.2). 
 
 
(R)-2-(2-t-Butyl-2H-tetrazol-5-yl) pyrrolidinium trifluoro acetate (244)                     
NH
N
N
NNH
N N N
NN
HCF3COOH
  CH2Cl2
r.t., 5 min
H H
TFA  
                                    243                                                        244 
CAS Registry Number 920748-33-0 
Molecular Formula   C11H18F3N5O2 
Molecular Weight    309.28 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
A 10 mL round bottomed flask, is charged at room temperature, with 2-tert-butyl-5-(R)-
2-pyrrolidine-2-yl-2H-tetrazole 243 (390 mg, 2 mmol) in dichloromethane (2 mL), then 
trifluoroacetic acid (228 mg, 2 mmol) is added. The mixture is stirred five minutes at 
room temperature and then the solvent is removed to obtain 615 mg of product as a 
brown crystalline material in ≥ 99 % yield. 
 
Compound characterization data: 
N N N
NN
H
H H
CF3COO
1
2
3
4 5
6
7
   
mp: 87-90 °C; TLC: Rf (nBuOH / H2O / AcOH 3:3:1, ninhydrin) = 0.43; UV (EtOH): 
λmax, nm (ε): 204 (2860); IR: ν 2988 (m, ע(C-H)), 2559 (brm, ע(N-H)), 1658 (s, ע(C=O, 
TFA)), 1508 (w, tetrazole), 1375 (m, δ(CH3)), 1202 (s, TFA), 1184 (s, TFA), 1136 (m, 
TFA), 836 (w, TFA), 724 (s, TFA), cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 1.71 (s, 
9H, H-C7), 2.10 (m, 2H, H-C3), 2.21 (m, 1H, H-C2), 2.44 (m, 1H, H-C2), 3.33 (m, 2H, H-
C4), 4.49 (dd, 3J 1,2 = 7.8 Hz, 1H, H-C1), 9.46 (br, 2H, NH2); 13C NMR (100 MHz, d6-
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DMSO): δ = 23.6 (CH2, C3), 29.1 (CH3, C7), 29.5 (CH2, C2), 45.6 (Cq, C4), 53.4 (CH, 
C1), 64.8 (Cq, C5), 162.3 (Cq, C5); MS: m/z 196 [MH-TFA]+, 140 [MH-tBu-TFA]+; X-
Ray: the structure was confirmed by X-ray analysis (See X-ray discussion; Chapter 4).  
 
 
(R)-2-(2-t-Butyl-2H-tetrazol-5-yl) pyrrolidinium chloride (245) 
N
H N
N
N
N HClH
N
N N
N
N
H H
Cl
H
 CH2Cl2
r.t., 5 min
 
                                    236                                                         245 
CAS Registry Number 920748-20-5 
Molecular Formula   C9H18ClN5 
Molecular Weight    231.71 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
                 
A 5 mL round bottomed flask, is charged at 0 °C, with 2-tert-butyl-5-(R)-2-pyrrolidine-2-
yl-2H-tetrazole (195 mg, 1 mmol) in dichloromethane (2 mL) and HCl (2 N, 0.5 mL, 1 
mmol). The mixture is stirred five minutes at room temperature and the solvent is 
removed to obtain 232 mg of the desired product as a pink crystalline material in ≥ 99 % 
yield.  
 
Compound characterization data: 
N+
N
N
NN
H
H
Cl-
1
2
3
4
5
6 7
H
 
mp: 160-164 °C, degradation starting at 136 °C; TLC: Rf (nBuOH / H2O / AcOH 3:3:1 
ninhydrin) = 0.44; IR: ν 2984 (s, ν(C-H)), 2940 (s, ν(C-H), 2821 (s, ν(C-H)), 2553 (brs, 
ν(C-H)), 1515 (w, tetrazole), 1456 (m, tetrazole), 1515 (w, tetrazole), 1375 (s, δ(CH3)) 
cm-1; 1H NMR (600 MHz, d6-DMSO): δ = 1.75 (s, 9H, H-C7), 2.23 (m, 3H, H-C2,3), 2.43 
(m, 1H, H-C2), 3.31 (m, 2H, H-C4), 4.48 (br, 1H, H-C1), 9.40 (br, 1H, NH), 10.30 (br, 
1H, NH); 13C NMR (150 MHz, d6-DMSO): δ = 23.3 (CH2, C3), 29.2 (CH3, C7), 30.0 
(CH2, C2), 45.1 (CH2, C4), 52.9 (CH, C1), 64.5 (Cq, C6), 161.7 (Cq, C5);  MS: m/z 196 
[M-HCl]+. 
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2-(1-Methyl-1-phenyl-ethyl)5-(R)-pyrrolidine-2-yl-2H-tetrazole  (235) 
N
H HN N
N
N
CH2Cl2
CF3COOH
N
H N N
N
N
+
H H
r.t., 3d
 
                       115                            246                                               235 
CAS Registry Number 920748-24-9 
Molecular Formula   C14H19N5 
Molecular Weight    257.33 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
                                                       
A 100 mL, three necked round-bottomed flask is charged, at room temperature under an 
argon atmosphere, with R-5-pyrrolidine-2-yl-tetrazole 115 (4.16 g, 30 mmol) and 
trifluoroacetic acid (4 mL) to obtain a yellow solution. The solution is diluted with  
dichloromethane (20 mL) and then α-methylstirene (4.55 mL, 35 mmol) are added at 
room temperature, in three portion over a period of ten minutes. The homogeneous 
yellow mixture is stirred for three days. The mixture is transferred into a separatory 
funnel and washed four times with NaOH (1 N, 20 mL portion) and once with water (20 
mL) to remove the trifluoroacetic acid. The organic phase is evaporated to give an oil 
which crystallize by standing twenty minutes at room temperature. The white crystalline 
material is washed with a small amount of hexane to remove the excess of methylstyrole, 
and then re-crystallized from methanol / ethyl acetate 1:3 to give the pure product as a 
white crystalline material (7.10 g, 92 % yield).  
 
Compound characterization data: 
NH
N
N
NN
1
2
3
4
5
6
7
8
9
10
11H
               
mp: 38-40 °C; TLC: Rf (nBuOH / H2O / AcOH 3:3:1, ninhydrin) = 0.5; HPLC: 4.80 
min; Optical rotation: [ ]25Dα  = +4.4° (in MeOH, c = 1.00), [ ]
25
Dα  = +24.9° (in CH2Cl2, c = 
1.00); IR: ν 3267 (w, ע(N-H)), 3091 (w, ע(C-H)), 3061 (w, ע(C-H)), 3010 (m, ע(C-H)), 
2992 (s, ע(C-H)), 2984 (s, ע(C-H)), 2959 (s, ע(C-H)), 2863 (s, עsim(CH3)), 1962-1677 (w, 
overtones γ(C-H, Ph)), 1600 (w, ע(C=C)), 1497 (s, ע(C=C)), 1448 (s, ע(C=C)), 1367 (s, 
δ(CH3)), 766 (s, γ(C-H, Ph)), 697 (s, ע(Ph)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 
1.83 (m, 3H, H-C2,3), 2.09 (s, 6H, H-C7), 2.10 (m, 1H, H-C2), 2.75 (br, 1H, NH), 2.27 (m, 
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1H), 2.87 (m, 2H, H-C4), 4.36 (dd, 3J 1,2 = 7.6, 7.8 Hz, 1H, H-C1), 7.07 (m, 2H, H-C9), 
7.34 (m, 3H, H-C10,11); 13C NMR (150 MHz, d6-DMSO): δ = 25.3 (CH2, C3), 28.7 (CH3, 
C7), 31.3 (CH2, C2), 46.3 (CH2, C4), 53.2 (CH, C1), 67.8 (Cq, C6), 124.6 (CH, C9), 127.6 
(CH, C11), 128.7 (CH, C10), 144.2 (Cq, C8), 168.8 (Cq, C5); MS: m/z 258 [MH]+, 140 
[MH-Cumyl]+; HR-MS: calc’d for [MH]+ = 258.1713, found 258.1712 (∆M (ppm) = 
0.4); X-Ray: the structure was confirmed by X-ray analysis (See X-ray discussion; 
Chapter 4).  
 
 
2-[(1-Methyl-1-phenyl-ethyl)-2H-tetrazol-5-yl] pyrrolidinium saccharinate (248) 
N
H N N
N
N
H
NH
S
O
O
O
+ CH2Cl2
N
N N
N
N
H
N
S
O
O
O
H H
 
                       247                           235                                                248 
CAS Registry Number 920748-28-3 
Molecular Formula   C21H24N6O3S 
Molecular Weight    440.52 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
A 10 mL round bottomed flask is charged with 2-(methyl-1phenyl-ethyl)-5-(R)-
pyrrolidine-2-yl-2H-tetrazole (128 mg, 0.5 mmol), and o-benzoic acid sulfimide (91 mg, 
0.5 mmol) in dichloromethane (2 mL) to obtain a colorless solution. The solvent is 
removed to obtain a colorless oil which is  dissolved in dichloromethane (0.5 mL) and 
diethyl ether (1 mL). The product crystallized after standing at room temperature for 
three hours into an open flask. The white crystalline material is filtered, and washed with 
diethyl ether / dichloromethane (3:1, 1 mL) to give 110 mg of product. The mother liquor 
is lead standing over the night into a closed flask. The product is filtered to give 110 mg 
as second crop. 
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Compound characterization data: 
N
N N
N
N
H
N
S
O
O
O
H H
1
23
10
5 6
7 8
9
4
11
12
13
14
16
15
18
 
 mp: 108-111 °C; UV (EtOH): λmax, nm (ε): 264 (204), 201 (6130); IR: ν 2993 (m, ע(C-
H)), 2958 (m, ע(C-H)), 2558 (brm, ע(N-H)), 1651 (m, ע(C=O)), 1587 (m, ע(C=C)), 1458 
(m, ע(C=C)), 1448 (m, ע(C=C)), 1335 (m, δ(CH3)), 1152 (s, עasim(SO2)), 770 (s, γ(C-H, 
Ph)), 700 (s, γ(Ph)) cm-1; 1H NMR (500 Mz, d6-DMSO): δ = 2.13 (s, 6H, H-C11), 2.07 
(m, 2H, H-C3), 2.31 (m, 2H, H-C2), 3.35 (m, 2H, H-C4), 5.04 (dd, 3J 1,2  = 8.0 Hz, 1H, H-
C1), 7.13 (m, 2H, H-C8), 7.30 (m, 1H, H-C10), 7.34 (m, 2H, H-C9), 7.59 (m, 3H, H-C14-16 ), 
7.66 (m, 1H, H-C12), 9.48 (br, 2H, NH2+ ); 13C NMR (150 MHz, d6-DMSO): δ = 23.1 
(CH2, C3), 28.7 (CH3, C11), 28.9 (CH2, C2), 45.3 (CH2, C4), 53.2 (CH, C1), 69.0 (Cq, C6), 
119.2 (CH, Ar), 122.6 (CH, Ar), 124.7 (CH, C8), 127.9 (CH, C10), 128.6 (CH, C9), 131.2 
(CH, Ar), 131.7 (CH, Ar), 134.5 (Cq, Ar), 143.5 (Cq, Ar), 145.0 (Cq, Ar), 161.8 (Cq, 
C17), 167.5 (Cq, C5); MS: m/z 258 [MB]+, 140 [MB-Cumyl]+, 182 [MA]-; X-Ray: the 
structure was confirmed by X-ray analysis  (See X-ray discussion; Chapter 4).  
 
 
 1-Isopropyl-5-(R)-pyrrolidine-2-yl-1H-tetrazole (237) 
N
O
O
N N
NN
H2, Pd/C 10%
r.t., 7h
EtOH
H
N
H N
N
NN
H
 
                                        162                                                             237 
CAS Registry Number 920748-42-1 
Molecular Formula   C8H15N5 
Molecular Weight    181.24  g/mol 
Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
(R)-1-(1-isopropyl-1H-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 162 (2.8 
g, 8.89 mmol) and palladium on charcoal (0.3 g, 10 wt %) in ethanol (60 mL) are stirred 
under hydrogen at room temperature for seven hours. The catalyst is removed by 
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filtration through celite and the celite is washed sequentially twice with ethanol (30 mL 
portion) and twice with dichloromethane (20 mL). The filtrate is concentrated under 
reduced pressure (45 °C, 170 to 30 mbar) and dried under vacuum at room temperature 
for two to five hours (3.7 •10-1 mbar) to affort the desired  product as a yellow oil which 
crystallized as hydrochloride after standing at room temperature (1.69 g, 88 % yield). 
 
Compound characterization data: 
N
H N
N
NN
H
1
23
4
5
6 7       
mp: 178-180 °C; TLC: Rf (nBuOH / H2O / AcOH 3:3:1, ninhydrin) = 0.40; Optical 
rotation: [ ]25Dα  = +5.2 ° (in MeOH, c = 0.80); IR: ν 3200-2800 (brs,
 ν(N-H)), 2977 (s, 
ע(C-H)), 2954 (s, ע(C-H)), 2880 (s, עsim(CH3)), 1505 (w, tetrazole), 1453 (s, tetrazole), 
1371 (s, δ(CH3)) cm-1; 1H NMR (500 MHz, d6-DMSO) Tautomers (1:1): δ = 1.48 (d, 3J 
6,7
 = 6.5 Hz, 6H, H-C7), 1.51  (d, H-C7, 3J 6,7  = 6.5 Hz), 1.85 (m, 1H, H-C3), 1.96 (m, 1H, 
H-C3), 2.20 (m, 2H, H-C2), 3.01 (m, 1H, H-C4), 3.07 (m, 1H, H-C4),  4.77 (dd, 3J1,2  = 7.5 
Hz, 1H, H-C1), 5.04 (sep, 3J6,7  = 6.5 Hz, 1H, H-C6), 7.19 (br, 1H, NH); 13C NMR (150 
MHz, d6-DMSO): δ = 22.3 (CH3, C7), 22.4 (CH3, C7), 24.8 (CH2, C3), 30.0 (CH2, C2), 
46.0 (CH2, C4), 50.3 (CH2, C6),  50.8 (CH, C1), 154.0 (Cq, C5); HR-MS: calc’d for 
[M+H]+ = 182.1400, found 182.1400 (∆M ( ppm ) = 0.1), calc’d for [MNa]+ = 204.1220, 
found 204.1219 (∆M ( ppm ) = 0.3); X-Ray: the hydrochloride structure was confirmed 
by X-ray analysis with NH2+ every two molecules  (See X-ray discussion; Chapter 4).  
 
 
2-Isopropyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole (238) 
N
O
O
N N
NN
N
H N
N
NN
H2, Pd/C 10%
EtOH, r.t., 4h
H
H
 
                                        161                                                       238 
CAS Registry Number 920748-26-1 
Molecular Formula   C8H15N5 
Molecular Weight    181.24  g/mol 
Ref. V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
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2007/009716 
 
(R)-2-(2-Isopropyl-2H-tetrazol-5-yl)-pyrrolidine-1-carboxylic acid benzyl ester 161 (9.0 
g, 28.53 mmol) and palladium on charcoal (0.9 g, 10 wt %) in ethanol (180 mL) are 
stirred under hydrogen at room temperature for four hours. The catalyst is removed by 
filtration through celite and the celite is washed sequentially twice with ethanol (50 mL 
portion) and twice with dichloromethane (30 mL portion). The filtrate is concentrated 
under reduced pressure (45 °C, 170 to 30 mbar) and dried under vacuum at room 
temperature for two to five hours (3.7 •10-1 mbar) to affort the desired  product as a 
yellow oil (5.1 g, 98 % yield).  
 
Compound characterization data: 
N
H NH
NH
NN
H
1
23
4
5
6 7
 
TLC: Rf (nBuOH / H2O / AcOH 3:3:1, ninhydrin) = 0.42; Optical rotation: [ ]25Dα  = +6.6 
° (in MeOH, c = 1.00), [ ]25Dα  = -1.6 ° (in DMSO, c = 1.00), [ ]
25
Dα  = +15.8 ° (in CH2Cl2, c 
= 1.00); UV (EtOH): λmax, nm (ε): 203 (224); IR: ν 3334 (brm, ν(N-H)), 2978 (s, ע(C-H)), 
2960 (w, ע(C-H)), 2875 (s, עsim(CH3)), 1499 (m, tetrazole), 1458 (s, tetrazole), 1372 (s, 
δ(CH3)) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 1.55 (d, 3J6,7 = 6.8 Hz, 6H, H-C7), 
1.85 (m, 3H, H-C2,3), 2.15 (m, 1H, H-C2), 2.90 (m, 2H, H-C4), 4.33 (br, NH), 4.43 (dd, 
3
J1,2
 = 7.3, 6.8 Hz, 1H, H-C1), 5.07 (sep, 3J6,7 = 6.7 Hz, 1H, H-C6); 13C NMR (125 MHz, 
d6-DMSO): δ = 21.8 (CH3, C7), 25.3 (CH2, C3), 31.2 (CH2, C2), 46.2 (CH2, C4), 53.1 
(CH, C1), 56.4 (CH, C6), 168.3 (Cq, C5); MS: m/z 182 [MH]+, 113 [MH-C4H7N]+, 70 
[C4H8N]+; HR-MS: calc’d for [M+H]+ = 182.1400, found 182.1400 (∆M (ppm) = 0.3), 
calc’d for [M+Na]+ = 204.1220, found 204.1219 (∆M (ppm) = 0.1). 
 
 
2-Isopropyl-5-(R)-pyrrolidine-2-yl-2H-tetrazole squaric acid salt (250) 
N
H N
N
NN
H
O
O
OH
OH
+ CH2Cl2, THF N N N
NN
H
O O
O OH
H Hr.t.
 
                  249                            238                                                          250 
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Molecular Formula   C12H17N5O4 
Molecular Weight    295.31 g/mol 
 
A 5 mL round bottomed flask is charged with 2-isopropyl-5-(R)-pyrrolidine-2-yl-2H-
tetrazole 238 (181 mg, 1 mmol) and 3,4-dihydroxy-3-cyclobutene-1,2-dione (114 mg, 1 
mmol) in THF (1 mL) and dichloromethane (1 mL) to obtain a brown solution. After 
standing over the night at room temperature, a mixture 1 : 1 of methanol and chloroform 
(1 mL) are added to the brown oil. Diethyl ether (1.5 mL) is added at room temperaturen 
and the product crystallized after standing at room temperature for one day into an open 
flask as a brown solide.  
 
Compound characterization data: 
N N N
NN
H
O
O
O
OH
H H
1
23
4
5
6
7
8
10
911
 
mp: 110-112 °C; UV: c = 0.0098 g/L in MeOH: a) λmax 258 (ε = 20604), b) λmax 244 nm 
(ε = 22089); Optical rotation: [ ]25Dα  = +12.8° (in MeOH, c = 1.00); IR: ν 3511 (brs, ν 
(O-H), 3393 (brm, ν(N-H), 2983 (brs, ν(C-H), 1648 (s, ν(C=O)), 1562 (brs, ν(C=C), 
tetrazole) cm-1; 1H NMR (500 MHz, d6-DMSO): δ = 1.58 (d, 3J6,7 = 6.8 Hz, 6H, H-C7), 
2.08 (m, 2H, H-C3), 2.26 (m, 1H, H-C2), 2.45 (m, 1H, H-C2), 3.35 (m, 2H, H-C4), 5.02 
(dd, 3J 1,2  = 7.8, 8.0 Hz, 1H, H-C1), 5.16 (sep, 3J6,7  = 6.8 Hz, 1H, H-C6), 8.31 (br, OH), 
9.45 (br, NH), 10.09 (br, 1H, NH); 13C NMR (150 MHz, d6-DMSO): δ = 21.6, 21.8 
(CH3, C7), 23.2 (CH2, C3), 29.0 (CH2, C2), 45.3 (CH2, C4), 53.1 (CH, C1), 56.7 (CH, C6), 
161.8 (Cq, C5), 193.8 (Cq, C8-11); MS: m/z 182 [MB+H]+, 113 [MA-H]+, 182 [MA]-; X-
Ray: the structure was confirmed by X-ray analysis (See X-ray discussion; Chapter 4). 
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5.3.2.2. Synthesis of pyrrolidine tetrazole metal salts 
  
(R)-5-Pyrrolidine-2-yl-tetrazole sodium salt (239) 
 
Method A:  
NH
N
H
N
NN
NH
N
N
NN
NaOCH3
Na
CH3OH
H H
 
                                           115                                             239 
CAS Registry Number 920748-22-7 
Molecular Formula   C5H8N5Na 
Molecular Weight    161.14 g/mol 
Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
A 25 mL round bottomed flask is charged, at room temperature, with (R)-5-pyrrolidine-2-
yl-tetrazole 115 (417 mg, 3 mmol) in methanol (6 mL). Sodium methylate (170 mg, 3 
mmol) are added at room temperature and the resulting solution is stirred one hour. The 
solvent is removed and the product is dried in vacuum at room temperature for three 
hours to give a white crystalline material in quantitative yield. 
 
Method B:  
NH
N
H
N
NN
NH
N
N
NN
NaOH
Na
CH3OH
H H
 
                                           115                                            239 
A 10 mL flask is charged at room temperature, with (R)-5-pyrrolidine-2-yl-tetrazole 115 
(417 mg, 3 mmol) dissolved in NaOH (1 N, 3 mL) and methanol (1 mL). The colorless 
solution is stirred for twenty minutes at room temperature and then the solvent is 
removed to give 484 mg of white crystalline material. The product is re-dissolved in 
methanol (1.5 mL) at 60 °C. The colorless solution is cooled at 0 °C and treated with 
diethylether (2.5 mL). The product crystallized after standing three hours at room 
temperature in an open flask to give a white crystalline material in ≥ 99 % yield. 
 
Compound characterization data: 
N
H N N
N
N
Na
H
1
2
4
3
5
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mp: 62-64 °C; TLC: Rf (nBuOH / water/ AcOH 3:3:1, ninhydrin) = 0.26; Optical 
rotation: [ ]25Dα  = +17.9 ° (in MeOH, c = 0.66); IR: ν 2981 (s, ע(C-H)), 2963 (s, ע(C-H)), 
2587 (brs, ע(N-H)), 1606 (brs, tetrazole), 1455 (s, tetrazole), 1440 (s, tetrazole), 1422 (s, 
tetrazole), cm-1; 1H NMR (600 MHz, d6-DMSO): δ = 1.9 (m, 3H, H-C2,3), 2.17 (m, 1H, 
H-C2), 3.10 (m, 2H, H-C4), 4.55 (dd, 3J1,2 = 7.3, 7.5 Hz, 1H, H-C1); 13C NMR (150 MHz, 
d6-DMSO): δ = 24.0 (CH2, C3), 31.0 (CH2, C2), 45.0 (CH2, C4), 54.7 (CH, C1), 166.3 (Cq, 
C5); MS: m/z 140 [MH-Na]+; HR-MS: calc’d for [M-Na]- = 138.0785, found 138.0785 
(∆M (ppm) = 0.2). 
 
 
 (R)-5-Pyrrolidine-2-yl-tetrazole potassium salt (240) 
NH
N
H
N
NN
NH
N
N
NN
KOH
K
CH3OH
H H
 
                                             115                                            240 
CAS Registry Number 920748-30-7 
Molecular Formula   C5H8N5K 
Molecular Weight    177.26 g/mol 
Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
                              
A 10 mL flask is charged at room temperature, with (R)-5-pyrrolidine-2-yl-tetrazole (347 
mg, 2.5 mmol), and KOH (140 mg, 2.5 mmol) in methanol (4 mL). The colorless solution 
is stirred for twenty minutes at room temperature and then the solvent is removed to give 
a white crystalline material (440 mg). The product is re-dissolved in  of methanol (1.5 
mL) at 60 °C. The colorless solution is cooled at room temperaure and treated with 
diethylether (2.5 mL). The solution is cooled at 0 °C and the product crystallized after 
standing in an open flask three hours at room temperature to give a whie crystalline 
material in ≥ 99 % yield.  
 
Compound characterization data: 
N
H N N
N
N
K
H
1
2
4
3
5
 
mp: 58-62 °C; TLC: Rf (nBuOH / water/ AcOH 3:3:1, ninhydrin) = 0.24; Optical 
rotation: [ ]25Dα  = +22.7 ° (in MeOH, c = 0.99); IR: ν 2975 (brs, ע(C-H)), 2879 (brm, ע(C-
H)), 2581 (brw, ע(N-H)), 1489 (w, tetrazole), 1429 (brs, tetrazole), 1410 (brs, tetrazole) 
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cm-1; 1H NMR (600 MHz, d6-DMSO): δ = 1.69 (m, 3H, H-C2,3), 1.94 (m, 1H, H-C2), 
2.66 (m, 1H, H-C4), 3.02 (m, 1H, H-C4), 4.09 (dd, 3J1,2= 6.8 Hz, 1H, H-C1); 13C NMR 
(125 MHz, d6-DMSO): δ = 25.4 (CH2, C3), 32.5 (CH2, C2), 44.2 (CH2, C4), 54.9 (CH, 
C1), 173.5 (Cq, C5); HR-MS: calc’d for [M-K]- = 138.0785, found 138.0785 (∆M (ppm) 
< 0.1). 
 
 
(R)-5-Pyrrolidine-2-yl-tetrazole cesium salt (241) 
NH
N
H
N
NN
NH
N
N
NN
CsOH
H2O
H H
Cs
 
                                             115                                           241 
CAS Registry Number 920748-36-3 
Molecular Formula   C5H8N5Cs 
Molecular Weight    217.06 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
 
A 10 mL flask is charged, at room temperature, with (R)-5-pyrrolidine-2-yl-tetrazole 115 
(417 mg, 3 mmol) dissolved in water (4 mL), and with cesium hydroxide monohydrate  
(504 mg, 3 mmol). The colorless solution is stirred for twenty minutes at room 
temperature and then the solvent is removed to give 810 mg of white crystalline material. 
The product is re dissolved in methanol (1.5 mL) at 50 °C, and the colorless solution is 
treated with diethylether (2.5 mL). The solution is first cooled at 0 °C, and the product 
crystallized after standing in an open flask three hours at room temperature. The product 
is filtered give 650 mg of a white crystalline material in ≥ 98 % yield.  
 
Compound characterization data: 
 
mp: 55-58 °C; TLC: Rf (nBuOH / water/ AcOH 3:3:1, ninhydrin) = 0.25; IR: ν 2975 
(brs, ע(C-H)), 2876 (brm, ע(C-H)), 1537 (brs, tetrazole), 1428 (brs, tetrazole), 1408 (brs, 
tetrazole) cm-1; 1H NMR (400 MHz, d6-DMSO): δ = 1.71 (m, 3H, H-C2,3), 1.94 (m, 1H, 
H-C2), 2.70 (m, 1H, H-C4), 3.04 (m, 1H, H-C4), 4.12 (dd, 3J 1,2 = 6.8 Hz, 1H, H-C1); 13C 
NMR (125 MHz, d6-DMSO): δ = 25.6 (CH2, C3), 32.7 (CH2, C2), 46.3 (CH2, C4), 54.8 
(CH, C1), 164.0 (Cq, C5); HR-MS: calc’d for [M-Cs]- = 138.0785, found 138.0785 (∆M ( 
ppm ) = 0.1). 
N
H N N
N
N
Cs
H
1
2
4
3
5
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(R)-5-Pyrrolidine-2-yl-tetrazole palladium (II) complex (242) 
 
N
H
N
N
NHNH N N N
NNH
NNN
N
N H
PdH
H
Pd(OAc)2
THF, H2O
50 °C, 1h
              
                                  115                                                             242            
Molecular Formula   C10H18N10OPd 
Molecular Weight    400.74 g/mol 
Analysis Ref. 
V. Aureggi, G. Sedelmeier, Novartis Pharma AG, 2007, WO 
2007/009716 
                                                     
A 10 mL, one necked round bottomed flask is charged, at room temperature, with (R)-5-
pyrrolidine-2-yl-tetrazole 115 (139 mg, 1 mmol) and palladium acetate (112 g, 0.5 mmol) 
dissolved in a solution of THF / water (1.5 mL, 2:1). The mixture is warmed one hour 
under stirring at 50 °C. The product crystallized in ≥ 98 % yield from the solvent after 
standing at room temperature for two hours. 
 
Compound characterization data:  
 
N N N
NN
NNN
N N
Pd
H
H
1
2
3
4
5
H
H
 
mp: 268-271 °C decomposition; UV (EtOH): λmax, nm (ε): 288 (48), 204 (2650); IR: ν 
3132 (sbr, ע(N-H)), 2989 (m, ע(C-H)), 2955 (m, ע(C-H)), 2876 (w, ע(C-H)), 1507 (w, 
tetrazole), 1452 (s, tetrazole), 1404 (s, tetrazole) cm-1; 1H NMR (600 MHz, d6-DMSO): δ 
= 1.87 (m, 3H, H-C2,3), 2.44 (m, 1H, H-C2), 3.44 (m, 2H, H-C4), 4.51 (dd, 1H, 3J1,2 = 7.3 
Hz H-C1), 7.57 (m, NH+); 13C NMR (150 MHz, d6-DMSO): δ = 26.4 (CH2, C3), 31.0 
(CH2, C2), 52.2 (CH2, C4), 56.9 (CH, C1), 167.2 (Cq, C5); X-Ray: the structure was 
confirmed by X-ray analysis (See X-ray discussion; Chapter 4).  
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5.3.3. Enamines Formation 
  
 
5.3.3.1. Typical procedures for the enamine formation 
  
5.3.3.1.1. TP4: Typical procedure for the enamine formation 
 
N
H
N
N N
N
NH
H
N N
N
NH
O
H +
K2CO3
CH2Cl2
 
Scheme 140. Enamine formation 
 
A 25 mL, round-bottomed flask is charged, at room temperature, with (R)-tert-
butyl-pyrrolidine tetrazole (487 mL, 2.5 mmol) dissolved in dichloromethane (3 ml), 
potassium carbonate (691 mg, 5 mmol) and then isovaleraldehyde (0.37 mL, 4 mmol) in 
dichloromethane (2 mL). The mixture is stirred at room temperature for twenty minutes, 
the potassium carbonate is filtered, the solvent and excess of isovaleraldehyde are 
removed with the rotary evaporator to give the product as a colorless oil in (673 mg, ≥ 99 
% yield).  
  
5.3.3.1.2. TP5: Typical procedure for the enamine formation: NMR tube 
experiment 
 
O
H N
H
NDMSO+
N N
N
NH
H
N N
N
NH
 
Scheme 141. Equilibrium of the enamine formation 
 
A NMR tube is charged, at room temperature, with 2-tert-butyl-5-(S)-pyrrolidine-2-
yl-2H-tetrazole (19.5 mg, 0.1 mmol) dissolved in d-DMSO (0.5 ml) and with 
isovaleraldehyde (8.6 ml, 0.1 mmol) in of d-DMSO (0.3 ml). 
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5.3.3.2. Enamine formation from aldeydes 
 
 
5-{1-[-2-Phenylprop-1-en-1-yl]-pyrrolidine-2-yl}-tetrazole (259) 
H
CH3
O
+ N
H
H
N N
N
H
N DMSO
N
H
N N
N
H
N
H3C
N
H
N N
N
H
N
CH3
E Z
+
 
           303                       115                                     259a                                   259b 
Molecular Formula   C14H17N5 
Molecular Weight    255.32 g/mol 
 
TP5: One equivalent of 2-phenylpropionaldehyde and one equivalent of 2(R)-(tetrazol-5-
yl)-pyrrolidine 115 are used in a 0.1 mmol scale experiment. The mixture is checked via 
H-NMR after five minutes and shows 90 % of enamine formation (75 % E-isomer , 25 % 
Z-isomer).  
 
Compound characterization data: 
E-Isomer (259a) 
N N N
NHN
H3C H
1
23
4
5
6
7
8
9
10
11
12
H
 
1
H NMR (400 MHz, d6-DMSO): δ = 1.96 (s, 3H, H-C8), 2.08 (m, 3H, H-C2,3), 2.33 (m, 
1H, H-C2 ), 3.26 (m, 1H, H-C4), 3.68 (m, 1H, H-C4), 4.90 (dd, 3J1,2  = 7.5 Hz, 1H, H-C1), 
6.42 (s, 1H, H-C6), 7.23 (m, 5H, H-C10-12). 
 
Z-Isomer (259b) 
 
N
CH3
N N
NHN
H
1'
2'3'
4'
5'
6'7'
8'
9'10'
11'
12'
H
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1
H NMR (400 MHz, d6-DMSO): δ = 1.87 (s, 3H, H-C8’), 2.08 (m, 3H, H-C2’,3’), 2.25 (m, 
1H, H-C2’ ), 3.09 (m, 1H, H-C4’), 3.26 (m, 1H, H-C4’), 4.73 (dd, 3J1’,2’  = 7.0, 6.8 Hz, 1H, 
H-C1’), 6.1 (s, 1H, H-C6’), 7.1  m, 5H, H-C10’-12’). 
 
 
2-tert-Butyl-5-{1-[2-phenylprop-1-en-1-yl]-pyrrolidine-2-yl}-2H-tetrazole (260) 
CH3H
O
N
H N N
N
N
H N N N
N
N
H
H
CH3
N N N
N
N
H
H
CH3
+
E Z
Solvent
+
 
      303                    243                                           260a                                     260b 
Molecular Formula   C18H28N5 
Molecular Weight    311.42 g/mol 
 
Method 1: 
TP5: One equivalent of 2-phenylpropionaldehyde and one equivalent of 2(S)-tert-butyl-
5-pyrrolidine-2-yl-2H-tetrazole 243 are used in a 0.09 mmol scale experiment in d6-
DMSO. The is mixture is checked via H-NMR after seventeen hours and shows 98 % of 
enamine formation (51 % E-isomer , 49 % Z-isomer).  
 
Method 2: 
TP5: One equivalent of 2-phenylpropionaldehyde and one equivalent of 2(S)-tert-butyl-
5-pyrrolidine-2-yl-2H-tetrazole 243 are used in a 0.09 mmol scale experiment in CD3CN. 
The is mixture is checked via H-NMR after seventeen hours and shows 90 % of enamine 
formation (84 % E-isomer , 16 % Z-isomer).  
 
Compound characterization data: 
E-Isomer (260a) 
N N N
NN
H3C H
1
23
4
5
6
7
8
9
10
11
12
13
14H
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1
H NMR (400 MHz, d6-DMSO): δ = 1.65 (s, 9H, H-C14), 1.95 (s, 3H, H-C8), 1.95 (m, 
3H, H-C3), 2.06-2.30 (m, 2H, H-C2 ), 3.04-3.63 (m, 2H, H-C4), 4.80 (dd, 3J1,2  = 7.0, 7.3 
Hz, 1H, H-C1), 6.44 (s, 1H, H-C6), 7.05-7.20 (m, 5H, H-C10-12); (400 MHz, CD3CN): δ =  
1.70 (s, 9H, H-C14), 2.02 (d, 4J6,8  = 1.2 Hz, 3H, H-C8), 2.10-2.36 (m, 4H, H-C2,3), 3.34 
(m, 1H, H-C4), 3.69 (m, 1H, H-C4), 4.78 (dd, 3J1,2  = 7.0, 7.5 Hz, 1H, H-C1), 6.41 (d, 4J6,8  
= 1.2 Hz, 1H, H-C6), 7.10-7.29 ( m, 5H, H-C10-12 ). 
 
Z-Isomer (260b) 
N
CH3
N N
NN
H
1'
2'3'
4'
5'
6'7'
8'
9'10'
11'
12'
13'
14'H
 
1
H NMR (400 MHz, d6-DMSO): δ = 1.68 (s, 3H, H-C14’), 1.86 (s, 3H, H-C8’), 1.73-1.95 
(m, 2H, H-C3’), 2.06-2.30 (m, 2H, H-C2’), 3.04-3.63 (m, 2H, H-C4’), 4.67 (dd, 3J1’,2’  = 7.0 
Hz, 1H, H-C1’), 6.11 (s, 1H, H-C6’), 7.05-7.20 (m, 5H, H-C10’-12’); (400 MHz, CD3CN): δ 
= 1.73 (s, 9H, H-C14’), 1.92 (d, 4J6’,8’ = 1.0 Hz, 3H, H-C8’), 2.15-2.6 (m, 4H, H-C2’,3’), 
3.11 (m, 2H, H-C4’), 4.65 (dd, 3J1’,2’ = 7.0, 7.3 Hz, 1H, H-C1’), 6.12 (d, 4J6’,8’  = 1.0 Hz, 
1H, H-C6’), 7.10-7.29 (m, 5H, H-C10’-12’). 
 
 
 (R,E)-N-Benzyl-3-methyl-N-(1-phenylethyl)-but-1-en-1-amine (261) 
O
N
H
CH3 CH2Cl2
K2CO3 N
CH3
r.t.
+H
 
                    213                             304                                                             261 
Molecular Formula   C20H25N   
Molecular Weight    279.43 g/mol 
 
TP4: 1.67 equivalents  of isovaleraldehyde are used in 3 mmol scale experiment. The 
reaction is stirred for five hours at room temperature to give a mixture of starting amine 
and desired enamine as a colorless oil (23 % of enamine by 1H-NMR). 
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Compound characterization data: 
N
CH3
1
2
3
4 5
6
7
8
9
10
11
1213
14
15
 
1
H NMR (400 Mz, d6-DMSO): δ = 0.82 (d, 3J4,5 = 6.7 Hz, 6H, H-C5), 1.40 (d, 3J1,8 = 7.0 
Hz, 3H, H-C8), 2.11 (m, 3J4,5 = 6.7 Hz, 1H, H-C4), 3.81 ( d, 2J 6,6’ = 15.6 Hz, 1H, H-C6), 
3.92 (d, 2J6,6’ = 15.6 Hz, 1H, H-C6’), 4.09 (dd, 3J2,3 = 13.8 Hz, 1H, H-C3), 4.24 (q, 3J1,8 = 
7.0 Hz, 1H, H-C1), 6.06 (d, 3J2,3 = 13.8 Hz, 1H, H-C2), 7.21 (m, 10H, ArH). 
 
 
5-{1-[(1E)-3-Methylbut-1-en-1-yl]-pyrrolidine-2-yl}-tetrazole  (262) 
O
H N
H N N
NH
NH N N N
NH
N
H
H
DMSO
+
 
                               213                  114                                             262 
Molecular Formula   C10H17N5 
Molecular Weight    207.28 g/mol 
 
TP5: One equivalent of isovaleraldehyde and one equivalent of 2(S)-(tetrazol-5-yl)-
pyrrolidine 114 are used in a 0.095 mmol scale experiment. The mixture is checked via 
H-NMR after five minutes and shows 70 % of enamine conversion.  
 
Compound characterization data: 
N N N
N
N
H
H
H
1
23
4
5
6
7
8
9  
1
H NMR (400 MHz, d6-DMS): δ = 4.05 (dd, 3J6,7  = 13.8 Hz, 1H, H-C7), 4.67 (dd, 3J1,2 = 
8.1, 8.8 Hz, 1H, H-C1), 6.0 (d, 3J6,7  = 13.8 Hz, 1H, H-C6) 
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1-[(1E)-3-Methylbut-1-en-1-yl]-(S)-proline (305) 
O
H
N
H
OH
O
H N
OH
O
H
H
+
DMSO
 
                                    213                      193                                     305      
Molecular Formula   C10H17NO2 
Molecular Weight      183.25 g/mol 
 
TP5: One equivalent of isovaleraldehyde are used in 0.1 mmol scale experiment. The 
mixture is checked via H-NMR after five minutes and shows 18 % of enamine formation. 
 
Compound characterization data: 
9N
H
H
1
23
4
56
7
8
O
OH
 
1
H NMR (400 Mz, d6-DMSO): δ = 3.99 (dd, 3J5,6 = 13.8 Hz, 1H, H-C5), 6.04 (d, 3J5,6 = 
13.8 Hz, 1H, H-C5) 
 
 
2-tert-Butyl-5-[(R)-1-(E)-3-methyl-but-1-enyl)-pyrrolidine-2-yl]-2H-tetrazole (264) 
N
H N N
N
NH
N
H
N N
N
NH
O
H
K2CO3
CH2Cl2
+
 
                  213                      236                                                    264 
Molecular Formula   C14H29N5 
Molecular Weight    263.39 g/mol 
 
TP4: 1.6 equivalents  of isovaleraldehyde are used in a 2.5 mmol scale experiment. The 
reaction is stirred for twenty minutes at room temperature to give 659 mg of product as a 
colorless oil in ≥ 99 % yield.  
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Compound characterization data: 
N
H
N N
N
NH
1
23
4
5
6
78
10
119
 
IR: ν 3040 (w, ע(C-H)), 2955 (vs, עasim(CH3)), 2869 (s, עsim(CH3), ע(C-H), 1655 (s, 
ע(C=C)), 1372 (s, δ(CH3)), 936 (m, δ(C-H, C=C trans)) cm-1; 1H NMR (400 Mz, d6-
DMSO): δ = 0.85 (d, 3J7,8 = 6.5 Hz, 6H, H-C8), 1.66 (s, 9H, H-C11), 1.93 (m, 1H, H-C3 ), 
2.06 (m, 1H, H-C7), 2.10 (m, 2H, H-C2,3), 2.24 (m, 1H, H-C2), 2.96 (m, 1H, H-C4), 3.13 
(m, 1H, H-C4),  4.05 (dd, 3J5,6  = 13.8, 3J6,7 = 7.0 Hz, 1H, H-C6), 4.57 (dd, 3J1,2  = 7.8, 8.0 
Hz, 1H, H-C1), 6.00 (d, 3J5,6  = 13.8 Hz, 1H, H-C5,); 13C NMR (125 Mz, d6-DMSO): δ =  
23.5 (CH2, C3), 24.2 (CH3, C8), 28.7 (CH3, C11), 28.8 (CH, C7), 31.0 (CH2, C2), 48.2 
(CH2, C4), 55.5 (CH, C1), 63.3 (Cq, C10), 107.2 (CH, C6), 131.9 (CH, C5), 167.1 (Cq, C9); 
MS: m/z 264  [MH]+, 248 [M-CH3]+, 138 [M-tButyl-tetrazole]+. 
 
 
5-[(R)-1-(E)-3-Methyl-but-1-enyl)-pyrrolidine-2-yl]-2-(1-methyl-1-phenyl-ethyl)-2H-
tetrazole (263) 
N
H
N
N N
N
NH
H
N N
N
NH
O
H +
K2CO3
CH2Cl2, r.t., 20 min
 
          213                         235                                                                          263 
Molecular Formula   C19H27N5 
Molecular Weight    325.46 g/mol 
 
TP4: 1.67 equivalents  of isovaleraldehyde are used in 1 mmol scale experiment. The 
reaction is stirred for twenty minutes at room temperature to give 326 mg of product as a 
colorless oil in ≥ 98 % yield.  
 
Compound characterization data: 
N
H
N N
N
NH
1
23
4
56
7
8
10
11 12
13
14
9
15
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IR: ν 3091 (w, ע(C-H)), 3061 (w, ע(C-H)), 3030 (w, ע(C-H)), 2954 (vs, עasim(CH3)), 2867 
(s, עsim(CH3)), 1655 (s, ע(C=C)), 1602 (w, ע(C=C)), 1498 (s, ע(C=C)), 1449 (s, ע(C=C)),  
1371 (s, δ(CH3)), 936 (m, δ(C-H, C=C trans)), 762 (s, γ (C-H, Ph)), 698 (s, γ (Ph) cm-1; 
1
H NMR (400 Mz, d6-DMSO): δ = 0.84 (d, 3J7,8 = 6.5 Hz, 6H, H-C8), 1.93 (m, 2H, H-
C3), 2.06 (s, 6H, H-C10), 2.06 (m, 1H, H-C7), 2.22 (m, 2H, H-C2), 2.96 (m, 1H, H-C4), 
3.12 (m, 1H, H-C4), 4.03 (dd, 3J5,6  = 13.8, 3J6,7 = 7.0 Hz, 1H, H-C6), 4.57 (dd, 3J1,2 = 7.8 , 
8.0 Hz 1H, H-C1), 5.95 (d, 3J5,6  =13.8 Hz, 1H, H-C5); 13C NMR (125 Mz, d6-DMSO): δ 
= 23.3 (CH2, C3), 24.1, 24.2 (CH3, C8), 28.6, 28.7 (CH3, C10), 31.2 (CH2, C2), 48.2 (CH2, 
C4), 55.4 (CH, C1), 68.0 (Cq, C9), 107.3 (CH, C6), 124.4 (CH, C12), 127.6 (CH, C14), 
128.5 (CH, C13), 131.7 (CH, C5), 144.3 (Cq, C11), 167.5 (Cq, C15); MS: m/z 326 [MH]+. 
 
 
(R,E)-1-Isopropyl-5-[1-(3-methylbut-1-enyl)-pyrrolidine-2-yl]-1H-tetrazole (265) 
O
H +
N
H
H
N N
N
N
CH2Cl2
K2CO3
N
H
N N
N
N
 
                            213                      237                                              265 
Molecular Formula   C13H25N5 
Molecular Weight    249.36 g/mol 
 
TP4: Two equivalents  of isovaleraldehyde are used in 1 mmol scale experiment. The 
reaction is stirred for twenty minutes at room temperature to give 250 mg of product as an 
orange oil in ≥ 99 %  yield.  
 
Compound characterization data: 
N
H
N N
N
N
1
23
4
5
6
7
8
9
10
11
 
1
H NMR (400 MHz, CDCl3): δ = 0.81 (m, 6H, H-C8), 1.48 (d, 3J10,11 = 6.5 Hz, 3H, H-
C11), 1.53 (d, 3J 10,11 = 6.8 Hz, 3H, H-C11), 1.83-2.09 (m, 3H, H-C2,3), 1.94-2.09 (m, 1H, 
H-C7), 2.35 (m, 1H, H-C2), 3.00 (m, 1H, H-C4), 3.33 (m, 1H, H-C4), 4.10 (dd, J35,6 = 13.8, 
J36,7 = 7.0 Hz, 1H, H-C6), 4.66 (dd, 3J1,2 = 7.0, 7.5 Hz, 1H, H-C1), 4.81 (m, 1H, H-C10, 
3
J10,11 = 6.5, 6.8 Hz), 5.79 (d, 3J5,6 = 13.8 Hz,  1H, H-C5); 13C NMR (100 MHz, CDCl3): δ 
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= 22.9 (CH3, C8), 23.8 (CH2, C3), 24.0 (CH3, C11), 29.4 (CH, C7), 32.6 (CH2, C2), 50.5 
(CH2, C4), 51.0 (CH, C10), 55.7 (CH, C1), 111.5 (CH, C6), 131.4 (CH, C6), 154.9 (Cq, 
C9). 
 
 
(R,E)-2-Isopropyl-5-[1-(3-methylbut-1-enyl)-pyrrolidine-2-yl]-2H-tetrazole (266) 
N
H N N
N
NH
O
H +
K2CO3
CH2Cl2, r.t., 20 min
N N N
N
N
H
H
 
                  213                 238                                                                  266 
Molecular Formula   C13H23N5 
Molecular Weight    249.36 g/mol 
 
TP4: 2 equivalents of isovaleraldehyde are used in 1 mmol scale experiment. The reaction 
is stirred for twenty minutes at room temperature to give 250 mg of product as a colorless 
oil in ≥ 99 % yield.  
 
Compound characterization data: 
N
N N
N
N
H
1
23
4
5
7
8 9
10
6
11
H
 
IR: ν 3049 (w, ע(C-H)), 2955 (vs, עasim(CH3), ע(C-H)), 2869 (s, עsim(CH3)), 1654 (s, 
ע(C=C)), 1459 (vs, tetrazole), 1371 (s, δ(CH3)), 936 (m, δ(C-H, C=C trans)) cm-1; 1H 
NMR (500 MHz, d6-DMSO): δ = 0.86 (d, 3J8,9 = 7.0 Hz, 6H, H-C9), 1.54 ( d, 3J10,11 = 6.5 
Hz, 6H, H-C11), 1.94 (m, 1H, H-C3), 2.09 (m, 4H, H-C2,3,8), 2.24 (m, 1H, H-C2), 2.96 (m, 
1H, H-C4), 3.13 (m, 1H, H-C4), 4.04 (dd, 3J6,7 = 13.8, 3J7,8 = 7.0 Hz, 1H, H-C7), 4.57 (dd, 
3
J1,2 = 7.8, 8.0 Hz, 1H, H-C1), 5.08 (m, 3J10,11 = 6.5 Hz, 1H, H-C10), 6.01 (d, 3J6,7 = 13.8 
Hz, 1H, H-C6); 13C NMR (125 MHz, d6-DMSO): δ = 21.8 (CH3, C9), 23.4 (CH3, C11), 
24.3 (CH2, C3), 28.8 (CH, C8), 31.1 (CH2, C2), 48.2 (CH2, C4), 55.5 (CH, C10), 55.8 (CH, 
C1), 107.1 (CH, C7), 131.9 (CH, C6), 167.4 (Cq, C5); MS: m/z 250 [MH]+, 249 [M]+, 234 
[M-CH3]+, 138 [M-i-Propyl-tetrazole]+. 
  
 
Chapter 6.    References 
 271 
5.3.3.3. Oxazolines formation 
 
(3R,4S)-3-Isobutyl-1,1-diphenyl-tetrahydro-pyrrolo [1,2-c]oxazole (267) 
O
H
N
H
OH
N
O+
CH2Cl2
  K2CO3
r.t., 20 min
 
                          213                    306                                                   267 
Molecular Formula   C23H31NO 
Molecular Weight    337.51 g/mol 
 
TP4: Two equivalents  of isovaleraldehyde are used in 0.71 mmol scale experiment. The 
reaction is stirred for twenty minutes at room temperature to give 240 mg of product as a 
colorless oil in ≥ 99 % yield.  
 
Compound characterization data: 
N
O
1
23
4
5
6
7
8
9
1011
12
1313'  
IR: ν 3085 (w, ע(C-H)), 3059 (w, ע(C-H)), 3024 (w, ע(C-H)), 2956 (brs, עasim(CH3), ע(C-
H)), 2870 (s, עsim(CH3)), 1950-1766 (w, overtones γ(C-H, Ph)), 1599 (w, ע(C=C)), 1491 
(s, ע(C=C)), 1448 (s, ע(C=C)), 1385 (w, δ(CH3)), 1156 (m, ע(C-O)), 1017 (s, ע(C-O)), 751 
(s, γ(C-H)), 702 (s, γ(Ph)) cm-1; 1H NMR (500 Mz, d6-DMSO): δ = 0.89 (d, 3J12,13 = 6.5 
Hz, 3H, H-C13), 0.99 (d, 3J12,13’ = 6.5 Hz, 3H, H-C13’), 1.19 (m, 1H, H-C2), 1.42 (m, 1H, 
H-C3), 1.52 (m, 1H, H-C3), 1.64 (m, 1H, H-C11), 1.79 (m, 1H, H-C11), 1.87 (m, 2H, H-
C2,12), 2.70 (m, 2H, H-C4), 4.27 (m, 3J1,2 = 7.0 Hz, 1H, H-C1), 4.34 (m, 1H, H-C5), 7.10 
(m, 1H, ArH), 7.21 (m, 3H, ArH), 7.34 (m, 4H, ArH), 7.55 (m, 2H, ArH); 13C NMR (125 
Mz, d6-DMSO): δ = 22.3, 24.1 (CH3, C13,13’), 28.7 (CH2, C2), 39.1 (CH2, C11), 46.3 (CH2, 
C4), 25.9 (CH2, C3), 25.5 (CH, C12), 73.1 (CH, C1), 86.8 (Cq, C6), 89.2 (CH, C5), 125.9 
(CH, Ar), 126.0 (CH, Ar), 126.5 (CH, Ar) 126.7  (CH, Ar), 127.8 (CH, Ar), 128.1 (CH, 
Ar), 144.2 (Cq, C7), 147.2 (Cq, C7’); MS: m/z 322 [MH]+. 
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(7a'S)-1',1'-diphenyltetrahydro-1'H-spiro[cyclohexane-1,3'-pyrrolo[1,2-
c][1,3]oxazole] (307) 
O
N
H HO
N
O
r.t.
+
DMSO
 
                             209                306                                               307 
Molecular Formula   C23H27NO 
Molecular Weight    333.48 g/mol 
 
TP5: One equivalent of cyclohexanone is used in 0.1 mmol scale experiment 
 
NO PRODUCT OBSERVED ! 
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5.3.4.  Organocatalysis  
  
 
5.3.4.1. Typical procedures for Michael additions  
 
5.3.4.1.1. TP6: Typical procedure for the Michael Addition  
N
H
NO2
NO2
+ *
*
O
H
N N
N
H
N
EtOH
O
 
                                209               211                                                   212 
Scheme 142. Michael addition organocatalized 
 
A 5 ml, one necked round bottomed flask, is charged, at room temperature, with 
cyclohexanone (0.155 ml, 1.5 mmol) dissolved in ethanol (1.5 ml), (R)-(tetrazol-5-yl)-
pyrrolidine as catalyst (42 mg, 0.3 mmol) and nitrostyrole (223 mg, 1.5 mmol). The 
mixture is stirred for thirty hours at room temperature. The mixture is quenched with HCl 
(3 ml), the aquesus phase is saturated with solid NaCl and the product extracted three 
times with dichloromethane (4 ml portions). The solvent is removed to give 380 mg of a 
yellow crystalline material. The crude is chromatographed (elution system: hexane / ethyl 
acetate 6:1) to give the product as a colorless crystalline material (360 mg, 97 % of 
yield).  
 
5.3.4.1.2. TP7: Typical procedure for the Michael Addition followed by reduction 
to primary alcohol 
H
O
NO2
O
H
N
H
NO2
OH
NO2
+
*
* *
*
NaBH4
H
N N
NH
N
 
            213              211                                                 214                                     268                 
Scheme 143. Michael addition followed by reduction 
 
A 5 ml, one necked round bottomed flask, is charged, at room temperature, with 
isovaleraldehyde (0.61 ml, 6 mmol) dissolved in dichloromethane (5 ml), 2(R)-(tetrazol-
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5-yl)-pyrrolidine 115 as catalyst (55 mg, 0.4 mmol) and nitrostyrole (298 mg, 2 mmol). 
The mixture is stirred for twenty hours at room temperature. The mixture is cooled at 0 
°C, ethanol (1.5 ml) is added and the mixture is carefully treated with sodium 
borohydrure (113.5 mg, 3 mmol). The mixture is gradually warmed at room temperature 
and stirred two hours. The mixture is cooled at 0 °C and quenched with HCl (2 ml, 
solution 2 M). The organic phase is washed twice with water (4 ml portion), the solvent is 
removed to give 474 mg of a brown oil. The crude is chromatographed  (elution system: 
hexane / ethyl acetate 9:1) to give the product as a yellow oil (422 mg, 89 % yield).  
   
(2S,3R)-2-(1-methylethyl)-4-nitro-3-phenylbutyraldehyde (214) 
 
O
NO2
H
O
+ **
r.t., sv
H
NO2
N
N
N
HN
N
H
H
 
                              213                    211                                               214 
 
CAS Registry Number 
(S,R) isomer:   475294-91-8 
(R,S) isomer:   384354-46-5 
(S,S) isomer:   768370-38-3 
Molecular Formula   C13H17NO3 
Molecular Weight    235.28 g/mol 
Analysis Ref. 
a) G. M. Betancort, C. F. Barbas, III, Org. Lett. 2001, 3,  3737; b) T. 
Ishii, S. Fujioka, Y. Sekiguchi, H. Kotsuki, J. Am. Chem. Soc. 2004, 
126, 9558; c) P. Kotrusz, S. Toma, H.-G. Schmalz, A. Adler, Eur. J. 
Org. Chem. 2004, 7, 1577; d) O. Andrey, A. Alexakis, A. Tomassini, 
G.Bernardinelli, Ad. Synth. Cat. 2004, 346, 1147; e) S. Mosse, M. 
Laars, K. Kriis, T. Kanger, A. Alexakis, Org. Lett. 2006, 8, 2559; f) 
S. Mosse, A. Alexakis, Org. Lett. 2006, 8, 3577; g) Y. Li, X.-Y. Liu, 
G. Zhao, Tetrahedron: Asymm. 2006, 17, 2034 
 
TP6: 2 equivalents of isovaleraldehyde are used in a 10 mmol scale experiment in 
dichloromethane with 2(R)-(tetrazol-5-yl)-pyrrolidine as catalyst as catalysts (20 %). The 
reaction is stirred for twenty hours at room temperature to give the product after 
chromatography as a colorless oil (1.82 g, 77 % yield, 57 % ee, syn / anti 8:1). 
 
Compound characterization data: 
O
NO2
1 2
3 4
7
8
9
5
6
10
6'
H
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TLC: syn: Rf (hexane / EtOAc 4:1) = 0.33, Anti: Rf (hexane / EtOAc 4:1) = 0.43; HPLC: 
syn: 10.04 min, anti: 9.62 min; Chiral HPLC: (syn isomer) A: 8.26 min, B: 13.01 min; 
Optical rotation: [ ]25Dα  = + 6.04° (in MeOH, c = 0.96); IR: ν 3065 (w, ע(C-H)), 3031 (w, 
ע(C-H)), 2965 (m, עasim(CH3)), 2936 (w, ע(C-H)), 2875 (w, עsim(CH3)), 1718 (s, ע(C=O)), 
1554 (s, עasim(NO2)), 1496 (w, ע(C=C)), 1466 (w, ע(C=C)), 1456 (w, ע(C=C)),  1379 (m, 
עsim(NO2)), 761 (w, γ (C-H, Ph)), 703 (w, γ(Ph)) cm-1; 1H NMR (600 MHz, d6-DMSO): δ 
= 0.74 (d, 3J5,6 = 7.0 Hz, 3H, H-C6), 0.96 (d, 3J5,6’ = 7.0 Hz, 3H, H-C6’), 1.48 (m, 3J5,6/6’ = 
7.0 Hz, 1H, H-C5), 2.83 (m, 3J1,2 = 2.8 Hz, 1H, H-C2), 3.83 (dt, 3J3,4 = 5.3, 3J2,3 = 10.6 Hz, 
1H, H-C3), 4.79 (dd, 3J3,4 = 5.3 Hz, 2H, H-C4), 7.33 (m, 5H, H-C8-10), 9.83 (d, 3J1,2 = 2.8 
Hz, 1H, H-C1); 13C NMR (150 Mz, d6-DMSO): δ = 16.6 (CH3, C6), 21.2 (CH3, C6’), 27.3 
(CH, C5), 41.6 (CH, C3), 57.6 (CH, C2), 78.9 (CH2, C4), 127.5 (CH, C10), 128.3 (CH, C9), 
128.6 (CH, C8), 137.9 (Cq, C7), 205.6 (CHO, C1); MS: m/z 253  [M+NH4]+. 
 
 
 (2S,3R)-2-Isopropyl-4-nitro-3-phenylbutan-1-ol (268) 
 
O
H
NaNH4
OH
EtOH
O
H r.t.
NO2 NO2
r.t.
Ct
NO2
+
 
          213                 211                                          214                                              268 
Molecular Formula   C13H19NO3 
Molecular Weight    237.30 g/mol 
 
TP7: Three equivalents  of isovaleraldehyde are used in two mmol scale experiment with 
the 2(R)-(tetrazol-5-yl)-pyrrolidine 115 as catalyst (20 %) to give the product after 
chromatography as a brown oil (422 mg, 89 % yield, 63 % ee of enantiomer B, syn / anti 
19:1).   
   
Compound characterization data: 
OH
NO2
1 2 3 4
7
8
9
5
6
10
6'  
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TLC: syn: Rf (hexane / EtOAc 9:1) = 0.06; HPLC: syn: 9.29 min, anti: 8.94 min; Chiral 
HPLC: (syn-isomer) enantiomer A: 11.63 min; enantiomer B: 13.78 min; Optical 
rotation: [ ]25Dα  = + 21.4 ° (in MeOH, c = 1.00); IR: ν 3433 (w, ע(O-H)), 3087 (w, ע(C-
H)), 3064 (w, ע(C-H)), 3030 (w, ע(C-H)), 2961 (m, עasim(CH3)), 2930 (w, ע(C-H)), 2875 
(w, עsim(CH3)), 1551 (vs, עasim(NO2)), 1496 (w, ע(C=C)), 1466 (w, ע(C=C)), 1455 (w, 
ע(C=C)), 1382 (m, עsim(NO2)), 1035 (w, ע(C-O)), 758 (w, γ (C-H, Ph)), 702 (m, γ (Ph)) 
cm-1; 1H NMR (600 MHz, d6-DMSO): δ = 0.72 (d, 3J5,6 = 7.0 Hz, 3H, H-C6), 0.87 (d, 
3
J5,6’ = 7.0 Hz,  3H, H-C6’), 1.43 (m, 1H, H-C5), 1.54 (m, 1H, H-C2), 3.51 (m, 2H, H-C1), 
3.56 (m, 1H, H-C3), 4.66 (m, 1H, OH), 5.08 (m, 2H, H-C4), 7.21 (m, 1H, H-C10), 7.27 (m, 
2H, H-C9), 7.30 (m, 2H, H-C8); 13C NMR (150 Mz, d6-DMSO): δ = 17.3 (CH3, C6), 21.6 
(CH3, C6’), 26.5 (CH, C5), 45.3 (CH, C3), 49.0 (CH, C2), 58.2 (CH2, C1), 79.2 (CH2, C4), 
127.0 (CH, C10), 128.0 (CH, C8), 128.4 (CH, C9), 140.2 (Cq, C7); MS: m/z 236 [M-H]-; 
HR-MS: calc’d for [M-H]- = 236.12922, found 236.12926 (∆M (ppm) = 0.2). 
 
 
2-[-2-Nitro-1-phenylethyl]-cyclohexanone (212) 
r.t., sv
N
N
N
HN
N
H
HO
NO2
O
NO2
+ *
*
 
                               209                 211                                                             212 
CAS Registry Number 
(R,R) isomer: 54568-74-8 
(S,S) isomer:  84025-87-6 
(R,S) isomer:  84025-84-3 
(S,R) isomer:  84025-83-2 
Molecular Formula   C14H17NO3 
Molecular Weight    247.29 g/mol 
Analysis Ref. 
a) S. J. Blarer, W. B. Schweizer, D. Seebach, Helv. Chim. Acta  
1982, 65, 1637; b) M. A. Brook, D. Seebach, Can. J. Chem. 1987, 
65,  836; c) A. J. A. Cobb, D. M. Shaw, D. Longbottom, J. B. Gold, 
V. S. Ley, Org. Bioo. Chem. 2005, 3, 84; d) Y. Xu, A. Cordova, 
Chem. Commun. 2006, 4, 460 
 
TP6: Stoichiometric amount of cyclohexanone are used in a 1.5 mmol experiment in 
ethanol with 2-(R)-(tetrazol-5-yl)-pyrrolidine as catalyst as catalysts (20 %). The reaction 
is stirred for thirty hours at room temperature to give the product after chromatography as 
a white crystalline material (360 mg, 97 % yield, 60 % ee enantiomer A, syn / anti 19:1). 
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Compound characterization data: 
O
NO2
1 2
3
4
5
6 7
8
9
10
11
12
 
mp: 103-106 °C; TLC: Rf (hexane / EtOAc 5:1) = 0.2; HPLC: syn: 8.44 min, anti: 7.97 
min; Chiral HPLC: (syn-isomer) enatiomer A: 13.03 min, enantiomer B: 17.10 min; 
Optical rotation: [ ]25Dα  = -6.2° (in MeOH, c = 0.81); IR: ν 3085 (w, ע(C-H)), 3057 (w, 
ע(C-H)), 3029 (w, ע(C-H)), 2957 (w, ע(C-H)), 2936 (w, ע(C-H)), 1699 (s, ע(C=O)), 1552 
(s, עasim(NO2)), 1495 (w, ע(C=C)), 1450 (w, ע(C=C)), 1385 (m, עsim(NO2)), 747 (w, γ (C-
H, Ph)), 698 (m, γ (Ph)) cm-1; 1H NMR (600 MHz, d6-DMSO): δ =  1.08 (m, 1H, H-C3), 
1.46 (m, 3H, H-C3), 1.50 (m, 1H, H-C5), 1.51 (m, 1H, H-C4), 1.64 (m, 1H, H-C4), 1.96 (m, 
1H, H-C5), 2.27 (m, 1H, H-C6), 2.41 (m, 1H, H-C6), 2.83 (m, 1H, H-C2), 3.67 (m, 1H, H-
C7), 4.86 (m, 2H, H-C12), 7.23 (m, 1H, H-C11), 7.30 (m, 4H, H-C9,10); 13C NMR (150 Mz, 
d6-DMSO): δ = 24.3 (CH2, C4), 27.9 (CH2, C5), 32.3 (CH2, C3), 42.1 (CH, C6), 43.4 (CH, 
C7), 51.4 (CH, C2), 78.8 (CH2, C12), 127.2 (CH, C11), 128.4 (CH, C10), 128.5 (CH, C9), 
138.4 (Cq, C8), 211.6 (Cq, C1); MS: m/z 248  [MH]+. 
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